data_2kgw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kgw _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.742 0 CA-C-O 119.171 -0.794 . . . . 0.0 114.424 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.45 -12.99 32.5 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.441 3.427 . . . . 0.0 114.882 -171.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 20.2 t -133.2 -3.01 3.11 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 126.908 2.083 . . . . 0.0 111.878 176.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.67 -20.01 66.13 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -171.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -139.25 31.27 2.15 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.922 2.089 . . . . 0.0 111.35 174.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.7 tp -63.14 -17.1 61.99 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -171.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -53.71 -46.87 70.91 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.601 0.76 . . . . 0.0 111.489 167.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 20.1 t -69.17 -40.76 77.94 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.382 0.673 . . . . 0.0 111.409 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.39 -38.18 89.2 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 59.4 mt -71.98 -36.91 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.741 0.816 . . . . 0.0 109.593 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -65.61 -34.01 77.24 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.131 0.972 . . . . 0.0 112.557 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -70.18 -33.76 72.13 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.913 0.885 . . . . 0.0 112.86 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.0 t -65.54 -44.92 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 118.488 0.586 . . . . 0.0 111.192 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 69.5 p -77.26 -25.53 51.56 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -176.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 66.12 14.71 61.89 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.628 1.585 . . . . 0.0 114.212 -171.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 118.43 -171.83 14.23 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 126.024 1.774 . . . . 0.0 112.831 -172.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -76.5 167.39 25.7 Favored 'Trans proline' 0 CA--C 1.549 1.272 0 C-N-CA 123.682 2.922 . . . . 0.0 111.85 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.94 140.01 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 126.16 1.784 . . . . 0.0 113.143 -168.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -106.73 169.44 8.53 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.109 2.164 . . . . 0.0 115.614 -170.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.41 ' CZ ' ' HG3' ' A' ' 277' ' ' ARG . 92.0 m-85 -143.3 100.89 3.71 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.389 1.075 . . . . 0.0 111.586 -171.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -115.47 -174.45 17.96 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.71 1.624 . . . . 0.0 113.026 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 24.7 t30 50.43 -75.68 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 128.468 2.707 . . . . 0.0 114.527 -171.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -79.39 -25.54 42.12 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.454 1.902 . . . . 0.0 112.894 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.68 0.27 86.21 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.15 1.357 . . . . 0.0 115.542 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -162.21 26.44 0.11 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.519 1.528 . . . . 0.0 113.451 -175.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.8 t -120.32 97.36 5.55 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.356 1.062 . . . . 0.0 110.839 -171.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 18.6 tp -70.11 141.03 52.78 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.472 1.109 . . . . 0.0 113.178 -173.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 6.4 pt -83.36 150.63 60.89 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.097 1.759 . . . . 0.0 113.906 -172.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.29 -31.21 73.82 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.48 2.786 . . . . 0.0 112.882 173.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.92 94.87 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.588 0.755 . . . . 0.0 112.384 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.01 -39.96 78.98 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 170.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -60.4 -28.64 68.4 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.469 -1.394 . . . . 0.0 112.683 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -71.96 -41.2 68.0 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.689 -1.257 . . . . 0.0 113.24 170.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 90.8 mt -55.99 -44.13 77.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.042 -1.036 . . . . 0.0 110.134 168.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 31.7 mt -64.37 -32.31 73.87 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.196 0.998 . . . . 0.0 113.177 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -59.68 -42.87 93.89 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.704 1.138 . . . . 0.0 111.996 171.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -72.94 -32.83 65.52 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.149 0.58 . . . . 0.0 112.555 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 69.9 t -67.04 -43.23 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.639 0.775 . . . . 0.0 111.097 172.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.41 -42.44 95.96 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.083 0.553 . . . . 0.0 111.994 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.71 -37.17 85.7 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.362 0.665 . . . . 0.0 112.047 176.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.64 -34.21 73.71 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.919 0.888 . . . . 0.0 112.963 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.18 -45.9 75.56 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.739 0.815 . . . . 0.0 110.213 171.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 53.4 tttp -62.59 -23.39 67.01 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.079 1.751 . . . . 0.0 113.714 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -75.2 -8.35 56.36 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.847 1.659 . . . . 0.0 114.597 170.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 38.2 t -151.95 66.86 6.89 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 126.068 1.747 . . . . 0.0 108.507 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -63.83 -6.61 11.22 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.378 2.719 . . . . 0.0 112.318 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -71.72 -18.52 62.14 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.833 1.653 . . . . 0.0 113.229 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -120.76 87.14 2.7 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.688 1.595 . . . . 0.0 110.525 -172.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 63.7 mtt85 -52.69 158.49 1.3 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.812 1.245 . . . . 0.0 111.955 172.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.5 m -127.73 159.91 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.063 1.345 . . . . 0.0 111.722 174.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.1 m -125.96 138.05 53.73 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.46 1.504 . . . . 0.0 108.619 171.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.4 mt -119.33 121.59 66.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.001 1.32 . . . . 0.0 107.495 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -109.29 151.02 27.12 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.457 0.703 . . . . 0.0 110.288 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -139.84 156.9 25.09 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 122.007 -0.433 . . . . 0.0 112.475 167.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -127.73 169.57 13.69 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.893 2.477 . . . . 0.0 109.111 -170.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.5 m -149.14 153.01 37.08 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 127.366 2.266 . . . . 0.0 108.521 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -61.45 165.7 4.58 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.568 -1.333 . . . . 0.0 111.523 167.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -100.72 20.56 14.98 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -175.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.3 m -71.09 -20.19 62.37 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.816 -1.178 . . . . 0.0 112.943 169.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.09 -151.85 21.33 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 125.885 1.707 . . . . 0.0 113.38 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 8.3 t -139.44 164.35 30.11 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.302 1.441 . . . . 0.0 110.374 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -52.67 -42.17 64.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.975 0.91 . . . . 0.0 112.469 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -68.63 -5.09 42.85 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.436 1.017 . . . . 0.0 115.328 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 6.1 mt -115.79 -33.46 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.417 1.887 . . . . 0.0 111.266 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -86.94 -26.87 23.65 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.464 1.106 . . . . 0.0 113.257 -175.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 19.9 mm -60.0 -53.4 65.57 Favored Pre-proline 0 N--CA 1.469 0.496 0 C-N-CA 124.803 1.241 . . . . 0.0 111.546 168.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.27 -34.8 15.38 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 CA-C-N 120.831 1.333 . . . . 0.0 113.099 176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 17.9 mt -66.18 -44.8 82.98 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 120.345 1.429 . . . . 0.0 112.747 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 34.8 p -65.77 -37.12 85.47 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.74 -39.84 76.54 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.255 0.622 . . . . 0.0 111.716 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -63.22 -40.85 98.64 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.768 1.227 . . . . 0.0 111.037 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.41 ' HG3' ' CZ ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -63.8 -38.63 91.8 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 118.762 0.71 . . . . 0.0 112.143 177.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -72.59 -38.85 67.73 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -67.41 -36.26 80.92 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 125.481 1.513 . . . . 0.0 111.795 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 59.2 mt -62.56 -42.49 96.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 118.805 0.729 . . . . 0.0 110.843 175.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.02 -41.82 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 117.954 0.343 . . . . 0.0 110.952 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.04 97.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -69.14 -36.43 77.45 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.598 0.759 . . . . 0.0 111.158 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -66.44 -42.76 87.16 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.6 mp -64.26 -41.81 96.77 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.02 0.528 . . . . 0.0 111.233 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.04 -37.42 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 123.142 0.577 . . . . 0.0 111.404 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.01 -35.4 76.62 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -69.35 -37.67 77.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.888 0.875 . . . . 0.0 112.855 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 161.91 -1.54 0.07 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 118.093 1.997 . . . . 0.0 118.093 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 4.9 t -76.88 142.73 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 120.015 1.908 . . . . 0.0 110.368 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.13 137.68 47.18 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.679 -1.263 . . . . 0.0 110.858 167.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -57.74 -27.14 58.65 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.384 0.992 . . . . 0.0 113.906 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.63 -30.7 70.87 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.628 1.171 . . . . 0.0 113.21 173.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -88.32 -2.81 58.82 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.007 1.323 . . . . 0.0 114.377 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 5.1 mt -125.81 123.66 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.361 0.982 . . . . 0.0 111.403 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -105.16 159.24 16.01 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.453 1.501 . . . . 0.0 110.64 167.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 40.6 p -134.87 146.01 48.82 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.165 0.986 . . . . 0.0 111.792 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 25.3 t -138.86 130.49 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.112 0.965 . . . . 0.0 111.396 -175.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -87.54 100.93 2.64 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.552 1.072 . . . . 0.0 111.691 172.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 43.2 mt -97.35 33.34 2.01 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.918 2.087 . . . . 0.0 110.065 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 3.64 -72.69 0.0 OUTLIER Glycine 0 C--N 1.351 1.373 0 N-CA-C 120.33 2.892 . . . . 0.0 120.33 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 23.4 p -144.79 17.96 1.63 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.615 1.707 . . . . 0.0 113.892 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.7 m -70.59 161.33 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.059 1.344 . . . . 0.0 112.597 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 38.44 53.56 3.94 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 125.866 1.666 . . . . 0.0 113.269 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -64.34 151.7 84.38 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.658 2.239 . . . . 0.0 113.667 -170.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 45.9 pt -126.44 -3.76 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.901 1.68 . . . . 0.0 113.685 -172.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -151.74 149.57 29.21 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.134 1.373 . . . . 0.0 111.439 172.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 69.8 m -70.36 147.36 49.66 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.41 1.484 . . . . 0.0 112.078 171.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -82.74 5.98 19.59 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.365 1.066 . . . . 0.0 113.802 173.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.42 -13.98 62.68 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.051 1.34 . . . . 0.0 114.444 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 67.6 p -138.33 147.78 56.85 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 125.713 1.605 . . . . 0.0 110.472 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -63.92 -31.36 67.15 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 123.333 2.689 . . . . 0.0 112.423 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.94 -38.62 91.58 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.605 -0.684 . . . . 0.0 112.413 171.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.38 -36.95 85.36 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 123.767 0.699 . . . . 0.0 112.53 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -58.69 -49.54 77.2 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.528 0.731 . . . . 0.0 110.709 172.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.9 -37.28 86.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.377 0.671 . . . . 0.0 112.349 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -68.05 -17.65 64.46 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.391 1.476 . . . . 0.0 113.831 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -113.21 -8.09 13.55 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -74.42 9.71 1.61 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.868 1.667 . . . . 0.0 113.865 167.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.42 153.28 2.23 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.812 2.445 . . . . 0.0 114.8 -170.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 8.3 p -123.32 145.9 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.464 1.506 . . . . 0.0 109.648 168.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -142.98 158.53 43.51 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.413 1.485 . . . . 0.0 112.898 -174.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 20.2 tt -133.08 141.32 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.756 1.623 . . . . 0.0 111.745 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 16.9 t -144.46 133.5 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.365 1.466 . . . . 0.0 109.568 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 38.4 t -70.34 137.63 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.708 0.803 . . . . 0.0 109.893 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.253 1.252 0 C-N-CA 125.275 1.43 . . . . 0.0 111.766 -171.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.73 0 CA-C-O 119.173 -0.793 . . . . 0.0 114.156 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -70.78 -14.54 32.94 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.337 3.358 . . . . 0.0 114.352 -171.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 22.2 t -128.17 -3.24 5.67 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 127.32 2.248 . . . . 0.0 111.666 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.83 -18.55 65.43 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 -171.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -138.46 29.88 2.4 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.022 2.129 . . . . 0.0 111.604 175.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 6.8 tp -63.11 -17.66 62.56 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -53.65 -45.68 70.3 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.057 0.844 . . . . 0.0 111.361 167.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 20.7 t -68.51 -42.03 79.13 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 122.935 0.494 . . . . 0.0 111.616 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.32 -41.42 98.91 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 176.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 66.1 mt -71.56 -35.64 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.994 0.918 . . . . 0.0 109.759 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -68.48 -36.99 79.74 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.987 0.915 . . . . 0.0 112.661 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.99 76.62 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.075 0.95 . . . . 0.0 112.24 175.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 22.5 t -63.06 -41.35 92.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.588 1.155 . . . . 0.0 111.761 173.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 82.3 p -82.92 -19.26 37.63 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 66.12 15.8 63.51 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.961 1.743 . . . . 0.0 114.804 -172.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 129.74 -159.12 22.47 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 125.593 1.568 . . . . 0.0 112.937 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -74.66 171.42 18.22 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.702 2.934 . . . . 0.0 111.785 171.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 28.9 mt -113.39 136.24 50.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.005 1.722 . . . . 0.0 109.193 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -124.03 161.98 24.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.363 1.465 . . . . 0.0 113.005 -172.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -138.23 99.33 3.83 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.021 0.928 . . . . 0.0 111.93 -169.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -74.96 164.7 54.61 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.707 1.146 . . . . 0.0 113.831 -171.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 32.88 -78.02 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 130.238 3.415 . . . . 0.0 116.07 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.75 -28.2 67.43 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.177 1.391 . . . . 0.0 113.164 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 96.97 11.32 53.45 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 116.816 1.486 . . . . 0.0 116.816 167.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -156.68 25.93 0.33 Allowed 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.288 1.435 . . . . 0.0 112.746 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 52.9 m -92.37 90.94 7.44 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.598 1.159 . . . . 0.0 112.56 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.4 mp -68.36 104.33 1.85 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.662 0.785 . . . . 0.0 110.218 171.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 21.3 pt -67.24 163.62 44.27 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 125.215 1.406 . . . . 0.0 110.567 173.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.57 -30.47 79.42 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 CA-C-N 121.433 1.548 . . . . 0.0 112.251 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -66.09 -31.59 72.55 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 170.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -62.4 -54.29 42.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.625 1.102 . . . . 0.0 110.976 170.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -60.51 -29.12 68.89 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.33 -0.856 . . . . 0.0 112.882 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -65.68 -51.17 61.57 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.168 -0.957 . . . . 0.0 112.005 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.5 pp -69.05 -30.29 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 118.348 0.522 . . . . 0.0 111.56 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 60.2 mt -66.49 -36.66 83.3 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.497 0.719 . . . . 0.0 112.348 171.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -40.18 93.3 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.6 -0.688 . . . . 0.0 111.683 173.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -67.63 -37.63 82.74 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 67.9 t -63.36 -44.0 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 119.031 0.832 . . . . 0.0 111.22 173.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.12 -40.62 94.48 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.924 0.489 . . . . 0.0 111.226 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -66.33 -36.49 83.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.674 0.79 . . . . 0.0 112.605 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -70.82 -35.79 72.65 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.708 1.203 . . . . 0.0 112.854 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.408 HD23 HG12 ' A' ' 255' ' ' VAL . 11.7 tp -72.62 -38.72 67.68 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.428 1.491 . . . . 0.0 111.737 175.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -60.14 -28.07 67.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.518 1.927 . . . . 0.0 112.788 172.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -78.38 -5.25 51.74 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.37 1.468 . . . . 0.0 114.468 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 34.0 t -151.62 65.7 6.56 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.1 1.36 . . . . 0.0 108.859 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -65.09 -8.25 17.82 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.216 2.61 . . . . 0.0 111.881 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -70.39 -21.56 62.84 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.744 1.617 . . . . 0.0 113.256 171.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -120.64 90.01 3.24 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.693 1.597 . . . . 0.0 109.621 -173.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 71.8 mtt85 -49.5 153.18 1.17 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.551 1.14 . . . . 0.0 112.167 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.408 HG12 HD23 ' A' ' 247' ' ' LEU . 1.5 t -127.31 160.14 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 123.057 1.408 . . . . 0.0 110.308 -177.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.6 m -138.37 144.73 40.43 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.697 -2.047 . . . . 0.0 110.428 -173.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 57.8 mt -128.7 112.77 27.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.164 1.385 . . . . 0.0 108.429 -172.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.9 153.14 17.91 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.049 0.94 . . . . 0.0 110.645 176.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -152.44 152.7 24.36 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 121.616 -0.677 . . . . 0.0 113.45 169.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -123.9 161.68 24.86 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 127.724 2.41 . . . . 0.0 109.011 -170.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 65.1 m -138.74 143.54 39.08 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.827 2.051 . . . . 0.0 109.376 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . 0.256 2.2 p30 -63.07 150.89 41.48 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 123.57 1.652 . . . . 0.0 114.551 -171.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -71.12 -2.3 15.24 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 113.164 -1.835 . . . . 0.0 115.299 -171.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.7 -15.71 61.68 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.14 0.976 . . . . 0.0 112.919 171.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.48 -165.43 41.31 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 125.312 1.434 . . . . 0.0 114.574 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 69.6 m -139.59 150.81 45.45 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.404 1.882 . . . . 0.0 109.681 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -54.37 -37.93 65.53 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -171.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.93 -26.73 71.46 Favored Glycine 0 CA--C 1.536 1.358 0 O-C-N 121.376 -0.828 . . . . 0.0 114.112 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 21.2 mm -98.01 -26.29 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.778 1.631 . . . . 0.0 112.195 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -88.69 -24.69 22.66 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.35 1.06 . . . . 0.0 113.139 -173.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 15.4 mm -57.92 -54.94 50.21 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 125.003 1.321 . . . . 0.0 111.989 167.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.98 -34.72 13.31 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 CA-C-N 120.723 1.294 . . . . 0.0 112.483 175.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.19 -40.79 86.59 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 120.211 1.369 . . . . 0.0 112.752 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 5.2 m -72.21 -35.17 68.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.314 0.961 . . . . 0.0 113.393 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.75 -39.26 80.41 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.228 0.611 . . . . 0.0 111.761 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -64.74 -38.77 92.13 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 123.812 0.845 . . . . 0.0 111.305 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -63.86 -40.21 96.01 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.747 0.703 . . . . 0.0 111.985 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.83 -37.9 79.5 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -67.33 -35.59 79.71 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.865 1.666 . . . . 0.0 112.425 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 62.7 mt -63.95 -42.28 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 123.329 0.652 . . . . 0.0 110.794 174.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 65.0 t -65.93 -42.64 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 122.067 -0.396 . . . . 0.0 111.111 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.57 -42.45 96.68 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.08 0.552 . . . . 0.0 111.512 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -65.38 -38.86 91.29 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.502 0.721 . . . . 0.0 111.792 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.62 -41.52 88.24 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.9 -42.94 89.57 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.549 0.739 . . . . 0.0 110.888 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.81 -37.02 77.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.479 0.712 . . . . 0.0 110.918 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -68.61 -33.81 74.67 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 33.5 ttt85 -69.0 -40.02 78.98 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.361 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 159.59 0.34 0.08 OUTLIER Glycine 0 CA--C 1.525 0.674 0 N-CA-C 117.514 1.766 . . . . 0.0 117.514 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.1 t -69.57 134.4 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 120.341 2.071 . . . . 0.0 109.455 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.72 138.2 58.45 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.923 -1.111 . . . . 0.0 110.628 169.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.57 -29.73 58.08 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.022 0.82 . . . . 0.0 113.452 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -63.51 -26.51 68.75 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.928 1.291 . . . . 0.0 113.892 173.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 24.3 m170 -98.48 4.25 48.32 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.987 1.715 . . . . 0.0 113.941 -174.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 16.2 mm -119.44 144.64 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.917 1.687 . . . . 0.0 109.255 174.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -136.18 161.13 36.59 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.222 1.809 . . . . 0.0 110.127 168.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 47.4 p -134.32 146.79 50.3 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.139 0.976 . . . . 0.0 111.386 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.0 t -138.85 120.47 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.23 1.012 . . . . 0.0 110.475 -173.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -83.95 99.28 2.21 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.561 1.076 . . . . 0.0 111.174 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 43.4 mt -97.47 31.95 2.39 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.862 2.065 . . . . 0.0 109.758 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 3.31 -72.07 0.0 OUTLIER Glycine 0 C--N 1.352 1.454 0 C-N-CA 128.006 2.717 . . . . 0.0 119.565 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 1.3 t -149.6 25.16 0.86 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.061 1.431 . . . . 0.0 113.152 173.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 14.2 m -67.79 161.08 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 120.921 -1.112 . . . . 0.0 112.149 174.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 39.98 53.94 5.74 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 125.959 1.704 . . . . 0.0 114.416 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.09 138.88 48.96 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.676 2.251 . . . . 0.0 111.597 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 26.0 pt -134.81 4.11 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.581 1.552 . . . . 0.0 113.438 -173.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.88 165.47 32.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.834 1.654 . . . . 0.0 110.689 170.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 18.3 m -116.73 159.47 22.22 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.868 1.667 . . . . 0.0 112.194 -172.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 49.2 p30 -79.42 5.25 13.17 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -67.54 -14.05 62.6 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.305 1.442 . . . . 0.0 114.587 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 42.4 p -138.22 147.8 57.22 Favored Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 126.485 1.914 . . . . 0.0 109.873 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -63.66 -31.3 69.95 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.142 2.561 . . . . 0.0 112.53 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -71.91 -36.4 69.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.876 0.87 . . . . 0.0 112.806 171.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.26 -37.57 94.12 Favored Glycine 0 N--CA 1.469 0.853 0 C-N-CA 124.006 0.812 . . . . 0.0 113.526 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -55.59 -49.97 71.36 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.819 1.248 . . . . 0.0 110.332 169.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.15 84.89 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -66.97 -18.85 65.58 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 174.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . 0.409 0.3 OUTLIER -110.6 17.82 20.32 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 167.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -112.85 10.74 19.12 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 127.264 2.226 . . . . 0.0 113.13 166.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -60.92 160.72 9.27 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -170.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 41.0 t -129.78 145.07 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 127.164 2.186 . . . . 0.0 108.897 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -134.32 155.98 49.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.259 1.424 . . . . 0.0 111.364 -174.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 39.0 mt -136.3 135.77 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.694 1.197 . . . . 0.0 108.903 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 47.7 t -140.66 132.94 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.582 1.553 . . . . 0.0 110.574 -171.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 14.6 p -90.57 125.87 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.002 0.921 . . . . 0.0 111.16 167.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 . . . . . 0 C--O 1.253 1.261 0 C-N-CA 125.792 1.637 . . . . 0.0 113.246 -177.859 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.448 0 CA-C-O 118.997 -0.891 . . . . 0.0 113.405 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -69.82 -18.58 36.63 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 124.113 3.209 . . . . 0.0 113.853 -171.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 44.7 t -120.85 -4.55 9.66 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.282 1.833 . . . . 0.0 112.303 176.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -64.58 -16.37 62.56 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -140.61 46.39 1.79 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.377 2.271 . . . . 0.0 110.955 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.0 mt -55.33 -28.56 54.56 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 118.402 -0.809 . . . . 0.0 112.548 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -54.78 -43.23 72.62 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.526 1.057 . . . . 0.0 111.528 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 19.2 t -69.57 -41.73 75.44 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.431 0.692 . . . . 0.0 111.99 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.68 -38.52 91.28 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 2.7 mm -68.69 -43.24 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -63.0 -38.38 90.94 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.605 -0.684 . . . . 0.0 112.245 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -71.12 -33.35 70.03 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.051 0.94 . . . . 0.0 113.224 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.08 -42.02 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 123.3 0.64 . . . . 0.0 111.409 172.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.8 m -86.34 -22.38 26.72 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 61.23 29.5 71.44 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.84 1.209 . . . . 0.0 113.866 -172.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 97.27 -175.33 30.61 Favored Glycine 0 CA--C 1.541 1.708 0 C-N-CA 125.71 1.624 . . . . 0.0 112.999 -171.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.18 150.34 33.1 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 123.685 2.923 . . . . 0.0 112.909 -174.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 52.5 mt -97.59 141.89 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.07 1.748 . . . . 0.0 110.952 -171.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -109.19 170.12 8.25 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.316 1.846 . . . . 0.0 115.866 -171.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -144.19 110.33 5.43 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.832 1.253 . . . . 0.0 110.372 -171.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -59.02 -166.24 0.14 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.989 1.756 . . . . 0.0 115.545 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -41.98 -39.74 1.98 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.528 1.931 . . . . 0.0 114.785 -175.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -62.1 -28.89 69.94 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.316 1.446 . . . . 0.0 114.363 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 96.0 -10.93 68.0 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.958 1.742 . . . . 0.0 115.687 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -152.57 12.23 0.53 Allowed 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -171.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 69.0 m -78.15 75.34 4.68 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 120.434 -1.416 . . . . 0.0 114.238 -171.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 14.5 tp -69.27 128.77 37.76 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.731 1.612 . . . . 0.0 110.659 171.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -98.81 164.04 17.69 Favored Pre-proline 0 N--CA 1.484 1.258 0 C-N-CA 124.441 1.096 . . . . 0.0 110.91 -171.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -63.81 -29.86 68.33 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.239 1.959 . . . . 0.0 112.985 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.16 90.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.777 0.831 . . . . 0.0 113.134 169.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -66.68 -43.34 84.71 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.457 -0.777 . . . . 0.0 111.468 172.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -61.29 -32.39 72.22 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.436 -0.79 . . . . 0.0 112.484 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -67.34 -41.07 85.82 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.669 -1.27 . . . . 0.0 112.278 172.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 67.7 mt -57.42 -46.03 85.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 O-C-N 121.345 -0.847 . . . . 0.0 110.441 169.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 39.6 mt -64.08 -35.09 79.6 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.436 -0.79 . . . . 0.0 112.906 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -61.16 -37.64 83.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.141 0.976 . . . . 0.0 112.614 173.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 86.5 mtt-85 -70.58 -37.01 73.88 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.687 1.195 . . . . 0.0 112.628 173.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.9 -41.95 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 118.91 0.777 . . . . 0.0 110.771 173.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.72 -38.14 90.0 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.712 0.805 . . . . 0.0 112.274 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.33 -38.11 89.15 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.446 0.698 . . . . 0.0 112.376 172.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -65.71 -34.84 79.14 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.625 0.77 . . . . 0.0 112.696 176.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -66.06 -45.64 80.62 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.98 1.312 . . . . 0.0 111.859 169.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.51 -30.19 70.46 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.551 1.54 . . . . 0.0 112.808 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.17 -9.66 58.8 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.078 1.751 . . . . 0.0 114.563 174.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 16.1 t -155.47 68.36 5.18 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 125.358 1.463 . . . . 0.0 108.885 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -62.62 -6.05 8.22 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.429 2.752 . . . . 0.0 112.679 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -73.17 -19.96 61.0 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.446 1.498 . . . . 0.0 113.324 172.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -115.54 93.91 4.48 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.21 1.404 . . . . 0.0 111.794 -171.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -50.65 147.5 4.66 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.118 1.367 . . . . 0.0 111.684 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 22.9 m -127.15 160.15 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.882 0.873 . . . . 0.0 111.487 167.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 22.9 m -127.26 139.38 52.95 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.909 1.683 . . . . 0.0 108.362 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 71.4 mt -119.13 123.83 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 124.923 1.289 . . . . 0.0 107.858 -171.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -113.76 148.6 36.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.302 0.641 . . . . 0.0 110.399 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -137.46 156.69 23.66 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 122.106 -0.371 . . . . 0.0 112.696 167.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -127.6 167.34 16.5 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.502 2.321 . . . . 0.0 109.885 -169.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.1 m -151.98 159.73 43.68 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.162 1.785 . . . . 0.0 110.627 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -63.75 163.02 12.32 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.956 -1.09 . . . . 0.0 111.43 166.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.438 ' ND2' ' HG ' ' A' ' 302' ' ' SER . 12.1 t-20 -104.98 20.34 19.0 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.564 0.746 . . . . 0.0 112.817 -175.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 16.3 m -69.92 -20.1 63.36 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.809 1.244 . . . . 0.0 112.628 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.6 -150.01 18.1 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 126.156 1.836 . . . . 0.0 113.249 173.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 71.4 m -135.3 162.72 31.79 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.073 1.749 . . . . 0.0 110.09 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -52.62 -41.16 63.45 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.984 0.914 . . . . 0.0 112.968 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -67.9 -4.39 33.93 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.672 1.13 . . . . 0.0 115.238 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 6.2 mt -116.55 -33.0 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.932 2.093 . . . . 0.0 111.172 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -81.53 -31.22 32.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.555 1.142 . . . . 0.0 112.919 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 23.4 mm -60.52 -54.17 57.47 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.322 1.449 . . . . 0.0 111.761 170.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.54 -32.6 24.43 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 CA-C-N 121.065 1.416 . . . . 0.0 113.333 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 26.3 mt -67.88 -43.8 78.5 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.347 1.43 . . . . 0.0 113.124 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 28.5 p -66.46 -37.54 85.36 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.14 -38.09 78.62 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.556 0.742 . . . . 0.0 111.967 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -65.19 -38.76 91.51 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 125.129 1.372 . . . . 0.0 111.036 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -45.62 90.42 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.52 0.6 . . . . 0.0 111.877 173.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.38 -36.17 76.53 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -68.34 -36.51 79.36 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 125.758 1.623 . . . . 0.0 111.97 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 58.9 mt -63.55 -43.07 98.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 118.788 0.722 . . . . 0.0 110.625 174.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 57.4 t -66.89 -42.62 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.753 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.07 -41.7 99.5 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.026 0.53 . . . . 0.0 111.743 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.85 -38.84 87.14 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.121 0.568 . . . . 0.0 111.501 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -68.27 -40.68 81.8 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.3 mp -64.88 -43.68 92.15 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.302 0.641 . . . . 0.0 111.005 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 55.1 t -67.73 -37.22 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 O-C-N 121.758 -0.589 . . . . 0.0 111.088 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.95 -34.0 72.85 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -42.99 86.19 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.817 0.847 . . . . 0.0 111.591 171.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 161.08 -0.95 0.07 OUTLIER Glycine 0 CA--C 1.528 0.871 0 N-CA-C 117.413 1.725 . . . . 0.0 117.413 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.4 t -72.48 136.15 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 120.514 2.157 . . . . 0.0 109.814 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.59 140.75 56.93 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 120.946 -1.096 . . . . 0.0 110.641 168.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.21 -27.31 52.15 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.399 1.0 . . . . 0.0 113.694 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -61.68 -30.14 70.54 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.822 1.249 . . . . 0.0 113.538 173.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -92.77 -0.71 57.22 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.606 1.562 . . . . 0.0 113.968 -174.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 25.0 mm -121.04 141.12 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.825 1.65 . . . . 0.0 109.501 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -135.09 161.37 35.52 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.733 1.613 . . . . 0.0 110.253 167.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 45.6 p -137.02 146.39 45.23 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.942 0.897 . . . . 0.0 112.372 -175.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 35.3 t -141.35 133.63 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.571 1.148 . . . . 0.0 111.118 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -89.5 100.3 2.65 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.508 1.051 . . . . 0.0 111.801 172.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 38.2 mt -95.58 32.13 1.87 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.707 2.003 . . . . 0.0 110.618 174.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 3.18 -70.34 0.0 OUTLIER Glycine 0 C--N 1.35 1.329 0 N-CA-C 120.366 2.906 . . . . 0.0 120.366 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' SER . . . . . 0.438 ' HG ' ' ND2' ' A' ' 263' ' ' ASN . 94.3 p -144.53 13.76 1.56 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.769 1.284 . . . . 0.0 114.281 178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 17.1 m -70.27 157.97 6.36 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 O-C-N 121.025 -1.047 . . . . 0.0 111.768 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 39.46 52.09 4.03 Favored Pre-proline 0 CA--C 1.557 1.23 0 C-N-CA 125.259 1.424 . . . . 0.0 114.119 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.18 112.73 1.78 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.38 2.72 . . . . 0.0 111.767 -171.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.489 HD13 ' H ' ' A' ' 306' ' ' ILE . 1.4 mp -71.02 -20.67 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 124.46 1.104 . . . . 0.0 112.476 -171.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -150.5 160.26 43.9 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.865 1.666 . . . . 0.0 112.376 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 49.6 m -71.19 151.25 44.55 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.177 1.791 . . . . 0.0 113.767 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -82.85 1.69 38.02 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.86 -14.4 63.01 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 40.6 p -141.42 147.58 47.06 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 126.326 1.85 . . . . 0.0 110.296 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -63.25 -32.58 73.22 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.166 2.577 . . . . 0.0 112.53 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -68.05 -36.45 79.89 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 173.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -70.2 -38.04 72.12 Favored Glycine 0 N--CA 1.467 0.722 0 C-N-CA 123.415 0.531 . . . . 0.0 113.361 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -57.63 -49.1 77.54 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 123.752 0.821 . . . . 0.0 109.975 171.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.17 84.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.57 0.748 . . . . 0.0 112.698 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -72.66 -12.74 61.15 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.225 1.41 . . . . 0.0 113.696 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.32 -12.5 15.04 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 170.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -81.96 2.48 30.56 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 126.571 1.948 . . . . 0.0 114.502 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 35.0 mtm180 -57.89 160.87 4.29 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -169.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.88 144.12 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.278 1.831 . . . . 0.0 109.954 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -139.7 159.41 42.23 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.137 1.375 . . . . 0.0 113.194 -173.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 4.5 mp -131.95 132.86 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.768 1.627 . . . . 0.0 108.71 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 21.4 t -140.58 138.52 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.635 1.574 . . . . 0.0 109.552 -171.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 22.4 t -69.7 135.81 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.029 -1.044 . . . . 0.0 110.429 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.5 t30 . . . . . 0 C--O 1.252 1.201 0 C-N-CA 125.143 1.377 . . . . 0.0 113.319 -177.901 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.728 0 CA-C-O 119.191 -0.783 . . . . 0.0 114.221 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -69.7 -15.34 37.27 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.323 3.349 . . . . 0.0 114.655 -171.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 22.0 t -128.91 -2.57 5.23 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 126.817 2.047 . . . . 0.0 111.776 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.64 -18.8 65.56 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -171.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -137.77 30.44 2.55 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.934 2.093 . . . . 0.0 111.52 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 6.9 tp -63.49 -16.58 61.1 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 121.521 -0.737 . . . . 0.0 112.949 -173.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -53.58 -45.6 70.02 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.954 0.797 . . . . 0.0 111.465 167.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 21.5 t -69.27 -42.77 75.09 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.292 0.637 . . . . 0.0 111.306 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.93 85.97 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 53.6 mt -73.53 -36.04 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.522 0.729 . . . . 0.0 109.659 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -65.08 -42.49 94.08 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.061 -1.024 . . . . 0.0 112.006 172.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.06 -37.56 87.97 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.947 0.899 . . . . 0.0 112.821 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.69 -28.36 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 118.354 0.525 . . . . 0.0 112.227 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.7 m -75.16 -26.5 59.16 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.094 0.958 . . . . 0.0 112.136 170.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.37 25.83 75.08 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.111 1.339 . . . . 0.0 113.65 -171.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 96.24 -176.71 33.13 Favored Glycine 0 CA--C 1.542 1.732 0 C-N-CA 125.532 1.539 . . . . 0.0 113.394 -172.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.24 147.83 33.58 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.834 3.023 . . . . 0.0 111.416 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -102.42 140.99 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -169.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -107.44 169.03 8.83 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.693 2.397 . . . . 0.0 113.763 -172.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -142.55 116.1 9.12 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.475 1.11 . . . . 0.0 110.608 -171.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -58.42 -170.22 0.24 Allowed Glycine 0 CA--C 1.535 1.302 0 C-N-CA 126.117 1.817 . . . . 0.0 116.39 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -46.43 -40.91 13.01 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.46 1.504 . . . . 0.0 115.017 -174.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.11 -33.27 71.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.396 1.478 . . . . 0.0 113.808 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 105.49 -5.06 40.55 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 117.02 1.568 . . . . 0.0 117.02 167.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -166.44 28.12 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 119.471 1.635 . . . . 0.0 113.038 -171.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 16.5 t -98.11 93.58 6.35 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.634 -1.291 . . . . 0.0 111.511 -171.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.0 mp -71.31 113.92 8.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.886 0.874 . . . . 0.0 109.82 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 11.8 pt -70.77 164.09 58.7 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 124.366 1.066 . . . . 0.0 110.23 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.25 -31.28 74.21 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 CA-C-N 121.942 1.729 . . . . 0.0 112.371 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -66.17 -32.35 73.74 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 170.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -59.03 -53.05 62.8 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.748 1.158 . . . . 0.0 110.697 171.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -58.59 -33.77 70.35 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.716 0.807 . . . . 0.0 112.611 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -66.24 -44.75 82.84 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.419 1.009 . . . . 0.0 112.505 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 34.2 mm -58.44 -43.61 87.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 121.589 -0.694 . . . . 0.0 110.747 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.13 -32.26 72.83 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.709 -0.619 . . . . 0.0 112.62 174.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -63.85 -41.38 97.82 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.578 1.151 . . . . 0.0 112.411 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -67.52 -38.69 84.61 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.423 1.089 . . . . 0.0 112.335 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 79.7 t -62.96 -45.03 99.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 123.507 0.723 . . . . 0.0 110.538 174.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.82 -36.84 84.52 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.155 0.582 . . . . 0.0 112.146 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.17 -39.29 92.71 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 172.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -65.62 -35.13 79.9 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.753 0.821 . . . . 0.0 112.73 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 97.0 mt -69.67 -41.6 75.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.44 1.096 . . . . 0.0 112.039 172.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.03 -23.93 67.68 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.392 1.877 . . . . 0.0 113.089 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.91 -8.75 57.94 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.536 1.534 . . . . 0.0 114.588 171.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 36.2 t -153.61 67.29 6.01 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.222 1.409 . . . . 0.0 108.85 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -64.68 -7.22 14.05 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.119 2.546 . . . . 0.0 112.013 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -70.14 -19.42 63.22 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.51 1.524 . . . . 0.0 113.215 171.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -118.99 89.88 3.22 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.513 1.525 . . . . 0.0 110.52 -172.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -51.53 150.97 3.38 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.04 1.336 . . . . 0.0 111.453 172.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 17.3 m -134.38 161.34 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.449 0.7 . . . . 0.0 112.669 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 20.8 m -128.03 137.37 52.17 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.153 1.381 . . . . 0.0 109.415 -178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.0 118.19 57.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.663 1.585 . . . . 0.0 107.7 -173.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.496 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 0.2 OUTLIER -98.98 151.19 21.17 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.022 1.329 . . . . 0.0 109.406 -178.023 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -152.01 155.49 26.16 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 121.491 -0.756 . . . . 0.0 113.912 168.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -132.53 168.4 18.29 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 129.033 2.933 . . . . 0.0 109.352 -170.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 31.2 m -145.27 151.56 38.56 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 127.102 2.161 . . . . 0.0 109.187 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -63.32 160.67 15.44 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 123.172 1.463 . . . . 0.0 113.574 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -83.04 7.87 14.49 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 113.993 -1.458 . . . . 0.0 114.927 -170.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.6 m -75.11 -15.26 60.61 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 120.993 -1.067 . . . . 0.0 113.508 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -95.24 -157.83 32.5 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.286 1.422 . . . . 0.0 114.595 -176.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 7.6 t -135.18 162.37 32.7 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.69 1.596 . . . . 0.0 110.371 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -52.84 -41.44 64.24 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.124 0.97 . . . . 0.0 112.796 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -67.83 -6.49 44.46 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 124.428 1.014 . . . . 0.0 115.238 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 4.2 mt -115.75 -33.63 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 126.644 1.978 . . . . 0.0 111.294 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -87.41 -24.35 24.23 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 18.3 mm -58.51 -54.06 59.87 Favored Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 124.531 1.132 . . . . 0.0 111.804 167.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.49 -33.23 11.12 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 120.579 1.243 . . . . 0.0 112.906 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 19.1 mt -65.11 -46.78 79.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 120.282 1.401 . . . . 0.0 112.092 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 24.2 m -70.87 -29.86 66.07 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -74.66 -34.96 62.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.788 0.835 . . . . 0.0 112.075 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -65.57 -39.89 92.15 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.027 0.931 . . . . 0.0 111.677 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.22 -43.17 98.87 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.271 0.942 . . . . 0.0 110.755 176.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.5 -37.98 86.25 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.27 -38.91 88.93 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.525 1.53 . . . . 0.0 112.036 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 74.1 mt -66.13 -39.52 84.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 122.688 0.395 . . . . 0.0 110.879 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.59 -44.75 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 O-C-N 121.972 -0.455 . . . . 0.0 110.906 173.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.92 -42.23 97.7 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.4 0.68 . . . . 0.0 111.662 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -66.72 -38.29 86.41 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.013 0.525 . . . . 0.0 111.897 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -68.81 -40.8 79.34 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.15 -43.22 95.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.328 0.651 . . . . 0.0 110.975 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 55.7 t -67.34 -37.46 79.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 O-C-N 121.753 -0.592 . . . . 0.0 111.257 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.43 -34.42 74.42 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -42.26 87.19 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.811 0.844 . . . . 0.0 111.796 172.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 161.64 -1.61 0.07 OUTLIER Glycine 0 CA--C 1.527 0.831 0 N-CA-C 117.473 1.749 . . . . 0.0 117.473 176.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 2.7 t -73.96 137.76 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 120.523 2.162 . . . . 0.0 109.493 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.78 137.91 58.07 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.655 -1.278 . . . . 0.0 110.461 168.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.8 -29.67 58.82 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.055 0.836 . . . . 0.0 113.456 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.44 -26.51 68.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.131 1.372 . . . . 0.0 113.782 173.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -97.25 2.23 50.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.801 1.641 . . . . 0.0 113.955 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 20.2 mm -119.64 141.78 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.699 1.6 . . . . 0.0 109.447 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -136.84 165.27 26.34 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.041 1.737 . . . . 0.0 110.535 169.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 44.6 p -136.02 145.68 46.33 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.277 1.031 . . . . 0.0 112.258 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 70.3 t -138.98 133.95 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.052 1.341 . . . . 0.0 110.919 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -103.24 105.32 2.67 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 126.131 1.825 . . . . 0.0 112.21 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.496 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 1.1 mp -103.94 32.8 3.73 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 129.138 2.975 . . . . 0.0 109.752 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 7.45 -73.92 0.0 OUTLIER Glycine 0 C--N 1.349 1.257 0 N-CA-C 119.467 2.547 . . . . 0.0 119.467 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 57.9 p -148.14 22.53 1.08 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.483 1.641 . . . . 0.0 114.435 172.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.7 m -70.13 159.55 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.092 1.357 . . . . 0.0 111.917 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 23.2 m120 39.76 52.74 4.75 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 125.062 1.345 . . . . 0.0 112.932 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -59.64 132.18 44.23 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.012 2.475 . . . . 0.0 113.674 -170.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 4.8 mp -77.13 -25.89 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 125.042 1.337 . . . . 0.0 111.586 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -157.53 153.66 27.33 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.664 1.986 . . . . 0.0 111.822 -172.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 66.7 m -66.42 150.42 48.93 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.179 1.392 . . . . 0.0 112.48 170.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -84.49 11.13 9.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.786 1.235 . . . . 0.0 113.854 174.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -67.18 -18.36 65.23 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -176.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 66.7 p -140.66 151.4 63.22 Favored Pre-proline 0 N--CA 1.474 0.744 0 C-N-CA 125.901 1.681 . . . . 0.0 110.141 176.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -61.94 -28.31 80.77 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.199 2.599 . . . . 0.0 112.601 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.0 -42.14 94.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.856 0.862 . . . . 0.0 112.554 172.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.14 -38.17 87.8 Favored Glycine 0 N--CA 1.465 0.619 0 O-C-N 121.791 -0.568 . . . . 0.0 112.787 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -57.99 -47.42 83.03 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.244 0.618 . . . . 0.0 110.526 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.85 -39.91 93.5 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.184 0.594 . . . . 0.0 112.537 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -68.61 -16.51 63.87 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.486 1.114 . . . . 0.0 113.816 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -115.86 -1.36 12.61 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 125.514 1.526 . . . . 0.0 114.517 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -82.68 3.95 26.94 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 126.136 1.774 . . . . 0.0 113.023 166.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.88 158.81 0.64 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 130.118 3.367 . . . . 0.0 117.144 -169.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 2.3 m -122.46 148.61 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 126.326 1.85 . . . . 0.0 111.656 166.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -130.08 166.26 20.53 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.84 2.056 . . . . 0.0 110.891 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 13.1 tt -140.74 144.0 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.524 1.13 . . . . 0.0 111.919 172.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 23.3 t -144.68 136.48 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.343 1.457 . . . . 0.0 110.187 -174.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.09 136.23 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.11 0.964 . . . . 0.0 110.754 174.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.576 1.55 . . . . 0.0 113.731 -178.556 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.49 0 CA-C-O 118.91 -0.939 . . . . 0.0 113.87 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -69.52 -19.98 36.56 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.995 3.13 . . . . 0.0 114.091 -171.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 9.9 t -122.57 -2.75 8.87 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 126.519 1.928 . . . . 0.0 111.762 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.54 -21.25 60.43 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 -171.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -137.48 38.56 2.46 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.516 2.326 . . . . 0.0 109.945 174.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 23.8 tp -61.13 -19.83 61.97 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.46 1.104 . . . . 0.0 113.796 -171.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -57.2 -46.31 82.99 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.74 -0.6 . . . . 0.0 111.843 169.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 22.8 t -68.66 -43.86 75.3 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 122.977 0.511 . . . . 0.0 111.284 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -71.57 -25.45 62.21 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 67.3 mt -83.07 -35.55 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 119.61 1.095 . . . . 0.0 110.627 171.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -63.44 -41.97 98.68 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.819 -1.175 . . . . 0.0 111.83 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.4 -36.34 83.67 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.212 1.005 . . . . 0.0 113.187 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.83 -27.72 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.9 m -80.38 -27.79 38.11 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.269 1.027 . . . . 0.0 112.437 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 69.95 25.69 75.27 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.02 1.295 . . . . 0.0 113.854 -172.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 88.88 -166.97 34.34 Favored Glycine 0 CA--C 1.54 1.656 0 C-N-CA 124.87 1.224 . . . . 0.0 113.57 -173.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.33 163.06 40.38 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.721 2.947 . . . . 0.0 112.312 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 19.3 mm -120.74 144.58 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.171 1.389 . . . . 0.0 111.069 -171.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -111.69 167.47 10.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.954 2.102 . . . . 0.0 113.115 -172.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -140.51 101.83 4.19 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.908 0.883 . . . . 0.0 111.803 -170.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -87.52 -178.26 48.23 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.541 1.067 . . . . 0.0 113.981 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 51.6 t30 36.17 -81.34 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 130.375 3.47 . . . . 0.0 115.796 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -71.13 -22.85 62.02 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.295 1.438 . . . . 0.0 114.084 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 89.2 10.23 66.36 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.918 1.247 . . . . 0.0 115.019 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -154.71 25.31 0.45 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 126.968 2.107 . . . . 0.0 112.105 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 58.2 m -81.67 81.84 7.6 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.878 1.271 . . . . 0.0 112.888 -171.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.76 101.33 0.47 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.689 0.756 . . . . 0.0 110.817 169.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . 0.532 HG13 ' H ' ' A' ' 236' ' ' ASP . 9.8 pt -61.79 154.86 64.94 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.768 1.627 . . . . 0.0 112.491 173.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -62.56 -31.3 80.01 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.344 2.029 . . . . 0.0 112.184 174.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.5 90.65 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.791 0.836 . . . . 0.0 112.858 170.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . 0.532 ' H ' HG13 ' A' ' 233' ' ' ILE . 21.9 t70 -62.61 -49.56 74.74 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.436 -0.79 . . . . 0.0 111.321 172.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -59.88 -30.24 68.86 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.166 -0.959 . . . . 0.0 112.912 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -70.72 -44.54 66.68 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 120.785 -1.197 . . . . 0.0 112.805 172.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 21.4 mm -57.89 -45.57 87.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.231 -0.918 . . . . 0.0 110.938 172.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.4 -32.07 73.5 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.954 0.902 . . . . 0.0 112.539 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -61.86 -42.55 99.19 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.088 0.955 . . . . 0.0 111.882 173.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -67.79 -35.65 79.03 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 87.9 t -64.45 -44.39 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.497 0.59 . . . . 0.0 110.916 173.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.81 89.86 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.422 0.689 . . . . 0.0 111.989 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.78 -39.13 93.51 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.122 0.569 . . . . 0.0 112.065 175.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -71.56 -30.68 66.15 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 79.3 mt -71.32 -40.76 70.56 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.976 0.911 . . . . 0.0 112.266 170.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -60.06 -27.05 66.64 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.121 1.368 . . . . 0.0 112.669 173.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -80.95 -6.96 59.37 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.11 1.764 . . . . 0.0 115.036 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 22.2 t -153.47 67.27 6.08 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.235 1.414 . . . . 0.0 108.862 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -63.84 -7.1 12.26 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.216 2.611 . . . . 0.0 112.39 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -71.28 -19.27 62.36 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.591 1.556 . . . . 0.0 113.24 171.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -117.88 89.04 3.04 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.543 1.537 . . . . 0.0 110.578 -173.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 68.1 mtt85 -53.26 155.45 2.72 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.544 1.138 . . . . 0.0 111.676 171.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 20.9 m -128.29 165.49 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.36 1.064 . . . . 0.0 111.844 171.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 30.2 m -127.98 137.14 52.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.403 1.481 . . . . 0.0 108.798 173.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.7 mt -113.69 117.32 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -102.49 156.82 17.35 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.323 0.649 . . . . 0.0 110.426 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -148.52 154.95 26.16 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 122.178 -0.326 . . . . 0.0 112.836 167.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -128.16 163.41 24.73 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 127.539 2.336 . . . . 0.0 109.918 -169.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 73.1 p -148.63 173.67 12.94 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.917 2.487 . . . . 0.0 110.392 170.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -72.15 158.36 36.06 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.458 -1.401 . . . . 0.0 113.001 -173.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -84.97 -9.64 57.86 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.695 1.198 . . . . 0.0 113.168 -172.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -22.66 67.02 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.382 2.273 . . . . 0.0 115.527 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -74.98 -143.24 0.93 Allowed Glycine 0 CA--C 1.54 1.615 0 C-N-CA 126.448 1.975 . . . . 0.0 115.358 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 26.3 t -149.59 137.15 20.1 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.868 1.667 . . . . 0.0 109.723 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -53.17 -34.02 55.1 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -65.59 -22.74 70.01 Favored Glycine 0 CA--C 1.537 1.428 0 O-C-N 121.435 -0.791 . . . . 0.0 114.21 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 16.9 mm -100.59 -32.33 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 126.496 1.918 . . . . 0.0 112.188 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -82.71 -27.36 31.23 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.8 mm -57.65 -55.35 45.7 Favored Pre-proline 0 N--CA 1.469 0.515 0 C-N-CA 124.722 1.209 . . . . 0.0 112.206 169.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.38 -30.26 15.71 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 CA-C-N 120.468 1.203 . . . . 0.0 112.713 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.6 mp -64.42 -51.12 64.77 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 120.228 1.377 . . . . 0.0 111.833 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.3 m -69.34 -32.31 71.32 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.071 -0.651 . . . . 0.0 112.544 -176.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.64 -38.66 80.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 174.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -67.69 -38.23 83.41 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.424 0.689 . . . . 0.0 111.594 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 66.5 mmt-85 -61.1 -44.14 97.81 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.959 0.8 . . . . 0.0 111.275 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.77 -37.57 79.43 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -66.58 -37.87 85.83 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 125.376 1.47 . . . . 0.0 111.733 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 19.3 mm -65.98 -39.06 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.62 0.645 . . . . 0.0 111.268 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 38.3 t -64.92 -46.09 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.322 0.51 . . . . 0.0 110.592 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -61.11 -41.52 96.84 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.304 0.642 . . . . 0.0 111.616 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.05 -36.97 84.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.554 1.142 . . . . 0.0 111.47 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -63.63 -45.01 92.18 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.6 mp -69.07 -37.06 78.28 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.977 0.418 . . . . 0.0 111.672 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.84 -37.01 76.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.942 0.897 . . . . 0.0 111.013 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.97 -35.0 79.0 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 20.9 ttt85 -69.05 -35.52 76.66 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 170.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 151.34 4.54 0.18 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 116.935 1.534 . . . . 0.0 116.935 167.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.8 t -69.49 136.01 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 120.046 1.923 . . . . 0.0 108.964 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.32 138.88 58.68 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.979 -1.076 . . . . 0.0 110.528 172.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.75 -29.85 58.89 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.013 0.816 . . . . 0.0 113.317 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.28 -28.68 69.89 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.857 1.263 . . . . 0.0 113.648 173.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -93.36 -2.2 55.04 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.471 1.508 . . . . 0.0 114.217 -174.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 9.0 mt -129.04 108.09 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.518 1.127 . . . . 0.0 110.155 175.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -88.69 161.92 16.57 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.028 0.931 . . . . 0.0 110.323 167.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 35.5 p -135.41 144.37 46.49 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.192 0.997 . . . . 0.0 111.452 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 30.2 t -138.0 129.81 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.56 0.744 . . . . 0.0 111.32 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -84.85 96.1 2.01 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.518 1.056 . . . . 0.0 111.112 170.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 47.6 mt -88.54 30.14 0.93 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.552 1.941 . . . . 0.0 109.97 171.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 6.86 -74.97 0.0 OUTLIER Glycine 0 C--N 1.354 1.554 0 C-N-CA 128.191 2.805 . . . . 0.0 119.769 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 95.1 p -149.6 23.79 0.89 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.583 1.192 . . . . 0.0 113.252 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 7.3 m -71.26 158.63 6.12 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 C-N-CA 124.509 1.124 . . . . 0.0 111.498 173.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 39.42 54.24 5.28 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 125.514 1.526 . . . . 0.0 114.288 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.09 139.08 59.42 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.689 2.259 . . . . 0.0 111.626 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 17.8 pt -134.59 6.81 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.925 1.29 . . . . 0.0 114.314 -171.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -146.54 140.08 25.89 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.485 1.114 . . . . 0.0 110.62 167.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 51.0 m -71.05 143.61 50.65 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.425 1.49 . . . . 0.0 113.126 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -74.23 1.69 10.81 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 171.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.07 -17.26 63.23 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.053 1.341 . . . . 0.0 114.617 -175.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 67.9 p -140.47 150.94 62.51 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 125.49 1.516 . . . . 0.0 110.581 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -62.12 -30.06 81.85 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.25 2.633 . . . . 0.0 112.576 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -64.53 -44.42 90.92 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.575 0.75 . . . . 0.0 112.344 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.73 -35.46 85.58 Favored Glycine 0 CA--C 1.524 0.613 0 O-C-N 121.84 -0.538 . . . . 0.0 112.839 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -59.52 -49.35 78.11 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.073 0.949 . . . . 0.0 111.173 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.03 85.76 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.0 0.52 . . . . 0.0 111.969 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -71.12 -23.37 62.08 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.329 1.452 . . . . 0.0 114.302 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -99.82 -18.14 17.31 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 119.656 1.116 . . . . 0.0 112.866 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -71.96 13.63 0.28 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.317 1.447 . . . . 0.0 114.337 170.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -61.86 163.8 7.14 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.206 1.802 . . . . 0.0 115.662 -170.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 28.9 m -125.29 151.52 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.941 1.696 . . . . 0.0 110.158 167.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -145.48 147.5 32.24 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.36 1.064 . . . . 0.0 111.919 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.3 132.52 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.171 1.388 . . . . 0.0 109.404 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 21.8 t -140.88 133.97 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.211 1.405 . . . . 0.0 109.895 -172.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.18 141.27 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 121.409 -0.807 . . . . 0.0 110.342 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.285 1.434 . . . . 0.0 111.864 -171.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.749 0 CA-C-O 119.04 -0.866 . . . . 0.0 114.833 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.51 -19.07 28.86 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.84 3.027 . . . . 0.0 113.854 -172.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 43.3 t -121.38 -7.43 9.25 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.948 2.099 . . . . 0.0 111.998 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -63.76 -16.04 60.15 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.354 1.462 . . . . 0.0 114.861 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -137.21 41.33 2.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.4 2.28 . . . . 0.0 111.167 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 9.0 mt -46.82 -38.52 10.35 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.67 0.788 . . . . 0.0 111.822 172.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -59.95 -38.53 82.72 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.995 0.518 . . . . 0.0 111.956 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.2 t -68.78 -48.08 64.56 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.465 0.706 . . . . 0.0 112.061 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.9 85.51 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 177.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 90.8 mt -75.05 -34.54 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.335 1.054 . . . . 0.0 110.091 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -65.87 -41.28 91.79 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.816 -1.177 . . . . 0.0 111.712 172.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.91 -36.03 83.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.725 0.81 . . . . 0.0 113.153 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.4 p -80.06 -27.34 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.2 m -88.39 -25.75 22.53 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.534 1.134 . . . . 0.0 113.03 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.77 24.68 75.48 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.348 1.452 . . . . 0.0 114.061 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 101.57 -162.34 17.73 Favored Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.346 1.451 . . . . 0.0 112.54 -171.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -73.15 168.2 25.35 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.716 2.944 . . . . 0.0 112.561 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 40.9 mm -112.79 114.46 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.46 1.504 . . . . 0.0 110.63 -173.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -81.66 173.23 12.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.806 2.042 . . . . 0.0 112.671 171.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -118.7 151.68 37.53 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.859 0.864 . . . . 0.0 110.735 -173.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -59.66 165.73 10.44 Favored Glycine 0 CA--C 1.543 1.843 0 O-C-N 120.875 -1.141 . . . . 0.0 110.892 165.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -48.91 -22.33 0.82 Allowed 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 117.036 2.235 . . . . 0.0 117.036 -171.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -59.28 -22.46 61.2 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.582 1.553 . . . . 0.0 114.666 170.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.71 9.39 74.94 Favored Glycine 0 CA--C 1.543 1.827 0 C-N-CA 124.977 1.275 . . . . 0.0 114.79 -176.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -159.72 -5.82 0.06 Allowed 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 118.918 2.932 . . . . 0.0 118.918 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.6 m -72.43 81.72 1.06 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 122.355 2.343 . . . . 0.0 114.368 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 16.5 tp -63.75 109.61 1.77 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.422 2.289 . . . . 0.0 111.07 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . 0.555 HG13 ' H ' ' A' ' 236' ' ' ASP . 10.4 pt -71.93 159.33 85.75 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 124.655 1.182 . . . . 0.0 112.853 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.97 -29.17 87.48 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.493 2.129 . . . . 0.0 112.17 174.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.95 98.1 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 169.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . 0.555 ' H ' HG13 ' A' ' 233' ' ' ILE . 94.4 m-20 -66.27 -41.35 90.02 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.515 -0.741 . . . . 0.0 112.108 173.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -60.94 -32.16 71.68 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.282 -0.886 . . . . 0.0 112.404 172.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -69.89 -42.87 72.86 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.353 -1.467 . . . . 0.0 112.222 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 65.9 mt -56.7 -47.2 82.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.63 -0.669 . . . . 0.0 110.398 171.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.99 -30.97 72.0 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.493 0.717 . . . . 0.0 112.869 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -64.39 -43.08 95.58 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.588 -0.695 . . . . 0.0 111.824 174.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -64.32 -39.26 93.56 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.004 0.922 . . . . 0.0 112.082 175.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 70.0 t -65.36 -41.56 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.961 0.904 . . . . 0.0 111.601 175.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.08 95.74 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.237 0.615 . . . . 0.0 111.791 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -65.27 -39.01 92.04 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.817 0.847 . . . . 0.0 111.995 175.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -65.95 -35.68 81.26 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.756 0.822 . . . . 0.0 112.568 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 16.8 tp -73.57 -39.63 64.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.189 0.996 . . . . 0.0 112.157 173.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -60.71 -28.53 68.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.392 1.477 . . . . 0.0 112.497 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -75.94 -7.5 54.72 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.046 1.738 . . . . 0.0 114.788 173.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 24.3 t -150.69 68.93 8.5 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.435 1.494 . . . . 0.0 108.59 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -62.13 -7.1 9.23 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.459 2.773 . . . . 0.0 112.493 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -73.16 -18.03 61.31 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.737 1.615 . . . . 0.0 113.277 174.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -124.93 79.65 1.8 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.042 1.337 . . . . 0.0 111.306 -171.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -48.72 159.66 0.22 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.332 1.853 . . . . 0.0 113.104 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.3 162.28 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-O 121.712 0.768 . . . . 0.0 112.336 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.3 m -127.68 137.16 52.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.409 1.484 . . . . 0.0 108.993 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 94.3 mt -113.09 119.98 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 125.418 1.487 . . . . 0.0 107.689 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.452 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 0.5 OUTLIER -102.6 150.5 23.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.265 1.426 . . . . 0.0 109.437 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -149.99 151.91 23.91 Favored Glycine 0 CA--C 1.532 1.131 0 O-C-N 121.785 -0.572 . . . . 0.0 112.501 167.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -128.24 176.47 7.65 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 128.719 2.808 . . . . 0.0 109.075 -170.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.6 t -161.95 153.64 18.77 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 128.047 2.539 . . . . 0.0 111.832 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -63.91 160.91 16.64 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.353 -0.842 . . . . 0.0 109.906 165.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -93.56 33.85 1.23 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.658 0.783 . . . . 0.0 112.466 -175.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 24.3 m -68.51 -20.93 64.61 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.605 -1.31 . . . . 0.0 112.996 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -95.53 -142.09 12.55 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 126.001 1.762 . . . . 0.0 113.06 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 64.1 m -134.26 161.88 33.7 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.489 1.916 . . . . 0.0 109.342 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -54.03 -37.56 64.25 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.98 -1.075 . . . . 0.0 113.832 -174.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.11 -9.2 59.84 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.586 1.088 . . . . 0.0 115.107 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 8.7 mt -111.89 -31.16 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 127.14 2.176 . . . . 0.0 111.098 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -80.05 -33.07 39.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.867 1.267 . . . . 0.0 113.341 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 16.7 mm -56.91 -54.9 49.4 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 125.894 1.678 . . . . 0.0 112.687 172.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -70.16 -27.87 24.02 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.381 1.387 . . . . 0.0 112.314 174.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.81 -50.64 71.51 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 120.507 1.503 . . . . 0.0 111.256 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.7 m -68.65 -33.03 73.3 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.64 -36.43 73.42 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.83 0.852 . . . . 0.0 112.014 176.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -62.08 -46.09 90.61 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.547 0.739 . . . . 0.0 111.195 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -64.45 -36.86 85.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.816 0.28 . . . . 0.0 110.835 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -70.19 -38.49 75.37 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -65.05 -39.69 93.67 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 125.013 1.325 . . . . 0.0 110.653 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 67.7 mt -60.13 -42.81 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.179 0.592 . . . . 0.0 111.18 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 38.4 t -65.61 -43.77 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.192 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -61.88 -41.3 97.71 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.178 0.513 . . . . 0.0 111.937 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.5 -39.54 88.76 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.337 1.055 . . . . 0.0 111.046 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -66.01 -42.26 89.93 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.35 -40.96 94.26 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.094 0.557 . . . . 0.0 111.161 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.6 t -67.95 -38.2 79.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 O-C-N 121.66 -0.65 . . . . 0.0 111.063 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.0 -33.59 73.91 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.871 0.868 . . . . 0.0 113.202 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -64.07 -45.73 87.47 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.719 0.808 . . . . 0.0 110.953 170.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 158.54 2.43 0.08 OUTLIER Glycine 0 CA--C 1.528 0.87 0 N-CA-C 117.298 1.679 . . . . 0.0 117.298 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 4.4 t -72.77 135.83 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 120.404 2.102 . . . . 0.0 109.365 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.18 141.16 58.17 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.857 -1.152 . . . . 0.0 110.581 170.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.25 -27.79 53.35 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.193 0.902 . . . . 0.0 113.586 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.31 -28.28 69.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.764 1.226 . . . . 0.0 113.896 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -97.2 -0.05 47.48 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.707 1.603 . . . . 0.0 114.034 -173.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 18.7 mm -119.54 140.55 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.827 1.651 . . . . 0.0 109.157 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -132.16 162.13 31.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.691 1.596 . . . . 0.0 109.622 167.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 39.0 p -135.15 146.75 49.07 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.86 0.864 . . . . 0.0 112.017 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 25.8 t -140.42 136.0 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.912 1.285 . . . . 0.0 109.721 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -107.74 105.03 2.17 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.164 1.84 . . . . 0.0 110.887 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.452 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 1.9 mp -98.69 17.13 19.99 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 127.5 2.32 . . . . 0.0 112.969 -171.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 18.2 -97.37 0.01 OUTLIER Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.981 1.277 . . . . 0.0 116.287 -171.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 4.1 m -119.96 13.05 12.15 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -171.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 4.8 m -65.63 161.44 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 121.152 -0.967 . . . . 0.0 111.581 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 16.3 m120 40.41 54.8 6.82 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 125.305 1.442 . . . . 0.0 114.157 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.68 138.95 56.0 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.215 2.61 . . . . 0.0 112.27 -173.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 11.8 pt -138.84 0.81 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 125.074 1.349 . . . . 0.0 114.594 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -148.68 139.6 22.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.455 1.102 . . . . 0.0 110.677 167.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 39.8 m -71.76 148.72 46.05 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.62 1.568 . . . . 0.0 113.798 -173.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -73.98 -2.79 25.58 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 171.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.46 -17.9 64.29 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.11 1.364 . . . . 0.0 114.529 -172.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 79.7 p -140.57 149.99 58.98 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.414 1.486 . . . . 0.0 110.561 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -62.13 -27.34 78.76 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.19 2.593 . . . . 0.0 112.634 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -62.4 -46.66 87.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.669 0.787 . . . . 0.0 111.764 170.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.22 -35.16 82.35 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 123.545 0.593 . . . . 0.0 112.669 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -59.03 -50.26 74.76 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.967 0.907 . . . . 0.0 110.896 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.74 -19.03 58.11 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 121.431 -0.793 . . . . 0.0 112.502 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -82.43 -15.07 53.93 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.07 1.748 . . . . 0.0 114.758 168.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.403 ' C ' ' H ' ' A' ' 320' ' ' ARG 0.251 17.1 t-20 -101.17 -22.23 14.73 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 120.292 1.405 . . . . 0.0 111.286 168.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -68.95 11.24 0.21 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.04 -1.662 . . . . 0.0 114.308 166.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.403 ' H ' ' C ' ' A' ' 318' ' ' ASN . 16.5 ptp180 -61.15 165.97 4.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.732 2.013 . . . . 0.0 113.575 -175.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 18.6 m -130.38 151.03 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.728 1.611 . . . . 0.0 111.262 176.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -139.62 159.83 41.27 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.368 1.467 . . . . 0.0 111.397 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 14.7 tt -135.81 135.16 51.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.8 1.24 . . . . 0.0 112.171 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 59.8 t -137.4 122.59 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.029 1.332 . . . . 0.0 110.223 -171.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 38.9 t -70.25 133.57 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.46 1.104 . . . . 0.0 109.274 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 . . . . . 0 C--O 1.251 1.153 0 C-N-CA 124.394 1.078 . . . . 0.0 113.307 -171.623 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.469 0 CA-C-O 118.986 -0.897 . . . . 0.0 114.287 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -70.83 -18.11 32.24 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.91 3.074 . . . . 0.0 113.689 -173.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 30.6 t -124.33 3.48 8.46 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 127.0 2.12 . . . . 0.0 111.601 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.25 -19.85 66.15 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.409 -1.432 . . . . 0.0 114.572 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -139.6 47.83 1.85 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.955 2.502 . . . . 0.0 109.755 172.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.49 -34.14 34.52 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.912 1.685 . . . . 0.0 112.314 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -66.68 -46.92 74.1 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.106 0.963 . . . . 0.0 112.012 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 14.4 t -65.8 -39.25 90.73 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.169 0.987 . . . . 0.0 112.143 177.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.58 95.11 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 4.2 mt -74.28 -32.69 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.737 0.815 . . . . 0.0 112.116 174.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -64.22 -34.52 78.29 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.168 -0.957 . . . . 0.0 112.182 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -70.17 -36.38 74.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.216 1.006 . . . . 0.0 112.699 172.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 36.7 t -62.05 -43.18 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.143 0.977 . . . . 0.0 111.738 171.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 64.9 p -83.01 -19.28 37.29 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 64.4 18.06 62.72 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.721 1.629 . . . . 0.0 114.304 -171.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 121.9 -146.58 17.05 Favored Glycine 0 CA--C 1.544 1.898 0 C-N-CA 125.214 1.387 . . . . 0.0 112.881 -173.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.67 171.76 15.74 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.967 3.111 . . . . 0.0 112.129 172.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -131.25 144.78 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.441 1.096 . . . . 0.0 110.159 171.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -115.06 173.74 6.34 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.974 1.709 . . . . 0.0 114.393 -170.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -132.06 88.15 2.52 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.345 1.458 . . . . 0.0 109.423 -176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -66.55 164.1 42.35 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.531 1.539 . . . . 0.0 115.282 -171.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 29.9 -66.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.925 1 C-N-CA 131.842 4.057 . . . . 0.0 117.655 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -63.08 -26.02 68.64 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.158 1.383 . . . . 0.0 113.389 173.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.79 7.67 77.82 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.78 1.181 . . . . 0.0 115.002 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -156.69 13.67 0.28 Allowed 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 126.511 1.924 . . . . 0.0 114.557 -175.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 35.1 m -93.45 88.3 5.89 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.341 -1.474 . . . . 0.0 112.405 -170.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 16.9 tp -71.03 96.97 1.38 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.065 1.346 . . . . 0.0 110.328 171.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 4.2 pt -66.11 159.82 68.35 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 125.102 1.361 . . . . 0.0 111.988 -172.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.42 -33.61 78.94 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.269 1.979 . . . . 0.0 112.674 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -67.18 -29.84 69.64 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.925 1.084 . . . . 0.0 113.925 171.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.88 -47.26 86.47 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.521 1.055 . . . . 0.0 111.924 174.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -58.6 -24.25 60.54 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.303 1.041 . . . . 0.0 113.157 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -39.5 87.73 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.258 -0.901 . . . . 0.0 112.005 174.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 37.2 mm -58.69 -47.21 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 120.889 -1.132 . . . . 0.0 110.392 171.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 7.9 mp -62.01 -37.3 84.37 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.438 0.695 . . . . 0.0 111.887 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -61.25 -39.72 91.38 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.073 1.349 . . . . 0.0 112.573 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 13.7 mmt85 -69.03 -39.19 79.37 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 172.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.3 t -64.85 -40.21 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.124 0.57 . . . . 0.0 110.918 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.66 98.14 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.397 1.079 . . . . 0.0 111.95 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.85 -36.96 84.95 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -76.11 -29.03 57.72 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.41 -45.98 78.1 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.202 1.001 . . . . 0.0 111.437 169.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -58.07 -34.04 69.71 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.501 1.521 . . . . 0.0 112.645 173.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.96 -9.08 58.45 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.319 1.448 . . . . 0.0 114.564 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 13.1 t -157.74 66.54 3.61 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.01 1.324 . . . . 0.0 109.52 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -62.73 -9.3 15.76 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.085 2.523 . . . . 0.0 112.196 173.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -70.46 -16.61 62.94 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.776 1.63 . . . . 0.0 113.415 171.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -119.27 80.64 1.59 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.518 1.527 . . . . 0.0 110.687 -176.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 65.5 mtt85 -51.71 148.1 5.9 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.927 1.291 . . . . 0.0 111.553 173.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.54 158.41 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.519 1.128 . . . . 0.0 112.548 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 18.0 m -130.83 134.4 46.79 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 172.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 51.8 mt -104.76 124.85 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 125.198 1.399 . . . . 0.0 107.557 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -114.32 129.54 56.64 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.276 1.03 . . . . 0.0 109.799 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -119.3 157.43 15.39 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 122.089 -0.382 . . . . 0.0 112.154 173.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -125.47 167.82 14.48 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 128.156 2.582 . . . . 0.0 108.615 -170.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.5 m -144.57 169.3 18.23 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 127.076 2.15 . . . . 0.0 109.747 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.32 158.15 5.77 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.806 1.242 . . . . 0.0 111.701 170.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -96.88 -4.4 40.25 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 121.32 -0.863 . . . . 0.0 112.997 173.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 2.3 p -68.33 -31.02 70.14 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.848 1.659 . . . . 0.0 114.886 177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -76.19 -161.25 10.91 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 126.471 1.986 . . . . 0.0 114.082 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 8.0 t -130.59 154.25 48.05 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.608 1.563 . . . . 0.0 109.858 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -58.61 -32.58 69.14 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -171.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.46 -13.91 56.04 Favored Glycine 0 CA--C 1.541 1.671 0 O-C-N 121.058 -1.026 . . . . 0.0 114.859 171.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 2.9 mt -106.62 -34.33 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 127.101 2.161 . . . . 0.0 111.346 173.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -78.93 -31.78 45.32 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -174.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 20.6 mm -61.16 -53.92 58.69 Favored Pre-proline 0 N--CA 1.47 0.538 0 C-N-CA 125.969 1.708 . . . . 0.0 112.042 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.76 -34.86 17.53 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 CA-C-N 120.913 1.362 . . . . 0.0 112.561 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 6.9 mp -66.72 -43.26 84.72 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.68 1.127 . . . . 0.0 112.561 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 31.2 p -69.12 -36.12 77.17 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.38 -40.11 77.6 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.225 0.61 . . . . 0.0 111.335 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 54.4 mm-40 -62.65 -40.33 96.7 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.436 0.694 . . . . 0.0 111.347 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 29.3 mtt85 -68.7 -23.17 64.34 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -83.63 -39.69 19.95 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 167.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -65.29 -35.96 82.62 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.416 1.486 . . . . 0.0 112.254 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 74.9 mt -66.17 -39.98 85.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 118.892 0.769 . . . . 0.0 110.552 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 88.2 t -65.62 -45.68 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 122.179 -0.326 . . . . 0.0 110.669 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.2 96.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.72 0.408 . . . . 0.0 111.456 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.88 -39.01 92.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.718 0.807 . . . . 0.0 111.738 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -65.85 -42.47 90.4 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 175.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 2.1 mp -68.72 -37.59 79.59 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 122.003 -0.435 . . . . 0.0 111.916 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 45.9 t -66.22 -40.1 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 O-C-N 121.439 -0.788 . . . . 0.0 110.731 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.09 -33.51 75.63 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 19.9 ttt85 -66.34 -41.95 88.84 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.478 168.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 156.91 1.04 0.1 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 173.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.8 t -69.64 132.9 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 120.399 2.099 . . . . 0.0 109.3 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.71 135.92 53.49 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.196 -0.94 . . . . 0.0 110.069 172.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.07 -26.81 50.13 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.525 1.06 . . . . 0.0 113.819 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.66 -29.52 70.13 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.763 1.225 . . . . 0.0 113.61 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -96.43 -7.61 34.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.155 1.782 . . . . 0.0 113.977 -175.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 3.4 tt -139.27 99.37 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 122.352 1.072 . . . . 0.0 112.331 -171.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -102.4 169.97 8.36 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.327 1.451 . . . . 0.0 112.265 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 40.1 p -137.85 146.92 44.03 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.417 1.087 . . . . 0.0 113.171 -176.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.4 t -141.15 139.51 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.433 1.493 . . . . 0.0 110.98 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -95.51 113.62 4.67 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.538 1.066 . . . . 0.0 111.429 169.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 42.3 mt -105.21 33.39 3.69 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.072 2.549 . . . . 0.0 110.13 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 0.72 -69.79 0.0 OUTLIER Glycine 0 C--N 1.35 1.359 0 N-CA-C 120.154 2.822 . . . . 0.0 120.154 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 54.2 p -148.72 24.65 0.96 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.7 1.75 . . . . 0.0 114.447 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 8.5 m -64.75 155.95 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 O-C-N 121.252 -0.905 . . . . 0.0 110.676 167.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 39.24 55.11 5.51 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 125.2 1.4 . . . . 0.0 114.083 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -61.71 149.51 89.65 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.237 2.625 . . . . 0.0 112.004 -172.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.38 -2.97 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -170.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -153.04 154.01 34.04 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.177 -0.952 . . . . 0.0 112.642 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 68.1 m -67.41 138.15 56.47 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.42 1.488 . . . . 0.0 111.237 167.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -92.25 11.64 25.08 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.603 1.161 . . . . 0.0 112.026 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.34 -16.56 62.44 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.408 1.483 . . . . 0.0 114.433 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 70.7 p -137.67 148.42 61.09 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 125.618 1.567 . . . . 0.0 110.425 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -61.78 -31.22 85.54 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.226 2.618 . . . . 0.0 112.568 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.88 -36.35 77.98 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -71.27 -39.8 61.72 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 121.529 0.516 . . . . 0.0 112.874 172.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -56.92 -45.85 82.4 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 124.123 0.969 . . . . 0.0 110.839 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.66 -39.55 88.78 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.906 0.882 . . . . 0.0 112.74 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -72.33 -20.43 61.48 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.551 1.54 . . . . 0.0 114.031 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -102.6 -15.04 16.51 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.092 1.357 . . . . 0.0 113.364 172.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -82.07 12.61 4.03 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 126.614 1.966 . . . . 0.0 113.141 166.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -56.89 168.34 0.65 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.454 1.902 . . . . 0.0 115.326 -171.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 14.0 p -129.64 142.33 44.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 125.179 1.392 . . . . 0.0 110.189 167.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -139.91 165.34 27.59 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.76 2.024 . . . . 0.0 110.737 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 14.8 tt -138.28 154.0 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.1 0.96 . . . . 0.0 112.636 -175.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.5 161.55 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.334 1.854 . . . . 0.0 110.461 -175.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 59.0 t -107.3 135.84 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.52 1.128 . . . . 0.0 109.359 173.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.177 0 C-N-CA 125.177 1.391 . . . . 0.0 111.774 -173.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.745 0 CA-C-O 119.105 -0.831 . . . . 0.0 114.789 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.36 -19.37 38.1 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 124.055 3.17 . . . . 0.0 114.401 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 43.9 t -122.63 -8.4 8.5 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.254 1.822 . . . . 0.0 112.295 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -63.6 -16.76 61.76 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -174.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -137.89 40.71 2.34 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.199 2.2 . . . . 0.0 111.093 174.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.2 mt -46.86 -38.43 10.34 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.189 0.995 . . . . 0.0 112.193 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -60.46 -38.52 84.46 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.438 0.695 . . . . 0.0 112.296 -175.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.3 t -70.81 -45.64 64.26 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.359 0.664 . . . . 0.0 111.959 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.64 -40.67 97.75 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 15.3 mt -73.16 -33.83 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.883 0.873 . . . . 0.0 110.728 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.3 -39.16 92.13 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.363 -0.835 . . . . 0.0 112.046 172.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.97 76.34 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.273 1.029 . . . . 0.0 113.046 176.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.7 t -64.55 -40.8 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.139 0.976 . . . . 0.0 111.245 172.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 16.9 m -84.12 -24.49 30.26 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.881 0.873 . . . . 0.0 112.96 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.38 15.37 72.66 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 126.23 1.871 . . . . 0.0 115.135 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 126.78 -156.41 20.09 Favored Glycine 0 CA--C 1.542 1.747 0 C-N-CA 125.311 1.434 . . . . 0.0 112.962 -174.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.64 170.43 20.02 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 124.16 3.24 . . . . 0.0 111.817 169.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.93 108.69 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.579 1.151 . . . . 0.0 110.752 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -80.54 171.7 14.71 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.469 2.308 . . . . 0.0 112.554 169.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -119.29 150.95 39.27 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.099 0.475 . . . . 0.0 111.147 -171.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -57.31 170.76 3.26 Favored Glycine 0 CA--C 1.541 1.716 0 O-C-N 121.147 -0.971 . . . . 0.0 111.863 166.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -48.68 -28.19 3.39 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -171.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -65.29 -17.92 64.89 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.92 8.41 76.07 Favored Glycine 0 CA--C 1.542 1.774 0 C-N-CA 124.698 1.142 . . . . 0.0 115.215 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -167.53 8.88 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.1 t -73.84 105.42 5.11 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 122.053 2.206 . . . . 0.0 112.12 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.7 mp -74.13 102.5 4.26 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.169 0.988 . . . . 0.0 111.479 172.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . 0.471 HG13 ' H ' ' A' ' 236' ' ' ASP . 5.9 pt -56.97 152.65 27.13 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.065 1.746 . . . . 0.0 112.635 167.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -63.15 -29.57 74.26 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.619 2.212 . . . . 0.0 112.406 173.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.71 92.03 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.737 0.815 . . . . 0.0 112.952 172.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . 0.471 ' H ' HG13 ' A' ' 233' ' ' ILE . 28.4 t70 -61.62 -47.8 83.78 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 119.025 0.83 . . . . 0.0 111.663 171.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -61.11 -35.0 75.84 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.559 -0.713 . . . . 0.0 112.488 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -69.27 -42.65 75.24 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.761 -1.212 . . . . 0.0 112.555 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 56.1 mt -56.49 -47.26 82.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 121.162 -0.962 . . . . 0.0 110.496 171.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 73.5 mt -64.49 -33.34 75.66 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.585 0.754 . . . . 0.0 112.69 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -62.61 -41.58 99.07 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.289 1.036 . . . . 0.0 112.676 175.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -69.57 -36.49 76.33 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 74.3 t -67.31 -41.42 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.504 0.722 . . . . 0.0 111.19 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.01 93.7 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.889 0.876 . . . . 0.0 112.246 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -65.75 -36.98 85.11 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.751 -0.593 . . . . 0.0 112.047 173.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -63.5 -36.15 82.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.153 0.981 . . . . 0.0 112.711 174.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.457 HD22 HG11 ' A' ' 255' ' ' VAL . 5.4 mp -66.71 -41.76 87.45 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.487 0.585 . . . . 0.0 112.173 171.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -60.93 -30.75 70.39 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.421 1.088 . . . . 0.0 112.532 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -74.99 -9.51 58.61 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.909 1.684 . . . . 0.0 114.627 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 17.1 t -155.92 69.39 5.1 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.483 1.513 . . . . 0.0 108.644 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -62.96 -5.54 7.82 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.518 2.812 . . . . 0.0 112.716 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -74.16 -17.89 60.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.463 1.505 . . . . 0.0 113.256 171.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -118.78 83.52 2.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.453 1.501 . . . . 0.0 111.251 -171.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 55.7 mtt85 -55.23 157.39 3.58 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.123 1.369 . . . . 0.0 112.129 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.457 HG11 HD22 ' A' ' 247' ' ' LEU . 4.5 m -126.18 161.29 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 169.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.6 m -128.89 140.77 51.53 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.339 1.456 . . . . 0.0 109.258 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 61.7 mt -113.84 127.03 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.815 1.246 . . . . 0.0 108.759 -173.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.416 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 1.4 m120 -119.73 118.4 30.8 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.919 1.688 . . . . 0.0 107.764 -172.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -121.77 151.16 16.98 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 118.549 0.613 . . . . 0.0 112.791 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -127.35 168.69 14.47 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 128.423 2.689 . . . . 0.0 109.81 -170.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.2 m -152.42 156.69 40.0 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.362 1.865 . . . . 0.0 109.642 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.66 157.63 37.65 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.53 -1.356 . . . . 0.0 109.761 165.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -92.0 33.22 1.07 Allowed 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 121.431 0.634 . . . . 0.0 112.642 -177.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 13.0 m -66.29 -23.14 66.33 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.016 1.326 . . . . 0.0 112.773 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -99.93 -139.69 10.96 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 126.384 1.945 . . . . 0.0 112.752 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 62.2 m -139.25 163.57 32.12 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.603 1.961 . . . . 0.0 109.587 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -53.61 -38.93 64.49 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 121.035 -1.04 . . . . 0.0 113.196 -177.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -65.93 -10.12 49.7 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 124.589 1.09 . . . . 0.0 115.197 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 13.8 mt -110.1 -32.45 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.796 2.038 . . . . 0.0 111.156 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -82.35 -29.77 30.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.344 1.058 . . . . 0.0 112.927 -174.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 21.1 mm -59.37 -55.57 44.71 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 125.724 1.61 . . . . 0.0 111.759 169.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.87 -31.93 19.11 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 CA-C-N 120.836 1.334 . . . . 0.0 113.284 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 4.3 mp -64.65 -50.63 66.32 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 120.23 1.377 . . . . 0.0 111.865 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 46.5 p -65.38 -33.19 75.37 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -72.32 -38.06 68.76 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.884 0.874 . . . . 0.0 112.169 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -62.92 -41.78 99.58 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.764 1.226 . . . . 0.0 111.103 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.7 mmt-85 -63.19 -38.74 92.37 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.678 0.672 . . . . 0.0 111.598 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -71.33 -38.4 71.69 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -65.68 -37.74 87.33 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 125.264 1.426 . . . . 0.0 112.08 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 82.1 mt -64.59 -41.36 92.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 118.587 0.631 . . . . 0.0 110.572 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 86.2 t -65.42 -41.73 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 122.047 -0.408 . . . . 0.0 111.527 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -64.68 -41.14 96.26 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.939 0.496 . . . . 0.0 111.882 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.59 -37.71 87.4 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.827 0.851 . . . . 0.0 111.57 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -65.09 -42.15 94.32 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 174.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.2 mp -63.99 -40.75 97.07 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.843 -0.536 . . . . 0.0 111.716 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 53.3 t -68.16 -38.45 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.67 0.788 . . . . 0.0 110.798 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.25 -34.39 77.35 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.131 0.972 . . . . 0.0 112.879 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -43.64 93.83 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.903 0.881 . . . . 0.0 111.279 170.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 156.67 1.86 0.1 OUTLIER Glycine 0 CA--C 1.53 1.019 0 N-CA-C 117.746 1.858 . . . . 0.0 117.746 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.0 m -73.67 145.83 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-N 121.066 2.433 . . . . 0.0 110.799 -174.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.61 140.25 55.53 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.616 -0.678 . . . . 0.0 110.788 172.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -54.54 -27.94 43.35 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.309 1.433 . . . . 0.0 113.843 171.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.1 -32.14 72.67 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.395 1.078 . . . . 0.0 113.316 172.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -90.23 2.29 55.57 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.261 1.424 . . . . 0.0 114.218 -173.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 14.9 tt -138.88 139.95 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.482 0.713 . . . . 0.0 112.559 -171.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -139.4 164.31 30.19 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.217 1.407 . . . . 0.0 111.631 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 45.9 p -138.99 146.11 40.52 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.662 1.185 . . . . 0.0 111.977 -175.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 40.5 t -142.18 138.39 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.792 1.637 . . . . 0.0 109.934 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -107.75 97.97 1.2 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.117 1.818 . . . . 0.0 111.692 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.416 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 1.9 mp -97.01 29.96 2.9 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.443 2.697 . . . . 0.0 110.223 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 0.61 -66.14 0.0 OUTLIER Glycine 0 C--N 1.346 1.122 0 N-CA-C 120.919 3.127 . . . . 0.0 120.919 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 91.5 p -146.81 16.1 1.23 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.064 1.432 . . . . 0.0 114.732 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 17.7 m -71.76 154.37 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 O-C-N 121.106 -0.996 . . . . 0.0 111.098 171.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 22.4 m120 41.71 50.16 4.45 Favored Pre-proline 0 CA--C 1.559 1.327 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.6 125.35 12.64 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.838 2.359 . . . . 0.0 111.404 -174.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 2.0 pp -97.84 -1.11 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -173.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -146.32 166.95 24.78 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.855 1.662 . . . . 0.0 111.714 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 85.9 p -80.92 158.58 25.22 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 122.253 1.025 . . . . 0.0 113.411 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -86.7 -4.87 59.23 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.601 1.16 . . . . 0.0 110.987 165.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.57 -18.69 61.59 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.815 1.646 . . . . 0.0 114.447 -174.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 71.6 p -133.26 142.88 45.95 Favored Pre-proline 0 N--CA 1.474 0.759 0 CA-C-N 119.337 0.971 . . . . 0.0 110.575 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.7 -28.12 68.74 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.447 2.764 . . . . 0.0 112.707 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -66.08 -41.14 91.1 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.43 -0.794 . . . . 0.0 111.468 170.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -64.49 -38.23 95.49 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 124.184 0.897 . . . . 0.0 113.087 174.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -58.96 -49.0 79.52 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 124.21 1.004 . . . . 0.0 111.23 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -75.85 -22.84 55.83 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.249 -0.907 . . . . 0.0 112.105 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -70.18 -34.58 73.14 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.061 1.344 . . . . 0.0 112.769 167.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.41 ' C ' ' H ' ' A' ' 320' ' ' ARG . 0.9 OUTLIER -91.69 -16.51 26.85 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.144 1.378 . . . . 0.0 112.65 177.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 57.3 mtt180 -70.54 11.81 0.32 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.831 1.652 . . . . 0.0 113.779 167.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 318' ' ' ASN . 16.0 ptp180 -60.51 162.44 6.35 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.521 1.928 . . . . 0.0 114.038 -173.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.21 151.66 32.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.24 172.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -139.63 159.11 42.93 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.894 1.678 . . . . 0.0 111.542 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.35 129.28 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.179 1.392 . . . . 0.0 108.708 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 64.8 t -134.05 129.57 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.209 1.404 . . . . 0.0 110.359 -171.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 23.8 t -72.84 134.92 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.546 0.738 . . . . 0.0 109.749 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.208 0 C-N-CA 125.036 1.335 . . . . 0.0 111.707 -171.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.668 0 CA-C-O 119.198 -0.779 . . . . 0.0 114.626 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -70.21 -16.78 35.76 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.14 3.227 . . . . 0.0 114.277 -171.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 49.3 t -120.45 -2.99 9.93 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 126.759 2.024 . . . . 0.0 111.832 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -63.59 -17.8 63.23 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 -171.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -138.3 29.4 2.46 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.953 2.101 . . . . 0.0 111.475 173.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.79 -19.14 64.77 Favored 'General case' 0 C--O 1.221 -0.44 0 O-C-N 121.437 -0.789 . . . . 0.0 112.721 -172.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -55.94 -40.12 72.7 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.642 1.11 . . . . 0.0 111.529 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 17.5 t -68.33 -44.49 75.2 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.311 0.645 . . . . 0.0 111.878 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.94 -35.96 82.85 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 55.0 mt -70.18 -39.96 77.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.651 1.58 . . . . 0.0 109.493 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -63.9 -40.01 95.51 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.11 -0.994 . . . . 0.0 111.897 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.96 -38.34 90.65 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.121 0.968 . . . . 0.0 112.772 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.91 -28.78 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 118.677 0.671 . . . . 0.0 112.201 177.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.4 m -71.52 -26.41 62.65 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.693 1.197 . . . . 0.0 112.24 169.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.03 25.48 74.62 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.409 1.481 . . . . 0.0 113.637 -172.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 97.3 -170.54 25.93 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.28 1.419 . . . . 0.0 112.751 -171.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.09 140.96 38.78 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.32 2.68 . . . . 0.0 110.992 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.94 142.05 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.634 1.174 . . . . 0.0 112.03 -170.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -104.88 174.16 6.0 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.219 1.807 . . . . 0.0 115.115 -171.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -134.29 84.14 2.09 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.14 1.376 . . . . 0.0 108.858 -173.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -48.54 151.96 2.73 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 126.727 2.108 . . . . 0.0 115.047 -170.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -2.63 -42.12 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 1 C-N-CA 133.628 4.771 . . . . 0.0 120.62 -171.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -63.19 -20.43 65.41 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.204 1.002 . . . . 0.0 113.472 168.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.67 8.06 77.51 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.465 1.507 . . . . 0.0 115.047 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -154.19 19.58 0.5 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 127.361 2.265 . . . . 0.0 112.005 -176.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 7.5 t -82.74 81.99 8.26 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.741 -1.225 . . . . 0.0 113.17 -170.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 22.0 tp -82.13 77.65 8.91 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.834 1.254 . . . . 0.0 110.206 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 3.8 pt -58.21 157.89 15.62 Favored Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 125.624 1.57 . . . . 0.0 112.135 -173.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -61.65 -32.68 87.2 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.224 1.949 . . . . 0.0 112.648 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -68.55 -29.12 67.61 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 172.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -59.1 -41.83 89.05 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.818 1.19 . . . . 0.0 112.359 175.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -60.96 -27.57 68.35 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.561 0.745 . . . . 0.0 112.933 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -64.01 -40.65 96.83 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.67 1.123 . . . . 0.0 111.752 175.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 45.2 mm -58.9 -44.52 90.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 121.579 -0.7 . . . . 0.0 110.221 171.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.05 -36.86 84.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.486 0.714 . . . . 0.0 112.795 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -60.97 -41.73 96.94 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 119.074 0.852 . . . . 0.0 112.157 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -66.3 -40.21 89.84 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.954 0.901 . . . . 0.0 112.311 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 76.2 t -66.78 -41.57 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 123.78 0.832 . . . . 0.0 110.81 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.02 -39.27 93.15 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.355 0.662 . . . . 0.0 112.049 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.7 -38.22 88.62 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.252 0.621 . . . . 0.0 112.082 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.38 -30.93 67.96 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 178.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.79 -43.23 72.53 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.025 0.93 . . . . 0.0 112.585 169.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -60.43 -27.5 67.54 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.325 1.45 . . . . 0.0 112.745 174.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -79.36 -8.13 58.85 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.006 1.723 . . . . 0.0 114.843 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 37.2 t -152.99 68.5 6.72 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 125.285 1.434 . . . . 0.0 108.903 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -62.59 -8.85 14.03 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.244 2.63 . . . . 0.0 112.271 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -72.23 -16.5 61.94 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.669 1.588 . . . . 0.0 113.507 173.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -121.54 81.28 1.78 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.274 1.429 . . . . 0.0 110.705 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -49.89 143.04 8.16 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.412 1.485 . . . . 0.0 111.502 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 16.8 m -135.42 163.03 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 176.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 5.2 t -143.07 146.39 33.75 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 3.4 mt -101.92 106.7 20.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.476 -169.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -81.87 154.41 25.86 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 166.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -148.69 152.75 24.74 Favored Glycine 0 CA--C 1.523 0.564 0 O-C-N 121.84 -0.537 . . . . 0.0 112.36 168.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -116.62 169.96 8.95 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.74 2.416 . . . . 0.0 108.633 -170.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.4 p -149.95 145.86 26.72 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.292 2.637 . . . . 0.0 109.78 171.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -63.44 168.31 4.68 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 120.984 -1.073 . . . . 0.0 112.929 174.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -101.33 21.08 14.67 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -171.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 3.9 m -68.71 -19.14 64.35 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.867 -1.145 . . . . 0.0 112.772 172.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -98.22 -152.55 28.12 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.12 1.819 . . . . 0.0 113.985 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 73.7 m -129.72 145.8 51.52 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.735 1.614 . . . . 0.0 110.472 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -53.56 -37.12 62.58 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.71 1.204 . . . . 0.0 113.754 -171.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -60.0 -28.86 66.88 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 123.955 0.788 . . . . 0.0 113.959 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 18.7 mm -95.94 -24.17 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 126.156 1.782 . . . . 0.0 112.142 175.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -86.76 -23.97 25.25 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -175.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 21.8 mm -58.67 -54.28 57.84 Favored Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 125.121 1.368 . . . . 0.0 112.228 167.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -70.63 -33.44 13.29 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 121.075 1.42 . . . . 0.0 113.116 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -72.35 -36.52 68.82 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.58 1.082 . . . . 0.0 112.856 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 61.7 p -68.82 -36.66 78.5 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.72 1.145 . . . . 0.0 113.536 171.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.36 85.12 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.339 1.055 . . . . 0.0 111.577 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -61.2 -42.7 99.05 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 124.918 1.287 . . . . 0.0 110.745 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 22.7 mtt85 -64.56 -32.12 73.64 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -75.92 -39.57 55.97 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 171.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -60.22 -45.65 92.45 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 125.319 1.448 . . . . 0.0 110.351 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 41.0 mm -66.27 -35.52 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 118.675 0.67 . . . . 0.0 111.011 -177.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.81 -44.28 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 O-C-N 121.992 -0.443 . . . . 0.0 111.162 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -66.1 -36.59 83.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.341 0.657 . . . . 0.0 111.658 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -63.03 -41.23 99.48 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.668 1.187 . . . . 0.0 111.458 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -64.1 -43.01 96.67 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 172.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.4 mp -63.12 -40.93 99.04 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.779 0.832 . . . . 0.0 111.659 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 39.1 t -63.98 -42.31 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.872 0.869 . . . . 0.0 110.922 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.36 -31.8 70.46 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -42.03 75.76 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.142 0.977 . . . . 0.0 111.901 172.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 159.77 -0.26 0.08 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 117.494 1.757 . . . . 0.0 117.494 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 2.6 t -74.87 124.28 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 120.664 2.232 . . . . 0.0 109.2 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.31 142.36 57.8 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.048 -1.032 . . . . 0.0 110.837 173.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -53.17 -28.88 35.24 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.169 1.366 . . . . 0.0 113.613 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -68.31 -22.57 64.71 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.23 1.412 . . . . 0.0 114.671 175.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -108.46 2.4 22.29 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.305 1.842 . . . . 0.0 113.898 -172.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 2.8 tp -133.76 124.85 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.372 1.469 . . . . 0.0 110.005 -172.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -122.91 172.69 8.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.731 1.212 . . . . 0.0 110.789 171.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 40.0 p -141.73 151.91 43.36 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.458 1.103 . . . . 0.0 112.527 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 7.8 t -142.57 132.77 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.396 1.078 . . . . 0.0 111.143 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -93.75 120.76 6.39 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 123.881 0.753 . . . . 0.0 111.256 169.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 63.8 mt -111.65 18.9 18.59 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.352 1.861 . . . . 0.0 113.327 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 16.47 -105.87 0.01 OUTLIER Glycine 0 CA--C 1.541 1.666 0 C-N-CA 124.863 1.22 . . . . 0.0 116.103 -171.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 16.9 m -111.47 13.51 21.44 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -172.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 6.3 m -61.33 159.17 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.68 1.127 . . . . 0.0 111.737 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 38.1 53.99 3.84 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 125.622 1.569 . . . . 0.0 113.78 175.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -64.06 150.79 87.62 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.922 2.414 . . . . 0.0 113.081 -171.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 22.8 pt -134.72 -4.94 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 127.211 2.205 . . . . 0.0 113.365 -171.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -147.77 152.81 38.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.593 1.157 . . . . 0.0 112.399 170.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 69.5 m -76.73 157.44 31.69 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.746 1.618 . . . . 0.0 112.936 174.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -73.14 -3.64 27.78 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.121 1.368 . . . . 0.0 113.273 170.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.19 -21.04 66.3 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.86 1.664 . . . . 0.0 115.367 -170.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 78.3 p -140.41 147.45 49.65 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 124.198 0.999 . . . . 0.0 111.182 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.73 -27.8 75.94 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.381 2.721 . . . . 0.0 112.603 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -65.06 -41.19 95.35 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.939 0.896 . . . . 0.0 112.386 170.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.55 -39.9 95.8 Favored Glycine 0 C--N 1.336 0.554 0 O-C-N 121.728 -0.607 . . . . 0.0 112.518 173.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -59.08 -43.29 91.79 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.771 0.828 . . . . 0.0 111.578 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.97 -41.61 99.59 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.892 0.877 . . . . 0.0 112.3 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.99 -11.41 60.86 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.613 1.565 . . . . 0.0 114.302 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . 0.256 0.4 OUTLIER -119.69 15.75 12.74 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.522 1.529 . . . . 0.0 111.667 172.001 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -105.56 8.58 33.36 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.992 1.717 . . . . 0.0 112.345 166.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -63.5 161.19 14.93 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -170.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 2.5 m -126.25 144.68 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 127.217 2.207 . . . . 0.0 110.779 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -147.57 134.69 20.42 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.468 1.107 . . . . 0.0 113.182 -171.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 23.2 mm -85.73 142.55 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.595 1.558 . . . . 0.0 110.758 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 43.5 t -139.6 129.39 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.394 1.077 . . . . 0.0 109.483 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 9.0 p -77.35 133.41 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.409 -0.807 . . . . 0.0 111.228 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 14.1 m120 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 125.233 1.413 . . . . 0.0 111.988 -177.698 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.711 0 CA-C-O 119.129 -0.817 . . . . 0.0 115.113 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -71.05 -14.76 32.2 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 124.19 3.26 . . . . 0.0 114.681 -171.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 33.0 t -133.6 -1.86 3.07 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 126.802 2.041 . . . . 0.0 112.092 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -62.24 -20.4 64.19 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 117.515 2.413 . . . . 0.0 117.515 -171.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -140.64 30.76 1.88 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.947 2.099 . . . . 0.0 111.292 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.0 tp -62.97 -19.73 64.58 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.341 -0.85 . . . . 0.0 113.221 -171.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -56.99 -39.5 74.77 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.222 0.919 . . . . 0.0 111.557 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 15.6 t -68.88 -43.63 74.91 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.549 0.74 . . . . 0.0 111.873 173.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.46 -35.01 79.63 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 60.8 mt -70.6 -39.49 76.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.466 1.506 . . . . 0.0 109.479 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -66.66 -33.42 75.6 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.221 -0.924 . . . . 0.0 112.873 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -70.43 -37.86 74.47 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.21 1.004 . . . . 0.0 112.402 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.26 -27.82 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 118.57 0.623 . . . . 0.0 112.451 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 68.5 p -84.8 -25.89 27.87 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 170.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.2 11.76 71.34 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 125.59 1.567 . . . . 0.0 113.855 -171.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 124.56 -174.46 17.07 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 126.565 2.031 . . . . 0.0 112.915 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -76.02 150.46 33.94 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.536 2.824 . . . . 0.0 110.337 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 10.5 mm -108.2 139.94 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -169.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -95.07 174.48 7.06 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 128.009 2.523 . . . . 0.0 114.613 -171.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -138.38 116.27 11.58 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.573 1.149 . . . . 0.0 110.636 -175.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -58.84 -162.71 0.07 OUTLIER Glycine 0 N--CA 1.477 1.381 0 C-N-CA 127.799 2.619 . . . . 0.0 117.056 -174.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -45.7 -37.59 5.99 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.451 1.9 . . . . 0.0 115.556 -175.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -69.65 -24.79 63.68 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.013 1.325 . . . . 0.0 113.913 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 90.37 -4.43 82.52 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 127.228 2.347 . . . . 0.0 115.16 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -156.34 16.87 0.34 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.132 1.373 . . . . 0.0 113.936 -171.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.0 t -85.33 100.1 11.59 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.647 -1.283 . . . . 0.0 110.851 -172.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 14.6 tp -80.26 93.83 5.97 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.615 1.166 . . . . 0.0 109.829 176.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 6.4 pt -63.49 160.0 46.38 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 125.776 1.631 . . . . 0.0 111.826 -173.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -61.91 -32.17 84.86 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.227 1.951 . . . . 0.0 112.596 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -67.67 -32.28 72.85 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 171.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.67 -44.32 90.17 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.508 1.049 . . . . 0.0 112.049 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -61.83 -20.12 63.31 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.01 0.924 . . . . 0.0 113.144 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -76.01 -42.75 47.08 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.557 1.071 . . . . 0.0 112.188 173.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 47.4 mm -58.92 -44.84 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 O-C-N 121.359 -0.838 . . . . 0.0 110.281 171.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.12 -34.68 78.97 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.654 0.782 . . . . 0.0 112.989 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -61.05 -42.12 97.87 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.049 0.94 . . . . 0.0 112.2 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -65.95 -38.47 88.69 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.303 1.041 . . . . 0.0 112.494 175.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 94.8 t -65.06 -42.68 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.167 0.587 . . . . 0.0 111.168 174.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.77 94.95 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.071 0.548 . . . . 0.0 111.875 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -64.08 -40.46 96.29 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.509 0.724 . . . . 0.0 111.988 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -70.96 -30.09 66.28 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.818 0.847 . . . . 0.0 113.092 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -43.98 73.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.838 0.855 . . . . 0.0 112.079 169.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -63.68 -23.07 67.22 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.014 1.326 . . . . 0.0 113.537 174.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.06 -10.02 59.08 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.275 1.43 . . . . 0.0 114.574 170.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 40.2 t -156.3 66.48 4.29 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 125.702 1.601 . . . . 0.0 109.141 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -64.78 -7.81 15.94 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.922 2.414 . . . . 0.0 111.773 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.91 -21.57 65.99 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.175 1.39 . . . . 0.0 113.017 170.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -107.93 95.22 5.53 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.123 1.369 . . . . 0.0 111.225 -175.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 23.3 mtt180 -49.72 141.21 10.23 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.524 1.13 . . . . 0.0 110.876 167.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.46 166.05 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.892 1.277 . . . . 0.0 111.561 173.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 7.2 t -149.16 146.74 27.81 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 118.387 2.736 . . . . 0.0 118.387 170.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 26.3 mt -100.4 115.02 40.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 124.982 1.313 . . . . 0.0 108.937 -171.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -93.93 155.64 17.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.99 -0.444 . . . . 0.0 110.043 169.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -147.19 152.56 24.69 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 121.7 0.611 . . . . 0.0 113.349 167.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.86 170.43 10.11 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.187 2.595 . . . . 0.0 109.982 -169.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 51.0 p -143.65 160.86 39.93 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.188 2.195 . . . . 0.0 110.485 167.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.94 152.0 28.84 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 122.578 1.18 . . . . 0.0 112.232 168.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -3.85 29.42 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -171.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.93 -16.4 63.83 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.261 1.825 . . . . 0.0 114.931 -173.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.57 -157.78 31.93 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.306 1.431 . . . . 0.0 114.219 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 68.1 m -131.58 143.7 50.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.682 1.593 . . . . 0.0 109.702 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -50.57 -40.17 51.51 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.715 1.206 . . . . 0.0 114.019 -171.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -63.96 -27.19 70.93 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 123.657 0.646 . . . . 0.0 114.113 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 11.3 mm -97.72 -24.51 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.842 1.657 . . . . 0.0 111.767 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -80.42 -32.89 37.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.124 0.97 . . . . 0.0 113.193 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 18.6 mm -55.17 -55.86 34.76 Favored Pre-proline 0 N--CA 1.471 0.588 0 C-N-CA 125.418 1.487 . . . . 0.0 112.298 171.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.84 -30.14 17.71 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 120.721 1.293 . . . . 0.0 112.811 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 16.7 mt -66.02 -44.77 83.72 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 119.778 1.172 . . . . 0.0 112.789 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.33 -37.3 80.4 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 176.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.72 -34.47 75.68 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.249 1.02 . . . . 0.0 111.61 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -63.17 -42.83 99.45 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.293 1.037 . . . . 0.0 110.855 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -60.13 -44.01 95.26 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.875 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.25 -37.28 77.87 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -64.32 -41.36 96.86 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 125.631 1.573 . . . . 0.0 111.576 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 37.0 mm -67.14 -38.72 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 118.785 0.72 . . . . 0.0 110.896 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 99.7 t -68.04 -42.33 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 O-C-N 121.938 -0.476 . . . . 0.0 111.385 177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -65.64 -40.02 92.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.265 0.626 . . . . 0.0 111.305 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.15 -39.25 93.62 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.306 0.642 . . . . 0.0 111.75 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -65.02 -42.95 93.95 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.9 mp -67.53 -39.94 85.06 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.896 0.478 . . . . 0.0 111.41 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 50.7 t -66.65 -39.36 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 123.822 0.849 . . . . 0.0 110.672 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.73 -34.19 76.37 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 176.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -69.04 -38.08 78.95 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.76 -0.638 . . . . 0.0 112.612 170.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 151.46 9.32 0.1 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-O 117.481 -1.733 . . . . 0.0 116.952 168.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.9 130.13 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 120.482 2.141 . . . . 0.0 108.985 176.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.98 135.92 57.75 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.256 -0.902 . . . . 0.0 110.722 172.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -57.34 -29.82 60.73 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.696 1.141 . . . . 0.0 113.859 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.73 -37.26 85.84 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 122.161 -0.611 . . . . 0.0 112.476 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -85.49 -1.34 56.97 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.437 1.495 . . . . 0.0 113.966 -171.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 15.1 tt -139.85 93.64 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 124.92 1.288 . . . . 0.0 111.58 -171.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -85.64 174.2 9.58 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.209 -0.932 . . . . 0.0 110.632 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 38.4 p -136.26 148.77 48.17 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.485 1.114 . . . . 0.0 111.869 172.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 11.1 t -137.33 132.12 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.889 0.876 . . . . 0.0 111.994 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -91.06 104.91 3.22 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.589 1.09 . . . . 0.0 111.761 173.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 39.9 mt -105.38 32.08 4.5 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.989 2.115 . . . . 0.0 110.866 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 2.59 -72.66 0.0 OUTLIER Glycine 0 C--N 1.35 1.325 0 C-N-CA 127.796 2.617 . . . . 0.0 119.543 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 88.2 p -147.35 21.42 1.2 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.245 1.523 . . . . 0.0 113.989 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 9.0 m -66.43 156.38 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 121.083 -1.01 . . . . 0.0 111.618 172.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 35.91 55.64 2.65 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 125.978 1.711 . . . . 0.0 113.769 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -61.57 123.97 13.73 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.212 2.608 . . . . 0.0 112.588 -171.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 47.1 pt -90.7 -3.0 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.512 1.125 . . . . 0.0 113.86 -173.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -153.08 166.8 31.32 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.81 1.644 . . . . 0.0 111.683 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 79.0 p -70.33 171.2 10.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.801 1.24 . . . . 0.0 113.633 175.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -113.29 3.42 15.94 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.828 1.251 . . . . 0.0 111.453 166.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.33 -21.39 62.06 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.718 1.607 . . . . 0.0 113.647 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 66.0 p -132.38 149.0 71.91 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 124.606 1.162 . . . . 0.0 110.934 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -62.35 -29.62 79.83 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.484 2.789 . . . . 0.0 112.541 176.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.51 -42.38 98.49 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.597 0.759 . . . . 0.0 112.239 171.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -66.25 -39.0 94.26 Favored Glycine 0 C--N 1.336 0.543 0 O-C-N 121.829 -0.544 . . . . 0.0 112.609 175.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -58.92 -46.85 86.93 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.46 0.704 . . . . 0.0 111.096 175.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.12 -40.92 99.01 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.713 0.805 . . . . 0.0 111.864 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -70.63 -12.04 61.31 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.397 1.479 . . . . 0.0 114.131 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . 0.256 49.7 t30 -120.3 3.75 10.82 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.806 1.243 . . . . 0.0 113.958 172.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -83.09 1.48 40.03 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.335 1.454 . . . . 0.0 112.087 164.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.46 156.73 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 131.569 3.947 . . . . 0.0 115.914 -170.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 1.3 m -119.39 141.64 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.116 1.766 . . . . 0.0 110.989 167.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -136.18 166.92 22.29 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.952 1.701 . . . . 0.0 111.438 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 13.7 tt -133.54 142.81 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.199 0.999 . . . . 0.0 112.062 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 47.5 t -138.79 130.34 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.51 0.724 . . . . 0.0 109.726 -171.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 42.7 t -82.26 127.54 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.347 0.659 . . . . 0.0 110.328 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 61.7 t30 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 130.143 3.377 . . . . 0.0 116.38 177.905 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 119.377 -0.344 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.61 159.34 53.1 Favored 'Trans proline' 0 CA--C 1.547 1.134 0 C-N-CA 123.46 2.773 . . . . 0.0 112.636 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.65 163.46 38.89 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.571 2.847 . . . . 0.0 112.406 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 78.15 -170.82 55.03 Favored Glycine 0 CA--C 1.543 1.837 0 C-N-CA 123.949 0.785 . . . . 0.0 114.515 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.89 162.76 40.14 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 123.755 2.97 . . . . 0.0 112.807 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -67.19 165.75 25.57 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.588 2.859 . . . . 0.0 113.117 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -135.44 25.41 3.47 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.452 1.501 . . . . 0.0 113.086 -171.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 36.8 p -58.35 151.83 18.89 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.786 1.234 . . . . 0.0 112.708 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 50.31 57.44 10.29 Favored Glycine 0 CA--C 1.542 1.742 0 C-N-CA 125.119 1.342 . . . . 0.0 114.424 -171.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.45 -12.99 32.5 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.441 3.427 . . . . 0.0 114.882 -171.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 20.2 t -133.2 -3.01 3.11 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 126.908 2.083 . . . . 0.0 111.878 176.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.67 -20.01 66.13 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -171.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -139.25 31.27 2.15 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.922 2.089 . . . . 0.0 111.35 174.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.7 tp -63.14 -17.1 61.99 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -171.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -53.71 -46.87 70.91 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.601 0.76 . . . . 0.0 111.489 167.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 20.1 t -69.17 -40.76 77.94 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.382 0.673 . . . . 0.0 111.409 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.39 -38.18 89.2 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 59.4 mt -71.98 -36.91 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.741 0.816 . . . . 0.0 109.593 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -65.61 -34.01 77.24 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.131 0.972 . . . . 0.0 112.557 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -70.18 -33.76 72.13 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.913 0.885 . . . . 0.0 112.86 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.0 t -65.54 -44.92 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 118.488 0.586 . . . . 0.0 111.192 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 69.5 p -77.26 -25.53 51.56 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -176.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 66.12 14.71 61.89 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.628 1.585 . . . . 0.0 114.212 -171.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 118.43 -171.83 14.23 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 126.024 1.774 . . . . 0.0 112.831 -172.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -76.5 167.39 25.7 Favored 'Trans proline' 0 CA--C 1.549 1.272 0 C-N-CA 123.682 2.922 . . . . 0.0 111.85 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.94 140.01 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 126.16 1.784 . . . . 0.0 113.143 -168.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -106.73 169.44 8.53 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.109 2.164 . . . . 0.0 115.614 -170.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.41 ' CZ ' ' HG3' ' A' ' 277' ' ' ARG . 92.0 m-85 -143.3 100.89 3.71 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.389 1.075 . . . . 0.0 111.586 -171.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -115.47 -174.45 17.96 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.71 1.624 . . . . 0.0 113.026 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 24.7 t30 50.43 -75.68 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 128.468 2.707 . . . . 0.0 114.527 -171.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -79.39 -25.54 42.12 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.454 1.902 . . . . 0.0 112.894 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.68 0.27 86.21 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.15 1.357 . . . . 0.0 115.542 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -162.21 26.44 0.11 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.519 1.528 . . . . 0.0 113.451 -175.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.8 t -120.32 97.36 5.55 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.356 1.062 . . . . 0.0 110.839 -171.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 18.6 tp -70.11 141.03 52.78 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.472 1.109 . . . . 0.0 113.178 -173.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 6.4 pt -83.36 150.63 60.89 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.097 1.759 . . . . 0.0 113.906 -172.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.29 -31.21 73.82 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.48 2.786 . . . . 0.0 112.882 173.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.92 94.87 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.588 0.755 . . . . 0.0 112.384 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.01 -39.96 78.98 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 170.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -60.4 -28.64 68.4 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.469 -1.394 . . . . 0.0 112.683 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -71.96 -41.2 68.0 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.689 -1.257 . . . . 0.0 113.24 170.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 90.8 mt -55.99 -44.13 77.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.042 -1.036 . . . . 0.0 110.134 168.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 31.7 mt -64.37 -32.31 73.87 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.196 0.998 . . . . 0.0 113.177 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -59.68 -42.87 93.89 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.704 1.138 . . . . 0.0 111.996 171.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -72.94 -32.83 65.52 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.149 0.58 . . . . 0.0 112.555 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 69.9 t -67.04 -43.23 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.639 0.775 . . . . 0.0 111.097 172.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.41 -42.44 95.96 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.083 0.553 . . . . 0.0 111.994 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.71 -37.17 85.7 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.362 0.665 . . . . 0.0 112.047 176.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.64 -34.21 73.71 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.919 0.888 . . . . 0.0 112.963 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.18 -45.9 75.56 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.739 0.815 . . . . 0.0 110.213 171.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 53.4 tttp -62.59 -23.39 67.01 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.079 1.751 . . . . 0.0 113.714 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -75.2 -8.35 56.36 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.847 1.659 . . . . 0.0 114.597 170.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 38.2 t -151.95 66.86 6.89 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 126.068 1.747 . . . . 0.0 108.507 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -63.83 -6.61 11.22 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.378 2.719 . . . . 0.0 112.318 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -71.72 -18.52 62.14 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.833 1.653 . . . . 0.0 113.229 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -120.76 87.14 2.7 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.688 1.595 . . . . 0.0 110.525 -172.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 63.7 mtt85 -52.69 158.49 1.3 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.812 1.245 . . . . 0.0 111.955 172.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.5 m -127.73 159.91 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.063 1.345 . . . . 0.0 111.722 174.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.1 m -125.96 138.05 53.73 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.46 1.504 . . . . 0.0 108.619 171.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.4 mt -119.33 121.59 66.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.001 1.32 . . . . 0.0 107.495 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -109.29 151.02 27.12 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.457 0.703 . . . . 0.0 110.288 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -139.84 156.9 25.09 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 122.007 -0.433 . . . . 0.0 112.475 167.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -127.73 169.57 13.69 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.893 2.477 . . . . 0.0 109.111 -170.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.5 m -149.14 153.01 37.08 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 127.366 2.266 . . . . 0.0 108.521 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -61.45 165.7 4.58 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.568 -1.333 . . . . 0.0 111.523 167.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -100.72 20.56 14.98 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -175.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.3 m -71.09 -20.19 62.37 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.816 -1.178 . . . . 0.0 112.943 169.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.09 -151.85 21.33 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 125.885 1.707 . . . . 0.0 113.38 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 8.3 t -139.44 164.35 30.11 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.302 1.441 . . . . 0.0 110.374 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -52.67 -42.17 64.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.975 0.91 . . . . 0.0 112.469 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -68.63 -5.09 42.85 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.436 1.017 . . . . 0.0 115.328 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 6.1 mt -115.79 -33.46 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.417 1.887 . . . . 0.0 111.266 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -86.94 -26.87 23.65 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.464 1.106 . . . . 0.0 113.257 -175.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 19.9 mm -60.0 -53.4 65.57 Favored Pre-proline 0 N--CA 1.469 0.496 0 C-N-CA 124.803 1.241 . . . . 0.0 111.546 168.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.27 -34.8 15.38 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 CA-C-N 120.831 1.333 . . . . 0.0 113.099 176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 17.9 mt -66.18 -44.8 82.98 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 120.345 1.429 . . . . 0.0 112.747 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 34.8 p -65.77 -37.12 85.47 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.74 -39.84 76.54 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.255 0.622 . . . . 0.0 111.716 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -63.22 -40.85 98.64 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.768 1.227 . . . . 0.0 111.037 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.41 ' HG3' ' CZ ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -63.8 -38.63 91.8 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 118.762 0.71 . . . . 0.0 112.143 177.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -72.59 -38.85 67.73 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -67.41 -36.26 80.92 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 125.481 1.513 . . . . 0.0 111.795 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 59.2 mt -62.56 -42.49 96.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 118.805 0.729 . . . . 0.0 110.843 175.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.02 -41.82 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 117.954 0.343 . . . . 0.0 110.952 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.04 97.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -69.14 -36.43 77.45 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.598 0.759 . . . . 0.0 111.158 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -66.44 -42.76 87.16 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.6 mp -64.26 -41.81 96.77 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.02 0.528 . . . . 0.0 111.233 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.04 -37.42 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 123.142 0.577 . . . . 0.0 111.404 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.01 -35.4 76.62 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -69.35 -37.67 77.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.888 0.875 . . . . 0.0 112.855 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 161.91 -1.54 0.07 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 118.093 1.997 . . . . 0.0 118.093 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 4.9 t -76.88 142.73 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 120.015 1.908 . . . . 0.0 110.368 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.13 137.68 47.18 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.679 -1.263 . . . . 0.0 110.858 167.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -57.74 -27.14 58.65 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.384 0.992 . . . . 0.0 113.906 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.63 -30.7 70.87 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.628 1.171 . . . . 0.0 113.21 173.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -88.32 -2.81 58.82 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.007 1.323 . . . . 0.0 114.377 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 5.1 mt -125.81 123.66 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.361 0.982 . . . . 0.0 111.403 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -105.16 159.24 16.01 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.453 1.501 . . . . 0.0 110.64 167.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 40.6 p -134.87 146.01 48.82 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.165 0.986 . . . . 0.0 111.792 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 25.3 t -138.86 130.49 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.112 0.965 . . . . 0.0 111.396 -175.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -87.54 100.93 2.64 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.552 1.072 . . . . 0.0 111.691 172.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 43.2 mt -97.35 33.34 2.01 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.918 2.087 . . . . 0.0 110.065 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 3.64 -72.69 0.0 OUTLIER Glycine 0 C--N 1.351 1.373 0 N-CA-C 120.33 2.892 . . . . 0.0 120.33 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 23.4 p -144.79 17.96 1.63 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.615 1.707 . . . . 0.0 113.892 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.7 m -70.59 161.33 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.059 1.344 . . . . 0.0 112.597 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 38.44 53.56 3.94 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 125.866 1.666 . . . . 0.0 113.269 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -64.34 151.7 84.38 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.658 2.239 . . . . 0.0 113.667 -170.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 45.9 pt -126.44 -3.76 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.901 1.68 . . . . 0.0 113.685 -172.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -151.74 149.57 29.21 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.134 1.373 . . . . 0.0 111.439 172.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 69.8 m -70.36 147.36 49.66 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.41 1.484 . . . . 0.0 112.078 171.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -82.74 5.98 19.59 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.365 1.066 . . . . 0.0 113.802 173.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.42 -13.98 62.68 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.051 1.34 . . . . 0.0 114.444 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 67.6 p -138.33 147.78 56.85 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 125.713 1.605 . . . . 0.0 110.472 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -63.92 -31.36 67.15 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 123.333 2.689 . . . . 0.0 112.423 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.94 -38.62 91.58 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.605 -0.684 . . . . 0.0 112.413 171.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.38 -36.95 85.36 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 123.767 0.699 . . . . 0.0 112.53 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -58.69 -49.54 77.2 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.528 0.731 . . . . 0.0 110.709 172.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.9 -37.28 86.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.377 0.671 . . . . 0.0 112.349 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -68.05 -17.65 64.46 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.391 1.476 . . . . 0.0 113.831 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -113.21 -8.09 13.55 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -74.42 9.71 1.61 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.868 1.667 . . . . 0.0 113.865 167.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.42 153.28 2.23 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.812 2.445 . . . . 0.0 114.8 -170.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 8.3 p -123.32 145.9 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.464 1.506 . . . . 0.0 109.648 168.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -142.98 158.53 43.51 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.413 1.485 . . . . 0.0 112.898 -174.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 20.2 tt -133.08 141.32 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.756 1.623 . . . . 0.0 111.745 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 16.9 t -144.46 133.5 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.365 1.466 . . . . 0.0 109.568 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 38.4 t -70.34 137.63 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.708 0.803 . . . . 0.0 109.893 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.253 1.252 0 C-N-CA 125.275 1.43 . . . . 0.0 111.766 -171.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 119.284 -0.388 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.57 160.89 47.44 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 123.481 2.787 . . . . 0.0 112.263 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.27 134.05 34.94 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.077 2.518 . . . . 0.0 111.662 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 171.81 56.82 0.04 OUTLIER Glycine 0 CA--C 1.539 1.561 0 CA-C-O 118.594 -1.115 . . . . 0.0 114.092 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.48 159.94 48.16 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 123.277 2.651 . . . . 0.0 112.557 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -64.5 133.27 36.43 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.311 2.674 . . . . 0.0 111.392 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.51 24.44 1.56 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.179 1.392 . . . . 0.0 113.176 -172.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 27.8 m -53.16 134.49 38.83 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.466 1.507 . . . . 0.0 112.685 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 57.95 58.83 12.53 Favored Glycine 0 CA--C 1.542 1.73 0 C-N-CA 124.625 1.107 . . . . 0.0 114.156 -173.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -70.78 -14.54 32.94 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.337 3.358 . . . . 0.0 114.352 -171.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 22.2 t -128.17 -3.24 5.67 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 127.32 2.248 . . . . 0.0 111.666 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.83 -18.55 65.43 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 -171.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -138.46 29.88 2.4 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.022 2.129 . . . . 0.0 111.604 175.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 6.8 tp -63.11 -17.66 62.56 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -53.65 -45.68 70.3 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.057 0.844 . . . . 0.0 111.361 167.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 20.7 t -68.51 -42.03 79.13 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 122.935 0.494 . . . . 0.0 111.616 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.32 -41.42 98.91 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 176.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 66.1 mt -71.56 -35.64 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.994 0.918 . . . . 0.0 109.759 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -68.48 -36.99 79.74 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.987 0.915 . . . . 0.0 112.661 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.99 76.62 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.075 0.95 . . . . 0.0 112.24 175.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 22.5 t -63.06 -41.35 92.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.588 1.155 . . . . 0.0 111.761 173.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 82.3 p -82.92 -19.26 37.63 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 66.12 15.8 63.51 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.961 1.743 . . . . 0.0 114.804 -172.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 129.74 -159.12 22.47 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 125.593 1.568 . . . . 0.0 112.937 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -74.66 171.42 18.22 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.702 2.934 . . . . 0.0 111.785 171.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 28.9 mt -113.39 136.24 50.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.005 1.722 . . . . 0.0 109.193 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -124.03 161.98 24.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.363 1.465 . . . . 0.0 113.005 -172.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -138.23 99.33 3.83 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.021 0.928 . . . . 0.0 111.93 -169.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -74.96 164.7 54.61 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.707 1.146 . . . . 0.0 113.831 -171.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 32.88 -78.02 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 130.238 3.415 . . . . 0.0 116.07 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.75 -28.2 67.43 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.177 1.391 . . . . 0.0 113.164 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 96.97 11.32 53.45 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 116.816 1.486 . . . . 0.0 116.816 167.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -156.68 25.93 0.33 Allowed 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.288 1.435 . . . . 0.0 112.746 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 52.9 m -92.37 90.94 7.44 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.598 1.159 . . . . 0.0 112.56 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.4 mp -68.36 104.33 1.85 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.662 0.785 . . . . 0.0 110.218 171.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 21.3 pt -67.24 163.62 44.27 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 125.215 1.406 . . . . 0.0 110.567 173.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.57 -30.47 79.42 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 CA-C-N 121.433 1.548 . . . . 0.0 112.251 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -66.09 -31.59 72.55 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 170.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -62.4 -54.29 42.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.625 1.102 . . . . 0.0 110.976 170.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -60.51 -29.12 68.89 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.33 -0.856 . . . . 0.0 112.882 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -65.68 -51.17 61.57 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.168 -0.957 . . . . 0.0 112.005 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.5 pp -69.05 -30.29 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 118.348 0.522 . . . . 0.0 111.56 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 60.2 mt -66.49 -36.66 83.3 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.497 0.719 . . . . 0.0 112.348 171.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -40.18 93.3 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.6 -0.688 . . . . 0.0 111.683 173.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -67.63 -37.63 82.74 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 67.9 t -63.36 -44.0 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 119.031 0.832 . . . . 0.0 111.22 173.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.12 -40.62 94.48 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.924 0.489 . . . . 0.0 111.226 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -66.33 -36.49 83.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.674 0.79 . . . . 0.0 112.605 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -70.82 -35.79 72.65 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.708 1.203 . . . . 0.0 112.854 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.408 HD23 HG12 ' A' ' 255' ' ' VAL . 11.7 tp -72.62 -38.72 67.68 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.428 1.491 . . . . 0.0 111.737 175.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -60.14 -28.07 67.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.518 1.927 . . . . 0.0 112.788 172.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -78.38 -5.25 51.74 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.37 1.468 . . . . 0.0 114.468 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 34.0 t -151.62 65.7 6.56 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.1 1.36 . . . . 0.0 108.859 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -65.09 -8.25 17.82 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.216 2.61 . . . . 0.0 111.881 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -70.39 -21.56 62.84 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.744 1.617 . . . . 0.0 113.256 171.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -120.64 90.01 3.24 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.693 1.597 . . . . 0.0 109.621 -173.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 71.8 mtt85 -49.5 153.18 1.17 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.551 1.14 . . . . 0.0 112.167 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.408 HG12 HD23 ' A' ' 247' ' ' LEU . 1.5 t -127.31 160.14 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 123.057 1.408 . . . . 0.0 110.308 -177.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.6 m -138.37 144.73 40.43 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.697 -2.047 . . . . 0.0 110.428 -173.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 57.8 mt -128.7 112.77 27.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.164 1.385 . . . . 0.0 108.429 -172.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.9 153.14 17.91 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.049 0.94 . . . . 0.0 110.645 176.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -152.44 152.7 24.36 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 121.616 -0.677 . . . . 0.0 113.45 169.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -123.9 161.68 24.86 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 127.724 2.41 . . . . 0.0 109.011 -170.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 65.1 m -138.74 143.54 39.08 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.827 2.051 . . . . 0.0 109.376 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . 0.256 2.2 p30 -63.07 150.89 41.48 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 123.57 1.652 . . . . 0.0 114.551 -171.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -71.12 -2.3 15.24 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 113.164 -1.835 . . . . 0.0 115.299 -171.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.7 -15.71 61.68 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.14 0.976 . . . . 0.0 112.919 171.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.48 -165.43 41.31 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 125.312 1.434 . . . . 0.0 114.574 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 69.6 m -139.59 150.81 45.45 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.404 1.882 . . . . 0.0 109.681 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -54.37 -37.93 65.53 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -171.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.93 -26.73 71.46 Favored Glycine 0 CA--C 1.536 1.358 0 O-C-N 121.376 -0.828 . . . . 0.0 114.112 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 21.2 mm -98.01 -26.29 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.778 1.631 . . . . 0.0 112.195 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -88.69 -24.69 22.66 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.35 1.06 . . . . 0.0 113.139 -173.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 15.4 mm -57.92 -54.94 50.21 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 125.003 1.321 . . . . 0.0 111.989 167.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.98 -34.72 13.31 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 CA-C-N 120.723 1.294 . . . . 0.0 112.483 175.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.19 -40.79 86.59 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 120.211 1.369 . . . . 0.0 112.752 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 5.2 m -72.21 -35.17 68.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.314 0.961 . . . . 0.0 113.393 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.75 -39.26 80.41 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.228 0.611 . . . . 0.0 111.761 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -64.74 -38.77 92.13 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 123.812 0.845 . . . . 0.0 111.305 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -63.86 -40.21 96.01 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.747 0.703 . . . . 0.0 111.985 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.83 -37.9 79.5 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -67.33 -35.59 79.71 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.865 1.666 . . . . 0.0 112.425 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 62.7 mt -63.95 -42.28 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 123.329 0.652 . . . . 0.0 110.794 174.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 65.0 t -65.93 -42.64 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 122.067 -0.396 . . . . 0.0 111.111 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.57 -42.45 96.68 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.08 0.552 . . . . 0.0 111.512 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -65.38 -38.86 91.29 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.502 0.721 . . . . 0.0 111.792 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.62 -41.52 88.24 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.9 -42.94 89.57 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.549 0.739 . . . . 0.0 110.888 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.81 -37.02 77.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.479 0.712 . . . . 0.0 110.918 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -68.61 -33.81 74.67 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 33.5 ttt85 -69.0 -40.02 78.98 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.361 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 159.59 0.34 0.08 OUTLIER Glycine 0 CA--C 1.525 0.674 0 N-CA-C 117.514 1.766 . . . . 0.0 117.514 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.1 t -69.57 134.4 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 120.341 2.071 . . . . 0.0 109.455 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.72 138.2 58.45 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.923 -1.111 . . . . 0.0 110.628 169.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.57 -29.73 58.08 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.022 0.82 . . . . 0.0 113.452 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -63.51 -26.51 68.75 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.928 1.291 . . . . 0.0 113.892 173.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 24.3 m170 -98.48 4.25 48.32 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.987 1.715 . . . . 0.0 113.941 -174.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 16.2 mm -119.44 144.64 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.917 1.687 . . . . 0.0 109.255 174.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -136.18 161.13 36.59 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.222 1.809 . . . . 0.0 110.127 168.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 47.4 p -134.32 146.79 50.3 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.139 0.976 . . . . 0.0 111.386 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.0 t -138.85 120.47 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.23 1.012 . . . . 0.0 110.475 -173.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -83.95 99.28 2.21 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.561 1.076 . . . . 0.0 111.174 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 43.4 mt -97.47 31.95 2.39 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.862 2.065 . . . . 0.0 109.758 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 3.31 -72.07 0.0 OUTLIER Glycine 0 C--N 1.352 1.454 0 C-N-CA 128.006 2.717 . . . . 0.0 119.565 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 1.3 t -149.6 25.16 0.86 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.061 1.431 . . . . 0.0 113.152 173.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 14.2 m -67.79 161.08 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 120.921 -1.112 . . . . 0.0 112.149 174.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 39.98 53.94 5.74 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 125.959 1.704 . . . . 0.0 114.416 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.09 138.88 48.96 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.676 2.251 . . . . 0.0 111.597 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 26.0 pt -134.81 4.11 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.581 1.552 . . . . 0.0 113.438 -173.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.88 165.47 32.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.834 1.654 . . . . 0.0 110.689 170.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 18.3 m -116.73 159.47 22.22 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.868 1.667 . . . . 0.0 112.194 -172.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 49.2 p30 -79.42 5.25 13.17 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -67.54 -14.05 62.6 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.305 1.442 . . . . 0.0 114.587 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 42.4 p -138.22 147.8 57.22 Favored Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 126.485 1.914 . . . . 0.0 109.873 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -63.66 -31.3 69.95 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.142 2.561 . . . . 0.0 112.53 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -71.91 -36.4 69.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.876 0.87 . . . . 0.0 112.806 171.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.26 -37.57 94.12 Favored Glycine 0 N--CA 1.469 0.853 0 C-N-CA 124.006 0.812 . . . . 0.0 113.526 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -55.59 -49.97 71.36 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.819 1.248 . . . . 0.0 110.332 169.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.15 84.89 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -66.97 -18.85 65.58 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 174.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . 0.409 0.3 OUTLIER -110.6 17.82 20.32 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 167.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -112.85 10.74 19.12 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 127.264 2.226 . . . . 0.0 113.13 166.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -60.92 160.72 9.27 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -170.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 41.0 t -129.78 145.07 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 127.164 2.186 . . . . 0.0 108.897 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -134.32 155.98 49.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.259 1.424 . . . . 0.0 111.364 -174.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 39.0 mt -136.3 135.77 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.694 1.197 . . . . 0.0 108.903 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 47.7 t -140.66 132.94 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.582 1.553 . . . . 0.0 110.574 -171.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 14.6 p -90.57 125.87 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.002 0.921 . . . . 0.0 111.16 167.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 . . . . . 0 C--O 1.253 1.261 0 C-N-CA 125.792 1.637 . . . . 0.0 113.246 -177.859 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 119.277 -0.392 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.68 160.23 50.49 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.53 2.82 . . . . 0.0 112.346 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.41 137.0 41.76 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.092 2.528 . . . . 0.0 111.524 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 164.19 61.67 0.02 OUTLIER Glycine 0 CA--C 1.538 1.528 0 CA-C-O 118.451 -1.194 . . . . 0.0 113.789 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -64.42 153.6 76.11 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 123.086 2.524 . . . . 0.0 112.528 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.63 157.1 56.58 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.485 2.79 . . . . 0.0 113.049 -175.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -80.82 36.7 0.4 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.135 1.774 . . . . 0.0 112.937 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 51.8 p -59.97 148.17 36.23 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.309 1.444 . . . . 0.0 113.516 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 170.94 62.29 0.04 OUTLIER Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.757 1.17 . . . . 0.0 113.405 -177.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -69.82 -18.58 36.63 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 124.113 3.209 . . . . 0.0 113.853 -171.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 44.7 t -120.85 -4.55 9.66 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.282 1.833 . . . . 0.0 112.303 176.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -64.58 -16.37 62.56 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -140.61 46.39 1.79 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.377 2.271 . . . . 0.0 110.955 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.0 mt -55.33 -28.56 54.56 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 118.402 -0.809 . . . . 0.0 112.548 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -54.78 -43.23 72.62 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.526 1.057 . . . . 0.0 111.528 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 19.2 t -69.57 -41.73 75.44 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.431 0.692 . . . . 0.0 111.99 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.68 -38.52 91.28 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 2.7 mm -68.69 -43.24 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -63.0 -38.38 90.94 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.605 -0.684 . . . . 0.0 112.245 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -71.12 -33.35 70.03 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.051 0.94 . . . . 0.0 113.224 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.08 -42.02 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 123.3 0.64 . . . . 0.0 111.409 172.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.8 m -86.34 -22.38 26.72 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 61.23 29.5 71.44 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.84 1.209 . . . . 0.0 113.866 -172.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 97.27 -175.33 30.61 Favored Glycine 0 CA--C 1.541 1.708 0 C-N-CA 125.71 1.624 . . . . 0.0 112.999 -171.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.18 150.34 33.1 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 123.685 2.923 . . . . 0.0 112.909 -174.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 52.5 mt -97.59 141.89 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.07 1.748 . . . . 0.0 110.952 -171.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -109.19 170.12 8.25 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.316 1.846 . . . . 0.0 115.866 -171.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -144.19 110.33 5.43 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.832 1.253 . . . . 0.0 110.372 -171.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -59.02 -166.24 0.14 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.989 1.756 . . . . 0.0 115.545 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -41.98 -39.74 1.98 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.528 1.931 . . . . 0.0 114.785 -175.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -62.1 -28.89 69.94 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.316 1.446 . . . . 0.0 114.363 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 96.0 -10.93 68.0 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.958 1.742 . . . . 0.0 115.687 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -152.57 12.23 0.53 Allowed 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -171.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 69.0 m -78.15 75.34 4.68 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 120.434 -1.416 . . . . 0.0 114.238 -171.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 14.5 tp -69.27 128.77 37.76 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.731 1.612 . . . . 0.0 110.659 171.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -98.81 164.04 17.69 Favored Pre-proline 0 N--CA 1.484 1.258 0 C-N-CA 124.441 1.096 . . . . 0.0 110.91 -171.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -63.81 -29.86 68.33 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.239 1.959 . . . . 0.0 112.985 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.16 90.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.777 0.831 . . . . 0.0 113.134 169.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -66.68 -43.34 84.71 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.457 -0.777 . . . . 0.0 111.468 172.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -61.29 -32.39 72.22 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.436 -0.79 . . . . 0.0 112.484 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -67.34 -41.07 85.82 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.669 -1.27 . . . . 0.0 112.278 172.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 67.7 mt -57.42 -46.03 85.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 O-C-N 121.345 -0.847 . . . . 0.0 110.441 169.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 39.6 mt -64.08 -35.09 79.6 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.436 -0.79 . . . . 0.0 112.906 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -61.16 -37.64 83.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.141 0.976 . . . . 0.0 112.614 173.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 86.5 mtt-85 -70.58 -37.01 73.88 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.687 1.195 . . . . 0.0 112.628 173.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.9 -41.95 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 118.91 0.777 . . . . 0.0 110.771 173.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.72 -38.14 90.0 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.712 0.805 . . . . 0.0 112.274 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.33 -38.11 89.15 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.446 0.698 . . . . 0.0 112.376 172.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -65.71 -34.84 79.14 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.625 0.77 . . . . 0.0 112.696 176.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -66.06 -45.64 80.62 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.98 1.312 . . . . 0.0 111.859 169.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.51 -30.19 70.46 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.551 1.54 . . . . 0.0 112.808 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.17 -9.66 58.8 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.078 1.751 . . . . 0.0 114.563 174.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 16.1 t -155.47 68.36 5.18 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 125.358 1.463 . . . . 0.0 108.885 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -62.62 -6.05 8.22 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.429 2.752 . . . . 0.0 112.679 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -73.17 -19.96 61.0 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.446 1.498 . . . . 0.0 113.324 172.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -115.54 93.91 4.48 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.21 1.404 . . . . 0.0 111.794 -171.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -50.65 147.5 4.66 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.118 1.367 . . . . 0.0 111.684 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 22.9 m -127.15 160.15 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.882 0.873 . . . . 0.0 111.487 167.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 22.9 m -127.26 139.38 52.95 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.909 1.683 . . . . 0.0 108.362 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 71.4 mt -119.13 123.83 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 124.923 1.289 . . . . 0.0 107.858 -171.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -113.76 148.6 36.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.302 0.641 . . . . 0.0 110.399 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -137.46 156.69 23.66 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 122.106 -0.371 . . . . 0.0 112.696 167.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -127.6 167.34 16.5 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.502 2.321 . . . . 0.0 109.885 -169.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.1 m -151.98 159.73 43.68 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.162 1.785 . . . . 0.0 110.627 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -63.75 163.02 12.32 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.956 -1.09 . . . . 0.0 111.43 166.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.438 ' ND2' ' HG ' ' A' ' 302' ' ' SER . 12.1 t-20 -104.98 20.34 19.0 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.564 0.746 . . . . 0.0 112.817 -175.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 16.3 m -69.92 -20.1 63.36 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.809 1.244 . . . . 0.0 112.628 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.6 -150.01 18.1 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 126.156 1.836 . . . . 0.0 113.249 173.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 71.4 m -135.3 162.72 31.79 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.073 1.749 . . . . 0.0 110.09 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -52.62 -41.16 63.45 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.984 0.914 . . . . 0.0 112.968 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -67.9 -4.39 33.93 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.672 1.13 . . . . 0.0 115.238 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 6.2 mt -116.55 -33.0 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.932 2.093 . . . . 0.0 111.172 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -81.53 -31.22 32.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.555 1.142 . . . . 0.0 112.919 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 23.4 mm -60.52 -54.17 57.47 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.322 1.449 . . . . 0.0 111.761 170.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.54 -32.6 24.43 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 CA-C-N 121.065 1.416 . . . . 0.0 113.333 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 26.3 mt -67.88 -43.8 78.5 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.347 1.43 . . . . 0.0 113.124 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 28.5 p -66.46 -37.54 85.36 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.14 -38.09 78.62 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.556 0.742 . . . . 0.0 111.967 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -65.19 -38.76 91.51 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 125.129 1.372 . . . . 0.0 111.036 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -45.62 90.42 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.52 0.6 . . . . 0.0 111.877 173.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.38 -36.17 76.53 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -68.34 -36.51 79.36 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 125.758 1.623 . . . . 0.0 111.97 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 58.9 mt -63.55 -43.07 98.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 118.788 0.722 . . . . 0.0 110.625 174.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 57.4 t -66.89 -42.62 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.753 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.07 -41.7 99.5 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.026 0.53 . . . . 0.0 111.743 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.85 -38.84 87.14 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.121 0.568 . . . . 0.0 111.501 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -68.27 -40.68 81.8 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.3 mp -64.88 -43.68 92.15 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.302 0.641 . . . . 0.0 111.005 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 55.1 t -67.73 -37.22 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 O-C-N 121.758 -0.589 . . . . 0.0 111.088 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.95 -34.0 72.85 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -42.99 86.19 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.817 0.847 . . . . 0.0 111.591 171.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 161.08 -0.95 0.07 OUTLIER Glycine 0 CA--C 1.528 0.871 0 N-CA-C 117.413 1.725 . . . . 0.0 117.413 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.4 t -72.48 136.15 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 120.514 2.157 . . . . 0.0 109.814 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.59 140.75 56.93 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 120.946 -1.096 . . . . 0.0 110.641 168.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.21 -27.31 52.15 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.399 1.0 . . . . 0.0 113.694 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -61.68 -30.14 70.54 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.822 1.249 . . . . 0.0 113.538 173.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -92.77 -0.71 57.22 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.606 1.562 . . . . 0.0 113.968 -174.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 25.0 mm -121.04 141.12 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.825 1.65 . . . . 0.0 109.501 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -135.09 161.37 35.52 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.733 1.613 . . . . 0.0 110.253 167.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 45.6 p -137.02 146.39 45.23 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.942 0.897 . . . . 0.0 112.372 -175.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 35.3 t -141.35 133.63 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.571 1.148 . . . . 0.0 111.118 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -89.5 100.3 2.65 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.508 1.051 . . . . 0.0 111.801 172.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 38.2 mt -95.58 32.13 1.87 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.707 2.003 . . . . 0.0 110.618 174.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 3.18 -70.34 0.0 OUTLIER Glycine 0 C--N 1.35 1.329 0 N-CA-C 120.366 2.906 . . . . 0.0 120.366 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.438 ' HG ' ' ND2' ' A' ' 263' ' ' ASN . 94.3 p -144.53 13.76 1.56 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.769 1.284 . . . . 0.0 114.281 178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 17.1 m -70.27 157.97 6.36 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 O-C-N 121.025 -1.047 . . . . 0.0 111.768 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 39.46 52.09 4.03 Favored Pre-proline 0 CA--C 1.557 1.23 0 C-N-CA 125.259 1.424 . . . . 0.0 114.119 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.18 112.73 1.78 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.38 2.72 . . . . 0.0 111.767 -171.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.489 HD13 ' H ' ' A' ' 306' ' ' ILE . 1.4 mp -71.02 -20.67 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 124.46 1.104 . . . . 0.0 112.476 -171.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -150.5 160.26 43.9 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.865 1.666 . . . . 0.0 112.376 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 49.6 m -71.19 151.25 44.55 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.177 1.791 . . . . 0.0 113.767 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -82.85 1.69 38.02 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.86 -14.4 63.01 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 40.6 p -141.42 147.58 47.06 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 126.326 1.85 . . . . 0.0 110.296 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -63.25 -32.58 73.22 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.166 2.577 . . . . 0.0 112.53 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -68.05 -36.45 79.89 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 173.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -70.2 -38.04 72.12 Favored Glycine 0 N--CA 1.467 0.722 0 C-N-CA 123.415 0.531 . . . . 0.0 113.361 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -57.63 -49.1 77.54 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 123.752 0.821 . . . . 0.0 109.975 171.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.17 84.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.57 0.748 . . . . 0.0 112.698 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -72.66 -12.74 61.15 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.225 1.41 . . . . 0.0 113.696 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.32 -12.5 15.04 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 170.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -81.96 2.48 30.56 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 126.571 1.948 . . . . 0.0 114.502 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 35.0 mtm180 -57.89 160.87 4.29 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -169.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.88 144.12 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.278 1.831 . . . . 0.0 109.954 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -139.7 159.41 42.23 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.137 1.375 . . . . 0.0 113.194 -173.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 4.5 mp -131.95 132.86 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.768 1.627 . . . . 0.0 108.71 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 21.4 t -140.58 138.52 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.635 1.574 . . . . 0.0 109.552 -171.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 22.4 t -69.7 135.81 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.029 -1.044 . . . . 0.0 110.429 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.5 t30 . . . . . 0 C--O 1.252 1.201 0 C-N-CA 125.143 1.377 . . . . 0.0 113.319 -177.901 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 119.366 -0.35 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -70.4 160.79 48.32 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.545 2.83 . . . . 0.0 112.514 178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.42 153.33 74.23 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.237 2.625 . . . . 0.0 111.97 174.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 168.99 -173.88 43.5 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 124.178 0.894 . . . . 0.0 113.821 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.59 163.78 33.64 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 123.883 3.055 . . . . 0.0 112.527 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.76 167.38 19.52 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.568 2.846 . . . . 0.0 113.103 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -126.81 25.57 6.33 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.584 1.554 . . . . 0.0 113.212 -171.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 18.4 t -55.61 141.33 37.98 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.759 1.224 . . . . 0.0 112.026 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 54.33 59.02 10.69 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 125.223 1.392 . . . . 0.0 114.221 -172.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -69.7 -15.34 37.27 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.323 3.349 . . . . 0.0 114.655 -171.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 22.0 t -128.91 -2.57 5.23 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 126.817 2.047 . . . . 0.0 111.776 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.64 -18.8 65.56 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -171.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -137.77 30.44 2.55 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.934 2.093 . . . . 0.0 111.52 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 6.9 tp -63.49 -16.58 61.1 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 121.521 -0.737 . . . . 0.0 112.949 -173.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -53.58 -45.6 70.02 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.954 0.797 . . . . 0.0 111.465 167.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 21.5 t -69.27 -42.77 75.09 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.292 0.637 . . . . 0.0 111.306 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.93 85.97 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 53.6 mt -73.53 -36.04 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.522 0.729 . . . . 0.0 109.659 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -65.08 -42.49 94.08 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.061 -1.024 . . . . 0.0 112.006 172.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.06 -37.56 87.97 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.947 0.899 . . . . 0.0 112.821 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.69 -28.36 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 118.354 0.525 . . . . 0.0 112.227 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.7 m -75.16 -26.5 59.16 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.094 0.958 . . . . 0.0 112.136 170.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.37 25.83 75.08 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.111 1.339 . . . . 0.0 113.65 -171.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 96.24 -176.71 33.13 Favored Glycine 0 CA--C 1.542 1.732 0 C-N-CA 125.532 1.539 . . . . 0.0 113.394 -172.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.24 147.83 33.58 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.834 3.023 . . . . 0.0 111.416 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -102.42 140.99 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -169.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -107.44 169.03 8.83 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.693 2.397 . . . . 0.0 113.763 -172.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -142.55 116.1 9.12 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.475 1.11 . . . . 0.0 110.608 -171.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -58.42 -170.22 0.24 Allowed Glycine 0 CA--C 1.535 1.302 0 C-N-CA 126.117 1.817 . . . . 0.0 116.39 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -46.43 -40.91 13.01 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.46 1.504 . . . . 0.0 115.017 -174.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.11 -33.27 71.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.396 1.478 . . . . 0.0 113.808 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 105.49 -5.06 40.55 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 117.02 1.568 . . . . 0.0 117.02 167.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -166.44 28.12 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 119.471 1.635 . . . . 0.0 113.038 -171.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 16.5 t -98.11 93.58 6.35 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.634 -1.291 . . . . 0.0 111.511 -171.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.0 mp -71.31 113.92 8.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.886 0.874 . . . . 0.0 109.82 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 11.8 pt -70.77 164.09 58.7 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 124.366 1.066 . . . . 0.0 110.23 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.25 -31.28 74.21 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 CA-C-N 121.942 1.729 . . . . 0.0 112.371 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -66.17 -32.35 73.74 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 170.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -59.03 -53.05 62.8 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.748 1.158 . . . . 0.0 110.697 171.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -58.59 -33.77 70.35 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.716 0.807 . . . . 0.0 112.611 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -66.24 -44.75 82.84 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.419 1.009 . . . . 0.0 112.505 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 34.2 mm -58.44 -43.61 87.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 121.589 -0.694 . . . . 0.0 110.747 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.13 -32.26 72.83 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.709 -0.619 . . . . 0.0 112.62 174.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -63.85 -41.38 97.82 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.578 1.151 . . . . 0.0 112.411 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -67.52 -38.69 84.61 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.423 1.089 . . . . 0.0 112.335 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 79.7 t -62.96 -45.03 99.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 123.507 0.723 . . . . 0.0 110.538 174.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.82 -36.84 84.52 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.155 0.582 . . . . 0.0 112.146 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.17 -39.29 92.71 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 172.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -65.62 -35.13 79.9 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.753 0.821 . . . . 0.0 112.73 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 97.0 mt -69.67 -41.6 75.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.44 1.096 . . . . 0.0 112.039 172.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.03 -23.93 67.68 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.392 1.877 . . . . 0.0 113.089 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.91 -8.75 57.94 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.536 1.534 . . . . 0.0 114.588 171.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 36.2 t -153.61 67.29 6.01 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.222 1.409 . . . . 0.0 108.85 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -64.68 -7.22 14.05 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.119 2.546 . . . . 0.0 112.013 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -70.14 -19.42 63.22 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.51 1.524 . . . . 0.0 113.215 171.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -118.99 89.88 3.22 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.513 1.525 . . . . 0.0 110.52 -172.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -51.53 150.97 3.38 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.04 1.336 . . . . 0.0 111.453 172.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 17.3 m -134.38 161.34 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.449 0.7 . . . . 0.0 112.669 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 20.8 m -128.03 137.37 52.17 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.153 1.381 . . . . 0.0 109.415 -178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.0 118.19 57.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.663 1.585 . . . . 0.0 107.7 -173.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.496 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 0.2 OUTLIER -98.98 151.19 21.17 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.022 1.329 . . . . 0.0 109.406 -178.023 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -152.01 155.49 26.16 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 121.491 -0.756 . . . . 0.0 113.912 168.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -132.53 168.4 18.29 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 129.033 2.933 . . . . 0.0 109.352 -170.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 31.2 m -145.27 151.56 38.56 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 127.102 2.161 . . . . 0.0 109.187 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -63.32 160.67 15.44 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 123.172 1.463 . . . . 0.0 113.574 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -83.04 7.87 14.49 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 113.993 -1.458 . . . . 0.0 114.927 -170.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.6 m -75.11 -15.26 60.61 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 120.993 -1.067 . . . . 0.0 113.508 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -95.24 -157.83 32.5 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.286 1.422 . . . . 0.0 114.595 -176.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 7.6 t -135.18 162.37 32.7 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.69 1.596 . . . . 0.0 110.371 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -52.84 -41.44 64.24 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.124 0.97 . . . . 0.0 112.796 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -67.83 -6.49 44.46 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 124.428 1.014 . . . . 0.0 115.238 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 4.2 mt -115.75 -33.63 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 126.644 1.978 . . . . 0.0 111.294 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -87.41 -24.35 24.23 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 18.3 mm -58.51 -54.06 59.87 Favored Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 124.531 1.132 . . . . 0.0 111.804 167.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.49 -33.23 11.12 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 120.579 1.243 . . . . 0.0 112.906 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 19.1 mt -65.11 -46.78 79.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 120.282 1.401 . . . . 0.0 112.092 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 24.2 m -70.87 -29.86 66.07 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -74.66 -34.96 62.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.788 0.835 . . . . 0.0 112.075 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -65.57 -39.89 92.15 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.027 0.931 . . . . 0.0 111.677 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.22 -43.17 98.87 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.271 0.942 . . . . 0.0 110.755 176.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.5 -37.98 86.25 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.27 -38.91 88.93 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.525 1.53 . . . . 0.0 112.036 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 74.1 mt -66.13 -39.52 84.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 122.688 0.395 . . . . 0.0 110.879 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.59 -44.75 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 O-C-N 121.972 -0.455 . . . . 0.0 110.906 173.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.92 -42.23 97.7 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.4 0.68 . . . . 0.0 111.662 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -66.72 -38.29 86.41 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.013 0.525 . . . . 0.0 111.897 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -68.81 -40.8 79.34 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.15 -43.22 95.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.328 0.651 . . . . 0.0 110.975 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 55.7 t -67.34 -37.46 79.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 O-C-N 121.753 -0.592 . . . . 0.0 111.257 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.43 -34.42 74.42 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -42.26 87.19 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.811 0.844 . . . . 0.0 111.796 172.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 161.64 -1.61 0.07 OUTLIER Glycine 0 CA--C 1.527 0.831 0 N-CA-C 117.473 1.749 . . . . 0.0 117.473 176.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 2.7 t -73.96 137.76 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 120.523 2.162 . . . . 0.0 109.493 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.78 137.91 58.07 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.655 -1.278 . . . . 0.0 110.461 168.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.8 -29.67 58.82 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.055 0.836 . . . . 0.0 113.456 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.44 -26.51 68.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.131 1.372 . . . . 0.0 113.782 173.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -97.25 2.23 50.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.801 1.641 . . . . 0.0 113.955 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 20.2 mm -119.64 141.78 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.699 1.6 . . . . 0.0 109.447 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -136.84 165.27 26.34 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.041 1.737 . . . . 0.0 110.535 169.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 44.6 p -136.02 145.68 46.33 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.277 1.031 . . . . 0.0 112.258 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 70.3 t -138.98 133.95 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.052 1.341 . . . . 0.0 110.919 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -103.24 105.32 2.67 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 126.131 1.825 . . . . 0.0 112.21 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.496 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 1.1 mp -103.94 32.8 3.73 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 129.138 2.975 . . . . 0.0 109.752 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 7.45 -73.92 0.0 OUTLIER Glycine 0 C--N 1.349 1.257 0 N-CA-C 119.467 2.547 . . . . 0.0 119.467 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 57.9 p -148.14 22.53 1.08 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.483 1.641 . . . . 0.0 114.435 172.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.7 m -70.13 159.55 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.092 1.357 . . . . 0.0 111.917 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 23.2 m120 39.76 52.74 4.75 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 125.062 1.345 . . . . 0.0 112.932 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -59.64 132.18 44.23 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.012 2.475 . . . . 0.0 113.674 -170.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 4.8 mp -77.13 -25.89 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 125.042 1.337 . . . . 0.0 111.586 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -157.53 153.66 27.33 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.664 1.986 . . . . 0.0 111.822 -172.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 66.7 m -66.42 150.42 48.93 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.179 1.392 . . . . 0.0 112.48 170.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -84.49 11.13 9.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.786 1.235 . . . . 0.0 113.854 174.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -67.18 -18.36 65.23 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -176.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 66.7 p -140.66 151.4 63.22 Favored Pre-proline 0 N--CA 1.474 0.744 0 C-N-CA 125.901 1.681 . . . . 0.0 110.141 176.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -61.94 -28.31 80.77 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.199 2.599 . . . . 0.0 112.601 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.0 -42.14 94.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.856 0.862 . . . . 0.0 112.554 172.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.14 -38.17 87.8 Favored Glycine 0 N--CA 1.465 0.619 0 O-C-N 121.791 -0.568 . . . . 0.0 112.787 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -57.99 -47.42 83.03 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.244 0.618 . . . . 0.0 110.526 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.85 -39.91 93.5 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.184 0.594 . . . . 0.0 112.537 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -68.61 -16.51 63.87 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.486 1.114 . . . . 0.0 113.816 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -115.86 -1.36 12.61 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 125.514 1.526 . . . . 0.0 114.517 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -82.68 3.95 26.94 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 126.136 1.774 . . . . 0.0 113.023 166.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.88 158.81 0.64 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 130.118 3.367 . . . . 0.0 117.144 -169.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 2.3 m -122.46 148.61 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 126.326 1.85 . . . . 0.0 111.656 166.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -130.08 166.26 20.53 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.84 2.056 . . . . 0.0 110.891 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 13.1 tt -140.74 144.0 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.524 1.13 . . . . 0.0 111.919 172.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 23.3 t -144.68 136.48 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.343 1.457 . . . . 0.0 110.187 -174.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.09 136.23 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.11 0.964 . . . . 0.0 110.754 174.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.576 1.55 . . . . 0.0 113.731 -178.556 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 119.287 -0.387 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.22 159.9 51.45 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 C-N-CA 123.503 2.802 . . . . 0.0 112.534 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.2 152.29 72.22 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.228 2.619 . . . . 0.0 112.158 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 166.28 -175.25 41.78 Favored Glycine 0 CA--C 1.54 1.616 0 C-N-CA 124.442 1.02 . . . . 0.0 113.712 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.46 162.19 40.03 Favored 'Trans proline' 0 CA--C 1.548 1.178 0 C-N-CA 123.735 2.957 . . . . 0.0 112.324 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.3 158.67 55.86 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.387 2.725 . . . . 0.0 112.772 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -87.3 20.64 2.71 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.677 1.591 . . . . 0.0 114.245 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.6 p -61.1 132.16 52.88 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.916 1.286 . . . . 0.0 112.594 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 159.91 61.52 0.01 OUTLIER Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.348 0.975 . . . . 0.0 113.87 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -69.52 -19.98 36.56 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.995 3.13 . . . . 0.0 114.091 -171.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 9.9 t -122.57 -2.75 8.87 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 126.519 1.928 . . . . 0.0 111.762 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.54 -21.25 60.43 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 -171.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -137.48 38.56 2.46 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.516 2.326 . . . . 0.0 109.945 174.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 23.8 tp -61.13 -19.83 61.97 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.46 1.104 . . . . 0.0 113.796 -171.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -57.2 -46.31 82.99 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.74 -0.6 . . . . 0.0 111.843 169.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 22.8 t -68.66 -43.86 75.3 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 122.977 0.511 . . . . 0.0 111.284 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -71.57 -25.45 62.21 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 67.3 mt -83.07 -35.55 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 119.61 1.095 . . . . 0.0 110.627 171.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -63.44 -41.97 98.68 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.819 -1.175 . . . . 0.0 111.83 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.4 -36.34 83.67 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.212 1.005 . . . . 0.0 113.187 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.83 -27.72 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.9 m -80.38 -27.79 38.11 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.269 1.027 . . . . 0.0 112.437 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 69.95 25.69 75.27 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.02 1.295 . . . . 0.0 113.854 -172.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 88.88 -166.97 34.34 Favored Glycine 0 CA--C 1.54 1.656 0 C-N-CA 124.87 1.224 . . . . 0.0 113.57 -173.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.33 163.06 40.38 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.721 2.947 . . . . 0.0 112.312 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 19.3 mm -120.74 144.58 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.171 1.389 . . . . 0.0 111.069 -171.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -111.69 167.47 10.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.954 2.102 . . . . 0.0 113.115 -172.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -140.51 101.83 4.19 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.908 0.883 . . . . 0.0 111.803 -170.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -87.52 -178.26 48.23 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.541 1.067 . . . . 0.0 113.981 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 51.6 t30 36.17 -81.34 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 130.375 3.47 . . . . 0.0 115.796 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -71.13 -22.85 62.02 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.295 1.438 . . . . 0.0 114.084 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 89.2 10.23 66.36 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.918 1.247 . . . . 0.0 115.019 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -154.71 25.31 0.45 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 126.968 2.107 . . . . 0.0 112.105 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 58.2 m -81.67 81.84 7.6 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.878 1.271 . . . . 0.0 112.888 -171.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.76 101.33 0.47 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.689 0.756 . . . . 0.0 110.817 169.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . 0.532 HG13 ' H ' ' A' ' 236' ' ' ASP . 9.8 pt -61.79 154.86 64.94 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.768 1.627 . . . . 0.0 112.491 173.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -62.56 -31.3 80.01 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.344 2.029 . . . . 0.0 112.184 174.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.5 90.65 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.791 0.836 . . . . 0.0 112.858 170.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.532 ' H ' HG13 ' A' ' 233' ' ' ILE . 21.9 t70 -62.61 -49.56 74.74 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.436 -0.79 . . . . 0.0 111.321 172.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -59.88 -30.24 68.86 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.166 -0.959 . . . . 0.0 112.912 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -70.72 -44.54 66.68 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 120.785 -1.197 . . . . 0.0 112.805 172.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 21.4 mm -57.89 -45.57 87.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.231 -0.918 . . . . 0.0 110.938 172.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.4 -32.07 73.5 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.954 0.902 . . . . 0.0 112.539 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -61.86 -42.55 99.19 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.088 0.955 . . . . 0.0 111.882 173.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -67.79 -35.65 79.03 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 87.9 t -64.45 -44.39 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.497 0.59 . . . . 0.0 110.916 173.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.81 89.86 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.422 0.689 . . . . 0.0 111.989 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.78 -39.13 93.51 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.122 0.569 . . . . 0.0 112.065 175.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -71.56 -30.68 66.15 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 79.3 mt -71.32 -40.76 70.56 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.976 0.911 . . . . 0.0 112.266 170.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -60.06 -27.05 66.64 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.121 1.368 . . . . 0.0 112.669 173.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -80.95 -6.96 59.37 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.11 1.764 . . . . 0.0 115.036 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 22.2 t -153.47 67.27 6.08 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.235 1.414 . . . . 0.0 108.862 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -63.84 -7.1 12.26 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.216 2.611 . . . . 0.0 112.39 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -71.28 -19.27 62.36 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.591 1.556 . . . . 0.0 113.24 171.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -117.88 89.04 3.04 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.543 1.537 . . . . 0.0 110.578 -173.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 68.1 mtt85 -53.26 155.45 2.72 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.544 1.138 . . . . 0.0 111.676 171.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 20.9 m -128.29 165.49 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.36 1.064 . . . . 0.0 111.844 171.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 30.2 m -127.98 137.14 52.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.403 1.481 . . . . 0.0 108.798 173.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.7 mt -113.69 117.32 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -102.49 156.82 17.35 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.323 0.649 . . . . 0.0 110.426 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -148.52 154.95 26.16 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 122.178 -0.326 . . . . 0.0 112.836 167.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -128.16 163.41 24.73 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 127.539 2.336 . . . . 0.0 109.918 -169.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 73.1 p -148.63 173.67 12.94 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.917 2.487 . . . . 0.0 110.392 170.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -72.15 158.36 36.06 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.458 -1.401 . . . . 0.0 113.001 -173.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -84.97 -9.64 57.86 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.695 1.198 . . . . 0.0 113.168 -172.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -22.66 67.02 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.382 2.273 . . . . 0.0 115.527 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -74.98 -143.24 0.93 Allowed Glycine 0 CA--C 1.54 1.615 0 C-N-CA 126.448 1.975 . . . . 0.0 115.358 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 26.3 t -149.59 137.15 20.1 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.868 1.667 . . . . 0.0 109.723 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -53.17 -34.02 55.1 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -65.59 -22.74 70.01 Favored Glycine 0 CA--C 1.537 1.428 0 O-C-N 121.435 -0.791 . . . . 0.0 114.21 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 16.9 mm -100.59 -32.33 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 126.496 1.918 . . . . 0.0 112.188 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -82.71 -27.36 31.23 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.8 mm -57.65 -55.35 45.7 Favored Pre-proline 0 N--CA 1.469 0.515 0 C-N-CA 124.722 1.209 . . . . 0.0 112.206 169.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.38 -30.26 15.71 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 CA-C-N 120.468 1.203 . . . . 0.0 112.713 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.6 mp -64.42 -51.12 64.77 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 120.228 1.377 . . . . 0.0 111.833 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.3 m -69.34 -32.31 71.32 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.071 -0.651 . . . . 0.0 112.544 -176.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.64 -38.66 80.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 174.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -67.69 -38.23 83.41 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.424 0.689 . . . . 0.0 111.594 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 66.5 mmt-85 -61.1 -44.14 97.81 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.959 0.8 . . . . 0.0 111.275 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.77 -37.57 79.43 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -66.58 -37.87 85.83 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 125.376 1.47 . . . . 0.0 111.733 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 19.3 mm -65.98 -39.06 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.62 0.645 . . . . 0.0 111.268 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 38.3 t -64.92 -46.09 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.322 0.51 . . . . 0.0 110.592 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -61.11 -41.52 96.84 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.304 0.642 . . . . 0.0 111.616 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.05 -36.97 84.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.554 1.142 . . . . 0.0 111.47 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -63.63 -45.01 92.18 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.6 mp -69.07 -37.06 78.28 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.977 0.418 . . . . 0.0 111.672 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.84 -37.01 76.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.942 0.897 . . . . 0.0 111.013 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.97 -35.0 79.0 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 20.9 ttt85 -69.05 -35.52 76.66 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 170.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 151.34 4.54 0.18 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 116.935 1.534 . . . . 0.0 116.935 167.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.8 t -69.49 136.01 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 120.046 1.923 . . . . 0.0 108.964 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.32 138.88 58.68 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.979 -1.076 . . . . 0.0 110.528 172.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.75 -29.85 58.89 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.013 0.816 . . . . 0.0 113.317 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.28 -28.68 69.89 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.857 1.263 . . . . 0.0 113.648 173.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -93.36 -2.2 55.04 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.471 1.508 . . . . 0.0 114.217 -174.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 9.0 mt -129.04 108.09 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.518 1.127 . . . . 0.0 110.155 175.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -88.69 161.92 16.57 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.028 0.931 . . . . 0.0 110.323 167.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 35.5 p -135.41 144.37 46.49 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.192 0.997 . . . . 0.0 111.452 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 30.2 t -138.0 129.81 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.56 0.744 . . . . 0.0 111.32 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -84.85 96.1 2.01 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.518 1.056 . . . . 0.0 111.112 170.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 47.6 mt -88.54 30.14 0.93 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.552 1.941 . . . . 0.0 109.97 171.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 6.86 -74.97 0.0 OUTLIER Glycine 0 C--N 1.354 1.554 0 C-N-CA 128.191 2.805 . . . . 0.0 119.769 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 95.1 p -149.6 23.79 0.89 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.583 1.192 . . . . 0.0 113.252 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 7.3 m -71.26 158.63 6.12 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 C-N-CA 124.509 1.124 . . . . 0.0 111.498 173.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 39.42 54.24 5.28 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 125.514 1.526 . . . . 0.0 114.288 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.09 139.08 59.42 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.689 2.259 . . . . 0.0 111.626 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 17.8 pt -134.59 6.81 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.925 1.29 . . . . 0.0 114.314 -171.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -146.54 140.08 25.89 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.485 1.114 . . . . 0.0 110.62 167.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 51.0 m -71.05 143.61 50.65 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.425 1.49 . . . . 0.0 113.126 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -74.23 1.69 10.81 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 171.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.07 -17.26 63.23 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.053 1.341 . . . . 0.0 114.617 -175.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 67.9 p -140.47 150.94 62.51 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 125.49 1.516 . . . . 0.0 110.581 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -62.12 -30.06 81.85 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.25 2.633 . . . . 0.0 112.576 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -64.53 -44.42 90.92 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.575 0.75 . . . . 0.0 112.344 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.73 -35.46 85.58 Favored Glycine 0 CA--C 1.524 0.613 0 O-C-N 121.84 -0.538 . . . . 0.0 112.839 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -59.52 -49.35 78.11 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.073 0.949 . . . . 0.0 111.173 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.03 85.76 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.0 0.52 . . . . 0.0 111.969 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -71.12 -23.37 62.08 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.329 1.452 . . . . 0.0 114.302 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -99.82 -18.14 17.31 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 119.656 1.116 . . . . 0.0 112.866 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -71.96 13.63 0.28 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.317 1.447 . . . . 0.0 114.337 170.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -61.86 163.8 7.14 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.206 1.802 . . . . 0.0 115.662 -170.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 28.9 m -125.29 151.52 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.941 1.696 . . . . 0.0 110.158 167.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -145.48 147.5 32.24 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.36 1.064 . . . . 0.0 111.919 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.3 132.52 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.171 1.388 . . . . 0.0 109.404 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 21.8 t -140.88 133.97 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.211 1.405 . . . . 0.0 109.895 -172.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.18 141.27 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 121.409 -0.807 . . . . 0.0 110.342 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.285 1.434 . . . . 0.0 111.864 -171.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 119.235 -0.412 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.61 160.88 47.53 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.481 2.788 . . . . 0.0 112.221 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.76 142.6 64.12 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.053 2.502 . . . . 0.0 112.008 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 172.59 57.5 0.05 OUTLIER Glycine 0 CA--C 1.538 1.521 0 CA-C-O 118.588 -1.118 . . . . 0.0 113.817 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.54 159.92 48.39 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.293 2.662 . . . . 0.0 112.611 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.65 155.13 71.83 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.228 2.619 . . . . 0.0 112.19 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.56 27.68 1.35 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.347 1.459 . . . . 0.0 112.702 -172.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 23.2 m -49.83 132.51 22.35 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.859 1.664 . . . . 0.0 113.463 -175.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 55.67 57.96 16.3 Favored Glycine 0 CA--C 1.542 1.749 0 C-N-CA 125.121 1.344 . . . . 0.0 114.833 -174.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.51 -19.07 28.86 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.84 3.027 . . . . 0.0 113.854 -172.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 43.3 t -121.38 -7.43 9.25 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.948 2.099 . . . . 0.0 111.998 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -63.76 -16.04 60.15 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.354 1.462 . . . . 0.0 114.861 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -137.21 41.33 2.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.4 2.28 . . . . 0.0 111.167 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 9.0 mt -46.82 -38.52 10.35 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.67 0.788 . . . . 0.0 111.822 172.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -59.95 -38.53 82.72 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.995 0.518 . . . . 0.0 111.956 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.2 t -68.78 -48.08 64.56 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.465 0.706 . . . . 0.0 112.061 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.9 85.51 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 177.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 90.8 mt -75.05 -34.54 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.335 1.054 . . . . 0.0 110.091 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -65.87 -41.28 91.79 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.816 -1.177 . . . . 0.0 111.712 172.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.91 -36.03 83.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.725 0.81 . . . . 0.0 113.153 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.4 p -80.06 -27.34 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.2 m -88.39 -25.75 22.53 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.534 1.134 . . . . 0.0 113.03 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.77 24.68 75.48 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.348 1.452 . . . . 0.0 114.061 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 101.57 -162.34 17.73 Favored Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.346 1.451 . . . . 0.0 112.54 -171.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -73.15 168.2 25.35 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.716 2.944 . . . . 0.0 112.561 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 40.9 mm -112.79 114.46 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.46 1.504 . . . . 0.0 110.63 -173.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -81.66 173.23 12.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.806 2.042 . . . . 0.0 112.671 171.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -118.7 151.68 37.53 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.859 0.864 . . . . 0.0 110.735 -173.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -59.66 165.73 10.44 Favored Glycine 0 CA--C 1.543 1.843 0 O-C-N 120.875 -1.141 . . . . 0.0 110.892 165.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -48.91 -22.33 0.82 Allowed 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 117.036 2.235 . . . . 0.0 117.036 -171.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -59.28 -22.46 61.2 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.582 1.553 . . . . 0.0 114.666 170.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.71 9.39 74.94 Favored Glycine 0 CA--C 1.543 1.827 0 C-N-CA 124.977 1.275 . . . . 0.0 114.79 -176.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -159.72 -5.82 0.06 Allowed 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 118.918 2.932 . . . . 0.0 118.918 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.6 m -72.43 81.72 1.06 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 122.355 2.343 . . . . 0.0 114.368 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 16.5 tp -63.75 109.61 1.77 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.422 2.289 . . . . 0.0 111.07 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . 0.555 HG13 ' H ' ' A' ' 236' ' ' ASP . 10.4 pt -71.93 159.33 85.75 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 124.655 1.182 . . . . 0.0 112.853 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.97 -29.17 87.48 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.493 2.129 . . . . 0.0 112.17 174.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.95 98.1 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 169.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.555 ' H ' HG13 ' A' ' 233' ' ' ILE . 94.4 m-20 -66.27 -41.35 90.02 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.515 -0.741 . . . . 0.0 112.108 173.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -60.94 -32.16 71.68 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.282 -0.886 . . . . 0.0 112.404 172.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -69.89 -42.87 72.86 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.353 -1.467 . . . . 0.0 112.222 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 65.9 mt -56.7 -47.2 82.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.63 -0.669 . . . . 0.0 110.398 171.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.99 -30.97 72.0 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.493 0.717 . . . . 0.0 112.869 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -64.39 -43.08 95.58 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.588 -0.695 . . . . 0.0 111.824 174.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -64.32 -39.26 93.56 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.004 0.922 . . . . 0.0 112.082 175.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 70.0 t -65.36 -41.56 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.961 0.904 . . . . 0.0 111.601 175.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.08 95.74 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.237 0.615 . . . . 0.0 111.791 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -65.27 -39.01 92.04 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.817 0.847 . . . . 0.0 111.995 175.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -65.95 -35.68 81.26 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.756 0.822 . . . . 0.0 112.568 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 16.8 tp -73.57 -39.63 64.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.189 0.996 . . . . 0.0 112.157 173.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -60.71 -28.53 68.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.392 1.477 . . . . 0.0 112.497 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -75.94 -7.5 54.72 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.046 1.738 . . . . 0.0 114.788 173.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 24.3 t -150.69 68.93 8.5 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.435 1.494 . . . . 0.0 108.59 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -62.13 -7.1 9.23 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.459 2.773 . . . . 0.0 112.493 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -73.16 -18.03 61.31 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.737 1.615 . . . . 0.0 113.277 174.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -124.93 79.65 1.8 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.042 1.337 . . . . 0.0 111.306 -171.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -48.72 159.66 0.22 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.332 1.853 . . . . 0.0 113.104 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.3 162.28 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-O 121.712 0.768 . . . . 0.0 112.336 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.3 m -127.68 137.16 52.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.409 1.484 . . . . 0.0 108.993 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 94.3 mt -113.09 119.98 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 125.418 1.487 . . . . 0.0 107.689 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.452 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 0.5 OUTLIER -102.6 150.5 23.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.265 1.426 . . . . 0.0 109.437 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -149.99 151.91 23.91 Favored Glycine 0 CA--C 1.532 1.131 0 O-C-N 121.785 -0.572 . . . . 0.0 112.501 167.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -128.24 176.47 7.65 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 128.719 2.808 . . . . 0.0 109.075 -170.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.6 t -161.95 153.64 18.77 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 128.047 2.539 . . . . 0.0 111.832 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -63.91 160.91 16.64 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.353 -0.842 . . . . 0.0 109.906 165.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -93.56 33.85 1.23 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.658 0.783 . . . . 0.0 112.466 -175.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 24.3 m -68.51 -20.93 64.61 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.605 -1.31 . . . . 0.0 112.996 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -95.53 -142.09 12.55 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 126.001 1.762 . . . . 0.0 113.06 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 64.1 m -134.26 161.88 33.7 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.489 1.916 . . . . 0.0 109.342 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -54.03 -37.56 64.25 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.98 -1.075 . . . . 0.0 113.832 -174.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.11 -9.2 59.84 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.586 1.088 . . . . 0.0 115.107 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 8.7 mt -111.89 -31.16 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 127.14 2.176 . . . . 0.0 111.098 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -80.05 -33.07 39.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.867 1.267 . . . . 0.0 113.341 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 16.7 mm -56.91 -54.9 49.4 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 125.894 1.678 . . . . 0.0 112.687 172.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -70.16 -27.87 24.02 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.381 1.387 . . . . 0.0 112.314 174.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.81 -50.64 71.51 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 120.507 1.503 . . . . 0.0 111.256 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.7 m -68.65 -33.03 73.3 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.64 -36.43 73.42 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.83 0.852 . . . . 0.0 112.014 176.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -62.08 -46.09 90.61 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.547 0.739 . . . . 0.0 111.195 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -64.45 -36.86 85.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.816 0.28 . . . . 0.0 110.835 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -70.19 -38.49 75.37 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -65.05 -39.69 93.67 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 125.013 1.325 . . . . 0.0 110.653 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 67.7 mt -60.13 -42.81 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.179 0.592 . . . . 0.0 111.18 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 38.4 t -65.61 -43.77 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.192 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -61.88 -41.3 97.71 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.178 0.513 . . . . 0.0 111.937 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.5 -39.54 88.76 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.337 1.055 . . . . 0.0 111.046 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -66.01 -42.26 89.93 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.35 -40.96 94.26 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.094 0.557 . . . . 0.0 111.161 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.6 t -67.95 -38.2 79.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 O-C-N 121.66 -0.65 . . . . 0.0 111.063 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.0 -33.59 73.91 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.871 0.868 . . . . 0.0 113.202 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -64.07 -45.73 87.47 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.719 0.808 . . . . 0.0 110.953 170.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 158.54 2.43 0.08 OUTLIER Glycine 0 CA--C 1.528 0.87 0 N-CA-C 117.298 1.679 . . . . 0.0 117.298 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 4.4 t -72.77 135.83 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 120.404 2.102 . . . . 0.0 109.365 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.18 141.16 58.17 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.857 -1.152 . . . . 0.0 110.581 170.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.25 -27.79 53.35 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.193 0.902 . . . . 0.0 113.586 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.31 -28.28 69.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.764 1.226 . . . . 0.0 113.896 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -97.2 -0.05 47.48 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.707 1.603 . . . . 0.0 114.034 -173.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 18.7 mm -119.54 140.55 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.827 1.651 . . . . 0.0 109.157 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -132.16 162.13 31.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.691 1.596 . . . . 0.0 109.622 167.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 39.0 p -135.15 146.75 49.07 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.86 0.864 . . . . 0.0 112.017 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 25.8 t -140.42 136.0 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.912 1.285 . . . . 0.0 109.721 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -107.74 105.03 2.17 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.164 1.84 . . . . 0.0 110.887 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.452 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 1.9 mp -98.69 17.13 19.99 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 127.5 2.32 . . . . 0.0 112.969 -171.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 18.2 -97.37 0.01 OUTLIER Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.981 1.277 . . . . 0.0 116.287 -171.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 4.1 m -119.96 13.05 12.15 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -171.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 4.8 m -65.63 161.44 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 121.152 -0.967 . . . . 0.0 111.581 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 16.3 m120 40.41 54.8 6.82 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 125.305 1.442 . . . . 0.0 114.157 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.68 138.95 56.0 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.215 2.61 . . . . 0.0 112.27 -173.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 11.8 pt -138.84 0.81 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 125.074 1.349 . . . . 0.0 114.594 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -148.68 139.6 22.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.455 1.102 . . . . 0.0 110.677 167.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 39.8 m -71.76 148.72 46.05 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.62 1.568 . . . . 0.0 113.798 -173.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -73.98 -2.79 25.58 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 171.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.46 -17.9 64.29 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.11 1.364 . . . . 0.0 114.529 -172.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 79.7 p -140.57 149.99 58.98 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.414 1.486 . . . . 0.0 110.561 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -62.13 -27.34 78.76 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.19 2.593 . . . . 0.0 112.634 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -62.4 -46.66 87.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.669 0.787 . . . . 0.0 111.764 170.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.22 -35.16 82.35 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 123.545 0.593 . . . . 0.0 112.669 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -59.03 -50.26 74.76 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.967 0.907 . . . . 0.0 110.896 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.74 -19.03 58.11 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 121.431 -0.793 . . . . 0.0 112.502 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -82.43 -15.07 53.93 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.07 1.748 . . . . 0.0 114.758 168.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.403 ' C ' ' H ' ' A' ' 320' ' ' ARG 0.251 17.1 t-20 -101.17 -22.23 14.73 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 120.292 1.405 . . . . 0.0 111.286 168.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -68.95 11.24 0.21 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.04 -1.662 . . . . 0.0 114.308 166.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.403 ' H ' ' C ' ' A' ' 318' ' ' ASN . 16.5 ptp180 -61.15 165.97 4.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.732 2.013 . . . . 0.0 113.575 -175.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 18.6 m -130.38 151.03 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.728 1.611 . . . . 0.0 111.262 176.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -139.62 159.83 41.27 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.368 1.467 . . . . 0.0 111.397 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 14.7 tt -135.81 135.16 51.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.8 1.24 . . . . 0.0 112.171 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 59.8 t -137.4 122.59 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.029 1.332 . . . . 0.0 110.223 -171.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 38.9 t -70.25 133.57 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.46 1.104 . . . . 0.0 109.274 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 . . . . . 0 C--O 1.251 1.153 0 C-N-CA 124.394 1.078 . . . . 0.0 113.307 -171.623 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 119.28 -0.39 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.15 160.74 48.68 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 123.503 2.802 . . . . 0.0 112.399 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.74 149.82 78.86 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.125 2.55 . . . . 0.0 112.144 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 175.71 57.8 0.06 OUTLIER Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.537 -1.146 . . . . 0.0 114.302 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -66.04 159.02 51.34 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.304 2.669 . . . . 0.0 112.49 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.46 116.27 3.97 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.35 2.7 . . . . 0.0 111.354 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -146.85 22.36 1.25 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.083 1.353 . . . . 0.0 113.121 -173.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 7.7 p -59.43 115.07 3.01 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.331 1.453 . . . . 0.0 112.737 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 169.48 60.38 0.03 OUTLIER Glycine 0 CA--C 1.537 1.469 0 C-N-CA 124.196 0.903 . . . . 0.0 114.287 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -70.83 -18.11 32.24 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.91 3.074 . . . . 0.0 113.689 -173.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 30.6 t -124.33 3.48 8.46 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 127.0 2.12 . . . . 0.0 111.601 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.25 -19.85 66.15 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.409 -1.432 . . . . 0.0 114.572 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -139.6 47.83 1.85 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.955 2.502 . . . . 0.0 109.755 172.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.49 -34.14 34.52 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.912 1.685 . . . . 0.0 112.314 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -66.68 -46.92 74.1 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.106 0.963 . . . . 0.0 112.012 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 14.4 t -65.8 -39.25 90.73 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.169 0.987 . . . . 0.0 112.143 177.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.58 95.11 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 4.2 mt -74.28 -32.69 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.737 0.815 . . . . 0.0 112.116 174.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -64.22 -34.52 78.29 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.168 -0.957 . . . . 0.0 112.182 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -70.17 -36.38 74.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.216 1.006 . . . . 0.0 112.699 172.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 36.7 t -62.05 -43.18 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.143 0.977 . . . . 0.0 111.738 171.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 64.9 p -83.01 -19.28 37.29 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 64.4 18.06 62.72 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.721 1.629 . . . . 0.0 114.304 -171.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 121.9 -146.58 17.05 Favored Glycine 0 CA--C 1.544 1.898 0 C-N-CA 125.214 1.387 . . . . 0.0 112.881 -173.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.67 171.76 15.74 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.967 3.111 . . . . 0.0 112.129 172.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -131.25 144.78 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.441 1.096 . . . . 0.0 110.159 171.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -115.06 173.74 6.34 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.974 1.709 . . . . 0.0 114.393 -170.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -132.06 88.15 2.52 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.345 1.458 . . . . 0.0 109.423 -176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -66.55 164.1 42.35 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.531 1.539 . . . . 0.0 115.282 -171.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 29.9 -66.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.925 1 C-N-CA 131.842 4.057 . . . . 0.0 117.655 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -63.08 -26.02 68.64 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.158 1.383 . . . . 0.0 113.389 173.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.79 7.67 77.82 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.78 1.181 . . . . 0.0 115.002 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -156.69 13.67 0.28 Allowed 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 126.511 1.924 . . . . 0.0 114.557 -175.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 35.1 m -93.45 88.3 5.89 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.341 -1.474 . . . . 0.0 112.405 -170.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 16.9 tp -71.03 96.97 1.38 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.065 1.346 . . . . 0.0 110.328 171.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 4.2 pt -66.11 159.82 68.35 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 125.102 1.361 . . . . 0.0 111.988 -172.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.42 -33.61 78.94 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.269 1.979 . . . . 0.0 112.674 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -67.18 -29.84 69.64 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.925 1.084 . . . . 0.0 113.925 171.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.88 -47.26 86.47 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.521 1.055 . . . . 0.0 111.924 174.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -58.6 -24.25 60.54 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.303 1.041 . . . . 0.0 113.157 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -39.5 87.73 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.258 -0.901 . . . . 0.0 112.005 174.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 37.2 mm -58.69 -47.21 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 120.889 -1.132 . . . . 0.0 110.392 171.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 7.9 mp -62.01 -37.3 84.37 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.438 0.695 . . . . 0.0 111.887 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -61.25 -39.72 91.38 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.073 1.349 . . . . 0.0 112.573 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 13.7 mmt85 -69.03 -39.19 79.37 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 172.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.3 t -64.85 -40.21 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.124 0.57 . . . . 0.0 110.918 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.66 98.14 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.397 1.079 . . . . 0.0 111.95 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.85 -36.96 84.95 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -76.11 -29.03 57.72 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.41 -45.98 78.1 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.202 1.001 . . . . 0.0 111.437 169.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -58.07 -34.04 69.71 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.501 1.521 . . . . 0.0 112.645 173.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.96 -9.08 58.45 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.319 1.448 . . . . 0.0 114.564 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 13.1 t -157.74 66.54 3.61 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.01 1.324 . . . . 0.0 109.52 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -62.73 -9.3 15.76 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.085 2.523 . . . . 0.0 112.196 173.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -70.46 -16.61 62.94 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.776 1.63 . . . . 0.0 113.415 171.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -119.27 80.64 1.59 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.518 1.527 . . . . 0.0 110.687 -176.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 65.5 mtt85 -51.71 148.1 5.9 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.927 1.291 . . . . 0.0 111.553 173.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.54 158.41 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.519 1.128 . . . . 0.0 112.548 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 18.0 m -130.83 134.4 46.79 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 172.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 51.8 mt -104.76 124.85 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 125.198 1.399 . . . . 0.0 107.557 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -114.32 129.54 56.64 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.276 1.03 . . . . 0.0 109.799 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -119.3 157.43 15.39 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 122.089 -0.382 . . . . 0.0 112.154 173.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -125.47 167.82 14.48 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 128.156 2.582 . . . . 0.0 108.615 -170.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.5 m -144.57 169.3 18.23 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 127.076 2.15 . . . . 0.0 109.747 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.32 158.15 5.77 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.806 1.242 . . . . 0.0 111.701 170.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -96.88 -4.4 40.25 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 121.32 -0.863 . . . . 0.0 112.997 173.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 2.3 p -68.33 -31.02 70.14 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.848 1.659 . . . . 0.0 114.886 177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -76.19 -161.25 10.91 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 126.471 1.986 . . . . 0.0 114.082 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 8.0 t -130.59 154.25 48.05 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.608 1.563 . . . . 0.0 109.858 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -58.61 -32.58 69.14 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -171.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.46 -13.91 56.04 Favored Glycine 0 CA--C 1.541 1.671 0 O-C-N 121.058 -1.026 . . . . 0.0 114.859 171.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 2.9 mt -106.62 -34.33 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 127.101 2.161 . . . . 0.0 111.346 173.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -78.93 -31.78 45.32 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -174.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 20.6 mm -61.16 -53.92 58.69 Favored Pre-proline 0 N--CA 1.47 0.538 0 C-N-CA 125.969 1.708 . . . . 0.0 112.042 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.76 -34.86 17.53 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 CA-C-N 120.913 1.362 . . . . 0.0 112.561 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 6.9 mp -66.72 -43.26 84.72 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.68 1.127 . . . . 0.0 112.561 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 31.2 p -69.12 -36.12 77.17 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.38 -40.11 77.6 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.225 0.61 . . . . 0.0 111.335 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 54.4 mm-40 -62.65 -40.33 96.7 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.436 0.694 . . . . 0.0 111.347 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 29.3 mtt85 -68.7 -23.17 64.34 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -83.63 -39.69 19.95 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 167.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -65.29 -35.96 82.62 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.416 1.486 . . . . 0.0 112.254 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 74.9 mt -66.17 -39.98 85.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 118.892 0.769 . . . . 0.0 110.552 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 88.2 t -65.62 -45.68 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 122.179 -0.326 . . . . 0.0 110.669 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.2 96.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.72 0.408 . . . . 0.0 111.456 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.88 -39.01 92.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.718 0.807 . . . . 0.0 111.738 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -65.85 -42.47 90.4 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 175.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 2.1 mp -68.72 -37.59 79.59 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 122.003 -0.435 . . . . 0.0 111.916 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 45.9 t -66.22 -40.1 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 O-C-N 121.439 -0.788 . . . . 0.0 110.731 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.09 -33.51 75.63 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 19.9 ttt85 -66.34 -41.95 88.84 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.478 168.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 156.91 1.04 0.1 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 173.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.8 t -69.64 132.9 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 120.399 2.099 . . . . 0.0 109.3 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.71 135.92 53.49 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.196 -0.94 . . . . 0.0 110.069 172.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.07 -26.81 50.13 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.525 1.06 . . . . 0.0 113.819 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.66 -29.52 70.13 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.763 1.225 . . . . 0.0 113.61 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -96.43 -7.61 34.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.155 1.782 . . . . 0.0 113.977 -175.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 3.4 tt -139.27 99.37 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 122.352 1.072 . . . . 0.0 112.331 -171.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -102.4 169.97 8.36 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.327 1.451 . . . . 0.0 112.265 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 40.1 p -137.85 146.92 44.03 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.417 1.087 . . . . 0.0 113.171 -176.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.4 t -141.15 139.51 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.433 1.493 . . . . 0.0 110.98 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -95.51 113.62 4.67 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.538 1.066 . . . . 0.0 111.429 169.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 42.3 mt -105.21 33.39 3.69 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.072 2.549 . . . . 0.0 110.13 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 0.72 -69.79 0.0 OUTLIER Glycine 0 C--N 1.35 1.359 0 N-CA-C 120.154 2.822 . . . . 0.0 120.154 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 54.2 p -148.72 24.65 0.96 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.7 1.75 . . . . 0.0 114.447 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 8.5 m -64.75 155.95 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 O-C-N 121.252 -0.905 . . . . 0.0 110.676 167.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 39.24 55.11 5.51 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 125.2 1.4 . . . . 0.0 114.083 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -61.71 149.51 89.65 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.237 2.625 . . . . 0.0 112.004 -172.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.38 -2.97 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -170.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -153.04 154.01 34.04 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.177 -0.952 . . . . 0.0 112.642 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 68.1 m -67.41 138.15 56.47 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.42 1.488 . . . . 0.0 111.237 167.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -92.25 11.64 25.08 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.603 1.161 . . . . 0.0 112.026 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.34 -16.56 62.44 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.408 1.483 . . . . 0.0 114.433 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 70.7 p -137.67 148.42 61.09 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 125.618 1.567 . . . . 0.0 110.425 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -61.78 -31.22 85.54 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.226 2.618 . . . . 0.0 112.568 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.88 -36.35 77.98 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -71.27 -39.8 61.72 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 121.529 0.516 . . . . 0.0 112.874 172.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -56.92 -45.85 82.4 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 124.123 0.969 . . . . 0.0 110.839 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.66 -39.55 88.78 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.906 0.882 . . . . 0.0 112.74 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -72.33 -20.43 61.48 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.551 1.54 . . . . 0.0 114.031 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -102.6 -15.04 16.51 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.092 1.357 . . . . 0.0 113.364 172.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -82.07 12.61 4.03 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 126.614 1.966 . . . . 0.0 113.141 166.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -56.89 168.34 0.65 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.454 1.902 . . . . 0.0 115.326 -171.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 14.0 p -129.64 142.33 44.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 125.179 1.392 . . . . 0.0 110.189 167.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -139.91 165.34 27.59 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.76 2.024 . . . . 0.0 110.737 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 14.8 tt -138.28 154.0 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.1 0.96 . . . . 0.0 112.636 -175.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.5 161.55 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.334 1.854 . . . . 0.0 110.461 -175.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 59.0 t -107.3 135.84 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.52 1.128 . . . . 0.0 109.359 173.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.177 0 C-N-CA 125.177 1.391 . . . . 0.0 111.774 -173.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 119.316 -0.373 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -71.71 161.71 44.33 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.553 2.835 . . . . 0.0 112.403 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.75 150.5 79.09 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.106 2.538 . . . . 0.0 111.871 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 175.39 59.53 0.06 OUTLIER Glycine 0 CA--C 1.538 1.491 0 CA-C-O 118.575 -1.125 . . . . 0.0 114.184 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.32 159.32 50.68 Favored 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 123.324 2.683 . . . . 0.0 112.767 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.71 165.77 28.4 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.701 2.934 . . . . 0.0 112.882 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -136.42 22.92 3.19 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.301 1.441 . . . . 0.0 113.271 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 24.9 m -56.04 139.85 45.44 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.785 1.634 . . . . 0.0 112.622 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 52.1 58.77 9.9 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 125.245 1.402 . . . . 0.0 114.789 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.36 -19.37 38.1 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 124.055 3.17 . . . . 0.0 114.401 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 43.9 t -122.63 -8.4 8.5 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.254 1.822 . . . . 0.0 112.295 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -63.6 -16.76 61.76 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -174.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -137.89 40.71 2.34 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.199 2.2 . . . . 0.0 111.093 174.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.2 mt -46.86 -38.43 10.34 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.189 0.995 . . . . 0.0 112.193 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -60.46 -38.52 84.46 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.438 0.695 . . . . 0.0 112.296 -175.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.3 t -70.81 -45.64 64.26 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.359 0.664 . . . . 0.0 111.959 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.64 -40.67 97.75 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 15.3 mt -73.16 -33.83 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.883 0.873 . . . . 0.0 110.728 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.3 -39.16 92.13 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.363 -0.835 . . . . 0.0 112.046 172.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.97 76.34 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.273 1.029 . . . . 0.0 113.046 176.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.7 t -64.55 -40.8 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.139 0.976 . . . . 0.0 111.245 172.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 16.9 m -84.12 -24.49 30.26 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.881 0.873 . . . . 0.0 112.96 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.38 15.37 72.66 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 126.23 1.871 . . . . 0.0 115.135 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 126.78 -156.41 20.09 Favored Glycine 0 CA--C 1.542 1.747 0 C-N-CA 125.311 1.434 . . . . 0.0 112.962 -174.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.64 170.43 20.02 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 124.16 3.24 . . . . 0.0 111.817 169.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.93 108.69 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.579 1.151 . . . . 0.0 110.752 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -80.54 171.7 14.71 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.469 2.308 . . . . 0.0 112.554 169.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -119.29 150.95 39.27 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.099 0.475 . . . . 0.0 111.147 -171.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -57.31 170.76 3.26 Favored Glycine 0 CA--C 1.541 1.716 0 O-C-N 121.147 -0.971 . . . . 0.0 111.863 166.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -48.68 -28.19 3.39 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -171.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -65.29 -17.92 64.89 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.92 8.41 76.07 Favored Glycine 0 CA--C 1.542 1.774 0 C-N-CA 124.698 1.142 . . . . 0.0 115.215 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -167.53 8.88 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.1 t -73.84 105.42 5.11 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 122.053 2.206 . . . . 0.0 112.12 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.7 mp -74.13 102.5 4.26 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.169 0.988 . . . . 0.0 111.479 172.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . 0.471 HG13 ' H ' ' A' ' 236' ' ' ASP . 5.9 pt -56.97 152.65 27.13 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.065 1.746 . . . . 0.0 112.635 167.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -63.15 -29.57 74.26 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.619 2.212 . . . . 0.0 112.406 173.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.71 92.03 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.737 0.815 . . . . 0.0 112.952 172.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.471 ' H ' HG13 ' A' ' 233' ' ' ILE . 28.4 t70 -61.62 -47.8 83.78 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 119.025 0.83 . . . . 0.0 111.663 171.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -61.11 -35.0 75.84 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.559 -0.713 . . . . 0.0 112.488 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -69.27 -42.65 75.24 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.761 -1.212 . . . . 0.0 112.555 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 56.1 mt -56.49 -47.26 82.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 121.162 -0.962 . . . . 0.0 110.496 171.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 73.5 mt -64.49 -33.34 75.66 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.585 0.754 . . . . 0.0 112.69 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -62.61 -41.58 99.07 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.289 1.036 . . . . 0.0 112.676 175.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -69.57 -36.49 76.33 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 74.3 t -67.31 -41.42 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.504 0.722 . . . . 0.0 111.19 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.01 93.7 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.889 0.876 . . . . 0.0 112.246 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -65.75 -36.98 85.11 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.751 -0.593 . . . . 0.0 112.047 173.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -63.5 -36.15 82.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.153 0.981 . . . . 0.0 112.711 174.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.457 HD22 HG11 ' A' ' 255' ' ' VAL . 5.4 mp -66.71 -41.76 87.45 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.487 0.585 . . . . 0.0 112.173 171.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -60.93 -30.75 70.39 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.421 1.088 . . . . 0.0 112.532 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -74.99 -9.51 58.61 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.909 1.684 . . . . 0.0 114.627 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 17.1 t -155.92 69.39 5.1 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.483 1.513 . . . . 0.0 108.644 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -62.96 -5.54 7.82 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.518 2.812 . . . . 0.0 112.716 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -74.16 -17.89 60.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.463 1.505 . . . . 0.0 113.256 171.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -118.78 83.52 2.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.453 1.501 . . . . 0.0 111.251 -171.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 55.7 mtt85 -55.23 157.39 3.58 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.123 1.369 . . . . 0.0 112.129 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.457 HG11 HD22 ' A' ' 247' ' ' LEU . 4.5 m -126.18 161.29 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 169.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.6 m -128.89 140.77 51.53 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.339 1.456 . . . . 0.0 109.258 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 61.7 mt -113.84 127.03 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.815 1.246 . . . . 0.0 108.759 -173.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.416 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 1.4 m120 -119.73 118.4 30.8 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.919 1.688 . . . . 0.0 107.764 -172.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -121.77 151.16 16.98 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 118.549 0.613 . . . . 0.0 112.791 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -127.35 168.69 14.47 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 128.423 2.689 . . . . 0.0 109.81 -170.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.2 m -152.42 156.69 40.0 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.362 1.865 . . . . 0.0 109.642 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.66 157.63 37.65 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.53 -1.356 . . . . 0.0 109.761 165.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -92.0 33.22 1.07 Allowed 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 121.431 0.634 . . . . 0.0 112.642 -177.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 13.0 m -66.29 -23.14 66.33 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.016 1.326 . . . . 0.0 112.773 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -99.93 -139.69 10.96 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 126.384 1.945 . . . . 0.0 112.752 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 62.2 m -139.25 163.57 32.12 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.603 1.961 . . . . 0.0 109.587 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -53.61 -38.93 64.49 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 121.035 -1.04 . . . . 0.0 113.196 -177.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -65.93 -10.12 49.7 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 124.589 1.09 . . . . 0.0 115.197 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 13.8 mt -110.1 -32.45 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.796 2.038 . . . . 0.0 111.156 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -82.35 -29.77 30.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.344 1.058 . . . . 0.0 112.927 -174.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 21.1 mm -59.37 -55.57 44.71 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 125.724 1.61 . . . . 0.0 111.759 169.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.87 -31.93 19.11 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 CA-C-N 120.836 1.334 . . . . 0.0 113.284 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 4.3 mp -64.65 -50.63 66.32 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 120.23 1.377 . . . . 0.0 111.865 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 46.5 p -65.38 -33.19 75.37 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -72.32 -38.06 68.76 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.884 0.874 . . . . 0.0 112.169 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -62.92 -41.78 99.58 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.764 1.226 . . . . 0.0 111.103 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.7 mmt-85 -63.19 -38.74 92.37 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.678 0.672 . . . . 0.0 111.598 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -71.33 -38.4 71.69 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -65.68 -37.74 87.33 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 125.264 1.426 . . . . 0.0 112.08 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 82.1 mt -64.59 -41.36 92.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 118.587 0.631 . . . . 0.0 110.572 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 86.2 t -65.42 -41.73 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 122.047 -0.408 . . . . 0.0 111.527 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -64.68 -41.14 96.26 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.939 0.496 . . . . 0.0 111.882 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.59 -37.71 87.4 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.827 0.851 . . . . 0.0 111.57 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -65.09 -42.15 94.32 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 174.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.2 mp -63.99 -40.75 97.07 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.843 -0.536 . . . . 0.0 111.716 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 53.3 t -68.16 -38.45 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.67 0.788 . . . . 0.0 110.798 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.25 -34.39 77.35 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.131 0.972 . . . . 0.0 112.879 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -43.64 93.83 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.903 0.881 . . . . 0.0 111.279 170.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 156.67 1.86 0.1 OUTLIER Glycine 0 CA--C 1.53 1.019 0 N-CA-C 117.746 1.858 . . . . 0.0 117.746 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.0 m -73.67 145.83 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-N 121.066 2.433 . . . . 0.0 110.799 -174.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.61 140.25 55.53 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.616 -0.678 . . . . 0.0 110.788 172.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -54.54 -27.94 43.35 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.309 1.433 . . . . 0.0 113.843 171.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.1 -32.14 72.67 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.395 1.078 . . . . 0.0 113.316 172.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -90.23 2.29 55.57 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.261 1.424 . . . . 0.0 114.218 -173.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 14.9 tt -138.88 139.95 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.482 0.713 . . . . 0.0 112.559 -171.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -139.4 164.31 30.19 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.217 1.407 . . . . 0.0 111.631 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 45.9 p -138.99 146.11 40.52 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.662 1.185 . . . . 0.0 111.977 -175.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 40.5 t -142.18 138.39 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.792 1.637 . . . . 0.0 109.934 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -107.75 97.97 1.2 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.117 1.818 . . . . 0.0 111.692 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.416 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 1.9 mp -97.01 29.96 2.9 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.443 2.697 . . . . 0.0 110.223 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 0.61 -66.14 0.0 OUTLIER Glycine 0 C--N 1.346 1.122 0 N-CA-C 120.919 3.127 . . . . 0.0 120.919 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 91.5 p -146.81 16.1 1.23 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.064 1.432 . . . . 0.0 114.732 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 17.7 m -71.76 154.37 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 O-C-N 121.106 -0.996 . . . . 0.0 111.098 171.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 22.4 m120 41.71 50.16 4.45 Favored Pre-proline 0 CA--C 1.559 1.327 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.6 125.35 12.64 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.838 2.359 . . . . 0.0 111.404 -174.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 2.0 pp -97.84 -1.11 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -173.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -146.32 166.95 24.78 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.855 1.662 . . . . 0.0 111.714 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 85.9 p -80.92 158.58 25.22 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 122.253 1.025 . . . . 0.0 113.411 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -86.7 -4.87 59.23 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.601 1.16 . . . . 0.0 110.987 165.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.57 -18.69 61.59 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.815 1.646 . . . . 0.0 114.447 -174.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 71.6 p -133.26 142.88 45.95 Favored Pre-proline 0 N--CA 1.474 0.759 0 CA-C-N 119.337 0.971 . . . . 0.0 110.575 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.7 -28.12 68.74 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.447 2.764 . . . . 0.0 112.707 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -66.08 -41.14 91.1 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.43 -0.794 . . . . 0.0 111.468 170.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -64.49 -38.23 95.49 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 124.184 0.897 . . . . 0.0 113.087 174.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -58.96 -49.0 79.52 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 124.21 1.004 . . . . 0.0 111.23 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -75.85 -22.84 55.83 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.249 -0.907 . . . . 0.0 112.105 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -70.18 -34.58 73.14 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.061 1.344 . . . . 0.0 112.769 167.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.41 ' C ' ' H ' ' A' ' 320' ' ' ARG . 0.9 OUTLIER -91.69 -16.51 26.85 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.144 1.378 . . . . 0.0 112.65 177.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 57.3 mtt180 -70.54 11.81 0.32 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.831 1.652 . . . . 0.0 113.779 167.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 318' ' ' ASN . 16.0 ptp180 -60.51 162.44 6.35 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.521 1.928 . . . . 0.0 114.038 -173.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.21 151.66 32.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.24 172.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -139.63 159.11 42.93 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.894 1.678 . . . . 0.0 111.542 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.35 129.28 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.179 1.392 . . . . 0.0 108.708 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 64.8 t -134.05 129.57 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.209 1.404 . . . . 0.0 110.359 -171.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 23.8 t -72.84 134.92 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.546 0.738 . . . . 0.0 109.749 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.208 0 C-N-CA 125.036 1.335 . . . . 0.0 111.707 -171.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 119.282 -0.389 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -67.9 156.9 64.12 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 123.404 2.736 . . . . 0.0 112.396 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -80.35 42.7 1.37 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.797 3.665 . . . . 0.0 113.76 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 145.37 178.12 20.67 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 126.308 1.908 . . . . 0.0 113.699 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -69.88 165.43 31.13 Favored 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 123.789 2.993 . . . . 0.0 112.16 173.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.46 62.51 6.24 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.772 3.648 . . . . 0.0 113.125 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.61 35.36 0.06 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 128.304 2.642 . . . . 0.0 114.443 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 12.1 t -58.49 148.79 27.15 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.325 1.45 . . . . 0.0 112.539 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 54.43 58.69 12.07 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 125.613 1.578 . . . . 0.0 114.626 -175.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -70.21 -16.78 35.76 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.14 3.227 . . . . 0.0 114.277 -171.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 49.3 t -120.45 -2.99 9.93 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 126.759 2.024 . . . . 0.0 111.832 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -63.59 -17.8 63.23 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 -171.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -138.3 29.4 2.46 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.953 2.101 . . . . 0.0 111.475 173.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.79 -19.14 64.77 Favored 'General case' 0 C--O 1.221 -0.44 0 O-C-N 121.437 -0.789 . . . . 0.0 112.721 -172.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -55.94 -40.12 72.7 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.642 1.11 . . . . 0.0 111.529 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 17.5 t -68.33 -44.49 75.2 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.311 0.645 . . . . 0.0 111.878 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.94 -35.96 82.85 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 55.0 mt -70.18 -39.96 77.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.651 1.58 . . . . 0.0 109.493 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -63.9 -40.01 95.51 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.11 -0.994 . . . . 0.0 111.897 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.96 -38.34 90.65 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.121 0.968 . . . . 0.0 112.772 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.91 -28.78 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 118.677 0.671 . . . . 0.0 112.201 177.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.4 m -71.52 -26.41 62.65 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.693 1.197 . . . . 0.0 112.24 169.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.03 25.48 74.62 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.409 1.481 . . . . 0.0 113.637 -172.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 97.3 -170.54 25.93 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.28 1.419 . . . . 0.0 112.751 -171.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.09 140.96 38.78 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.32 2.68 . . . . 0.0 110.992 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.94 142.05 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.634 1.174 . . . . 0.0 112.03 -170.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -104.88 174.16 6.0 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.219 1.807 . . . . 0.0 115.115 -171.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -134.29 84.14 2.09 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.14 1.376 . . . . 0.0 108.858 -173.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -48.54 151.96 2.73 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 126.727 2.108 . . . . 0.0 115.047 -170.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -2.63 -42.12 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 1 C-N-CA 133.628 4.771 . . . . 0.0 120.62 -171.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -63.19 -20.43 65.41 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.204 1.002 . . . . 0.0 113.472 168.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.67 8.06 77.51 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.465 1.507 . . . . 0.0 115.047 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -154.19 19.58 0.5 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 127.361 2.265 . . . . 0.0 112.005 -176.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 7.5 t -82.74 81.99 8.26 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.741 -1.225 . . . . 0.0 113.17 -170.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 22.0 tp -82.13 77.65 8.91 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.834 1.254 . . . . 0.0 110.206 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 3.8 pt -58.21 157.89 15.62 Favored Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 125.624 1.57 . . . . 0.0 112.135 -173.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -61.65 -32.68 87.2 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.224 1.949 . . . . 0.0 112.648 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -68.55 -29.12 67.61 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 172.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -59.1 -41.83 89.05 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.818 1.19 . . . . 0.0 112.359 175.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -60.96 -27.57 68.35 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.561 0.745 . . . . 0.0 112.933 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -64.01 -40.65 96.83 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.67 1.123 . . . . 0.0 111.752 175.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 45.2 mm -58.9 -44.52 90.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 121.579 -0.7 . . . . 0.0 110.221 171.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.05 -36.86 84.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.486 0.714 . . . . 0.0 112.795 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -60.97 -41.73 96.94 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 119.074 0.852 . . . . 0.0 112.157 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -66.3 -40.21 89.84 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.954 0.901 . . . . 0.0 112.311 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 76.2 t -66.78 -41.57 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 123.78 0.832 . . . . 0.0 110.81 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.02 -39.27 93.15 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.355 0.662 . . . . 0.0 112.049 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.7 -38.22 88.62 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.252 0.621 . . . . 0.0 112.082 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.38 -30.93 67.96 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 178.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.79 -43.23 72.53 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.025 0.93 . . . . 0.0 112.585 169.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -60.43 -27.5 67.54 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.325 1.45 . . . . 0.0 112.745 174.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -79.36 -8.13 58.85 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.006 1.723 . . . . 0.0 114.843 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 37.2 t -152.99 68.5 6.72 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 125.285 1.434 . . . . 0.0 108.903 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -62.59 -8.85 14.03 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.244 2.63 . . . . 0.0 112.271 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -72.23 -16.5 61.94 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.669 1.588 . . . . 0.0 113.507 173.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -121.54 81.28 1.78 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.274 1.429 . . . . 0.0 110.705 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -49.89 143.04 8.16 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.412 1.485 . . . . 0.0 111.502 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 16.8 m -135.42 163.03 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 176.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 5.2 t -143.07 146.39 33.75 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 3.4 mt -101.92 106.7 20.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.476 -169.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -81.87 154.41 25.86 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 166.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -148.69 152.75 24.74 Favored Glycine 0 CA--C 1.523 0.564 0 O-C-N 121.84 -0.537 . . . . 0.0 112.36 168.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -116.62 169.96 8.95 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.74 2.416 . . . . 0.0 108.633 -170.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.4 p -149.95 145.86 26.72 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.292 2.637 . . . . 0.0 109.78 171.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -63.44 168.31 4.68 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 120.984 -1.073 . . . . 0.0 112.929 174.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -101.33 21.08 14.67 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -171.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 3.9 m -68.71 -19.14 64.35 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.867 -1.145 . . . . 0.0 112.772 172.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -98.22 -152.55 28.12 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.12 1.819 . . . . 0.0 113.985 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 73.7 m -129.72 145.8 51.52 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.735 1.614 . . . . 0.0 110.472 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -53.56 -37.12 62.58 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.71 1.204 . . . . 0.0 113.754 -171.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -60.0 -28.86 66.88 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 123.955 0.788 . . . . 0.0 113.959 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 18.7 mm -95.94 -24.17 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 126.156 1.782 . . . . 0.0 112.142 175.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -86.76 -23.97 25.25 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -175.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 21.8 mm -58.67 -54.28 57.84 Favored Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 125.121 1.368 . . . . 0.0 112.228 167.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -70.63 -33.44 13.29 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 121.075 1.42 . . . . 0.0 113.116 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -72.35 -36.52 68.82 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.58 1.082 . . . . 0.0 112.856 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 61.7 p -68.82 -36.66 78.5 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.72 1.145 . . . . 0.0 113.536 171.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.36 85.12 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.339 1.055 . . . . 0.0 111.577 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -61.2 -42.7 99.05 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 124.918 1.287 . . . . 0.0 110.745 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 22.7 mtt85 -64.56 -32.12 73.64 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -75.92 -39.57 55.97 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 171.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -60.22 -45.65 92.45 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 125.319 1.448 . . . . 0.0 110.351 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 41.0 mm -66.27 -35.52 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 118.675 0.67 . . . . 0.0 111.011 -177.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.81 -44.28 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 O-C-N 121.992 -0.443 . . . . 0.0 111.162 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -66.1 -36.59 83.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.341 0.657 . . . . 0.0 111.658 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -63.03 -41.23 99.48 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.668 1.187 . . . . 0.0 111.458 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -64.1 -43.01 96.67 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 172.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.4 mp -63.12 -40.93 99.04 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.779 0.832 . . . . 0.0 111.659 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 39.1 t -63.98 -42.31 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.872 0.869 . . . . 0.0 110.922 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.36 -31.8 70.46 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -42.03 75.76 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.142 0.977 . . . . 0.0 111.901 172.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 159.77 -0.26 0.08 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 117.494 1.757 . . . . 0.0 117.494 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 2.6 t -74.87 124.28 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 120.664 2.232 . . . . 0.0 109.2 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.31 142.36 57.8 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.048 -1.032 . . . . 0.0 110.837 173.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -53.17 -28.88 35.24 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.169 1.366 . . . . 0.0 113.613 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -68.31 -22.57 64.71 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.23 1.412 . . . . 0.0 114.671 175.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -108.46 2.4 22.29 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.305 1.842 . . . . 0.0 113.898 -172.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 2.8 tp -133.76 124.85 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.372 1.469 . . . . 0.0 110.005 -172.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -122.91 172.69 8.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.731 1.212 . . . . 0.0 110.789 171.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 40.0 p -141.73 151.91 43.36 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.458 1.103 . . . . 0.0 112.527 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 7.8 t -142.57 132.77 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.396 1.078 . . . . 0.0 111.143 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -93.75 120.76 6.39 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 123.881 0.753 . . . . 0.0 111.256 169.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 63.8 mt -111.65 18.9 18.59 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.352 1.861 . . . . 0.0 113.327 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 16.47 -105.87 0.01 OUTLIER Glycine 0 CA--C 1.541 1.666 0 C-N-CA 124.863 1.22 . . . . 0.0 116.103 -171.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 16.9 m -111.47 13.51 21.44 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -172.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 6.3 m -61.33 159.17 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.68 1.127 . . . . 0.0 111.737 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 38.1 53.99 3.84 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 125.622 1.569 . . . . 0.0 113.78 175.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -64.06 150.79 87.62 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.922 2.414 . . . . 0.0 113.081 -171.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 22.8 pt -134.72 -4.94 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 127.211 2.205 . . . . 0.0 113.365 -171.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -147.77 152.81 38.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.593 1.157 . . . . 0.0 112.399 170.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 69.5 m -76.73 157.44 31.69 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.746 1.618 . . . . 0.0 112.936 174.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -73.14 -3.64 27.78 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.121 1.368 . . . . 0.0 113.273 170.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.19 -21.04 66.3 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.86 1.664 . . . . 0.0 115.367 -170.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 78.3 p -140.41 147.45 49.65 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 124.198 0.999 . . . . 0.0 111.182 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.73 -27.8 75.94 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.381 2.721 . . . . 0.0 112.603 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -65.06 -41.19 95.35 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.939 0.896 . . . . 0.0 112.386 170.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.55 -39.9 95.8 Favored Glycine 0 C--N 1.336 0.554 0 O-C-N 121.728 -0.607 . . . . 0.0 112.518 173.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -59.08 -43.29 91.79 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.771 0.828 . . . . 0.0 111.578 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.97 -41.61 99.59 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.892 0.877 . . . . 0.0 112.3 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.99 -11.41 60.86 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.613 1.565 . . . . 0.0 114.302 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . 0.256 0.4 OUTLIER -119.69 15.75 12.74 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.522 1.529 . . . . 0.0 111.667 172.001 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -105.56 8.58 33.36 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.992 1.717 . . . . 0.0 112.345 166.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -63.5 161.19 14.93 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -170.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 2.5 m -126.25 144.68 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 127.217 2.207 . . . . 0.0 110.779 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -147.57 134.69 20.42 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.468 1.107 . . . . 0.0 113.182 -171.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 23.2 mm -85.73 142.55 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.595 1.558 . . . . 0.0 110.758 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 43.5 t -139.6 129.39 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.394 1.077 . . . . 0.0 109.483 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 9.0 p -77.35 133.41 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.409 -0.807 . . . . 0.0 111.228 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 14.1 m120 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 125.233 1.413 . . . . 0.0 111.988 -177.698 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.225 0 CA-C-O 119.291 -0.385 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -70.5 160.39 49.65 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.458 2.772 . . . . 0.0 112.512 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.11 156.08 63.28 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.257 2.638 . . . . 0.0 111.973 173.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 69.56 -166.79 48.4 Favored Glycine 0 CA--C 1.544 1.894 0 C-N-CA 123.713 0.673 . . . . 0.0 114.029 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.51 159.58 52.87 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 123.322 2.681 . . . . 0.0 112.332 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.21 161.13 45.87 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.481 2.787 . . . . 0.0 112.797 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -75.57 22.21 0.13 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.117 1.767 . . . . 0.0 114.851 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 33.5 m -57.53 140.08 51.72 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.061 1.745 . . . . 0.0 112.844 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 48.91 58.35 7.78 Favored Glycine 0 CA--C 1.541 1.711 0 C-N-CA 125.627 1.584 . . . . 0.0 115.113 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -71.05 -14.76 32.2 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 124.19 3.26 . . . . 0.0 114.681 -171.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 33.0 t -133.6 -1.86 3.07 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 126.802 2.041 . . . . 0.0 112.092 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -62.24 -20.4 64.19 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 117.515 2.413 . . . . 0.0 117.515 -171.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -140.64 30.76 1.88 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.947 2.099 . . . . 0.0 111.292 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.0 tp -62.97 -19.73 64.58 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.341 -0.85 . . . . 0.0 113.221 -171.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -56.99 -39.5 74.77 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.222 0.919 . . . . 0.0 111.557 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 15.6 t -68.88 -43.63 74.91 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.549 0.74 . . . . 0.0 111.873 173.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.46 -35.01 79.63 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 60.8 mt -70.6 -39.49 76.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.466 1.506 . . . . 0.0 109.479 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -66.66 -33.42 75.6 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.221 -0.924 . . . . 0.0 112.873 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -70.43 -37.86 74.47 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.21 1.004 . . . . 0.0 112.402 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.26 -27.82 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 118.57 0.623 . . . . 0.0 112.451 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 68.5 p -84.8 -25.89 27.87 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 170.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.2 11.76 71.34 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 125.59 1.567 . . . . 0.0 113.855 -171.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 124.56 -174.46 17.07 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 126.565 2.031 . . . . 0.0 112.915 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -76.02 150.46 33.94 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.536 2.824 . . . . 0.0 110.337 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 10.5 mm -108.2 139.94 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -169.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -95.07 174.48 7.06 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 128.009 2.523 . . . . 0.0 114.613 -171.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -138.38 116.27 11.58 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.573 1.149 . . . . 0.0 110.636 -175.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -58.84 -162.71 0.07 OUTLIER Glycine 0 N--CA 1.477 1.381 0 C-N-CA 127.799 2.619 . . . . 0.0 117.056 -174.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -45.7 -37.59 5.99 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.451 1.9 . . . . 0.0 115.556 -175.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -69.65 -24.79 63.68 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.013 1.325 . . . . 0.0 113.913 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 90.37 -4.43 82.52 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 127.228 2.347 . . . . 0.0 115.16 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -156.34 16.87 0.34 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.132 1.373 . . . . 0.0 113.936 -171.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.0 t -85.33 100.1 11.59 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.647 -1.283 . . . . 0.0 110.851 -172.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 14.6 tp -80.26 93.83 5.97 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.615 1.166 . . . . 0.0 109.829 176.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 6.4 pt -63.49 160.0 46.38 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 125.776 1.631 . . . . 0.0 111.826 -173.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -61.91 -32.17 84.86 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.227 1.951 . . . . 0.0 112.596 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -67.67 -32.28 72.85 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 171.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.67 -44.32 90.17 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.508 1.049 . . . . 0.0 112.049 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -61.83 -20.12 63.31 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.01 0.924 . . . . 0.0 113.144 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -76.01 -42.75 47.08 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.557 1.071 . . . . 0.0 112.188 173.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 47.4 mm -58.92 -44.84 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 O-C-N 121.359 -0.838 . . . . 0.0 110.281 171.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.12 -34.68 78.97 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.654 0.782 . . . . 0.0 112.989 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -61.05 -42.12 97.87 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.049 0.94 . . . . 0.0 112.2 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -65.95 -38.47 88.69 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.303 1.041 . . . . 0.0 112.494 175.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 94.8 t -65.06 -42.68 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.167 0.587 . . . . 0.0 111.168 174.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.77 94.95 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.071 0.548 . . . . 0.0 111.875 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -64.08 -40.46 96.29 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.509 0.724 . . . . 0.0 111.988 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -70.96 -30.09 66.28 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.818 0.847 . . . . 0.0 113.092 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -43.98 73.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.838 0.855 . . . . 0.0 112.079 169.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -63.68 -23.07 67.22 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.014 1.326 . . . . 0.0 113.537 174.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.06 -10.02 59.08 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.275 1.43 . . . . 0.0 114.574 170.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 40.2 t -156.3 66.48 4.29 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 125.702 1.601 . . . . 0.0 109.141 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -64.78 -7.81 15.94 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.922 2.414 . . . . 0.0 111.773 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.91 -21.57 65.99 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.175 1.39 . . . . 0.0 113.017 170.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -107.93 95.22 5.53 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.123 1.369 . . . . 0.0 111.225 -175.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 23.3 mtt180 -49.72 141.21 10.23 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.524 1.13 . . . . 0.0 110.876 167.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.46 166.05 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.892 1.277 . . . . 0.0 111.561 173.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 7.2 t -149.16 146.74 27.81 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 118.387 2.736 . . . . 0.0 118.387 170.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 26.3 mt -100.4 115.02 40.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 124.982 1.313 . . . . 0.0 108.937 -171.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -93.93 155.64 17.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.99 -0.444 . . . . 0.0 110.043 169.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -147.19 152.56 24.69 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 121.7 0.611 . . . . 0.0 113.349 167.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.86 170.43 10.11 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.187 2.595 . . . . 0.0 109.982 -169.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 51.0 p -143.65 160.86 39.93 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.188 2.195 . . . . 0.0 110.485 167.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.94 152.0 28.84 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 122.578 1.18 . . . . 0.0 112.232 168.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -3.85 29.42 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -171.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.93 -16.4 63.83 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.261 1.825 . . . . 0.0 114.931 -173.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.57 -157.78 31.93 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.306 1.431 . . . . 0.0 114.219 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 68.1 m -131.58 143.7 50.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.682 1.593 . . . . 0.0 109.702 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -50.57 -40.17 51.51 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.715 1.206 . . . . 0.0 114.019 -171.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -63.96 -27.19 70.93 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 123.657 0.646 . . . . 0.0 114.113 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 11.3 mm -97.72 -24.51 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.842 1.657 . . . . 0.0 111.767 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -80.42 -32.89 37.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.124 0.97 . . . . 0.0 113.193 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 18.6 mm -55.17 -55.86 34.76 Favored Pre-proline 0 N--CA 1.471 0.588 0 C-N-CA 125.418 1.487 . . . . 0.0 112.298 171.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.84 -30.14 17.71 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 120.721 1.293 . . . . 0.0 112.811 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 16.7 mt -66.02 -44.77 83.72 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 119.778 1.172 . . . . 0.0 112.789 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.33 -37.3 80.4 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 176.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.72 -34.47 75.68 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.249 1.02 . . . . 0.0 111.61 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -63.17 -42.83 99.45 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.293 1.037 . . . . 0.0 110.855 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -60.13 -44.01 95.26 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.875 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.25 -37.28 77.87 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -64.32 -41.36 96.86 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 125.631 1.573 . . . . 0.0 111.576 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 37.0 mm -67.14 -38.72 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 118.785 0.72 . . . . 0.0 110.896 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 99.7 t -68.04 -42.33 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 O-C-N 121.938 -0.476 . . . . 0.0 111.385 177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -65.64 -40.02 92.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.265 0.626 . . . . 0.0 111.305 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.15 -39.25 93.62 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.306 0.642 . . . . 0.0 111.75 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -65.02 -42.95 93.95 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.9 mp -67.53 -39.94 85.06 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.896 0.478 . . . . 0.0 111.41 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 50.7 t -66.65 -39.36 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 123.822 0.849 . . . . 0.0 110.672 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.73 -34.19 76.37 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 176.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -69.04 -38.08 78.95 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.76 -0.638 . . . . 0.0 112.612 170.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 151.46 9.32 0.1 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-O 117.481 -1.733 . . . . 0.0 116.952 168.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.9 130.13 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 120.482 2.141 . . . . 0.0 108.985 176.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.98 135.92 57.75 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.256 -0.902 . . . . 0.0 110.722 172.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -57.34 -29.82 60.73 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.696 1.141 . . . . 0.0 113.859 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.73 -37.26 85.84 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 122.161 -0.611 . . . . 0.0 112.476 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -85.49 -1.34 56.97 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.437 1.495 . . . . 0.0 113.966 -171.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 15.1 tt -139.85 93.64 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 124.92 1.288 . . . . 0.0 111.58 -171.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -85.64 174.2 9.58 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.209 -0.932 . . . . 0.0 110.632 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 38.4 p -136.26 148.77 48.17 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.485 1.114 . . . . 0.0 111.869 172.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 11.1 t -137.33 132.12 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.889 0.876 . . . . 0.0 111.994 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -91.06 104.91 3.22 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.589 1.09 . . . . 0.0 111.761 173.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 39.9 mt -105.38 32.08 4.5 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.989 2.115 . . . . 0.0 110.866 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 2.59 -72.66 0.0 OUTLIER Glycine 0 C--N 1.35 1.325 0 C-N-CA 127.796 2.617 . . . . 0.0 119.543 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 88.2 p -147.35 21.42 1.2 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.245 1.523 . . . . 0.0 113.989 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 9.0 m -66.43 156.38 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 121.083 -1.01 . . . . 0.0 111.618 172.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 35.91 55.64 2.65 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 125.978 1.711 . . . . 0.0 113.769 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -61.57 123.97 13.73 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.212 2.608 . . . . 0.0 112.588 -171.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 47.1 pt -90.7 -3.0 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.512 1.125 . . . . 0.0 113.86 -173.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -153.08 166.8 31.32 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.81 1.644 . . . . 0.0 111.683 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 79.0 p -70.33 171.2 10.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.801 1.24 . . . . 0.0 113.633 175.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -113.29 3.42 15.94 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.828 1.251 . . . . 0.0 111.453 166.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.33 -21.39 62.06 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.718 1.607 . . . . 0.0 113.647 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 66.0 p -132.38 149.0 71.91 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 124.606 1.162 . . . . 0.0 110.934 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -62.35 -29.62 79.83 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.484 2.789 . . . . 0.0 112.541 176.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.51 -42.38 98.49 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.597 0.759 . . . . 0.0 112.239 171.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -66.25 -39.0 94.26 Favored Glycine 0 C--N 1.336 0.543 0 O-C-N 121.829 -0.544 . . . . 0.0 112.609 175.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -58.92 -46.85 86.93 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.46 0.704 . . . . 0.0 111.096 175.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.12 -40.92 99.01 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.713 0.805 . . . . 0.0 111.864 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -70.63 -12.04 61.31 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.397 1.479 . . . . 0.0 114.131 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . 0.256 49.7 t30 -120.3 3.75 10.82 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.806 1.243 . . . . 0.0 113.958 172.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -83.09 1.48 40.03 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.335 1.454 . . . . 0.0 112.087 164.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.46 156.73 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 131.569 3.947 . . . . 0.0 115.914 -170.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 1.3 m -119.39 141.64 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.116 1.766 . . . . 0.0 110.989 167.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -136.18 166.92 22.29 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.952 1.701 . . . . 0.0 111.438 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 13.7 tt -133.54 142.81 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.199 0.999 . . . . 0.0 112.062 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 47.5 t -138.79 130.34 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.51 0.724 . . . . 0.0 109.726 -171.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 42.7 t -82.26 127.54 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.347 0.659 . . . . 0.0 110.328 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 61.7 t30 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 130.143 3.377 . . . . 0.0 116.38 177.905 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.742 0 CA-C-O 119.171 -0.794 . . . . 0.0 114.424 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.45 -12.99 32.5 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.441 3.427 . . . . 0.0 114.882 -171.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 20.2 t -133.2 -3.01 3.11 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 126.908 2.083 . . . . 0.0 111.878 176.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.67 -20.01 66.13 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -171.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -139.25 31.27 2.15 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.922 2.089 . . . . 0.0 111.35 174.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.7 tp -63.14 -17.1 61.99 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -171.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -53.71 -46.87 70.91 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.601 0.76 . . . . 0.0 111.489 167.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 20.1 t -69.17 -40.76 77.94 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.382 0.673 . . . . 0.0 111.409 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.39 -38.18 89.2 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 59.4 mt -71.98 -36.91 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.741 0.816 . . . . 0.0 109.593 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -65.61 -34.01 77.24 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.131 0.972 . . . . 0.0 112.557 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -70.18 -33.76 72.13 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.913 0.885 . . . . 0.0 112.86 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.0 t -65.54 -44.92 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 118.488 0.586 . . . . 0.0 111.192 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 69.5 p -77.26 -25.53 51.56 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -176.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 66.12 14.71 61.89 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.628 1.585 . . . . 0.0 114.212 -171.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 118.43 -171.83 14.23 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 126.024 1.774 . . . . 0.0 112.831 -172.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -76.5 167.39 25.7 Favored 'Trans proline' 0 CA--C 1.549 1.272 0 C-N-CA 123.682 2.922 . . . . 0.0 111.85 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.94 140.01 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 126.16 1.784 . . . . 0.0 113.143 -168.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -106.73 169.44 8.53 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.109 2.164 . . . . 0.0 115.614 -170.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.457 ' CZ ' ' HG3' ' A' ' 277' ' ' ARG . 92.0 m-85 -143.3 100.89 3.71 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.389 1.075 . . . . 0.0 111.586 -171.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -115.47 -174.45 17.96 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.71 1.624 . . . . 0.0 113.026 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 24.7 t30 50.43 -75.68 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 128.468 2.707 . . . . 0.0 114.527 -171.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -79.39 -25.54 42.12 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.454 1.902 . . . . 0.0 112.894 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.68 0.27 86.21 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.15 1.357 . . . . 0.0 115.542 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -162.21 26.44 0.11 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.519 1.528 . . . . 0.0 113.451 -175.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.8 t -120.32 97.36 5.55 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.356 1.062 . . . . 0.0 110.839 -171.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 18.6 tp -70.11 141.03 52.78 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.472 1.109 . . . . 0.0 113.178 -173.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.435 HG13 ' H ' ' A' ' 236' ' ' ASP . 6.4 pt -83.36 150.63 60.89 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.097 1.759 . . . . 0.0 113.906 -172.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.29 -31.21 73.82 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.48 2.786 . . . . 0.0 112.882 173.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.92 94.87 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.588 0.755 . . . . 0.0 112.384 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.435 ' H ' HG13 ' A' ' 233' ' ' ILE . 36.4 t70 -69.01 -39.96 78.98 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 170.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -60.4 -28.64 68.4 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.469 -1.394 . . . . 0.0 112.683 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -71.96 -41.2 68.0 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.689 -1.257 . . . . 0.0 113.24 170.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 90.8 mt -55.99 -44.13 77.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.042 -1.036 . . . . 0.0 110.134 168.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 31.7 mt -64.37 -32.31 73.87 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.196 0.998 . . . . 0.0 113.177 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -59.68 -42.87 93.89 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.704 1.138 . . . . 0.0 111.996 171.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -72.94 -32.83 65.52 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.149 0.58 . . . . 0.0 112.555 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 69.9 t -67.04 -43.23 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.639 0.775 . . . . 0.0 111.097 172.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.41 -42.44 95.96 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.083 0.553 . . . . 0.0 111.994 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.71 -37.17 85.7 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.362 0.665 . . . . 0.0 112.047 176.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.64 -34.21 73.71 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.919 0.888 . . . . 0.0 112.963 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.18 -45.9 75.56 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.739 0.815 . . . . 0.0 110.213 171.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 53.4 tttp -62.59 -23.39 67.01 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.079 1.751 . . . . 0.0 113.714 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -75.2 -8.35 56.36 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.847 1.659 . . . . 0.0 114.597 170.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 38.2 t -151.95 66.86 6.89 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 126.068 1.747 . . . . 0.0 108.507 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -63.83 -6.61 11.22 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.378 2.719 . . . . 0.0 112.318 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -71.72 -18.52 62.14 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.833 1.653 . . . . 0.0 113.229 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -120.76 87.14 2.7 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.688 1.595 . . . . 0.0 110.525 -172.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 63.7 mtt85 -52.69 158.49 1.3 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.812 1.245 . . . . 0.0 111.955 172.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.5 m -127.73 159.91 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.063 1.345 . . . . 0.0 111.722 174.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.1 m -125.96 138.05 53.73 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.46 1.504 . . . . 0.0 108.619 171.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.4 mt -119.33 121.59 66.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.001 1.32 . . . . 0.0 107.495 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -109.29 151.02 27.12 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.457 0.703 . . . . 0.0 110.288 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -139.84 156.9 25.09 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 122.007 -0.433 . . . . 0.0 112.475 167.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -127.73 169.57 13.69 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.893 2.477 . . . . 0.0 109.111 -170.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.5 m -149.14 153.01 37.08 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 127.366 2.266 . . . . 0.0 108.521 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -61.45 165.7 4.58 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.568 -1.333 . . . . 0.0 111.523 167.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -100.72 20.56 14.98 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -175.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.3 m -71.09 -20.19 62.37 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.816 -1.178 . . . . 0.0 112.943 169.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.09 -151.85 21.33 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 125.885 1.707 . . . . 0.0 113.38 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 8.3 t -139.44 164.35 30.11 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.302 1.441 . . . . 0.0 110.374 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -52.67 -42.17 64.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.975 0.91 . . . . 0.0 112.469 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -68.63 -5.09 42.85 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.436 1.017 . . . . 0.0 115.328 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 6.1 mt -115.79 -33.46 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.417 1.887 . . . . 0.0 111.266 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -86.94 -26.87 23.65 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.464 1.106 . . . . 0.0 113.257 -175.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 19.9 mm -60.0 -53.4 65.57 Favored Pre-proline 0 N--CA 1.469 0.496 0 C-N-CA 124.803 1.241 . . . . 0.0 111.546 168.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.27 -34.8 15.38 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 CA-C-N 120.831 1.333 . . . . 0.0 113.099 176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 17.9 mt -66.18 -44.8 82.98 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 120.345 1.429 . . . . 0.0 112.747 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 34.8 p -65.77 -37.12 85.47 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.74 -39.84 76.54 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.255 0.622 . . . . 0.0 111.716 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -63.22 -40.85 98.64 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.768 1.227 . . . . 0.0 111.037 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.457 ' HG3' ' CZ ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -63.8 -38.63 91.8 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 118.762 0.71 . . . . 0.0 112.143 177.481 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -72.59 -38.85 67.73 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -67.41 -36.26 80.92 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 125.481 1.513 . . . . 0.0 111.795 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 59.2 mt -62.56 -42.49 96.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 118.805 0.729 . . . . 0.0 110.843 175.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.02 -41.82 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 117.954 0.343 . . . . 0.0 110.952 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.04 97.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -69.14 -36.43 77.45 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.598 0.759 . . . . 0.0 111.158 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -66.44 -42.76 87.16 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.6 mp -64.26 -41.81 96.77 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.02 0.528 . . . . 0.0 111.233 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.04 -37.42 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 123.142 0.577 . . . . 0.0 111.404 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.01 -35.4 76.62 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -69.35 -37.67 77.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.888 0.875 . . . . 0.0 112.855 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 161.91 -1.54 0.07 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 118.093 1.997 . . . . 0.0 118.093 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 4.9 t -76.88 142.73 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 120.015 1.908 . . . . 0.0 110.368 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.13 137.68 47.18 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.679 -1.263 . . . . 0.0 110.858 167.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -57.74 -27.14 58.65 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.384 0.992 . . . . 0.0 113.906 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.63 -30.7 70.87 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.628 1.171 . . . . 0.0 113.21 173.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -88.32 -2.81 58.82 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.007 1.323 . . . . 0.0 114.377 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 5.1 mt -125.81 123.66 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.361 0.982 . . . . 0.0 111.403 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -105.16 159.24 16.01 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.453 1.501 . . . . 0.0 110.64 167.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 40.6 p -134.87 146.01 48.82 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.165 0.986 . . . . 0.0 111.792 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 25.3 t -138.86 130.49 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.112 0.965 . . . . 0.0 111.396 -175.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -87.54 100.93 2.64 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.552 1.072 . . . . 0.0 111.691 172.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 43.2 mt -97.35 33.34 2.01 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.918 2.087 . . . . 0.0 110.065 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 3.64 -72.69 0.0 OUTLIER Glycine 0 C--N 1.351 1.373 0 N-CA-C 120.33 2.892 . . . . 0.0 120.33 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 23.4 p -144.79 17.96 1.63 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.615 1.707 . . . . 0.0 113.892 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.7 m -70.59 161.33 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.059 1.344 . . . . 0.0 112.597 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 38.44 53.56 3.94 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 125.866 1.666 . . . . 0.0 113.269 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -64.34 151.7 84.38 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.658 2.239 . . . . 0.0 113.667 -170.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 45.9 pt -126.44 -3.76 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.901 1.68 . . . . 0.0 113.685 -172.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 318' ' ' ASN . . . -151.74 149.57 29.21 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.134 1.373 . . . . 0.0 111.439 172.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 69.8 m -70.36 147.36 49.66 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.41 1.484 . . . . 0.0 112.078 171.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -82.74 5.98 19.59 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.365 1.066 . . . . 0.0 113.802 173.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.42 -13.98 62.68 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.051 1.34 . . . . 0.0 114.444 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 67.6 p -138.33 147.78 56.85 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 125.713 1.605 . . . . 0.0 110.472 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -63.92 -31.36 67.15 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 123.333 2.689 . . . . 0.0 112.423 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.94 -38.62 91.58 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.605 -0.684 . . . . 0.0 112.413 171.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.38 -36.95 85.36 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 123.767 0.699 . . . . 0.0 112.53 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -58.69 -49.54 77.2 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.528 0.731 . . . . 0.0 110.709 172.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.9 -37.28 86.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.377 0.671 . . . . 0.0 112.349 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -68.05 -17.65 64.46 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.391 1.476 . . . . 0.0 113.831 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 307' ' ' ALA . 7.8 t30 -113.21 -8.09 13.55 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 174.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -74.42 9.71 1.61 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.868 1.667 . . . . 0.0 113.865 167.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.42 153.28 2.23 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.812 2.445 . . . . 0.0 114.8 -170.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 8.3 p -123.32 145.9 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.464 1.506 . . . . 0.0 109.648 168.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -142.98 158.53 43.51 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.413 1.485 . . . . 0.0 112.898 -174.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 20.2 tt -133.08 141.32 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.756 1.623 . . . . 0.0 111.745 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 16.9 t -144.46 133.5 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.365 1.466 . . . . 0.0 109.568 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 38.4 t -70.34 137.63 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.708 0.803 . . . . 0.0 109.893 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.253 1.252 0 C-N-CA 125.275 1.43 . . . . 0.0 111.766 -171.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.73 0 CA-C-O 119.173 -0.793 . . . . 0.0 114.156 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -70.78 -14.54 32.94 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.337 3.358 . . . . 0.0 114.352 -171.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 22.2 t -128.17 -3.24 5.67 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 127.32 2.248 . . . . 0.0 111.666 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.83 -18.55 65.43 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 -171.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -138.46 29.88 2.4 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.022 2.129 . . . . 0.0 111.604 175.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 6.8 tp -63.11 -17.66 62.56 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -53.65 -45.68 70.3 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.057 0.844 . . . . 0.0 111.361 167.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 20.7 t -68.51 -42.03 79.13 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 122.935 0.494 . . . . 0.0 111.616 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.32 -41.42 98.91 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 176.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 66.1 mt -71.56 -35.64 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.994 0.918 . . . . 0.0 109.759 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -68.48 -36.99 79.74 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.987 0.915 . . . . 0.0 112.661 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.99 76.62 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.075 0.95 . . . . 0.0 112.24 175.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 22.5 t -63.06 -41.35 92.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.588 1.155 . . . . 0.0 111.761 173.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 82.3 p -82.92 -19.26 37.63 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 66.12 15.8 63.51 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.961 1.743 . . . . 0.0 114.804 -172.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 129.74 -159.12 22.47 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 125.593 1.568 . . . . 0.0 112.937 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -74.66 171.42 18.22 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.702 2.934 . . . . 0.0 111.785 171.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 28.9 mt -113.39 136.24 50.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.005 1.722 . . . . 0.0 109.193 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -124.03 161.98 24.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.363 1.465 . . . . 0.0 113.005 -172.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -138.23 99.33 3.83 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.021 0.928 . . . . 0.0 111.93 -169.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -74.96 164.7 54.61 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.707 1.146 . . . . 0.0 113.831 -171.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 32.88 -78.02 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 130.238 3.415 . . . . 0.0 116.07 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.75 -28.2 67.43 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.177 1.391 . . . . 0.0 113.164 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 96.97 11.32 53.45 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 116.816 1.486 . . . . 0.0 116.816 167.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -156.68 25.93 0.33 Allowed 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.288 1.435 . . . . 0.0 112.746 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 52.9 m -92.37 90.94 7.44 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.598 1.159 . . . . 0.0 112.56 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.4 mp -68.36 104.33 1.85 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.662 0.785 . . . . 0.0 110.218 171.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.438 HG13 ' H ' ' A' ' 236' ' ' ASP . 21.3 pt -67.24 163.62 44.27 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 125.215 1.406 . . . . 0.0 110.567 173.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.57 -30.47 79.42 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 CA-C-N 121.433 1.548 . . . . 0.0 112.251 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -66.09 -31.59 72.55 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 170.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.438 ' H ' HG13 ' A' ' 233' ' ' ILE . 22.5 t0 -62.4 -54.29 42.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.625 1.102 . . . . 0.0 110.976 170.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -60.51 -29.12 68.89 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.33 -0.856 . . . . 0.0 112.882 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -65.68 -51.17 61.57 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.168 -0.957 . . . . 0.0 112.005 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.5 pp -69.05 -30.29 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 118.348 0.522 . . . . 0.0 111.56 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 60.2 mt -66.49 -36.66 83.3 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.497 0.719 . . . . 0.0 112.348 171.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -40.18 93.3 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.6 -0.688 . . . . 0.0 111.683 173.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -67.63 -37.63 82.74 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 67.9 t -63.36 -44.0 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 119.031 0.832 . . . . 0.0 111.22 173.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.12 -40.62 94.48 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.924 0.489 . . . . 0.0 111.226 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -66.33 -36.49 83.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.674 0.79 . . . . 0.0 112.605 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -70.82 -35.79 72.65 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.708 1.203 . . . . 0.0 112.854 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 11.7 tp -72.62 -38.72 67.68 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.428 1.491 . . . . 0.0 111.737 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -60.14 -28.07 67.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.518 1.927 . . . . 0.0 112.788 172.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -78.38 -5.25 51.74 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.37 1.468 . . . . 0.0 114.468 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 34.0 t -151.62 65.7 6.56 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.1 1.36 . . . . 0.0 108.859 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -65.09 -8.25 17.82 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.216 2.61 . . . . 0.0 111.881 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -70.39 -21.56 62.84 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.744 1.617 . . . . 0.0 113.256 171.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -120.64 90.01 3.24 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.693 1.597 . . . . 0.0 109.621 -173.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 71.8 mtt85 -49.5 153.18 1.17 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.551 1.14 . . . . 0.0 112.167 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.31 160.14 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 123.057 1.408 . . . . 0.0 110.308 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.6 m -138.37 144.73 40.43 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.697 -2.047 . . . . 0.0 110.428 -173.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 57.8 mt -128.7 112.77 27.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.164 1.385 . . . . 0.0 108.429 -172.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.9 153.14 17.91 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.049 0.94 . . . . 0.0 110.645 176.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -152.44 152.7 24.36 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 121.616 -0.677 . . . . 0.0 113.45 169.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -123.9 161.68 24.86 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 127.724 2.41 . . . . 0.0 109.011 -170.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 65.1 m -138.74 143.54 39.08 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.827 2.051 . . . . 0.0 109.376 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . 0.256 2.2 p30 -63.07 150.89 41.48 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 123.57 1.652 . . . . 0.0 114.551 -171.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -71.12 -2.3 15.24 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 113.164 -1.835 . . . . 0.0 115.299 -171.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.7 -15.71 61.68 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.14 0.976 . . . . 0.0 112.919 171.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.48 -165.43 41.31 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 125.312 1.434 . . . . 0.0 114.574 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 69.6 m -139.59 150.81 45.45 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.404 1.882 . . . . 0.0 109.681 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -54.37 -37.93 65.53 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -171.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.93 -26.73 71.46 Favored Glycine 0 CA--C 1.536 1.358 0 O-C-N 121.376 -0.828 . . . . 0.0 114.112 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 21.2 mm -98.01 -26.29 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.778 1.631 . . . . 0.0 112.195 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -88.69 -24.69 22.66 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.35 1.06 . . . . 0.0 113.139 -173.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 15.4 mm -57.92 -54.94 50.21 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 125.003 1.321 . . . . 0.0 111.989 167.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.98 -34.72 13.31 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 CA-C-N 120.723 1.294 . . . . 0.0 112.483 175.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.19 -40.79 86.59 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 120.211 1.369 . . . . 0.0 112.752 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 5.2 m -72.21 -35.17 68.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.314 0.961 . . . . 0.0 113.393 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.75 -39.26 80.41 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.228 0.611 . . . . 0.0 111.761 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -64.74 -38.77 92.13 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 123.812 0.845 . . . . 0.0 111.305 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -63.86 -40.21 96.01 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.747 0.703 . . . . 0.0 111.985 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.83 -37.9 79.5 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -67.33 -35.59 79.71 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.865 1.666 . . . . 0.0 112.425 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 62.7 mt -63.95 -42.28 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 123.329 0.652 . . . . 0.0 110.794 174.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 65.0 t -65.93 -42.64 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 122.067 -0.396 . . . . 0.0 111.111 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.57 -42.45 96.68 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.08 0.552 . . . . 0.0 111.512 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -65.38 -38.86 91.29 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.502 0.721 . . . . 0.0 111.792 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.62 -41.52 88.24 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.9 -42.94 89.57 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.549 0.739 . . . . 0.0 110.888 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.81 -37.02 77.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.479 0.712 . . . . 0.0 110.918 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -68.61 -33.81 74.67 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 33.5 ttt85 -69.0 -40.02 78.98 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.361 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 159.59 0.34 0.08 OUTLIER Glycine 0 CA--C 1.525 0.674 0 N-CA-C 117.514 1.766 . . . . 0.0 117.514 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.1 t -69.57 134.4 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 120.341 2.071 . . . . 0.0 109.455 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.72 138.2 58.45 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.923 -1.111 . . . . 0.0 110.628 169.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.57 -29.73 58.08 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.022 0.82 . . . . 0.0 113.452 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -63.51 -26.51 68.75 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.928 1.291 . . . . 0.0 113.892 173.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 24.3 m170 -98.48 4.25 48.32 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.987 1.715 . . . . 0.0 113.941 -174.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 16.2 mm -119.44 144.64 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.917 1.687 . . . . 0.0 109.255 174.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -136.18 161.13 36.59 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.222 1.809 . . . . 0.0 110.127 168.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 47.4 p -134.32 146.79 50.3 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.139 0.976 . . . . 0.0 111.386 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.0 t -138.85 120.47 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.23 1.012 . . . . 0.0 110.475 -173.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -83.95 99.28 2.21 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.561 1.076 . . . . 0.0 111.174 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 43.4 mt -97.47 31.95 2.39 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.862 2.065 . . . . 0.0 109.758 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 3.31 -72.07 0.0 OUTLIER Glycine 0 C--N 1.352 1.454 0 C-N-CA 128.006 2.717 . . . . 0.0 119.565 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 1.3 t -149.6 25.16 0.86 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.061 1.431 . . . . 0.0 113.152 173.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 14.2 m -67.79 161.08 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 120.921 -1.112 . . . . 0.0 112.149 174.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 39.98 53.94 5.74 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 125.959 1.704 . . . . 0.0 114.416 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.09 138.88 48.96 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.676 2.251 . . . . 0.0 111.597 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 26.0 pt -134.81 4.11 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.581 1.552 . . . . 0.0 113.438 -173.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.88 165.47 32.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.834 1.654 . . . . 0.0 110.689 170.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 18.3 m -116.73 159.47 22.22 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.868 1.667 . . . . 0.0 112.194 -172.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 49.2 p30 -79.42 5.25 13.17 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -67.54 -14.05 62.6 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.305 1.442 . . . . 0.0 114.587 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 42.4 p -138.22 147.8 57.22 Favored Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 126.485 1.914 . . . . 0.0 109.873 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -63.66 -31.3 69.95 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.142 2.561 . . . . 0.0 112.53 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -71.91 -36.4 69.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.876 0.87 . . . . 0.0 112.806 171.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.26 -37.57 94.12 Favored Glycine 0 N--CA 1.469 0.853 0 C-N-CA 124.006 0.812 . . . . 0.0 113.526 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -55.59 -49.97 71.36 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.819 1.248 . . . . 0.0 110.332 169.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.15 84.89 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -66.97 -18.85 65.58 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 174.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . 0.409 0.3 OUTLIER -110.6 17.82 20.32 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 167.842 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -112.85 10.74 19.12 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 127.264 2.226 . . . . 0.0 113.13 166.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -60.92 160.72 9.27 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -170.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 41.0 t -129.78 145.07 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 127.164 2.186 . . . . 0.0 108.897 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -134.32 155.98 49.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.259 1.424 . . . . 0.0 111.364 -174.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 39.0 mt -136.3 135.77 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.694 1.197 . . . . 0.0 108.903 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 47.7 t -140.66 132.94 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.582 1.553 . . . . 0.0 110.574 -171.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 14.6 p -90.57 125.87 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.002 0.921 . . . . 0.0 111.16 167.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 . . . . . 0 C--O 1.253 1.261 0 C-N-CA 125.792 1.637 . . . . 0.0 113.246 -177.859 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.448 0 CA-C-O 118.997 -0.891 . . . . 0.0 113.405 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -69.82 -18.58 36.63 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 124.113 3.209 . . . . 0.0 113.853 -171.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 44.7 t -120.85 -4.55 9.66 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.282 1.833 . . . . 0.0 112.303 176.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -64.58 -16.37 62.56 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -140.61 46.39 1.79 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.377 2.271 . . . . 0.0 110.955 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.0 mt -55.33 -28.56 54.56 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 118.402 -0.809 . . . . 0.0 112.548 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -54.78 -43.23 72.62 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.526 1.057 . . . . 0.0 111.528 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 19.2 t -69.57 -41.73 75.44 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.431 0.692 . . . . 0.0 111.99 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.68 -38.52 91.28 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 2.7 mm -68.69 -43.24 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -63.0 -38.38 90.94 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.605 -0.684 . . . . 0.0 112.245 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -71.12 -33.35 70.03 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.051 0.94 . . . . 0.0 113.224 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.08 -42.02 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 123.3 0.64 . . . . 0.0 111.409 172.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.8 m -86.34 -22.38 26.72 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 61.23 29.5 71.44 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.84 1.209 . . . . 0.0 113.866 -172.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 97.27 -175.33 30.61 Favored Glycine 0 CA--C 1.541 1.708 0 C-N-CA 125.71 1.624 . . . . 0.0 112.999 -171.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.18 150.34 33.1 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 123.685 2.923 . . . . 0.0 112.909 -174.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 52.5 mt -97.59 141.89 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.07 1.748 . . . . 0.0 110.952 -171.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -109.19 170.12 8.25 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.316 1.846 . . . . 0.0 115.866 -171.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -144.19 110.33 5.43 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.832 1.253 . . . . 0.0 110.372 -171.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -59.02 -166.24 0.14 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.989 1.756 . . . . 0.0 115.545 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -41.98 -39.74 1.98 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.528 1.931 . . . . 0.0 114.785 -175.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -62.1 -28.89 69.94 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.316 1.446 . . . . 0.0 114.363 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 96.0 -10.93 68.0 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.958 1.742 . . . . 0.0 115.687 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -152.57 12.23 0.53 Allowed 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -171.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 69.0 m -78.15 75.34 4.68 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 120.434 -1.416 . . . . 0.0 114.238 -171.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 14.5 tp -69.27 128.77 37.76 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.731 1.612 . . . . 0.0 110.659 171.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -98.81 164.04 17.69 Favored Pre-proline 0 N--CA 1.484 1.258 0 C-N-CA 124.441 1.096 . . . . 0.0 110.91 -171.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -63.81 -29.86 68.33 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.239 1.959 . . . . 0.0 112.985 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.16 90.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.777 0.831 . . . . 0.0 113.134 169.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -66.68 -43.34 84.71 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.457 -0.777 . . . . 0.0 111.468 172.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -61.29 -32.39 72.22 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.436 -0.79 . . . . 0.0 112.484 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -67.34 -41.07 85.82 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.669 -1.27 . . . . 0.0 112.278 172.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 67.7 mt -57.42 -46.03 85.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 O-C-N 121.345 -0.847 . . . . 0.0 110.441 169.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 39.6 mt -64.08 -35.09 79.6 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.436 -0.79 . . . . 0.0 112.906 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -61.16 -37.64 83.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.141 0.976 . . . . 0.0 112.614 173.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 86.5 mtt-85 -70.58 -37.01 73.88 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.687 1.195 . . . . 0.0 112.628 173.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.9 -41.95 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 118.91 0.777 . . . . 0.0 110.771 173.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.72 -38.14 90.0 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.712 0.805 . . . . 0.0 112.274 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.33 -38.11 89.15 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.446 0.698 . . . . 0.0 112.376 172.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -65.71 -34.84 79.14 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.625 0.77 . . . . 0.0 112.696 176.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.524 HD21 HG11 ' A' ' 255' ' ' VAL . 1.8 mm? -66.06 -45.64 80.62 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.98 1.312 . . . . 0.0 111.859 169.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.51 -30.19 70.46 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.551 1.54 . . . . 0.0 112.808 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.17 -9.66 58.8 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.078 1.751 . . . . 0.0 114.563 174.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 16.1 t -155.47 68.36 5.18 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 125.358 1.463 . . . . 0.0 108.885 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -62.62 -6.05 8.22 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.429 2.752 . . . . 0.0 112.679 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -73.17 -19.96 61.0 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.446 1.498 . . . . 0.0 113.324 172.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -115.54 93.91 4.48 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.21 1.404 . . . . 0.0 111.794 -171.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -50.65 147.5 4.66 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.118 1.367 . . . . 0.0 111.684 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.524 HG11 HD21 ' A' ' 247' ' ' LEU . 22.9 m -127.15 160.15 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.882 0.873 . . . . 0.0 111.487 167.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 22.9 m -127.26 139.38 52.95 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.909 1.683 . . . . 0.0 108.362 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 71.4 mt -119.13 123.83 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 124.923 1.289 . . . . 0.0 107.858 -171.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -113.76 148.6 36.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.302 0.641 . . . . 0.0 110.399 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -137.46 156.69 23.66 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 122.106 -0.371 . . . . 0.0 112.696 167.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -127.6 167.34 16.5 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.502 2.321 . . . . 0.0 109.885 -169.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.1 m -151.98 159.73 43.68 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.162 1.785 . . . . 0.0 110.627 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -63.75 163.02 12.32 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.956 -1.09 . . . . 0.0 111.43 166.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -104.98 20.34 19.0 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.564 0.746 . . . . 0.0 112.817 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 16.3 m -69.92 -20.1 63.36 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.809 1.244 . . . . 0.0 112.628 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.6 -150.01 18.1 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 126.156 1.836 . . . . 0.0 113.249 173.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 71.4 m -135.3 162.72 31.79 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.073 1.749 . . . . 0.0 110.09 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -52.62 -41.16 63.45 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.984 0.914 . . . . 0.0 112.968 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -67.9 -4.39 33.93 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.672 1.13 . . . . 0.0 115.238 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 6.2 mt -116.55 -33.0 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.932 2.093 . . . . 0.0 111.172 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -81.53 -31.22 32.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.555 1.142 . . . . 0.0 112.919 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 23.4 mm -60.52 -54.17 57.47 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.322 1.449 . . . . 0.0 111.761 170.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.54 -32.6 24.43 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 CA-C-N 121.065 1.416 . . . . 0.0 113.333 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 26.3 mt -67.88 -43.8 78.5 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.347 1.43 . . . . 0.0 113.124 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 28.5 p -66.46 -37.54 85.36 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.14 -38.09 78.62 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.556 0.742 . . . . 0.0 111.967 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -65.19 -38.76 91.51 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 125.129 1.372 . . . . 0.0 111.036 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -45.62 90.42 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.52 0.6 . . . . 0.0 111.877 173.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.38 -36.17 76.53 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -68.34 -36.51 79.36 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 125.758 1.623 . . . . 0.0 111.97 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 58.9 mt -63.55 -43.07 98.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 118.788 0.722 . . . . 0.0 110.625 174.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 57.4 t -66.89 -42.62 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.753 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.07 -41.7 99.5 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.026 0.53 . . . . 0.0 111.743 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.85 -38.84 87.14 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.121 0.568 . . . . 0.0 111.501 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -68.27 -40.68 81.8 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.3 mp -64.88 -43.68 92.15 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.302 0.641 . . . . 0.0 111.005 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 55.1 t -67.73 -37.22 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 O-C-N 121.758 -0.589 . . . . 0.0 111.088 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.95 -34.0 72.85 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -42.99 86.19 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.817 0.847 . . . . 0.0 111.591 171.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 161.08 -0.95 0.07 OUTLIER Glycine 0 CA--C 1.528 0.871 0 N-CA-C 117.413 1.725 . . . . 0.0 117.413 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.4 t -72.48 136.15 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 120.514 2.157 . . . . 0.0 109.814 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.59 140.75 56.93 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 120.946 -1.096 . . . . 0.0 110.641 168.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.21 -27.31 52.15 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.399 1.0 . . . . 0.0 113.694 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -61.68 -30.14 70.54 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.822 1.249 . . . . 0.0 113.538 173.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -92.77 -0.71 57.22 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.606 1.562 . . . . 0.0 113.968 -174.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 25.0 mm -121.04 141.12 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.825 1.65 . . . . 0.0 109.501 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -135.09 161.37 35.52 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.733 1.613 . . . . 0.0 110.253 167.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 45.6 p -137.02 146.39 45.23 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.942 0.897 . . . . 0.0 112.372 -175.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 35.3 t -141.35 133.63 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.571 1.148 . . . . 0.0 111.118 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -89.5 100.3 2.65 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.508 1.051 . . . . 0.0 111.801 172.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 38.2 mt -95.58 32.13 1.87 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.707 2.003 . . . . 0.0 110.618 174.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 3.18 -70.34 0.0 OUTLIER Glycine 0 C--N 1.35 1.329 0 N-CA-C 120.366 2.906 . . . . 0.0 120.366 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 94.3 p -144.53 13.76 1.56 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.769 1.284 . . . . 0.0 114.281 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 17.1 m -70.27 157.97 6.36 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 O-C-N 121.025 -1.047 . . . . 0.0 111.768 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 39.46 52.09 4.03 Favored Pre-proline 0 CA--C 1.557 1.23 0 C-N-CA 125.259 1.424 . . . . 0.0 114.119 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.18 112.73 1.78 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.38 2.72 . . . . 0.0 111.767 -171.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.538 ' H ' HD12 ' A' ' 306' ' ' ILE . 1.4 mp -71.02 -20.67 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 124.46 1.104 . . . . 0.0 112.476 -171.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -150.5 160.26 43.9 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.865 1.666 . . . . 0.0 112.376 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 49.6 m -71.19 151.25 44.55 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.177 1.791 . . . . 0.0 113.767 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -82.85 1.69 38.02 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.86 -14.4 63.01 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 40.6 p -141.42 147.58 47.06 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 126.326 1.85 . . . . 0.0 110.296 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -63.25 -32.58 73.22 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.166 2.577 . . . . 0.0 112.53 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -68.05 -36.45 79.89 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 173.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -70.2 -38.04 72.12 Favored Glycine 0 N--CA 1.467 0.722 0 C-N-CA 123.415 0.531 . . . . 0.0 113.361 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -57.63 -49.1 77.54 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 123.752 0.821 . . . . 0.0 109.975 171.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.17 84.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.57 0.748 . . . . 0.0 112.698 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -72.66 -12.74 61.15 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.225 1.41 . . . . 0.0 113.696 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.32 -12.5 15.04 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 170.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -81.96 2.48 30.56 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 126.571 1.948 . . . . 0.0 114.502 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 35.0 mtm180 -57.89 160.87 4.29 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -169.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.88 144.12 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.278 1.831 . . . . 0.0 109.954 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -139.7 159.41 42.23 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.137 1.375 . . . . 0.0 113.194 -173.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 4.5 mp -131.95 132.86 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.768 1.627 . . . . 0.0 108.71 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 21.4 t -140.58 138.52 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.635 1.574 . . . . 0.0 109.552 -171.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 22.4 t -69.7 135.81 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.029 -1.044 . . . . 0.0 110.429 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.5 t30 . . . . . 0 C--O 1.252 1.201 0 C-N-CA 125.143 1.377 . . . . 0.0 113.319 -177.901 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.728 0 CA-C-O 119.191 -0.783 . . . . 0.0 114.221 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -69.7 -15.34 37.27 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.323 3.349 . . . . 0.0 114.655 -171.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 22.0 t -128.91 -2.57 5.23 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 126.817 2.047 . . . . 0.0 111.776 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.64 -18.8 65.56 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -171.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -137.77 30.44 2.55 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.934 2.093 . . . . 0.0 111.52 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 6.9 tp -63.49 -16.58 61.1 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 121.521 -0.737 . . . . 0.0 112.949 -173.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -53.58 -45.6 70.02 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.954 0.797 . . . . 0.0 111.465 167.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 21.5 t -69.27 -42.77 75.09 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.292 0.637 . . . . 0.0 111.306 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.93 85.97 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 53.6 mt -73.53 -36.04 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.522 0.729 . . . . 0.0 109.659 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -65.08 -42.49 94.08 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.061 -1.024 . . . . 0.0 112.006 172.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.06 -37.56 87.97 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.947 0.899 . . . . 0.0 112.821 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.69 -28.36 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 118.354 0.525 . . . . 0.0 112.227 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.7 m -75.16 -26.5 59.16 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.094 0.958 . . . . 0.0 112.136 170.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.37 25.83 75.08 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.111 1.339 . . . . 0.0 113.65 -171.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 96.24 -176.71 33.13 Favored Glycine 0 CA--C 1.542 1.732 0 C-N-CA 125.532 1.539 . . . . 0.0 113.394 -172.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.24 147.83 33.58 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.834 3.023 . . . . 0.0 111.416 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -102.42 140.99 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -169.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -107.44 169.03 8.83 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.693 2.397 . . . . 0.0 113.763 -172.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -142.55 116.1 9.12 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.475 1.11 . . . . 0.0 110.608 -171.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -58.42 -170.22 0.24 Allowed Glycine 0 CA--C 1.535 1.302 0 C-N-CA 126.117 1.817 . . . . 0.0 116.39 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -46.43 -40.91 13.01 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.46 1.504 . . . . 0.0 115.017 -174.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.11 -33.27 71.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.396 1.478 . . . . 0.0 113.808 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 105.49 -5.06 40.55 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 117.02 1.568 . . . . 0.0 117.02 167.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -166.44 28.12 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 119.471 1.635 . . . . 0.0 113.038 -171.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 16.5 t -98.11 93.58 6.35 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.634 -1.291 . . . . 0.0 111.511 -171.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.0 mp -71.31 113.92 8.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.886 0.874 . . . . 0.0 109.82 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 11.8 pt -70.77 164.09 58.7 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 124.366 1.066 . . . . 0.0 110.23 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.25 -31.28 74.21 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 CA-C-N 121.942 1.729 . . . . 0.0 112.371 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -66.17 -32.35 73.74 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 170.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -59.03 -53.05 62.8 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.748 1.158 . . . . 0.0 110.697 171.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -58.59 -33.77 70.35 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.716 0.807 . . . . 0.0 112.611 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -66.24 -44.75 82.84 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.419 1.009 . . . . 0.0 112.505 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 34.2 mm -58.44 -43.61 87.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 121.589 -0.694 . . . . 0.0 110.747 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.13 -32.26 72.83 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.709 -0.619 . . . . 0.0 112.62 174.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -63.85 -41.38 97.82 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.578 1.151 . . . . 0.0 112.411 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -67.52 -38.69 84.61 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.423 1.089 . . . . 0.0 112.335 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 79.7 t -62.96 -45.03 99.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 123.507 0.723 . . . . 0.0 110.538 174.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.82 -36.84 84.52 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.155 0.582 . . . . 0.0 112.146 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.17 -39.29 92.71 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 172.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -65.62 -35.13 79.9 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.753 0.821 . . . . 0.0 112.73 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.462 ' CD2' HG11 ' A' ' 255' ' ' VAL . 97.0 mt -69.67 -41.6 75.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.44 1.096 . . . . 0.0 112.039 172.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.03 -23.93 67.68 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.392 1.877 . . . . 0.0 113.089 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.91 -8.75 57.94 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.536 1.534 . . . . 0.0 114.588 171.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 36.2 t -153.61 67.29 6.01 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.222 1.409 . . . . 0.0 108.85 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -64.68 -7.22 14.05 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.119 2.546 . . . . 0.0 112.013 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -70.14 -19.42 63.22 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.51 1.524 . . . . 0.0 113.215 171.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -118.99 89.88 3.22 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.513 1.525 . . . . 0.0 110.52 -172.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -51.53 150.97 3.38 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.04 1.336 . . . . 0.0 111.453 172.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.462 HG11 ' CD2' ' A' ' 247' ' ' LEU . 17.3 m -134.38 161.34 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.449 0.7 . . . . 0.0 112.669 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 20.8 m -128.03 137.37 52.17 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.153 1.381 . . . . 0.0 109.415 -178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.0 118.19 57.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.663 1.585 . . . . 0.0 107.7 -173.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.556 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 0.2 OUTLIER -98.98 151.19 21.17 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.022 1.329 . . . . 0.0 109.406 -178.023 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -152.01 155.49 26.16 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 121.491 -0.756 . . . . 0.0 113.912 168.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -132.53 168.4 18.29 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 129.033 2.933 . . . . 0.0 109.352 -170.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 31.2 m -145.27 151.56 38.56 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 127.102 2.161 . . . . 0.0 109.187 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -63.32 160.67 15.44 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 123.172 1.463 . . . . 0.0 113.574 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -83.04 7.87 14.49 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 113.993 -1.458 . . . . 0.0 114.927 -170.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.6 m -75.11 -15.26 60.61 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 120.993 -1.067 . . . . 0.0 113.508 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -95.24 -157.83 32.5 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.286 1.422 . . . . 0.0 114.595 -176.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 7.6 t -135.18 162.37 32.7 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.69 1.596 . . . . 0.0 110.371 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -52.84 -41.44 64.24 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.124 0.97 . . . . 0.0 112.796 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -67.83 -6.49 44.46 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 124.428 1.014 . . . . 0.0 115.238 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 4.2 mt -115.75 -33.63 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 126.644 1.978 . . . . 0.0 111.294 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -87.41 -24.35 24.23 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 18.3 mm -58.51 -54.06 59.87 Favored Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 124.531 1.132 . . . . 0.0 111.804 167.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.49 -33.23 11.12 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 120.579 1.243 . . . . 0.0 112.906 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 19.1 mt -65.11 -46.78 79.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 120.282 1.401 . . . . 0.0 112.092 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 24.2 m -70.87 -29.86 66.07 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -74.66 -34.96 62.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.788 0.835 . . . . 0.0 112.075 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -65.57 -39.89 92.15 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.027 0.931 . . . . 0.0 111.677 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.22 -43.17 98.87 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.271 0.942 . . . . 0.0 110.755 176.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.5 -37.98 86.25 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.27 -38.91 88.93 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.525 1.53 . . . . 0.0 112.036 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 74.1 mt -66.13 -39.52 84.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 122.688 0.395 . . . . 0.0 110.879 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.59 -44.75 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 O-C-N 121.972 -0.455 . . . . 0.0 110.906 173.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.92 -42.23 97.7 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.4 0.68 . . . . 0.0 111.662 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -66.72 -38.29 86.41 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.013 0.525 . . . . 0.0 111.897 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -68.81 -40.8 79.34 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.15 -43.22 95.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.328 0.651 . . . . 0.0 110.975 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 55.7 t -67.34 -37.46 79.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 O-C-N 121.753 -0.592 . . . . 0.0 111.257 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.43 -34.42 74.42 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -42.26 87.19 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.811 0.844 . . . . 0.0 111.796 172.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 161.64 -1.61 0.07 OUTLIER Glycine 0 CA--C 1.527 0.831 0 N-CA-C 117.473 1.749 . . . . 0.0 117.473 176.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 2.7 t -73.96 137.76 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 120.523 2.162 . . . . 0.0 109.493 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.78 137.91 58.07 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.655 -1.278 . . . . 0.0 110.461 168.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.8 -29.67 58.82 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.055 0.836 . . . . 0.0 113.456 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.44 -26.51 68.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.131 1.372 . . . . 0.0 113.782 173.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -97.25 2.23 50.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.801 1.641 . . . . 0.0 113.955 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 20.2 mm -119.64 141.78 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.699 1.6 . . . . 0.0 109.447 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -136.84 165.27 26.34 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.041 1.737 . . . . 0.0 110.535 169.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 44.6 p -136.02 145.68 46.33 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.277 1.031 . . . . 0.0 112.258 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 70.3 t -138.98 133.95 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.052 1.341 . . . . 0.0 110.919 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -103.24 105.32 2.67 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 126.131 1.825 . . . . 0.0 112.21 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.556 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 1.1 mp -103.94 32.8 3.73 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 129.138 2.975 . . . . 0.0 109.752 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 7.45 -73.92 0.0 OUTLIER Glycine 0 C--N 1.349 1.257 0 N-CA-C 119.467 2.547 . . . . 0.0 119.467 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 57.9 p -148.14 22.53 1.08 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.483 1.641 . . . . 0.0 114.435 172.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.7 m -70.13 159.55 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.092 1.357 . . . . 0.0 111.917 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 23.2 m120 39.76 52.74 4.75 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 125.062 1.345 . . . . 0.0 112.932 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -59.64 132.18 44.23 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.012 2.475 . . . . 0.0 113.674 -170.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 4.8 mp -77.13 -25.89 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 125.042 1.337 . . . . 0.0 111.586 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -157.53 153.66 27.33 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.664 1.986 . . . . 0.0 111.822 -172.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 66.7 m -66.42 150.42 48.93 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.179 1.392 . . . . 0.0 112.48 170.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -84.49 11.13 9.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.786 1.235 . . . . 0.0 113.854 174.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -67.18 -18.36 65.23 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -176.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 66.7 p -140.66 151.4 63.22 Favored Pre-proline 0 N--CA 1.474 0.744 0 C-N-CA 125.901 1.681 . . . . 0.0 110.141 176.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -61.94 -28.31 80.77 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.199 2.599 . . . . 0.0 112.601 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.0 -42.14 94.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.856 0.862 . . . . 0.0 112.554 172.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.14 -38.17 87.8 Favored Glycine 0 N--CA 1.465 0.619 0 O-C-N 121.791 -0.568 . . . . 0.0 112.787 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -57.99 -47.42 83.03 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.244 0.618 . . . . 0.0 110.526 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.85 -39.91 93.5 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.184 0.594 . . . . 0.0 112.537 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -68.61 -16.51 63.87 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.486 1.114 . . . . 0.0 113.816 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -115.86 -1.36 12.61 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 125.514 1.526 . . . . 0.0 114.517 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -82.68 3.95 26.94 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 126.136 1.774 . . . . 0.0 113.023 166.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.88 158.81 0.64 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 130.118 3.367 . . . . 0.0 117.144 -169.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 2.3 m -122.46 148.61 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 126.326 1.85 . . . . 0.0 111.656 166.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -130.08 166.26 20.53 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.84 2.056 . . . . 0.0 110.891 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 13.1 tt -140.74 144.0 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.524 1.13 . . . . 0.0 111.919 172.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 23.3 t -144.68 136.48 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.343 1.457 . . . . 0.0 110.187 -174.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.09 136.23 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.11 0.964 . . . . 0.0 110.754 174.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.576 1.55 . . . . 0.0 113.731 -178.556 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.49 0 CA-C-O 118.91 -0.939 . . . . 0.0 113.87 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -69.52 -19.98 36.56 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.995 3.13 . . . . 0.0 114.091 -171.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 9.9 t -122.57 -2.75 8.87 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 126.519 1.928 . . . . 0.0 111.762 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.54 -21.25 60.43 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 -171.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -137.48 38.56 2.46 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.516 2.326 . . . . 0.0 109.945 174.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 23.8 tp -61.13 -19.83 61.97 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.46 1.104 . . . . 0.0 113.796 -171.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -57.2 -46.31 82.99 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.74 -0.6 . . . . 0.0 111.843 169.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 22.8 t -68.66 -43.86 75.3 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 122.977 0.511 . . . . 0.0 111.284 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -71.57 -25.45 62.21 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 67.3 mt -83.07 -35.55 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 119.61 1.095 . . . . 0.0 110.627 171.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -63.44 -41.97 98.68 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.819 -1.175 . . . . 0.0 111.83 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.4 -36.34 83.67 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.212 1.005 . . . . 0.0 113.187 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.83 -27.72 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.9 m -80.38 -27.79 38.11 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.269 1.027 . . . . 0.0 112.437 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 69.95 25.69 75.27 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.02 1.295 . . . . 0.0 113.854 -172.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 88.88 -166.97 34.34 Favored Glycine 0 CA--C 1.54 1.656 0 C-N-CA 124.87 1.224 . . . . 0.0 113.57 -173.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.33 163.06 40.38 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.721 2.947 . . . . 0.0 112.312 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 19.3 mm -120.74 144.58 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.171 1.389 . . . . 0.0 111.069 -171.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -111.69 167.47 10.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.954 2.102 . . . . 0.0 113.115 -172.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -140.51 101.83 4.19 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.908 0.883 . . . . 0.0 111.803 -170.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -87.52 -178.26 48.23 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.541 1.067 . . . . 0.0 113.981 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 51.6 t30 36.17 -81.34 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 130.375 3.47 . . . . 0.0 115.796 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -71.13 -22.85 62.02 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.295 1.438 . . . . 0.0 114.084 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 89.2 10.23 66.36 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.918 1.247 . . . . 0.0 115.019 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -154.71 25.31 0.45 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 126.968 2.107 . . . . 0.0 112.105 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 58.2 m -81.67 81.84 7.6 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.878 1.271 . . . . 0.0 112.888 -171.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.76 101.33 0.47 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.689 0.756 . . . . 0.0 110.817 169.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.592 HG13 ' H ' ' A' ' 236' ' ' ASP . 9.8 pt -61.79 154.86 64.94 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.768 1.627 . . . . 0.0 112.491 173.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -62.56 -31.3 80.01 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.344 2.029 . . . . 0.0 112.184 174.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.5 90.65 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.791 0.836 . . . . 0.0 112.858 170.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.592 ' H ' HG13 ' A' ' 233' ' ' ILE . 21.9 t70 -62.61 -49.56 74.74 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.436 -0.79 . . . . 0.0 111.321 172.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -59.88 -30.24 68.86 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.166 -0.959 . . . . 0.0 112.912 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -70.72 -44.54 66.68 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 120.785 -1.197 . . . . 0.0 112.805 172.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 21.4 mm -57.89 -45.57 87.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.231 -0.918 . . . . 0.0 110.938 172.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.4 -32.07 73.5 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.954 0.902 . . . . 0.0 112.539 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -61.86 -42.55 99.19 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.088 0.955 . . . . 0.0 111.882 173.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -67.79 -35.65 79.03 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 87.9 t -64.45 -44.39 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.497 0.59 . . . . 0.0 110.916 173.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.81 89.86 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.422 0.689 . . . . 0.0 111.989 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.78 -39.13 93.51 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.122 0.569 . . . . 0.0 112.065 175.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -71.56 -30.68 66.15 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 79.3 mt -71.32 -40.76 70.56 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.976 0.911 . . . . 0.0 112.266 170.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -60.06 -27.05 66.64 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.121 1.368 . . . . 0.0 112.669 173.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -80.95 -6.96 59.37 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.11 1.764 . . . . 0.0 115.036 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 22.2 t -153.47 67.27 6.08 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.235 1.414 . . . . 0.0 108.862 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -63.84 -7.1 12.26 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.216 2.611 . . . . 0.0 112.39 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -71.28 -19.27 62.36 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.591 1.556 . . . . 0.0 113.24 171.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -117.88 89.04 3.04 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.543 1.537 . . . . 0.0 110.578 -173.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 68.1 mtt85 -53.26 155.45 2.72 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.544 1.138 . . . . 0.0 111.676 171.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 20.9 m -128.29 165.49 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.36 1.064 . . . . 0.0 111.844 171.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 30.2 m -127.98 137.14 52.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.403 1.481 . . . . 0.0 108.798 173.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.7 mt -113.69 117.32 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.421 ' HB3' HD12 ' A' ' 300' ' ' LEU . 21.5 m-20 -102.49 156.82 17.35 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.323 0.649 . . . . 0.0 110.426 175.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -148.52 154.95 26.16 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 122.178 -0.326 . . . . 0.0 112.836 167.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -128.16 163.41 24.73 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 127.539 2.336 . . . . 0.0 109.918 -169.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 73.1 p -148.63 173.67 12.94 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.917 2.487 . . . . 0.0 110.392 170.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -72.15 158.36 36.06 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.458 -1.401 . . . . 0.0 113.001 -173.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -84.97 -9.64 57.86 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.695 1.198 . . . . 0.0 113.168 -172.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -22.66 67.02 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.382 2.273 . . . . 0.0 115.527 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -74.98 -143.24 0.93 Allowed Glycine 0 CA--C 1.54 1.615 0 C-N-CA 126.448 1.975 . . . . 0.0 115.358 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 26.3 t -149.59 137.15 20.1 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.868 1.667 . . . . 0.0 109.723 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -53.17 -34.02 55.1 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -65.59 -22.74 70.01 Favored Glycine 0 CA--C 1.537 1.428 0 O-C-N 121.435 -0.791 . . . . 0.0 114.21 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 16.9 mm -100.59 -32.33 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 126.496 1.918 . . . . 0.0 112.188 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -82.71 -27.36 31.23 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.8 mm -57.65 -55.35 45.7 Favored Pre-proline 0 N--CA 1.469 0.515 0 C-N-CA 124.722 1.209 . . . . 0.0 112.206 169.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.38 -30.26 15.71 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 CA-C-N 120.468 1.203 . . . . 0.0 112.713 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.6 mp -64.42 -51.12 64.77 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 120.228 1.377 . . . . 0.0 111.833 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.3 m -69.34 -32.31 71.32 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.071 -0.651 . . . . 0.0 112.544 -176.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.64 -38.66 80.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 174.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -67.69 -38.23 83.41 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.424 0.689 . . . . 0.0 111.594 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 66.5 mmt-85 -61.1 -44.14 97.81 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.959 0.8 . . . . 0.0 111.275 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.77 -37.57 79.43 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -66.58 -37.87 85.83 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 125.376 1.47 . . . . 0.0 111.733 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 19.3 mm -65.98 -39.06 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.62 0.645 . . . . 0.0 111.268 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 38.3 t -64.92 -46.09 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.322 0.51 . . . . 0.0 110.592 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -61.11 -41.52 96.84 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.304 0.642 . . . . 0.0 111.616 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.05 -36.97 84.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.554 1.142 . . . . 0.0 111.47 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -63.63 -45.01 92.18 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.6 mp -69.07 -37.06 78.28 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.977 0.418 . . . . 0.0 111.672 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.84 -37.01 76.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.942 0.897 . . . . 0.0 111.013 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.97 -35.0 79.0 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 20.9 ttt85 -69.05 -35.52 76.66 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 170.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 151.34 4.54 0.18 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 116.935 1.534 . . . . 0.0 116.935 167.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.8 t -69.49 136.01 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 120.046 1.923 . . . . 0.0 108.964 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.32 138.88 58.68 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.979 -1.076 . . . . 0.0 110.528 172.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.75 -29.85 58.89 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.013 0.816 . . . . 0.0 113.317 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.28 -28.68 69.89 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.857 1.263 . . . . 0.0 113.648 173.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -93.36 -2.2 55.04 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.471 1.508 . . . . 0.0 114.217 -174.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 9.0 mt -129.04 108.09 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.518 1.127 . . . . 0.0 110.155 175.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -88.69 161.92 16.57 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.028 0.931 . . . . 0.0 110.323 167.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 35.5 p -135.41 144.37 46.49 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.192 0.997 . . . . 0.0 111.452 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 30.2 t -138.0 129.81 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.56 0.744 . . . . 0.0 111.32 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -84.85 96.1 2.01 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.518 1.056 . . . . 0.0 111.112 170.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.421 HD12 ' HB3' ' A' ' 258' ' ' ASN . 47.6 mt -88.54 30.14 0.93 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.552 1.941 . . . . 0.0 109.97 171.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 6.86 -74.97 0.0 OUTLIER Glycine 0 C--N 1.354 1.554 0 C-N-CA 128.191 2.805 . . . . 0.0 119.769 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 95.1 p -149.6 23.79 0.89 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.583 1.192 . . . . 0.0 113.252 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 7.3 m -71.26 158.63 6.12 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 C-N-CA 124.509 1.124 . . . . 0.0 111.498 173.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 39.42 54.24 5.28 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 125.514 1.526 . . . . 0.0 114.288 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.09 139.08 59.42 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.689 2.259 . . . . 0.0 111.626 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 17.8 pt -134.59 6.81 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.925 1.29 . . . . 0.0 114.314 -171.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.451 ' HB3' ' HB2' ' A' ' 318' ' ' ASN . . . -146.54 140.08 25.89 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.485 1.114 . . . . 0.0 110.62 167.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 51.0 m -71.05 143.61 50.65 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.425 1.49 . . . . 0.0 113.126 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -74.23 1.69 10.81 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 171.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.07 -17.26 63.23 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.053 1.341 . . . . 0.0 114.617 -175.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 67.9 p -140.47 150.94 62.51 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 125.49 1.516 . . . . 0.0 110.581 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -62.12 -30.06 81.85 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.25 2.633 . . . . 0.0 112.576 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -64.53 -44.42 90.92 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.575 0.75 . . . . 0.0 112.344 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.73 -35.46 85.58 Favored Glycine 0 CA--C 1.524 0.613 0 O-C-N 121.84 -0.538 . . . . 0.0 112.839 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -59.52 -49.35 78.11 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.073 0.949 . . . . 0.0 111.173 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.03 85.76 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.0 0.52 . . . . 0.0 111.969 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -71.12 -23.37 62.08 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.329 1.452 . . . . 0.0 114.302 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 307' ' ' ALA . 7.2 t30 -99.82 -18.14 17.31 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 119.656 1.116 . . . . 0.0 112.866 172.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -71.96 13.63 0.28 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.317 1.447 . . . . 0.0 114.337 170.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -61.86 163.8 7.14 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.206 1.802 . . . . 0.0 115.662 -170.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 28.9 m -125.29 151.52 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.941 1.696 . . . . 0.0 110.158 167.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -145.48 147.5 32.24 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.36 1.064 . . . . 0.0 111.919 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.3 132.52 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.171 1.388 . . . . 0.0 109.404 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 21.8 t -140.88 133.97 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.211 1.405 . . . . 0.0 109.895 -172.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.18 141.27 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 121.409 -0.807 . . . . 0.0 110.342 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.285 1.434 . . . . 0.0 111.864 -171.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.749 0 CA-C-O 119.04 -0.866 . . . . 0.0 114.833 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.51 -19.07 28.86 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.84 3.027 . . . . 0.0 113.854 -172.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 43.3 t -121.38 -7.43 9.25 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.948 2.099 . . . . 0.0 111.998 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -63.76 -16.04 60.15 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.354 1.462 . . . . 0.0 114.861 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -137.21 41.33 2.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.4 2.28 . . . . 0.0 111.167 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 9.0 mt -46.82 -38.52 10.35 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.67 0.788 . . . . 0.0 111.822 172.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -59.95 -38.53 82.72 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.995 0.518 . . . . 0.0 111.956 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.2 t -68.78 -48.08 64.56 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.465 0.706 . . . . 0.0 112.061 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.9 85.51 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 177.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 90.8 mt -75.05 -34.54 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.335 1.054 . . . . 0.0 110.091 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -65.87 -41.28 91.79 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.816 -1.177 . . . . 0.0 111.712 172.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.91 -36.03 83.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.725 0.81 . . . . 0.0 113.153 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.4 p -80.06 -27.34 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.2 m -88.39 -25.75 22.53 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.534 1.134 . . . . 0.0 113.03 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.77 24.68 75.48 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.348 1.452 . . . . 0.0 114.061 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 101.57 -162.34 17.73 Favored Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.346 1.451 . . . . 0.0 112.54 -171.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -73.15 168.2 25.35 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.716 2.944 . . . . 0.0 112.561 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 40.9 mm -112.79 114.46 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.46 1.504 . . . . 0.0 110.63 -173.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -81.66 173.23 12.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.806 2.042 . . . . 0.0 112.671 171.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -118.7 151.68 37.53 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.859 0.864 . . . . 0.0 110.735 -173.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -59.66 165.73 10.44 Favored Glycine 0 CA--C 1.543 1.843 0 O-C-N 120.875 -1.141 . . . . 0.0 110.892 165.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -48.91 -22.33 0.82 Allowed 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 117.036 2.235 . . . . 0.0 117.036 -171.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -59.28 -22.46 61.2 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.582 1.553 . . . . 0.0 114.666 170.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.71 9.39 74.94 Favored Glycine 0 CA--C 1.543 1.827 0 C-N-CA 124.977 1.275 . . . . 0.0 114.79 -176.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -159.72 -5.82 0.06 Allowed 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 118.918 2.932 . . . . 0.0 118.918 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.6 m -72.43 81.72 1.06 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 122.355 2.343 . . . . 0.0 114.368 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 16.5 tp -63.75 109.61 1.77 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.422 2.289 . . . . 0.0 111.07 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.614 HG13 ' H ' ' A' ' 236' ' ' ASP . 10.4 pt -71.93 159.33 85.75 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 124.655 1.182 . . . . 0.0 112.853 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.97 -29.17 87.48 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.493 2.129 . . . . 0.0 112.17 174.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.95 98.1 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 169.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.614 ' H ' HG13 ' A' ' 233' ' ' ILE . 94.4 m-20 -66.27 -41.35 90.02 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.515 -0.741 . . . . 0.0 112.108 173.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -60.94 -32.16 71.68 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.282 -0.886 . . . . 0.0 112.404 172.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -69.89 -42.87 72.86 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.353 -1.467 . . . . 0.0 112.222 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 65.9 mt -56.7 -47.2 82.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.63 -0.669 . . . . 0.0 110.398 171.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.99 -30.97 72.0 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.493 0.717 . . . . 0.0 112.869 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -64.39 -43.08 95.58 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.588 -0.695 . . . . 0.0 111.824 174.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -64.32 -39.26 93.56 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.004 0.922 . . . . 0.0 112.082 175.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 70.0 t -65.36 -41.56 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.961 0.904 . . . . 0.0 111.601 175.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.08 95.74 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.237 0.615 . . . . 0.0 111.791 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -65.27 -39.01 92.04 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.817 0.847 . . . . 0.0 111.995 175.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -65.95 -35.68 81.26 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.756 0.822 . . . . 0.0 112.568 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 16.8 tp -73.57 -39.63 64.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.189 0.996 . . . . 0.0 112.157 173.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -60.71 -28.53 68.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.392 1.477 . . . . 0.0 112.497 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -75.94 -7.5 54.72 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.046 1.738 . . . . 0.0 114.788 173.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 24.3 t -150.69 68.93 8.5 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.435 1.494 . . . . 0.0 108.59 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -62.13 -7.1 9.23 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.459 2.773 . . . . 0.0 112.493 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -73.16 -18.03 61.31 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.737 1.615 . . . . 0.0 113.277 174.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -124.93 79.65 1.8 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.042 1.337 . . . . 0.0 111.306 -171.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -48.72 159.66 0.22 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.332 1.853 . . . . 0.0 113.104 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.3 162.28 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-O 121.712 0.768 . . . . 0.0 112.336 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.3 m -127.68 137.16 52.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.409 1.484 . . . . 0.0 108.993 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 94.3 mt -113.09 119.98 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 125.418 1.487 . . . . 0.0 107.689 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.529 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 0.5 OUTLIER -102.6 150.5 23.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.265 1.426 . . . . 0.0 109.437 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -149.99 151.91 23.91 Favored Glycine 0 CA--C 1.532 1.131 0 O-C-N 121.785 -0.572 . . . . 0.0 112.501 167.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -128.24 176.47 7.65 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 128.719 2.808 . . . . 0.0 109.075 -170.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.6 t -161.95 153.64 18.77 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 128.047 2.539 . . . . 0.0 111.832 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -63.91 160.91 16.64 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.353 -0.842 . . . . 0.0 109.906 165.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -93.56 33.85 1.23 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.658 0.783 . . . . 0.0 112.466 -175.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 24.3 m -68.51 -20.93 64.61 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.605 -1.31 . . . . 0.0 112.996 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -95.53 -142.09 12.55 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 126.001 1.762 . . . . 0.0 113.06 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 64.1 m -134.26 161.88 33.7 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.489 1.916 . . . . 0.0 109.342 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -54.03 -37.56 64.25 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.98 -1.075 . . . . 0.0 113.832 -174.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.11 -9.2 59.84 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.586 1.088 . . . . 0.0 115.107 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 8.7 mt -111.89 -31.16 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 127.14 2.176 . . . . 0.0 111.098 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -80.05 -33.07 39.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.867 1.267 . . . . 0.0 113.341 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 16.7 mm -56.91 -54.9 49.4 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 125.894 1.678 . . . . 0.0 112.687 172.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -70.16 -27.87 24.02 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.381 1.387 . . . . 0.0 112.314 174.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.81 -50.64 71.51 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 120.507 1.503 . . . . 0.0 111.256 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.7 m -68.65 -33.03 73.3 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.64 -36.43 73.42 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.83 0.852 . . . . 0.0 112.014 176.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -62.08 -46.09 90.61 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.547 0.739 . . . . 0.0 111.195 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -64.45 -36.86 85.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.816 0.28 . . . . 0.0 110.835 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -70.19 -38.49 75.37 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -65.05 -39.69 93.67 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 125.013 1.325 . . . . 0.0 110.653 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 67.7 mt -60.13 -42.81 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.179 0.592 . . . . 0.0 111.18 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 38.4 t -65.61 -43.77 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.192 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -61.88 -41.3 97.71 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.178 0.513 . . . . 0.0 111.937 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.5 -39.54 88.76 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.337 1.055 . . . . 0.0 111.046 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -66.01 -42.26 89.93 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.35 -40.96 94.26 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.094 0.557 . . . . 0.0 111.161 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.6 t -67.95 -38.2 79.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 O-C-N 121.66 -0.65 . . . . 0.0 111.063 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.0 -33.59 73.91 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.871 0.868 . . . . 0.0 113.202 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -64.07 -45.73 87.47 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.719 0.808 . . . . 0.0 110.953 170.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 158.54 2.43 0.08 OUTLIER Glycine 0 CA--C 1.528 0.87 0 N-CA-C 117.298 1.679 . . . . 0.0 117.298 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 4.4 t -72.77 135.83 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 120.404 2.102 . . . . 0.0 109.365 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.18 141.16 58.17 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.857 -1.152 . . . . 0.0 110.581 170.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.25 -27.79 53.35 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.193 0.902 . . . . 0.0 113.586 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.31 -28.28 69.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.764 1.226 . . . . 0.0 113.896 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -97.2 -0.05 47.48 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.707 1.603 . . . . 0.0 114.034 -173.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 18.7 mm -119.54 140.55 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.827 1.651 . . . . 0.0 109.157 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -132.16 162.13 31.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.691 1.596 . . . . 0.0 109.622 167.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 39.0 p -135.15 146.75 49.07 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.86 0.864 . . . . 0.0 112.017 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 25.8 t -140.42 136.0 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.912 1.285 . . . . 0.0 109.721 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -107.74 105.03 2.17 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.164 1.84 . . . . 0.0 110.887 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.529 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 1.9 mp -98.69 17.13 19.99 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 127.5 2.32 . . . . 0.0 112.969 -171.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 18.2 -97.37 0.01 OUTLIER Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.981 1.277 . . . . 0.0 116.287 -171.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 4.1 m -119.96 13.05 12.15 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -171.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 4.8 m -65.63 161.44 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 121.152 -0.967 . . . . 0.0 111.581 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 16.3 m120 40.41 54.8 6.82 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 125.305 1.442 . . . . 0.0 114.157 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.68 138.95 56.0 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.215 2.61 . . . . 0.0 112.27 -173.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 11.8 pt -138.84 0.81 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 125.074 1.349 . . . . 0.0 114.594 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 318' ' ' ASN . . . -148.68 139.6 22.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.455 1.102 . . . . 0.0 110.677 167.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 39.8 m -71.76 148.72 46.05 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.62 1.568 . . . . 0.0 113.798 -173.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -73.98 -2.79 25.58 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 171.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.46 -17.9 64.29 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.11 1.364 . . . . 0.0 114.529 -172.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 79.7 p -140.57 149.99 58.98 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.414 1.486 . . . . 0.0 110.561 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -62.13 -27.34 78.76 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.19 2.593 . . . . 0.0 112.634 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -62.4 -46.66 87.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.669 0.787 . . . . 0.0 111.764 170.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.22 -35.16 82.35 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 123.545 0.593 . . . . 0.0 112.669 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -59.03 -50.26 74.76 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.967 0.907 . . . . 0.0 110.896 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.74 -19.03 58.11 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 121.431 -0.793 . . . . 0.0 112.502 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -82.43 -15.07 53.93 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.07 1.748 . . . . 0.0 114.758 168.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 307' ' ' ALA 0.251 17.1 t-20 -101.17 -22.23 14.73 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 120.292 1.405 . . . . 0.0 111.286 168.658 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -68.95 11.24 0.21 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.04 -1.662 . . . . 0.0 114.308 166.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -61.15 165.97 4.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.732 2.013 . . . . 0.0 113.575 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 18.6 m -130.38 151.03 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.728 1.611 . . . . 0.0 111.262 176.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -139.62 159.83 41.27 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.368 1.467 . . . . 0.0 111.397 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 14.7 tt -135.81 135.16 51.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.8 1.24 . . . . 0.0 112.171 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 59.8 t -137.4 122.59 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.029 1.332 . . . . 0.0 110.223 -171.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 38.9 t -70.25 133.57 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.46 1.104 . . . . 0.0 109.274 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 . . . . . 0 C--O 1.251 1.153 0 C-N-CA 124.394 1.078 . . . . 0.0 113.307 -171.623 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.469 0 CA-C-O 118.986 -0.897 . . . . 0.0 114.287 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -70.83 -18.11 32.24 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.91 3.074 . . . . 0.0 113.689 -173.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 30.6 t -124.33 3.48 8.46 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 127.0 2.12 . . . . 0.0 111.601 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.25 -19.85 66.15 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.409 -1.432 . . . . 0.0 114.572 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -139.6 47.83 1.85 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.955 2.502 . . . . 0.0 109.755 172.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.49 -34.14 34.52 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.912 1.685 . . . . 0.0 112.314 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -66.68 -46.92 74.1 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.106 0.963 . . . . 0.0 112.012 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 14.4 t -65.8 -39.25 90.73 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.169 0.987 . . . . 0.0 112.143 177.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.58 95.11 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 4.2 mt -74.28 -32.69 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.737 0.815 . . . . 0.0 112.116 174.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -64.22 -34.52 78.29 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.168 -0.957 . . . . 0.0 112.182 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -70.17 -36.38 74.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.216 1.006 . . . . 0.0 112.699 172.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 36.7 t -62.05 -43.18 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.143 0.977 . . . . 0.0 111.738 171.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 64.9 p -83.01 -19.28 37.29 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 64.4 18.06 62.72 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.721 1.629 . . . . 0.0 114.304 -171.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 121.9 -146.58 17.05 Favored Glycine 0 CA--C 1.544 1.898 0 C-N-CA 125.214 1.387 . . . . 0.0 112.881 -173.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.67 171.76 15.74 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.967 3.111 . . . . 0.0 112.129 172.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -131.25 144.78 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.441 1.096 . . . . 0.0 110.159 171.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -115.06 173.74 6.34 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.974 1.709 . . . . 0.0 114.393 -170.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -132.06 88.15 2.52 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.345 1.458 . . . . 0.0 109.423 -176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -66.55 164.1 42.35 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.531 1.539 . . . . 0.0 115.282 -171.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 29.9 -66.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.925 1 C-N-CA 131.842 4.057 . . . . 0.0 117.655 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -63.08 -26.02 68.64 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.158 1.383 . . . . 0.0 113.389 173.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.79 7.67 77.82 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.78 1.181 . . . . 0.0 115.002 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -156.69 13.67 0.28 Allowed 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 126.511 1.924 . . . . 0.0 114.557 -175.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 35.1 m -93.45 88.3 5.89 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.341 -1.474 . . . . 0.0 112.405 -170.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 16.9 tp -71.03 96.97 1.38 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.065 1.346 . . . . 0.0 110.328 171.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.405 ' HB ' ' HD2' ' A' ' 234' ' ' PRO . 4.2 pt -66.11 159.82 68.35 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 125.102 1.361 . . . . 0.0 111.988 -172.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 233' ' ' ILE . 36.5 Cg_endo -62.42 -33.61 78.94 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.269 1.979 . . . . 0.0 112.674 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -67.18 -29.84 69.64 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.925 1.084 . . . . 0.0 113.925 171.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.88 -47.26 86.47 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.521 1.055 . . . . 0.0 111.924 174.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -58.6 -24.25 60.54 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.303 1.041 . . . . 0.0 113.157 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -39.5 87.73 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.258 -0.901 . . . . 0.0 112.005 174.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 37.2 mm -58.69 -47.21 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 120.889 -1.132 . . . . 0.0 110.392 171.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 7.9 mp -62.01 -37.3 84.37 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.438 0.695 . . . . 0.0 111.887 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -61.25 -39.72 91.38 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.073 1.349 . . . . 0.0 112.573 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 13.7 mmt85 -69.03 -39.19 79.37 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 172.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.3 t -64.85 -40.21 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.124 0.57 . . . . 0.0 110.918 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.66 98.14 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.397 1.079 . . . . 0.0 111.95 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.85 -36.96 84.95 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -76.11 -29.03 57.72 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.528 HD21 HG11 ' A' ' 255' ' ' VAL . 1.0 OUTLIER -66.41 -45.98 78.1 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.202 1.001 . . . . 0.0 111.437 169.568 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -58.07 -34.04 69.71 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.501 1.521 . . . . 0.0 112.645 173.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.96 -9.08 58.45 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.319 1.448 . . . . 0.0 114.564 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 13.1 t -157.74 66.54 3.61 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.01 1.324 . . . . 0.0 109.52 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -62.73 -9.3 15.76 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.085 2.523 . . . . 0.0 112.196 173.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -70.46 -16.61 62.94 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.776 1.63 . . . . 0.0 113.415 171.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -119.27 80.64 1.59 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.518 1.527 . . . . 0.0 110.687 -176.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 65.5 mtt85 -51.71 148.1 5.9 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.927 1.291 . . . . 0.0 111.553 173.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.528 HG11 HD21 ' A' ' 247' ' ' LEU . 34.2 m -125.54 158.41 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.519 1.128 . . . . 0.0 112.548 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 18.0 m -130.83 134.4 46.79 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 172.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 51.8 mt -104.76 124.85 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 125.198 1.399 . . . . 0.0 107.557 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.406 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 21.7 m-20 -114.32 129.54 56.64 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.276 1.03 . . . . 0.0 109.799 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -119.3 157.43 15.39 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 122.089 -0.382 . . . . 0.0 112.154 173.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -125.47 167.82 14.48 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 128.156 2.582 . . . . 0.0 108.615 -170.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.5 m -144.57 169.3 18.23 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 127.076 2.15 . . . . 0.0 109.747 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.32 158.15 5.77 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.806 1.242 . . . . 0.0 111.701 170.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -96.88 -4.4 40.25 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 121.32 -0.863 . . . . 0.0 112.997 173.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 2.3 p -68.33 -31.02 70.14 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.848 1.659 . . . . 0.0 114.886 177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -76.19 -161.25 10.91 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 126.471 1.986 . . . . 0.0 114.082 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 8.0 t -130.59 154.25 48.05 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.608 1.563 . . . . 0.0 109.858 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -58.61 -32.58 69.14 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -171.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.46 -13.91 56.04 Favored Glycine 0 CA--C 1.541 1.671 0 O-C-N 121.058 -1.026 . . . . 0.0 114.859 171.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 2.9 mt -106.62 -34.33 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 127.101 2.161 . . . . 0.0 111.346 173.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -78.93 -31.78 45.32 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -174.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 20.6 mm -61.16 -53.92 58.69 Favored Pre-proline 0 N--CA 1.47 0.538 0 C-N-CA 125.969 1.708 . . . . 0.0 112.042 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.76 -34.86 17.53 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 CA-C-N 120.913 1.362 . . . . 0.0 112.561 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 6.9 mp -66.72 -43.26 84.72 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.68 1.127 . . . . 0.0 112.561 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 31.2 p -69.12 -36.12 77.17 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.38 -40.11 77.6 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.225 0.61 . . . . 0.0 111.335 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 54.4 mm-40 -62.65 -40.33 96.7 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.436 0.694 . . . . 0.0 111.347 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 29.3 mtt85 -68.7 -23.17 64.34 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -83.63 -39.69 19.95 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 167.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -65.29 -35.96 82.62 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.416 1.486 . . . . 0.0 112.254 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 74.9 mt -66.17 -39.98 85.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 118.892 0.769 . . . . 0.0 110.552 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 88.2 t -65.62 -45.68 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 122.179 -0.326 . . . . 0.0 110.669 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.2 96.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.72 0.408 . . . . 0.0 111.456 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.88 -39.01 92.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.718 0.807 . . . . 0.0 111.738 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -65.85 -42.47 90.4 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 175.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 2.1 mp -68.72 -37.59 79.59 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 122.003 -0.435 . . . . 0.0 111.916 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 45.9 t -66.22 -40.1 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 O-C-N 121.439 -0.788 . . . . 0.0 110.731 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.09 -33.51 75.63 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 19.9 ttt85 -66.34 -41.95 88.84 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.478 168.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 156.91 1.04 0.1 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 173.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.8 t -69.64 132.9 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 120.399 2.099 . . . . 0.0 109.3 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.71 135.92 53.49 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.196 -0.94 . . . . 0.0 110.069 172.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.07 -26.81 50.13 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.525 1.06 . . . . 0.0 113.819 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.66 -29.52 70.13 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.763 1.225 . . . . 0.0 113.61 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -96.43 -7.61 34.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.155 1.782 . . . . 0.0 113.977 -175.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 3.4 tt -139.27 99.37 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 122.352 1.072 . . . . 0.0 112.331 -171.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -102.4 169.97 8.36 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.327 1.451 . . . . 0.0 112.265 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 40.1 p -137.85 146.92 44.03 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.417 1.087 . . . . 0.0 113.171 -176.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.4 t -141.15 139.51 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.433 1.493 . . . . 0.0 110.98 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -95.51 113.62 4.67 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.538 1.066 . . . . 0.0 111.429 169.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.406 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 42.3 mt -105.21 33.39 3.69 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.072 2.549 . . . . 0.0 110.13 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 0.72 -69.79 0.0 OUTLIER Glycine 0 C--N 1.35 1.359 0 N-CA-C 120.154 2.822 . . . . 0.0 120.154 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 54.2 p -148.72 24.65 0.96 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.7 1.75 . . . . 0.0 114.447 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 8.5 m -64.75 155.95 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 O-C-N 121.252 -0.905 . . . . 0.0 110.676 167.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 39.24 55.11 5.51 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 125.2 1.4 . . . . 0.0 114.083 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -61.71 149.51 89.65 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.237 2.625 . . . . 0.0 112.004 -172.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.38 -2.97 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -170.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' A' ' 318' ' ' ASN . . . -153.04 154.01 34.04 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.177 -0.952 . . . . 0.0 112.642 177.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 68.1 m -67.41 138.15 56.47 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.42 1.488 . . . . 0.0 111.237 167.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -92.25 11.64 25.08 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.603 1.161 . . . . 0.0 112.026 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.34 -16.56 62.44 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.408 1.483 . . . . 0.0 114.433 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 70.7 p -137.67 148.42 61.09 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 125.618 1.567 . . . . 0.0 110.425 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -61.78 -31.22 85.54 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.226 2.618 . . . . 0.0 112.568 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.88 -36.35 77.98 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -71.27 -39.8 61.72 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 121.529 0.516 . . . . 0.0 112.874 172.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -56.92 -45.85 82.4 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 124.123 0.969 . . . . 0.0 110.839 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.66 -39.55 88.78 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.906 0.882 . . . . 0.0 112.74 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -72.33 -20.43 61.48 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.551 1.54 . . . . 0.0 114.031 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 307' ' ' ALA . 39.8 t30 -102.6 -15.04 16.51 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.092 1.357 . . . . 0.0 113.364 172.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -82.07 12.61 4.03 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 126.614 1.966 . . . . 0.0 113.141 166.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -56.89 168.34 0.65 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.454 1.902 . . . . 0.0 115.326 -171.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 14.0 p -129.64 142.33 44.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 125.179 1.392 . . . . 0.0 110.189 167.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -139.91 165.34 27.59 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.76 2.024 . . . . 0.0 110.737 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 14.8 tt -138.28 154.0 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.1 0.96 . . . . 0.0 112.636 -175.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.5 161.55 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.334 1.854 . . . . 0.0 110.461 -175.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 59.0 t -107.3 135.84 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.52 1.128 . . . . 0.0 109.359 173.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.177 0 C-N-CA 125.177 1.391 . . . . 0.0 111.774 -173.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.745 0 CA-C-O 119.105 -0.831 . . . . 0.0 114.789 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.36 -19.37 38.1 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 124.055 3.17 . . . . 0.0 114.401 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 43.9 t -122.63 -8.4 8.5 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.254 1.822 . . . . 0.0 112.295 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -63.6 -16.76 61.76 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -174.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -137.89 40.71 2.34 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.199 2.2 . . . . 0.0 111.093 174.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.2 mt -46.86 -38.43 10.34 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.189 0.995 . . . . 0.0 112.193 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -60.46 -38.52 84.46 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.438 0.695 . . . . 0.0 112.296 -175.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.3 t -70.81 -45.64 64.26 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.359 0.664 . . . . 0.0 111.959 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.64 -40.67 97.75 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 15.3 mt -73.16 -33.83 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.883 0.873 . . . . 0.0 110.728 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.3 -39.16 92.13 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.363 -0.835 . . . . 0.0 112.046 172.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.97 76.34 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.273 1.029 . . . . 0.0 113.046 176.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.7 t -64.55 -40.8 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.139 0.976 . . . . 0.0 111.245 172.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 16.9 m -84.12 -24.49 30.26 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.881 0.873 . . . . 0.0 112.96 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.38 15.37 72.66 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 126.23 1.871 . . . . 0.0 115.135 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 126.78 -156.41 20.09 Favored Glycine 0 CA--C 1.542 1.747 0 C-N-CA 125.311 1.434 . . . . 0.0 112.962 -174.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.64 170.43 20.02 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 124.16 3.24 . . . . 0.0 111.817 169.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.93 108.69 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.579 1.151 . . . . 0.0 110.752 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -80.54 171.7 14.71 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.469 2.308 . . . . 0.0 112.554 169.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.442 ' O ' ' HB1' ' A' ' 316' ' ' ALA . 81.2 m-85 -119.29 150.95 39.27 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.099 0.475 . . . . 0.0 111.147 -171.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -57.31 170.76 3.26 Favored Glycine 0 CA--C 1.541 1.716 0 O-C-N 121.147 -0.971 . . . . 0.0 111.863 166.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -48.68 -28.19 3.39 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -171.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -65.29 -17.92 64.89 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.92 8.41 76.07 Favored Glycine 0 CA--C 1.542 1.774 0 C-N-CA 124.698 1.142 . . . . 0.0 115.215 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -167.53 8.88 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.1 t -73.84 105.42 5.11 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 122.053 2.206 . . . . 0.0 112.12 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.7 mp -74.13 102.5 4.26 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.169 0.988 . . . . 0.0 111.479 172.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.532 HG13 ' H ' ' A' ' 236' ' ' ASP . 5.9 pt -56.97 152.65 27.13 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.065 1.746 . . . . 0.0 112.635 167.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -63.15 -29.57 74.26 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.619 2.212 . . . . 0.0 112.406 173.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.71 92.03 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.737 0.815 . . . . 0.0 112.952 172.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.532 ' H ' HG13 ' A' ' 233' ' ' ILE . 28.4 t70 -61.62 -47.8 83.78 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 119.025 0.83 . . . . 0.0 111.663 171.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -61.11 -35.0 75.84 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.559 -0.713 . . . . 0.0 112.488 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -69.27 -42.65 75.24 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.761 -1.212 . . . . 0.0 112.555 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 56.1 mt -56.49 -47.26 82.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 121.162 -0.962 . . . . 0.0 110.496 171.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 73.5 mt -64.49 -33.34 75.66 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.585 0.754 . . . . 0.0 112.69 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -62.61 -41.58 99.07 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.289 1.036 . . . . 0.0 112.676 175.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -69.57 -36.49 76.33 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 74.3 t -67.31 -41.42 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.504 0.722 . . . . 0.0 111.19 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.01 93.7 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.889 0.876 . . . . 0.0 112.246 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -65.75 -36.98 85.11 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.751 -0.593 . . . . 0.0 112.047 173.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -63.5 -36.15 82.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.153 0.981 . . . . 0.0 112.711 174.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.71 -41.76 87.45 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.487 0.585 . . . . 0.0 112.173 171.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -60.93 -30.75 70.39 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.421 1.088 . . . . 0.0 112.532 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -74.99 -9.51 58.61 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.909 1.684 . . . . 0.0 114.627 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 17.1 t -155.92 69.39 5.1 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.483 1.513 . . . . 0.0 108.644 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -62.96 -5.54 7.82 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.518 2.812 . . . . 0.0 112.716 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -74.16 -17.89 60.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.463 1.505 . . . . 0.0 113.256 171.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -118.78 83.52 2.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.453 1.501 . . . . 0.0 111.251 -171.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 55.7 mtt85 -55.23 157.39 3.58 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.123 1.369 . . . . 0.0 112.129 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.18 161.29 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.6 m -128.89 140.77 51.53 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.339 1.456 . . . . 0.0 109.258 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 61.7 mt -113.84 127.03 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.815 1.246 . . . . 0.0 108.759 -173.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.508 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 1.4 m120 -119.73 118.4 30.8 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.919 1.688 . . . . 0.0 107.764 -172.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -121.77 151.16 16.98 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 118.549 0.613 . . . . 0.0 112.791 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -127.35 168.69 14.47 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 128.423 2.689 . . . . 0.0 109.81 -170.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.2 m -152.42 156.69 40.0 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.362 1.865 . . . . 0.0 109.642 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.66 157.63 37.65 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.53 -1.356 . . . . 0.0 109.761 165.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -92.0 33.22 1.07 Allowed 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 121.431 0.634 . . . . 0.0 112.642 -177.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 13.0 m -66.29 -23.14 66.33 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.016 1.326 . . . . 0.0 112.773 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -99.93 -139.69 10.96 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 126.384 1.945 . . . . 0.0 112.752 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 62.2 m -139.25 163.57 32.12 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.603 1.961 . . . . 0.0 109.587 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -53.61 -38.93 64.49 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 121.035 -1.04 . . . . 0.0 113.196 -177.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -65.93 -10.12 49.7 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 124.589 1.09 . . . . 0.0 115.197 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 13.8 mt -110.1 -32.45 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.796 2.038 . . . . 0.0 111.156 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -82.35 -29.77 30.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.344 1.058 . . . . 0.0 112.927 -174.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 21.1 mm -59.37 -55.57 44.71 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 125.724 1.61 . . . . 0.0 111.759 169.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.87 -31.93 19.11 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 CA-C-N 120.836 1.334 . . . . 0.0 113.284 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 4.3 mp -64.65 -50.63 66.32 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 120.23 1.377 . . . . 0.0 111.865 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 46.5 p -65.38 -33.19 75.37 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -72.32 -38.06 68.76 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.884 0.874 . . . . 0.0 112.169 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -62.92 -41.78 99.58 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.764 1.226 . . . . 0.0 111.103 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.7 mmt-85 -63.19 -38.74 92.37 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.678 0.672 . . . . 0.0 111.598 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -71.33 -38.4 71.69 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -65.68 -37.74 87.33 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 125.264 1.426 . . . . 0.0 112.08 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 82.1 mt -64.59 -41.36 92.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 118.587 0.631 . . . . 0.0 110.572 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 86.2 t -65.42 -41.73 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 122.047 -0.408 . . . . 0.0 111.527 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -64.68 -41.14 96.26 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.939 0.496 . . . . 0.0 111.882 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.59 -37.71 87.4 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.827 0.851 . . . . 0.0 111.57 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -65.09 -42.15 94.32 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 174.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.2 mp -63.99 -40.75 97.07 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.843 -0.536 . . . . 0.0 111.716 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 53.3 t -68.16 -38.45 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.67 0.788 . . . . 0.0 110.798 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.25 -34.39 77.35 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.131 0.972 . . . . 0.0 112.879 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -43.64 93.83 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.903 0.881 . . . . 0.0 111.279 170.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 156.67 1.86 0.1 OUTLIER Glycine 0 CA--C 1.53 1.019 0 N-CA-C 117.746 1.858 . . . . 0.0 117.746 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.0 m -73.67 145.83 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-N 121.066 2.433 . . . . 0.0 110.799 -174.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.61 140.25 55.53 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.616 -0.678 . . . . 0.0 110.788 172.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -54.54 -27.94 43.35 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.309 1.433 . . . . 0.0 113.843 171.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.1 -32.14 72.67 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.395 1.078 . . . . 0.0 113.316 172.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -90.23 2.29 55.57 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.261 1.424 . . . . 0.0 114.218 -173.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 14.9 tt -138.88 139.95 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.482 0.713 . . . . 0.0 112.559 -171.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -139.4 164.31 30.19 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.217 1.407 . . . . 0.0 111.631 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 45.9 p -138.99 146.11 40.52 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.662 1.185 . . . . 0.0 111.977 -175.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 40.5 t -142.18 138.39 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.792 1.637 . . . . 0.0 109.934 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -107.75 97.97 1.2 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.117 1.818 . . . . 0.0 111.692 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.508 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 1.9 mp -97.01 29.96 2.9 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.443 2.697 . . . . 0.0 110.223 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 0.61 -66.14 0.0 OUTLIER Glycine 0 C--N 1.346 1.122 0 N-CA-C 120.919 3.127 . . . . 0.0 120.919 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 91.5 p -146.81 16.1 1.23 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.064 1.432 . . . . 0.0 114.732 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 17.7 m -71.76 154.37 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 O-C-N 121.106 -0.996 . . . . 0.0 111.098 171.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 22.4 m120 41.71 50.16 4.45 Favored Pre-proline 0 CA--C 1.559 1.327 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.6 125.35 12.64 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.838 2.359 . . . . 0.0 111.404 -174.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 2.0 pp -97.84 -1.11 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -173.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -146.32 166.95 24.78 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.855 1.662 . . . . 0.0 111.714 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 85.9 p -80.92 158.58 25.22 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 122.253 1.025 . . . . 0.0 113.411 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -86.7 -4.87 59.23 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.601 1.16 . . . . 0.0 110.987 165.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.57 -18.69 61.59 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.815 1.646 . . . . 0.0 114.447 -174.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 71.6 p -133.26 142.88 45.95 Favored Pre-proline 0 N--CA 1.474 0.759 0 CA-C-N 119.337 0.971 . . . . 0.0 110.575 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.7 -28.12 68.74 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.447 2.764 . . . . 0.0 112.707 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -66.08 -41.14 91.1 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.43 -0.794 . . . . 0.0 111.468 170.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -64.49 -38.23 95.49 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 124.184 0.897 . . . . 0.0 113.087 174.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -58.96 -49.0 79.52 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 124.21 1.004 . . . . 0.0 111.23 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 225' ' ' PHE . . . -75.85 -22.84 55.83 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.249 -0.907 . . . . 0.0 112.105 -175.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -70.18 -34.58 73.14 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.061 1.344 . . . . 0.0 112.769 167.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.69 -16.51 26.85 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.144 1.378 . . . . 0.0 112.65 177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 57.3 mtt180 -70.54 11.81 0.32 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.831 1.652 . . . . 0.0 113.779 167.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -60.51 162.44 6.35 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.521 1.928 . . . . 0.0 114.038 -173.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.21 151.66 32.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.24 172.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -139.63 159.11 42.93 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.894 1.678 . . . . 0.0 111.542 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.35 129.28 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.179 1.392 . . . . 0.0 108.708 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 64.8 t -134.05 129.57 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.209 1.404 . . . . 0.0 110.359 -171.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 23.8 t -72.84 134.92 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.546 0.738 . . . . 0.0 109.749 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.208 0 C-N-CA 125.036 1.335 . . . . 0.0 111.707 -171.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.668 0 CA-C-O 119.198 -0.779 . . . . 0.0 114.626 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -70.21 -16.78 35.76 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.14 3.227 . . . . 0.0 114.277 -171.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 49.3 t -120.45 -2.99 9.93 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 126.759 2.024 . . . . 0.0 111.832 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -63.59 -17.8 63.23 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 -171.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -138.3 29.4 2.46 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.953 2.101 . . . . 0.0 111.475 173.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.79 -19.14 64.77 Favored 'General case' 0 C--O 1.221 -0.44 0 O-C-N 121.437 -0.789 . . . . 0.0 112.721 -172.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -55.94 -40.12 72.7 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.642 1.11 . . . . 0.0 111.529 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 17.5 t -68.33 -44.49 75.2 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.311 0.645 . . . . 0.0 111.878 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.94 -35.96 82.85 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 55.0 mt -70.18 -39.96 77.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.651 1.58 . . . . 0.0 109.493 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -63.9 -40.01 95.51 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.11 -0.994 . . . . 0.0 111.897 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.96 -38.34 90.65 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.121 0.968 . . . . 0.0 112.772 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.91 -28.78 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 118.677 0.671 . . . . 0.0 112.201 177.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.4 m -71.52 -26.41 62.65 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.693 1.197 . . . . 0.0 112.24 169.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.03 25.48 74.62 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.409 1.481 . . . . 0.0 113.637 -172.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 97.3 -170.54 25.93 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.28 1.419 . . . . 0.0 112.751 -171.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.09 140.96 38.78 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.32 2.68 . . . . 0.0 110.992 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.94 142.05 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.634 1.174 . . . . 0.0 112.03 -170.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -104.88 174.16 6.0 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.219 1.807 . . . . 0.0 115.115 -171.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -134.29 84.14 2.09 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.14 1.376 . . . . 0.0 108.858 -173.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -48.54 151.96 2.73 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 126.727 2.108 . . . . 0.0 115.047 -170.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -2.63 -42.12 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 1 C-N-CA 133.628 4.771 . . . . 0.0 120.62 -171.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -63.19 -20.43 65.41 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.204 1.002 . . . . 0.0 113.472 168.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.67 8.06 77.51 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.465 1.507 . . . . 0.0 115.047 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -154.19 19.58 0.5 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 127.361 2.265 . . . . 0.0 112.005 -176.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 7.5 t -82.74 81.99 8.26 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.741 -1.225 . . . . 0.0 113.17 -170.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 22.0 tp -82.13 77.65 8.91 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.834 1.254 . . . . 0.0 110.206 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 3.8 pt -58.21 157.89 15.62 Favored Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 125.624 1.57 . . . . 0.0 112.135 -173.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -61.65 -32.68 87.2 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.224 1.949 . . . . 0.0 112.648 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -68.55 -29.12 67.61 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 172.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -59.1 -41.83 89.05 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.818 1.19 . . . . 0.0 112.359 175.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -60.96 -27.57 68.35 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.561 0.745 . . . . 0.0 112.933 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -64.01 -40.65 96.83 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.67 1.123 . . . . 0.0 111.752 175.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 45.2 mm -58.9 -44.52 90.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 121.579 -0.7 . . . . 0.0 110.221 171.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.05 -36.86 84.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.486 0.714 . . . . 0.0 112.795 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -60.97 -41.73 96.94 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 119.074 0.852 . . . . 0.0 112.157 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -66.3 -40.21 89.84 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.954 0.901 . . . . 0.0 112.311 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 76.2 t -66.78 -41.57 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 123.78 0.832 . . . . 0.0 110.81 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.02 -39.27 93.15 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.355 0.662 . . . . 0.0 112.049 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.7 -38.22 88.62 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.252 0.621 . . . . 0.0 112.082 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.38 -30.93 67.96 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 178.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.405 HD21 ' CG1' ' A' ' 255' ' ' VAL . 0.4 OUTLIER -69.79 -43.23 72.53 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.025 0.93 . . . . 0.0 112.585 169.626 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -60.43 -27.5 67.54 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.325 1.45 . . . . 0.0 112.745 174.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -79.36 -8.13 58.85 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.006 1.723 . . . . 0.0 114.843 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 37.2 t -152.99 68.5 6.72 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 125.285 1.434 . . . . 0.0 108.903 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -62.59 -8.85 14.03 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.244 2.63 . . . . 0.0 112.271 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -72.23 -16.5 61.94 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.669 1.588 . . . . 0.0 113.507 173.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -121.54 81.28 1.78 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.274 1.429 . . . . 0.0 110.705 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -49.89 143.04 8.16 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.412 1.485 . . . . 0.0 111.502 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.405 ' CG1' HD21 ' A' ' 247' ' ' LEU . 16.8 m -135.42 163.03 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 176.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 5.2 t -143.07 146.39 33.75 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 3.4 mt -101.92 106.7 20.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.476 -169.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.426 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 21.8 m-20 -81.87 154.41 25.86 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 166.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -148.69 152.75 24.74 Favored Glycine 0 CA--C 1.523 0.564 0 O-C-N 121.84 -0.537 . . . . 0.0 112.36 168.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -116.62 169.96 8.95 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.74 2.416 . . . . 0.0 108.633 -170.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.4 p -149.95 145.86 26.72 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.292 2.637 . . . . 0.0 109.78 171.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -63.44 168.31 4.68 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 120.984 -1.073 . . . . 0.0 112.929 174.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -101.33 21.08 14.67 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -171.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 3.9 m -68.71 -19.14 64.35 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.867 -1.145 . . . . 0.0 112.772 172.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -98.22 -152.55 28.12 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.12 1.819 . . . . 0.0 113.985 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 73.7 m -129.72 145.8 51.52 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.735 1.614 . . . . 0.0 110.472 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -53.56 -37.12 62.58 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.71 1.204 . . . . 0.0 113.754 -171.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -60.0 -28.86 66.88 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 123.955 0.788 . . . . 0.0 113.959 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 18.7 mm -95.94 -24.17 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 126.156 1.782 . . . . 0.0 112.142 175.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -86.76 -23.97 25.25 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -175.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 21.8 mm -58.67 -54.28 57.84 Favored Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 125.121 1.368 . . . . 0.0 112.228 167.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -70.63 -33.44 13.29 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 121.075 1.42 . . . . 0.0 113.116 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.457 HD13 HH12 ' A' ' 277' ' ' ARG . 1.2 mm? -72.35 -36.52 68.82 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.58 1.082 . . . . 0.0 112.856 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 61.7 p -68.82 -36.66 78.5 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.72 1.145 . . . . 0.0 113.536 171.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.36 85.12 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.339 1.055 . . . . 0.0 111.577 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -61.2 -42.7 99.05 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 124.918 1.287 . . . . 0.0 110.745 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.457 HH12 HD13 ' A' ' 273' ' ' LEU . 22.7 mtt85 -64.56 -32.12 73.64 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -75.92 -39.57 55.97 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 171.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -60.22 -45.65 92.45 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 125.319 1.448 . . . . 0.0 110.351 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 41.0 mm -66.27 -35.52 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 118.675 0.67 . . . . 0.0 111.011 -177.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.81 -44.28 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 O-C-N 121.992 -0.443 . . . . 0.0 111.162 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -66.1 -36.59 83.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.341 0.657 . . . . 0.0 111.658 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -63.03 -41.23 99.48 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.668 1.187 . . . . 0.0 111.458 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -64.1 -43.01 96.67 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 172.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.4 mp -63.12 -40.93 99.04 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.779 0.832 . . . . 0.0 111.659 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 39.1 t -63.98 -42.31 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.872 0.869 . . . . 0.0 110.922 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.36 -31.8 70.46 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -42.03 75.76 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.142 0.977 . . . . 0.0 111.901 172.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 159.77 -0.26 0.08 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 117.494 1.757 . . . . 0.0 117.494 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 2.6 t -74.87 124.28 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 120.664 2.232 . . . . 0.0 109.2 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.31 142.36 57.8 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.048 -1.032 . . . . 0.0 110.837 173.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -53.17 -28.88 35.24 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.169 1.366 . . . . 0.0 113.613 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -68.31 -22.57 64.71 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.23 1.412 . . . . 0.0 114.671 175.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -108.46 2.4 22.29 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.305 1.842 . . . . 0.0 113.898 -172.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 2.8 tp -133.76 124.85 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.372 1.469 . . . . 0.0 110.005 -172.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -122.91 172.69 8.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.731 1.212 . . . . 0.0 110.789 171.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 40.0 p -141.73 151.91 43.36 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.458 1.103 . . . . 0.0 112.527 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 7.8 t -142.57 132.77 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.396 1.078 . . . . 0.0 111.143 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -93.75 120.76 6.39 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 123.881 0.753 . . . . 0.0 111.256 169.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.426 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 63.8 mt -111.65 18.9 18.59 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.352 1.861 . . . . 0.0 113.327 -175.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 16.47 -105.87 0.01 OUTLIER Glycine 0 CA--C 1.541 1.666 0 C-N-CA 124.863 1.22 . . . . 0.0 116.103 -171.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 16.9 m -111.47 13.51 21.44 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -172.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 6.3 m -61.33 159.17 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.68 1.127 . . . . 0.0 111.737 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 38.1 53.99 3.84 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 125.622 1.569 . . . . 0.0 113.78 175.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -64.06 150.79 87.62 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.922 2.414 . . . . 0.0 113.081 -171.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 22.8 pt -134.72 -4.94 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 127.211 2.205 . . . . 0.0 113.365 -171.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 318' ' ' ASN . . . -147.77 152.81 38.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.593 1.157 . . . . 0.0 112.399 170.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 69.5 m -76.73 157.44 31.69 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.746 1.618 . . . . 0.0 112.936 174.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -73.14 -3.64 27.78 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.121 1.368 . . . . 0.0 113.273 170.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.19 -21.04 66.3 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.86 1.664 . . . . 0.0 115.367 -170.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 78.3 p -140.41 147.45 49.65 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 124.198 0.999 . . . . 0.0 111.182 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.73 -27.8 75.94 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.381 2.721 . . . . 0.0 112.603 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -65.06 -41.19 95.35 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.939 0.896 . . . . 0.0 112.386 170.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.55 -39.9 95.8 Favored Glycine 0 C--N 1.336 0.554 0 O-C-N 121.728 -0.607 . . . . 0.0 112.518 173.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -59.08 -43.29 91.79 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.771 0.828 . . . . 0.0 111.578 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.97 -41.61 99.59 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.892 0.877 . . . . 0.0 112.3 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.99 -11.41 60.86 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.613 1.565 . . . . 0.0 114.302 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.549 ' HB2' ' HB3' ' A' ' 307' ' ' ALA 0.256 0.4 OUTLIER -119.69 15.75 12.74 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.522 1.529 . . . . 0.0 111.667 172.001 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -105.56 8.58 33.36 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.992 1.717 . . . . 0.0 112.345 166.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -63.5 161.19 14.93 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -170.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 2.5 m -126.25 144.68 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 127.217 2.207 . . . . 0.0 110.779 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -147.57 134.69 20.42 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.468 1.107 . . . . 0.0 113.182 -171.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 23.2 mm -85.73 142.55 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.595 1.558 . . . . 0.0 110.758 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 43.5 t -139.6 129.39 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.394 1.077 . . . . 0.0 109.483 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 9.0 p -77.35 133.41 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.409 -0.807 . . . . 0.0 111.228 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 14.1 m120 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 125.233 1.413 . . . . 0.0 111.988 -177.698 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.711 0 CA-C-O 119.129 -0.817 . . . . 0.0 115.113 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -71.05 -14.76 32.2 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 124.19 3.26 . . . . 0.0 114.681 -171.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 33.0 t -133.6 -1.86 3.07 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 126.802 2.041 . . . . 0.0 112.092 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -62.24 -20.4 64.19 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 117.515 2.413 . . . . 0.0 117.515 -171.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -140.64 30.76 1.88 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.947 2.099 . . . . 0.0 111.292 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.0 tp -62.97 -19.73 64.58 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.341 -0.85 . . . . 0.0 113.221 -171.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -56.99 -39.5 74.77 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.222 0.919 . . . . 0.0 111.557 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 15.6 t -68.88 -43.63 74.91 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.549 0.74 . . . . 0.0 111.873 173.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.46 -35.01 79.63 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 60.8 mt -70.6 -39.49 76.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.466 1.506 . . . . 0.0 109.479 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -66.66 -33.42 75.6 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.221 -0.924 . . . . 0.0 112.873 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -70.43 -37.86 74.47 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.21 1.004 . . . . 0.0 112.402 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.26 -27.82 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 118.57 0.623 . . . . 0.0 112.451 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 68.5 p -84.8 -25.89 27.87 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 170.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.2 11.76 71.34 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 125.59 1.567 . . . . 0.0 113.855 -171.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 124.56 -174.46 17.07 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 126.565 2.031 . . . . 0.0 112.915 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -76.02 150.46 33.94 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.536 2.824 . . . . 0.0 110.337 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 10.5 mm -108.2 139.94 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -169.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -95.07 174.48 7.06 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 128.009 2.523 . . . . 0.0 114.613 -171.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -138.38 116.27 11.58 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.573 1.149 . . . . 0.0 110.636 -175.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -58.84 -162.71 0.07 OUTLIER Glycine 0 N--CA 1.477 1.381 0 C-N-CA 127.799 2.619 . . . . 0.0 117.056 -174.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -45.7 -37.59 5.99 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.451 1.9 . . . . 0.0 115.556 -175.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -69.65 -24.79 63.68 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.013 1.325 . . . . 0.0 113.913 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 90.37 -4.43 82.52 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 127.228 2.347 . . . . 0.0 115.16 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -156.34 16.87 0.34 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.132 1.373 . . . . 0.0 113.936 -171.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.0 t -85.33 100.1 11.59 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.647 -1.283 . . . . 0.0 110.851 -172.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 14.6 tp -80.26 93.83 5.97 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.615 1.166 . . . . 0.0 109.829 176.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 6.4 pt -63.49 160.0 46.38 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 125.776 1.631 . . . . 0.0 111.826 -173.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -61.91 -32.17 84.86 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.227 1.951 . . . . 0.0 112.596 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -67.67 -32.28 72.85 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 171.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.67 -44.32 90.17 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.508 1.049 . . . . 0.0 112.049 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -61.83 -20.12 63.31 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.01 0.924 . . . . 0.0 113.144 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -76.01 -42.75 47.08 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.557 1.071 . . . . 0.0 112.188 173.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 47.4 mm -58.92 -44.84 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 O-C-N 121.359 -0.838 . . . . 0.0 110.281 171.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.12 -34.68 78.97 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.654 0.782 . . . . 0.0 112.989 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -61.05 -42.12 97.87 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.049 0.94 . . . . 0.0 112.2 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -65.95 -38.47 88.69 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.303 1.041 . . . . 0.0 112.494 175.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 94.8 t -65.06 -42.68 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.167 0.587 . . . . 0.0 111.168 174.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.77 94.95 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.071 0.548 . . . . 0.0 111.875 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -64.08 -40.46 96.29 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.509 0.724 . . . . 0.0 111.988 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -70.96 -30.09 66.28 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.818 0.847 . . . . 0.0 113.092 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.591 HD21 HG11 ' A' ' 255' ' ' VAL . 0.2 OUTLIER -69.2 -43.98 73.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.838 0.855 . . . . 0.0 112.079 169.705 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -63.68 -23.07 67.22 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.014 1.326 . . . . 0.0 113.537 174.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.06 -10.02 59.08 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.275 1.43 . . . . 0.0 114.574 170.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 40.2 t -156.3 66.48 4.29 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 125.702 1.601 . . . . 0.0 109.141 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -64.78 -7.81 15.94 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.922 2.414 . . . . 0.0 111.773 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.91 -21.57 65.99 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.175 1.39 . . . . 0.0 113.017 170.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -107.93 95.22 5.53 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.123 1.369 . . . . 0.0 111.225 -175.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 23.3 mtt180 -49.72 141.21 10.23 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.524 1.13 . . . . 0.0 110.876 167.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.591 HG11 HD21 ' A' ' 247' ' ' LEU . 16.8 m -137.46 166.05 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.892 1.277 . . . . 0.0 111.561 173.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 7.2 t -149.16 146.74 27.81 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 118.387 2.736 . . . . 0.0 118.387 170.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 26.3 mt -100.4 115.02 40.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 124.982 1.313 . . . . 0.0 108.937 -171.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.407 ' HB3' HD12 ' A' ' 300' ' ' LEU . 7.2 m-20 -93.93 155.64 17.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.99 -0.444 . . . . 0.0 110.043 169.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -147.19 152.56 24.69 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 121.7 0.611 . . . . 0.0 113.349 167.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.86 170.43 10.11 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.187 2.595 . . . . 0.0 109.982 -169.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 51.0 p -143.65 160.86 39.93 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.188 2.195 . . . . 0.0 110.485 167.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.94 152.0 28.84 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 122.578 1.18 . . . . 0.0 112.232 168.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -3.85 29.42 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -171.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.93 -16.4 63.83 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.261 1.825 . . . . 0.0 114.931 -173.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.57 -157.78 31.93 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.306 1.431 . . . . 0.0 114.219 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 68.1 m -131.58 143.7 50.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.682 1.593 . . . . 0.0 109.702 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -50.57 -40.17 51.51 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.715 1.206 . . . . 0.0 114.019 -171.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -63.96 -27.19 70.93 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 123.657 0.646 . . . . 0.0 114.113 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 11.3 mm -97.72 -24.51 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.842 1.657 . . . . 0.0 111.767 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -80.42 -32.89 37.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.124 0.97 . . . . 0.0 113.193 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 18.6 mm -55.17 -55.86 34.76 Favored Pre-proline 0 N--CA 1.471 0.588 0 C-N-CA 125.418 1.487 . . . . 0.0 112.298 171.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.84 -30.14 17.71 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 120.721 1.293 . . . . 0.0 112.811 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 16.7 mt -66.02 -44.77 83.72 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 119.778 1.172 . . . . 0.0 112.789 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.33 -37.3 80.4 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 176.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.72 -34.47 75.68 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.249 1.02 . . . . 0.0 111.61 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -63.17 -42.83 99.45 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.293 1.037 . . . . 0.0 110.855 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -60.13 -44.01 95.26 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.875 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.25 -37.28 77.87 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -64.32 -41.36 96.86 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 125.631 1.573 . . . . 0.0 111.576 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 37.0 mm -67.14 -38.72 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 118.785 0.72 . . . . 0.0 110.896 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 99.7 t -68.04 -42.33 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 O-C-N 121.938 -0.476 . . . . 0.0 111.385 177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -65.64 -40.02 92.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.265 0.626 . . . . 0.0 111.305 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.15 -39.25 93.62 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.306 0.642 . . . . 0.0 111.75 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -65.02 -42.95 93.95 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.9 mp -67.53 -39.94 85.06 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.896 0.478 . . . . 0.0 111.41 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 50.7 t -66.65 -39.36 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 123.822 0.849 . . . . 0.0 110.672 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.73 -34.19 76.37 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 176.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -69.04 -38.08 78.95 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.76 -0.638 . . . . 0.0 112.612 170.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 151.46 9.32 0.1 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-O 117.481 -1.733 . . . . 0.0 116.952 168.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.9 130.13 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 120.482 2.141 . . . . 0.0 108.985 176.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.98 135.92 57.75 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.256 -0.902 . . . . 0.0 110.722 172.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -57.34 -29.82 60.73 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.696 1.141 . . . . 0.0 113.859 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.73 -37.26 85.84 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 122.161 -0.611 . . . . 0.0 112.476 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -85.49 -1.34 56.97 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.437 1.495 . . . . 0.0 113.966 -171.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 15.1 tt -139.85 93.64 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 124.92 1.288 . . . . 0.0 111.58 -171.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -85.64 174.2 9.58 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.209 -0.932 . . . . 0.0 110.632 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 38.4 p -136.26 148.77 48.17 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.485 1.114 . . . . 0.0 111.869 172.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 11.1 t -137.33 132.12 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.889 0.876 . . . . 0.0 111.994 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -91.06 104.91 3.22 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.589 1.09 . . . . 0.0 111.761 173.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.407 HD12 ' HB3' ' A' ' 258' ' ' ASN . 39.9 mt -105.38 32.08 4.5 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.989 2.115 . . . . 0.0 110.866 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 2.59 -72.66 0.0 OUTLIER Glycine 0 C--N 1.35 1.325 0 C-N-CA 127.796 2.617 . . . . 0.0 119.543 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 88.2 p -147.35 21.42 1.2 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.245 1.523 . . . . 0.0 113.989 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 9.0 m -66.43 156.38 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 121.083 -1.01 . . . . 0.0 111.618 172.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 35.91 55.64 2.65 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 125.978 1.711 . . . . 0.0 113.769 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -61.57 123.97 13.73 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.212 2.608 . . . . 0.0 112.588 -171.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 47.1 pt -90.7 -3.0 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.512 1.125 . . . . 0.0 113.86 -173.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 318' ' ' ASN . . . -153.08 166.8 31.32 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.81 1.644 . . . . 0.0 111.683 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 79.0 p -70.33 171.2 10.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.801 1.24 . . . . 0.0 113.633 175.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -113.29 3.42 15.94 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.828 1.251 . . . . 0.0 111.453 166.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.33 -21.39 62.06 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.718 1.607 . . . . 0.0 113.647 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 66.0 p -132.38 149.0 71.91 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 124.606 1.162 . . . . 0.0 110.934 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -62.35 -29.62 79.83 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.484 2.789 . . . . 0.0 112.541 176.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.51 -42.38 98.49 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.597 0.759 . . . . 0.0 112.239 171.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -66.25 -39.0 94.26 Favored Glycine 0 C--N 1.336 0.543 0 O-C-N 121.829 -0.544 . . . . 0.0 112.609 175.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -58.92 -46.85 86.93 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.46 0.704 . . . . 0.0 111.096 175.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.12 -40.92 99.01 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.713 0.805 . . . . 0.0 111.864 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -70.63 -12.04 61.31 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.397 1.479 . . . . 0.0 114.131 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 307' ' ' ALA 0.256 49.7 t30 -120.3 3.75 10.82 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.806 1.243 . . . . 0.0 113.958 172.315 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 54.2 mtt180 -83.09 1.48 40.03 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.335 1.454 . . . . 0.0 112.087 164.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.46 156.73 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 131.569 3.947 . . . . 0.0 115.914 -170.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 1.3 m -119.39 141.64 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.116 1.766 . . . . 0.0 110.989 167.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -136.18 166.92 22.29 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.952 1.701 . . . . 0.0 111.438 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 13.7 tt -133.54 142.81 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.199 0.999 . . . . 0.0 112.062 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 47.5 t -138.79 130.34 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.51 0.724 . . . . 0.0 109.726 -171.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 42.7 t -82.26 127.54 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.347 0.659 . . . . 0.0 110.328 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 61.7 t30 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 130.143 3.377 . . . . 0.0 116.38 177.905 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 119.377 -0.344 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.61 159.34 53.1 Favored 'Trans proline' 0 CA--C 1.547 1.134 0 C-N-CA 123.46 2.773 . . . . 0.0 112.636 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.65 163.46 38.89 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.571 2.847 . . . . 0.0 112.406 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 78.15 -170.82 55.03 Favored Glycine 0 CA--C 1.543 1.837 0 C-N-CA 123.949 0.785 . . . . 0.0 114.515 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.89 162.76 40.14 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 123.755 2.97 . . . . 0.0 112.807 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -67.19 165.75 25.57 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.588 2.859 . . . . 0.0 113.117 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -135.44 25.41 3.47 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.452 1.501 . . . . 0.0 113.086 -171.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 36.8 p -58.35 151.83 18.89 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.786 1.234 . . . . 0.0 112.708 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 50.31 57.44 10.29 Favored Glycine 0 CA--C 1.542 1.742 0 C-N-CA 125.119 1.342 . . . . 0.0 114.424 -171.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.45 -12.99 32.5 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.441 3.427 . . . . 0.0 114.882 -171.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 20.2 t -133.2 -3.01 3.11 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 126.908 2.083 . . . . 0.0 111.878 176.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.67 -20.01 66.13 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -171.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -139.25 31.27 2.15 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.922 2.089 . . . . 0.0 111.35 174.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.7 tp -63.14 -17.1 61.99 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -171.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -53.71 -46.87 70.91 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.601 0.76 . . . . 0.0 111.489 167.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 20.1 t -69.17 -40.76 77.94 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.382 0.673 . . . . 0.0 111.409 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.39 -38.18 89.2 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 59.4 mt -71.98 -36.91 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.741 0.816 . . . . 0.0 109.593 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -65.61 -34.01 77.24 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.131 0.972 . . . . 0.0 112.557 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -70.18 -33.76 72.13 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.913 0.885 . . . . 0.0 112.86 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.0 t -65.54 -44.92 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 118.488 0.586 . . . . 0.0 111.192 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 69.5 p -77.26 -25.53 51.56 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -176.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 66.12 14.71 61.89 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.628 1.585 . . . . 0.0 114.212 -171.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 118.43 -171.83 14.23 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 126.024 1.774 . . . . 0.0 112.831 -172.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -76.5 167.39 25.7 Favored 'Trans proline' 0 CA--C 1.549 1.272 0 C-N-CA 123.682 2.922 . . . . 0.0 111.85 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.94 140.01 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 126.16 1.784 . . . . 0.0 113.143 -168.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -106.73 169.44 8.53 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.109 2.164 . . . . 0.0 115.614 -170.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.457 ' CZ ' ' HG3' ' A' ' 277' ' ' ARG . 92.0 m-85 -143.3 100.89 3.71 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.389 1.075 . . . . 0.0 111.586 -171.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -115.47 -174.45 17.96 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.71 1.624 . . . . 0.0 113.026 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 24.7 t30 50.43 -75.68 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 128.468 2.707 . . . . 0.0 114.527 -171.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -79.39 -25.54 42.12 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.454 1.902 . . . . 0.0 112.894 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.68 0.27 86.21 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.15 1.357 . . . . 0.0 115.542 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -162.21 26.44 0.11 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.519 1.528 . . . . 0.0 113.451 -175.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.8 t -120.32 97.36 5.55 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.356 1.062 . . . . 0.0 110.839 -171.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 18.6 tp -70.11 141.03 52.78 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.472 1.109 . . . . 0.0 113.178 -173.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.435 HG13 ' H ' ' A' ' 236' ' ' ASP . 6.4 pt -83.36 150.63 60.89 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.097 1.759 . . . . 0.0 113.906 -172.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.29 -31.21 73.82 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.48 2.786 . . . . 0.0 112.882 173.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.92 94.87 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.588 0.755 . . . . 0.0 112.384 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.435 ' H ' HG13 ' A' ' 233' ' ' ILE . 36.4 t70 -69.01 -39.96 78.98 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 170.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -60.4 -28.64 68.4 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.469 -1.394 . . . . 0.0 112.683 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -71.96 -41.2 68.0 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.689 -1.257 . . . . 0.0 113.24 170.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 90.8 mt -55.99 -44.13 77.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.042 -1.036 . . . . 0.0 110.134 168.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 31.7 mt -64.37 -32.31 73.87 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.196 0.998 . . . . 0.0 113.177 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -59.68 -42.87 93.89 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.704 1.138 . . . . 0.0 111.996 171.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -72.94 -32.83 65.52 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.149 0.58 . . . . 0.0 112.555 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 69.9 t -67.04 -43.23 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.639 0.775 . . . . 0.0 111.097 172.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.41 -42.44 95.96 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.083 0.553 . . . . 0.0 111.994 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.71 -37.17 85.7 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.362 0.665 . . . . 0.0 112.047 176.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.64 -34.21 73.71 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.919 0.888 . . . . 0.0 112.963 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.18 -45.9 75.56 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.739 0.815 . . . . 0.0 110.213 171.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 53.4 tttp -62.59 -23.39 67.01 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.079 1.751 . . . . 0.0 113.714 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -75.2 -8.35 56.36 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.847 1.659 . . . . 0.0 114.597 170.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 38.2 t -151.95 66.86 6.89 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 126.068 1.747 . . . . 0.0 108.507 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -63.83 -6.61 11.22 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.378 2.719 . . . . 0.0 112.318 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -71.72 -18.52 62.14 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.833 1.653 . . . . 0.0 113.229 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -120.76 87.14 2.7 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.688 1.595 . . . . 0.0 110.525 -172.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 63.7 mtt85 -52.69 158.49 1.3 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.812 1.245 . . . . 0.0 111.955 172.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.5 m -127.73 159.91 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.063 1.345 . . . . 0.0 111.722 174.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.1 m -125.96 138.05 53.73 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.46 1.504 . . . . 0.0 108.619 171.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.4 mt -119.33 121.59 66.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.001 1.32 . . . . 0.0 107.495 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -109.29 151.02 27.12 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.457 0.703 . . . . 0.0 110.288 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -139.84 156.9 25.09 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 122.007 -0.433 . . . . 0.0 112.475 167.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -127.73 169.57 13.69 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.893 2.477 . . . . 0.0 109.111 -170.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.5 m -149.14 153.01 37.08 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 127.366 2.266 . . . . 0.0 108.521 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -61.45 165.7 4.58 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.568 -1.333 . . . . 0.0 111.523 167.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -100.72 20.56 14.98 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -175.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.3 m -71.09 -20.19 62.37 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.816 -1.178 . . . . 0.0 112.943 169.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.09 -151.85 21.33 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 125.885 1.707 . . . . 0.0 113.38 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 8.3 t -139.44 164.35 30.11 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.302 1.441 . . . . 0.0 110.374 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -52.67 -42.17 64.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.975 0.91 . . . . 0.0 112.469 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -68.63 -5.09 42.85 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.436 1.017 . . . . 0.0 115.328 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 6.1 mt -115.79 -33.46 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.417 1.887 . . . . 0.0 111.266 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -86.94 -26.87 23.65 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.464 1.106 . . . . 0.0 113.257 -175.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 19.9 mm -60.0 -53.4 65.57 Favored Pre-proline 0 N--CA 1.469 0.496 0 C-N-CA 124.803 1.241 . . . . 0.0 111.546 168.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.27 -34.8 15.38 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 CA-C-N 120.831 1.333 . . . . 0.0 113.099 176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 17.9 mt -66.18 -44.8 82.98 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 120.345 1.429 . . . . 0.0 112.747 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 34.8 p -65.77 -37.12 85.47 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.74 -39.84 76.54 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.255 0.622 . . . . 0.0 111.716 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -63.22 -40.85 98.64 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.768 1.227 . . . . 0.0 111.037 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.457 ' HG3' ' CZ ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -63.8 -38.63 91.8 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 118.762 0.71 . . . . 0.0 112.143 177.481 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -72.59 -38.85 67.73 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -67.41 -36.26 80.92 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 125.481 1.513 . . . . 0.0 111.795 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 59.2 mt -62.56 -42.49 96.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 118.805 0.729 . . . . 0.0 110.843 175.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.02 -41.82 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 117.954 0.343 . . . . 0.0 110.952 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.04 97.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -69.14 -36.43 77.45 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.598 0.759 . . . . 0.0 111.158 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -66.44 -42.76 87.16 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.6 mp -64.26 -41.81 96.77 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.02 0.528 . . . . 0.0 111.233 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.04 -37.42 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 123.142 0.577 . . . . 0.0 111.404 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.01 -35.4 76.62 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -69.35 -37.67 77.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.888 0.875 . . . . 0.0 112.855 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 161.91 -1.54 0.07 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 118.093 1.997 . . . . 0.0 118.093 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 4.9 t -76.88 142.73 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 120.015 1.908 . . . . 0.0 110.368 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.13 137.68 47.18 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.679 -1.263 . . . . 0.0 110.858 167.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -57.74 -27.14 58.65 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.384 0.992 . . . . 0.0 113.906 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.63 -30.7 70.87 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.628 1.171 . . . . 0.0 113.21 173.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -88.32 -2.81 58.82 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.007 1.323 . . . . 0.0 114.377 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 5.1 mt -125.81 123.66 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.361 0.982 . . . . 0.0 111.403 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -105.16 159.24 16.01 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.453 1.501 . . . . 0.0 110.64 167.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 40.6 p -134.87 146.01 48.82 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.165 0.986 . . . . 0.0 111.792 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 25.3 t -138.86 130.49 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.112 0.965 . . . . 0.0 111.396 -175.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -87.54 100.93 2.64 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.552 1.072 . . . . 0.0 111.691 172.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 43.2 mt -97.35 33.34 2.01 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.918 2.087 . . . . 0.0 110.065 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 3.64 -72.69 0.0 OUTLIER Glycine 0 C--N 1.351 1.373 0 N-CA-C 120.33 2.892 . . . . 0.0 120.33 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 23.4 p -144.79 17.96 1.63 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.615 1.707 . . . . 0.0 113.892 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.7 m -70.59 161.33 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.059 1.344 . . . . 0.0 112.597 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 38.44 53.56 3.94 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 125.866 1.666 . . . . 0.0 113.269 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -64.34 151.7 84.38 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.658 2.239 . . . . 0.0 113.667 -170.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 45.9 pt -126.44 -3.76 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.901 1.68 . . . . 0.0 113.685 -172.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 318' ' ' ASN . . . -151.74 149.57 29.21 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.134 1.373 . . . . 0.0 111.439 172.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 69.8 m -70.36 147.36 49.66 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.41 1.484 . . . . 0.0 112.078 171.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -82.74 5.98 19.59 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.365 1.066 . . . . 0.0 113.802 173.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.42 -13.98 62.68 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.051 1.34 . . . . 0.0 114.444 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 67.6 p -138.33 147.78 56.85 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 125.713 1.605 . . . . 0.0 110.472 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -63.92 -31.36 67.15 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 123.333 2.689 . . . . 0.0 112.423 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.94 -38.62 91.58 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.605 -0.684 . . . . 0.0 112.413 171.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.38 -36.95 85.36 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 123.767 0.699 . . . . 0.0 112.53 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -58.69 -49.54 77.2 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.528 0.731 . . . . 0.0 110.709 172.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.9 -37.28 86.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.377 0.671 . . . . 0.0 112.349 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -68.05 -17.65 64.46 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.391 1.476 . . . . 0.0 113.831 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 307' ' ' ALA . 7.8 t30 -113.21 -8.09 13.55 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 174.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -74.42 9.71 1.61 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.868 1.667 . . . . 0.0 113.865 167.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.42 153.28 2.23 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.812 2.445 . . . . 0.0 114.8 -170.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 8.3 p -123.32 145.9 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.464 1.506 . . . . 0.0 109.648 168.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -142.98 158.53 43.51 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.413 1.485 . . . . 0.0 112.898 -174.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 20.2 tt -133.08 141.32 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.756 1.623 . . . . 0.0 111.745 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 16.9 t -144.46 133.5 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.365 1.466 . . . . 0.0 109.568 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 38.4 t -70.34 137.63 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.708 0.803 . . . . 0.0 109.893 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.253 1.252 0 C-N-CA 125.275 1.43 . . . . 0.0 111.766 -171.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 119.284 -0.388 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.57 160.89 47.44 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 123.481 2.787 . . . . 0.0 112.263 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.27 134.05 34.94 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.077 2.518 . . . . 0.0 111.662 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 171.81 56.82 0.04 OUTLIER Glycine 0 CA--C 1.539 1.561 0 CA-C-O 118.594 -1.115 . . . . 0.0 114.092 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.48 159.94 48.16 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 123.277 2.651 . . . . 0.0 112.557 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -64.5 133.27 36.43 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.311 2.674 . . . . 0.0 111.392 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.51 24.44 1.56 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.179 1.392 . . . . 0.0 113.176 -172.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 27.8 m -53.16 134.49 38.83 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.466 1.507 . . . . 0.0 112.685 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 57.95 58.83 12.53 Favored Glycine 0 CA--C 1.542 1.73 0 C-N-CA 124.625 1.107 . . . . 0.0 114.156 -173.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -70.78 -14.54 32.94 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.337 3.358 . . . . 0.0 114.352 -171.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 22.2 t -128.17 -3.24 5.67 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 127.32 2.248 . . . . 0.0 111.666 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.83 -18.55 65.43 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 -171.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -138.46 29.88 2.4 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.022 2.129 . . . . 0.0 111.604 175.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 6.8 tp -63.11 -17.66 62.56 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -53.65 -45.68 70.3 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.057 0.844 . . . . 0.0 111.361 167.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 20.7 t -68.51 -42.03 79.13 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 122.935 0.494 . . . . 0.0 111.616 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.32 -41.42 98.91 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 176.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 66.1 mt -71.56 -35.64 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.994 0.918 . . . . 0.0 109.759 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -68.48 -36.99 79.74 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.987 0.915 . . . . 0.0 112.661 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.99 76.62 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.075 0.95 . . . . 0.0 112.24 175.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 22.5 t -63.06 -41.35 92.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.588 1.155 . . . . 0.0 111.761 173.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 82.3 p -82.92 -19.26 37.63 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 66.12 15.8 63.51 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.961 1.743 . . . . 0.0 114.804 -172.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 129.74 -159.12 22.47 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 125.593 1.568 . . . . 0.0 112.937 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -74.66 171.42 18.22 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.702 2.934 . . . . 0.0 111.785 171.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 28.9 mt -113.39 136.24 50.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.005 1.722 . . . . 0.0 109.193 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -124.03 161.98 24.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.363 1.465 . . . . 0.0 113.005 -172.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -138.23 99.33 3.83 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.021 0.928 . . . . 0.0 111.93 -169.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -74.96 164.7 54.61 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.707 1.146 . . . . 0.0 113.831 -171.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 32.88 -78.02 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 130.238 3.415 . . . . 0.0 116.07 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.75 -28.2 67.43 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.177 1.391 . . . . 0.0 113.164 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 96.97 11.32 53.45 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 116.816 1.486 . . . . 0.0 116.816 167.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -156.68 25.93 0.33 Allowed 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.288 1.435 . . . . 0.0 112.746 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 52.9 m -92.37 90.94 7.44 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.598 1.159 . . . . 0.0 112.56 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.4 mp -68.36 104.33 1.85 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.662 0.785 . . . . 0.0 110.218 171.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.438 HG13 ' H ' ' A' ' 236' ' ' ASP . 21.3 pt -67.24 163.62 44.27 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 125.215 1.406 . . . . 0.0 110.567 173.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.57 -30.47 79.42 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 CA-C-N 121.433 1.548 . . . . 0.0 112.251 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -66.09 -31.59 72.55 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 170.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.438 ' H ' HG13 ' A' ' 233' ' ' ILE . 22.5 t0 -62.4 -54.29 42.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.625 1.102 . . . . 0.0 110.976 170.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -60.51 -29.12 68.89 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.33 -0.856 . . . . 0.0 112.882 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -65.68 -51.17 61.57 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.168 -0.957 . . . . 0.0 112.005 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.5 pp -69.05 -30.29 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 118.348 0.522 . . . . 0.0 111.56 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 60.2 mt -66.49 -36.66 83.3 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.497 0.719 . . . . 0.0 112.348 171.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -40.18 93.3 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.6 -0.688 . . . . 0.0 111.683 173.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -67.63 -37.63 82.74 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 67.9 t -63.36 -44.0 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 119.031 0.832 . . . . 0.0 111.22 173.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.12 -40.62 94.48 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.924 0.489 . . . . 0.0 111.226 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -66.33 -36.49 83.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.674 0.79 . . . . 0.0 112.605 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -70.82 -35.79 72.65 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.708 1.203 . . . . 0.0 112.854 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 11.7 tp -72.62 -38.72 67.68 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.428 1.491 . . . . 0.0 111.737 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -60.14 -28.07 67.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.518 1.927 . . . . 0.0 112.788 172.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -78.38 -5.25 51.74 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.37 1.468 . . . . 0.0 114.468 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 34.0 t -151.62 65.7 6.56 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.1 1.36 . . . . 0.0 108.859 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -65.09 -8.25 17.82 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.216 2.61 . . . . 0.0 111.881 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -70.39 -21.56 62.84 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.744 1.617 . . . . 0.0 113.256 171.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -120.64 90.01 3.24 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.693 1.597 . . . . 0.0 109.621 -173.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 71.8 mtt85 -49.5 153.18 1.17 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.551 1.14 . . . . 0.0 112.167 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.31 160.14 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 123.057 1.408 . . . . 0.0 110.308 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.6 m -138.37 144.73 40.43 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.697 -2.047 . . . . 0.0 110.428 -173.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 57.8 mt -128.7 112.77 27.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.164 1.385 . . . . 0.0 108.429 -172.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.9 153.14 17.91 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.049 0.94 . . . . 0.0 110.645 176.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -152.44 152.7 24.36 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 121.616 -0.677 . . . . 0.0 113.45 169.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -123.9 161.68 24.86 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 127.724 2.41 . . . . 0.0 109.011 -170.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 65.1 m -138.74 143.54 39.08 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.827 2.051 . . . . 0.0 109.376 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . 0.256 2.2 p30 -63.07 150.89 41.48 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 123.57 1.652 . . . . 0.0 114.551 -171.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -71.12 -2.3 15.24 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 113.164 -1.835 . . . . 0.0 115.299 -171.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.7 -15.71 61.68 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.14 0.976 . . . . 0.0 112.919 171.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.48 -165.43 41.31 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 125.312 1.434 . . . . 0.0 114.574 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 69.6 m -139.59 150.81 45.45 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.404 1.882 . . . . 0.0 109.681 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -54.37 -37.93 65.53 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -171.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.93 -26.73 71.46 Favored Glycine 0 CA--C 1.536 1.358 0 O-C-N 121.376 -0.828 . . . . 0.0 114.112 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 21.2 mm -98.01 -26.29 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.778 1.631 . . . . 0.0 112.195 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -88.69 -24.69 22.66 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.35 1.06 . . . . 0.0 113.139 -173.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 15.4 mm -57.92 -54.94 50.21 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 125.003 1.321 . . . . 0.0 111.989 167.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.98 -34.72 13.31 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 CA-C-N 120.723 1.294 . . . . 0.0 112.483 175.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.19 -40.79 86.59 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 120.211 1.369 . . . . 0.0 112.752 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 5.2 m -72.21 -35.17 68.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.314 0.961 . . . . 0.0 113.393 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.75 -39.26 80.41 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.228 0.611 . . . . 0.0 111.761 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -64.74 -38.77 92.13 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 123.812 0.845 . . . . 0.0 111.305 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -63.86 -40.21 96.01 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.747 0.703 . . . . 0.0 111.985 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.83 -37.9 79.5 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -67.33 -35.59 79.71 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.865 1.666 . . . . 0.0 112.425 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 62.7 mt -63.95 -42.28 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 123.329 0.652 . . . . 0.0 110.794 174.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 65.0 t -65.93 -42.64 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 122.067 -0.396 . . . . 0.0 111.111 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.57 -42.45 96.68 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.08 0.552 . . . . 0.0 111.512 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -65.38 -38.86 91.29 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.502 0.721 . . . . 0.0 111.792 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.62 -41.52 88.24 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.9 -42.94 89.57 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.549 0.739 . . . . 0.0 110.888 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.81 -37.02 77.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.479 0.712 . . . . 0.0 110.918 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -68.61 -33.81 74.67 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 33.5 ttt85 -69.0 -40.02 78.98 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.361 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 159.59 0.34 0.08 OUTLIER Glycine 0 CA--C 1.525 0.674 0 N-CA-C 117.514 1.766 . . . . 0.0 117.514 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.1 t -69.57 134.4 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 120.341 2.071 . . . . 0.0 109.455 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.72 138.2 58.45 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.923 -1.111 . . . . 0.0 110.628 169.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.57 -29.73 58.08 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.022 0.82 . . . . 0.0 113.452 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -63.51 -26.51 68.75 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.928 1.291 . . . . 0.0 113.892 173.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 24.3 m170 -98.48 4.25 48.32 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.987 1.715 . . . . 0.0 113.941 -174.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 16.2 mm -119.44 144.64 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.917 1.687 . . . . 0.0 109.255 174.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -136.18 161.13 36.59 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.222 1.809 . . . . 0.0 110.127 168.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 47.4 p -134.32 146.79 50.3 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.139 0.976 . . . . 0.0 111.386 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.0 t -138.85 120.47 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.23 1.012 . . . . 0.0 110.475 -173.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -83.95 99.28 2.21 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.561 1.076 . . . . 0.0 111.174 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 43.4 mt -97.47 31.95 2.39 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.862 2.065 . . . . 0.0 109.758 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 3.31 -72.07 0.0 OUTLIER Glycine 0 C--N 1.352 1.454 0 C-N-CA 128.006 2.717 . . . . 0.0 119.565 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 1.3 t -149.6 25.16 0.86 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.061 1.431 . . . . 0.0 113.152 173.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 14.2 m -67.79 161.08 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 120.921 -1.112 . . . . 0.0 112.149 174.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 39.98 53.94 5.74 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 125.959 1.704 . . . . 0.0 114.416 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.09 138.88 48.96 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.676 2.251 . . . . 0.0 111.597 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 26.0 pt -134.81 4.11 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.581 1.552 . . . . 0.0 113.438 -173.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.88 165.47 32.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.834 1.654 . . . . 0.0 110.689 170.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 18.3 m -116.73 159.47 22.22 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.868 1.667 . . . . 0.0 112.194 -172.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 49.2 p30 -79.42 5.25 13.17 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -67.54 -14.05 62.6 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.305 1.442 . . . . 0.0 114.587 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 42.4 p -138.22 147.8 57.22 Favored Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 126.485 1.914 . . . . 0.0 109.873 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -63.66 -31.3 69.95 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.142 2.561 . . . . 0.0 112.53 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -71.91 -36.4 69.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.876 0.87 . . . . 0.0 112.806 171.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.26 -37.57 94.12 Favored Glycine 0 N--CA 1.469 0.853 0 C-N-CA 124.006 0.812 . . . . 0.0 113.526 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -55.59 -49.97 71.36 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.819 1.248 . . . . 0.0 110.332 169.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.15 84.89 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -66.97 -18.85 65.58 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 174.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . 0.409 0.3 OUTLIER -110.6 17.82 20.32 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 167.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -112.85 10.74 19.12 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 127.264 2.226 . . . . 0.0 113.13 166.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -60.92 160.72 9.27 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -170.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 41.0 t -129.78 145.07 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 127.164 2.186 . . . . 0.0 108.897 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -134.32 155.98 49.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.259 1.424 . . . . 0.0 111.364 -174.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 39.0 mt -136.3 135.77 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.694 1.197 . . . . 0.0 108.903 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 47.7 t -140.66 132.94 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.582 1.553 . . . . 0.0 110.574 -171.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 14.6 p -90.57 125.87 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.002 0.921 . . . . 0.0 111.16 167.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 . . . . . 0 C--O 1.253 1.261 0 C-N-CA 125.792 1.637 . . . . 0.0 113.246 -177.859 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 119.277 -0.392 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.68 160.23 50.49 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.53 2.82 . . . . 0.0 112.346 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.41 137.0 41.76 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.092 2.528 . . . . 0.0 111.524 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 164.19 61.67 0.02 OUTLIER Glycine 0 CA--C 1.538 1.528 0 CA-C-O 118.451 -1.194 . . . . 0.0 113.789 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -64.42 153.6 76.11 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 123.086 2.524 . . . . 0.0 112.528 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.63 157.1 56.58 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.485 2.79 . . . . 0.0 113.049 -175.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -80.82 36.7 0.4 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.135 1.774 . . . . 0.0 112.937 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 51.8 p -59.97 148.17 36.23 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.309 1.444 . . . . 0.0 113.516 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 170.94 62.29 0.04 OUTLIER Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.757 1.17 . . . . 0.0 113.405 -177.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -69.82 -18.58 36.63 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 124.113 3.209 . . . . 0.0 113.853 -171.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 44.7 t -120.85 -4.55 9.66 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.282 1.833 . . . . 0.0 112.303 176.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -64.58 -16.37 62.56 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -140.61 46.39 1.79 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.377 2.271 . . . . 0.0 110.955 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.0 mt -55.33 -28.56 54.56 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 118.402 -0.809 . . . . 0.0 112.548 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -54.78 -43.23 72.62 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.526 1.057 . . . . 0.0 111.528 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 19.2 t -69.57 -41.73 75.44 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.431 0.692 . . . . 0.0 111.99 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.68 -38.52 91.28 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 2.7 mm -68.69 -43.24 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -63.0 -38.38 90.94 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.605 -0.684 . . . . 0.0 112.245 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -71.12 -33.35 70.03 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.051 0.94 . . . . 0.0 113.224 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.08 -42.02 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 123.3 0.64 . . . . 0.0 111.409 172.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.8 m -86.34 -22.38 26.72 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 61.23 29.5 71.44 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.84 1.209 . . . . 0.0 113.866 -172.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 97.27 -175.33 30.61 Favored Glycine 0 CA--C 1.541 1.708 0 C-N-CA 125.71 1.624 . . . . 0.0 112.999 -171.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.18 150.34 33.1 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 123.685 2.923 . . . . 0.0 112.909 -174.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 52.5 mt -97.59 141.89 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.07 1.748 . . . . 0.0 110.952 -171.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -109.19 170.12 8.25 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.316 1.846 . . . . 0.0 115.866 -171.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -144.19 110.33 5.43 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.832 1.253 . . . . 0.0 110.372 -171.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -59.02 -166.24 0.14 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.989 1.756 . . . . 0.0 115.545 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -41.98 -39.74 1.98 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.528 1.931 . . . . 0.0 114.785 -175.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -62.1 -28.89 69.94 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.316 1.446 . . . . 0.0 114.363 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 96.0 -10.93 68.0 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.958 1.742 . . . . 0.0 115.687 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -152.57 12.23 0.53 Allowed 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -171.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 69.0 m -78.15 75.34 4.68 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 120.434 -1.416 . . . . 0.0 114.238 -171.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 14.5 tp -69.27 128.77 37.76 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.731 1.612 . . . . 0.0 110.659 171.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -98.81 164.04 17.69 Favored Pre-proline 0 N--CA 1.484 1.258 0 C-N-CA 124.441 1.096 . . . . 0.0 110.91 -171.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -63.81 -29.86 68.33 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.239 1.959 . . . . 0.0 112.985 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.16 90.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.777 0.831 . . . . 0.0 113.134 169.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -66.68 -43.34 84.71 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.457 -0.777 . . . . 0.0 111.468 172.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -61.29 -32.39 72.22 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.436 -0.79 . . . . 0.0 112.484 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -67.34 -41.07 85.82 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.669 -1.27 . . . . 0.0 112.278 172.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 67.7 mt -57.42 -46.03 85.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 O-C-N 121.345 -0.847 . . . . 0.0 110.441 169.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 39.6 mt -64.08 -35.09 79.6 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.436 -0.79 . . . . 0.0 112.906 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -61.16 -37.64 83.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.141 0.976 . . . . 0.0 112.614 173.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 86.5 mtt-85 -70.58 -37.01 73.88 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.687 1.195 . . . . 0.0 112.628 173.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.9 -41.95 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 118.91 0.777 . . . . 0.0 110.771 173.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.72 -38.14 90.0 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.712 0.805 . . . . 0.0 112.274 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.33 -38.11 89.15 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.446 0.698 . . . . 0.0 112.376 172.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -65.71 -34.84 79.14 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.625 0.77 . . . . 0.0 112.696 176.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.524 HD21 HG11 ' A' ' 255' ' ' VAL . 1.8 mm? -66.06 -45.64 80.62 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.98 1.312 . . . . 0.0 111.859 169.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.51 -30.19 70.46 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.551 1.54 . . . . 0.0 112.808 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.17 -9.66 58.8 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.078 1.751 . . . . 0.0 114.563 174.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 16.1 t -155.47 68.36 5.18 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 125.358 1.463 . . . . 0.0 108.885 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -62.62 -6.05 8.22 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.429 2.752 . . . . 0.0 112.679 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -73.17 -19.96 61.0 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.446 1.498 . . . . 0.0 113.324 172.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -115.54 93.91 4.48 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.21 1.404 . . . . 0.0 111.794 -171.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -50.65 147.5 4.66 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.118 1.367 . . . . 0.0 111.684 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.524 HG11 HD21 ' A' ' 247' ' ' LEU . 22.9 m -127.15 160.15 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.882 0.873 . . . . 0.0 111.487 167.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 22.9 m -127.26 139.38 52.95 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.909 1.683 . . . . 0.0 108.362 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 71.4 mt -119.13 123.83 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 124.923 1.289 . . . . 0.0 107.858 -171.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -113.76 148.6 36.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.302 0.641 . . . . 0.0 110.399 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -137.46 156.69 23.66 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 122.106 -0.371 . . . . 0.0 112.696 167.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -127.6 167.34 16.5 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.502 2.321 . . . . 0.0 109.885 -169.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.1 m -151.98 159.73 43.68 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.162 1.785 . . . . 0.0 110.627 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -63.75 163.02 12.32 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.956 -1.09 . . . . 0.0 111.43 166.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -104.98 20.34 19.0 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.564 0.746 . . . . 0.0 112.817 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 16.3 m -69.92 -20.1 63.36 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.809 1.244 . . . . 0.0 112.628 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.6 -150.01 18.1 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 126.156 1.836 . . . . 0.0 113.249 173.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 71.4 m -135.3 162.72 31.79 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.073 1.749 . . . . 0.0 110.09 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -52.62 -41.16 63.45 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.984 0.914 . . . . 0.0 112.968 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -67.9 -4.39 33.93 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.672 1.13 . . . . 0.0 115.238 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 6.2 mt -116.55 -33.0 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.932 2.093 . . . . 0.0 111.172 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -81.53 -31.22 32.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.555 1.142 . . . . 0.0 112.919 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 23.4 mm -60.52 -54.17 57.47 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.322 1.449 . . . . 0.0 111.761 170.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.54 -32.6 24.43 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 CA-C-N 121.065 1.416 . . . . 0.0 113.333 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 26.3 mt -67.88 -43.8 78.5 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.347 1.43 . . . . 0.0 113.124 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 28.5 p -66.46 -37.54 85.36 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.14 -38.09 78.62 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.556 0.742 . . . . 0.0 111.967 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -65.19 -38.76 91.51 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 125.129 1.372 . . . . 0.0 111.036 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -45.62 90.42 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.52 0.6 . . . . 0.0 111.877 173.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.38 -36.17 76.53 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -68.34 -36.51 79.36 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 125.758 1.623 . . . . 0.0 111.97 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 58.9 mt -63.55 -43.07 98.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 118.788 0.722 . . . . 0.0 110.625 174.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 57.4 t -66.89 -42.62 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.753 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.07 -41.7 99.5 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.026 0.53 . . . . 0.0 111.743 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.85 -38.84 87.14 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.121 0.568 . . . . 0.0 111.501 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -68.27 -40.68 81.8 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.3 mp -64.88 -43.68 92.15 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.302 0.641 . . . . 0.0 111.005 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 55.1 t -67.73 -37.22 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 O-C-N 121.758 -0.589 . . . . 0.0 111.088 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.95 -34.0 72.85 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -42.99 86.19 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.817 0.847 . . . . 0.0 111.591 171.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 161.08 -0.95 0.07 OUTLIER Glycine 0 CA--C 1.528 0.871 0 N-CA-C 117.413 1.725 . . . . 0.0 117.413 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.4 t -72.48 136.15 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 120.514 2.157 . . . . 0.0 109.814 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.59 140.75 56.93 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 120.946 -1.096 . . . . 0.0 110.641 168.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.21 -27.31 52.15 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.399 1.0 . . . . 0.0 113.694 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -61.68 -30.14 70.54 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.822 1.249 . . . . 0.0 113.538 173.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -92.77 -0.71 57.22 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.606 1.562 . . . . 0.0 113.968 -174.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 25.0 mm -121.04 141.12 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.825 1.65 . . . . 0.0 109.501 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -135.09 161.37 35.52 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.733 1.613 . . . . 0.0 110.253 167.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 45.6 p -137.02 146.39 45.23 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.942 0.897 . . . . 0.0 112.372 -175.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 35.3 t -141.35 133.63 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.571 1.148 . . . . 0.0 111.118 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -89.5 100.3 2.65 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.508 1.051 . . . . 0.0 111.801 172.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 38.2 mt -95.58 32.13 1.87 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.707 2.003 . . . . 0.0 110.618 174.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 3.18 -70.34 0.0 OUTLIER Glycine 0 C--N 1.35 1.329 0 N-CA-C 120.366 2.906 . . . . 0.0 120.366 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 94.3 p -144.53 13.76 1.56 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.769 1.284 . . . . 0.0 114.281 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 17.1 m -70.27 157.97 6.36 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 O-C-N 121.025 -1.047 . . . . 0.0 111.768 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 39.46 52.09 4.03 Favored Pre-proline 0 CA--C 1.557 1.23 0 C-N-CA 125.259 1.424 . . . . 0.0 114.119 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.18 112.73 1.78 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.38 2.72 . . . . 0.0 111.767 -171.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.538 ' H ' HD12 ' A' ' 306' ' ' ILE . 1.4 mp -71.02 -20.67 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 124.46 1.104 . . . . 0.0 112.476 -171.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -150.5 160.26 43.9 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.865 1.666 . . . . 0.0 112.376 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 49.6 m -71.19 151.25 44.55 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.177 1.791 . . . . 0.0 113.767 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -82.85 1.69 38.02 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.86 -14.4 63.01 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 40.6 p -141.42 147.58 47.06 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 126.326 1.85 . . . . 0.0 110.296 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -63.25 -32.58 73.22 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.166 2.577 . . . . 0.0 112.53 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -68.05 -36.45 79.89 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 173.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -70.2 -38.04 72.12 Favored Glycine 0 N--CA 1.467 0.722 0 C-N-CA 123.415 0.531 . . . . 0.0 113.361 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -57.63 -49.1 77.54 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 123.752 0.821 . . . . 0.0 109.975 171.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.17 84.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.57 0.748 . . . . 0.0 112.698 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -72.66 -12.74 61.15 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.225 1.41 . . . . 0.0 113.696 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.32 -12.5 15.04 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 170.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -81.96 2.48 30.56 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 126.571 1.948 . . . . 0.0 114.502 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 35.0 mtm180 -57.89 160.87 4.29 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -169.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.88 144.12 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.278 1.831 . . . . 0.0 109.954 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -139.7 159.41 42.23 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.137 1.375 . . . . 0.0 113.194 -173.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 4.5 mp -131.95 132.86 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.768 1.627 . . . . 0.0 108.71 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 21.4 t -140.58 138.52 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.635 1.574 . . . . 0.0 109.552 -171.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 22.4 t -69.7 135.81 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.029 -1.044 . . . . 0.0 110.429 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.5 t30 . . . . . 0 C--O 1.252 1.201 0 C-N-CA 125.143 1.377 . . . . 0.0 113.319 -177.901 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 119.366 -0.35 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -70.4 160.79 48.32 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.545 2.83 . . . . 0.0 112.514 178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.42 153.33 74.23 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.237 2.625 . . . . 0.0 111.97 174.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 168.99 -173.88 43.5 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 124.178 0.894 . . . . 0.0 113.821 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.59 163.78 33.64 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 123.883 3.055 . . . . 0.0 112.527 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.76 167.38 19.52 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.568 2.846 . . . . 0.0 113.103 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -126.81 25.57 6.33 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.584 1.554 . . . . 0.0 113.212 -171.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 18.4 t -55.61 141.33 37.98 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.759 1.224 . . . . 0.0 112.026 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 54.33 59.02 10.69 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 125.223 1.392 . . . . 0.0 114.221 -172.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -69.7 -15.34 37.27 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.323 3.349 . . . . 0.0 114.655 -171.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 22.0 t -128.91 -2.57 5.23 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 126.817 2.047 . . . . 0.0 111.776 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.64 -18.8 65.56 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -171.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -137.77 30.44 2.55 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.934 2.093 . . . . 0.0 111.52 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 6.9 tp -63.49 -16.58 61.1 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 121.521 -0.737 . . . . 0.0 112.949 -173.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -53.58 -45.6 70.02 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.954 0.797 . . . . 0.0 111.465 167.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 21.5 t -69.27 -42.77 75.09 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.292 0.637 . . . . 0.0 111.306 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.93 85.97 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 53.6 mt -73.53 -36.04 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.522 0.729 . . . . 0.0 109.659 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -65.08 -42.49 94.08 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.061 -1.024 . . . . 0.0 112.006 172.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.06 -37.56 87.97 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.947 0.899 . . . . 0.0 112.821 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.69 -28.36 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 118.354 0.525 . . . . 0.0 112.227 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.7 m -75.16 -26.5 59.16 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.094 0.958 . . . . 0.0 112.136 170.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.37 25.83 75.08 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.111 1.339 . . . . 0.0 113.65 -171.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 96.24 -176.71 33.13 Favored Glycine 0 CA--C 1.542 1.732 0 C-N-CA 125.532 1.539 . . . . 0.0 113.394 -172.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.24 147.83 33.58 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.834 3.023 . . . . 0.0 111.416 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -102.42 140.99 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -169.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -107.44 169.03 8.83 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.693 2.397 . . . . 0.0 113.763 -172.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -142.55 116.1 9.12 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.475 1.11 . . . . 0.0 110.608 -171.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -58.42 -170.22 0.24 Allowed Glycine 0 CA--C 1.535 1.302 0 C-N-CA 126.117 1.817 . . . . 0.0 116.39 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -46.43 -40.91 13.01 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.46 1.504 . . . . 0.0 115.017 -174.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.11 -33.27 71.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.396 1.478 . . . . 0.0 113.808 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 105.49 -5.06 40.55 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 117.02 1.568 . . . . 0.0 117.02 167.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -166.44 28.12 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 119.471 1.635 . . . . 0.0 113.038 -171.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 16.5 t -98.11 93.58 6.35 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.634 -1.291 . . . . 0.0 111.511 -171.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.0 mp -71.31 113.92 8.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.886 0.874 . . . . 0.0 109.82 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 11.8 pt -70.77 164.09 58.7 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 124.366 1.066 . . . . 0.0 110.23 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.25 -31.28 74.21 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 CA-C-N 121.942 1.729 . . . . 0.0 112.371 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -66.17 -32.35 73.74 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 170.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -59.03 -53.05 62.8 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.748 1.158 . . . . 0.0 110.697 171.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -58.59 -33.77 70.35 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.716 0.807 . . . . 0.0 112.611 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -66.24 -44.75 82.84 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.419 1.009 . . . . 0.0 112.505 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 34.2 mm -58.44 -43.61 87.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 121.589 -0.694 . . . . 0.0 110.747 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.13 -32.26 72.83 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.709 -0.619 . . . . 0.0 112.62 174.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -63.85 -41.38 97.82 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.578 1.151 . . . . 0.0 112.411 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -67.52 -38.69 84.61 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.423 1.089 . . . . 0.0 112.335 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 79.7 t -62.96 -45.03 99.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 123.507 0.723 . . . . 0.0 110.538 174.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.82 -36.84 84.52 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.155 0.582 . . . . 0.0 112.146 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.17 -39.29 92.71 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 172.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -65.62 -35.13 79.9 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.753 0.821 . . . . 0.0 112.73 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.462 ' CD2' HG11 ' A' ' 255' ' ' VAL . 97.0 mt -69.67 -41.6 75.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.44 1.096 . . . . 0.0 112.039 172.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.03 -23.93 67.68 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.392 1.877 . . . . 0.0 113.089 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.91 -8.75 57.94 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.536 1.534 . . . . 0.0 114.588 171.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 36.2 t -153.61 67.29 6.01 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.222 1.409 . . . . 0.0 108.85 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -64.68 -7.22 14.05 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.119 2.546 . . . . 0.0 112.013 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -70.14 -19.42 63.22 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.51 1.524 . . . . 0.0 113.215 171.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -118.99 89.88 3.22 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.513 1.525 . . . . 0.0 110.52 -172.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -51.53 150.97 3.38 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.04 1.336 . . . . 0.0 111.453 172.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.462 HG11 ' CD2' ' A' ' 247' ' ' LEU . 17.3 m -134.38 161.34 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.449 0.7 . . . . 0.0 112.669 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 20.8 m -128.03 137.37 52.17 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.153 1.381 . . . . 0.0 109.415 -178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.0 118.19 57.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.663 1.585 . . . . 0.0 107.7 -173.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.556 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 0.2 OUTLIER -98.98 151.19 21.17 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.022 1.329 . . . . 0.0 109.406 -178.023 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -152.01 155.49 26.16 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 121.491 -0.756 . . . . 0.0 113.912 168.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -132.53 168.4 18.29 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 129.033 2.933 . . . . 0.0 109.352 -170.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 31.2 m -145.27 151.56 38.56 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 127.102 2.161 . . . . 0.0 109.187 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -63.32 160.67 15.44 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 123.172 1.463 . . . . 0.0 113.574 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -83.04 7.87 14.49 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 113.993 -1.458 . . . . 0.0 114.927 -170.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.6 m -75.11 -15.26 60.61 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 120.993 -1.067 . . . . 0.0 113.508 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -95.24 -157.83 32.5 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.286 1.422 . . . . 0.0 114.595 -176.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 7.6 t -135.18 162.37 32.7 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.69 1.596 . . . . 0.0 110.371 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -52.84 -41.44 64.24 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.124 0.97 . . . . 0.0 112.796 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -67.83 -6.49 44.46 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 124.428 1.014 . . . . 0.0 115.238 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 4.2 mt -115.75 -33.63 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 126.644 1.978 . . . . 0.0 111.294 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -87.41 -24.35 24.23 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 18.3 mm -58.51 -54.06 59.87 Favored Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 124.531 1.132 . . . . 0.0 111.804 167.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.49 -33.23 11.12 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 120.579 1.243 . . . . 0.0 112.906 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 19.1 mt -65.11 -46.78 79.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 120.282 1.401 . . . . 0.0 112.092 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 24.2 m -70.87 -29.86 66.07 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -74.66 -34.96 62.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.788 0.835 . . . . 0.0 112.075 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -65.57 -39.89 92.15 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.027 0.931 . . . . 0.0 111.677 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.22 -43.17 98.87 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.271 0.942 . . . . 0.0 110.755 176.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.5 -37.98 86.25 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.27 -38.91 88.93 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.525 1.53 . . . . 0.0 112.036 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 74.1 mt -66.13 -39.52 84.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 122.688 0.395 . . . . 0.0 110.879 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.59 -44.75 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 O-C-N 121.972 -0.455 . . . . 0.0 110.906 173.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.92 -42.23 97.7 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.4 0.68 . . . . 0.0 111.662 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -66.72 -38.29 86.41 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.013 0.525 . . . . 0.0 111.897 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -68.81 -40.8 79.34 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.15 -43.22 95.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.328 0.651 . . . . 0.0 110.975 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 55.7 t -67.34 -37.46 79.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 O-C-N 121.753 -0.592 . . . . 0.0 111.257 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.43 -34.42 74.42 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -42.26 87.19 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.811 0.844 . . . . 0.0 111.796 172.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 161.64 -1.61 0.07 OUTLIER Glycine 0 CA--C 1.527 0.831 0 N-CA-C 117.473 1.749 . . . . 0.0 117.473 176.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 2.7 t -73.96 137.76 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 120.523 2.162 . . . . 0.0 109.493 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.78 137.91 58.07 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.655 -1.278 . . . . 0.0 110.461 168.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.8 -29.67 58.82 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.055 0.836 . . . . 0.0 113.456 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.44 -26.51 68.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.131 1.372 . . . . 0.0 113.782 173.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -97.25 2.23 50.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.801 1.641 . . . . 0.0 113.955 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 20.2 mm -119.64 141.78 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.699 1.6 . . . . 0.0 109.447 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -136.84 165.27 26.34 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.041 1.737 . . . . 0.0 110.535 169.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 44.6 p -136.02 145.68 46.33 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.277 1.031 . . . . 0.0 112.258 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 70.3 t -138.98 133.95 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.052 1.341 . . . . 0.0 110.919 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -103.24 105.32 2.67 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 126.131 1.825 . . . . 0.0 112.21 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.556 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 1.1 mp -103.94 32.8 3.73 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 129.138 2.975 . . . . 0.0 109.752 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 7.45 -73.92 0.0 OUTLIER Glycine 0 C--N 1.349 1.257 0 N-CA-C 119.467 2.547 . . . . 0.0 119.467 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 57.9 p -148.14 22.53 1.08 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.483 1.641 . . . . 0.0 114.435 172.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.7 m -70.13 159.55 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.092 1.357 . . . . 0.0 111.917 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 23.2 m120 39.76 52.74 4.75 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 125.062 1.345 . . . . 0.0 112.932 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -59.64 132.18 44.23 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.012 2.475 . . . . 0.0 113.674 -170.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 4.8 mp -77.13 -25.89 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 125.042 1.337 . . . . 0.0 111.586 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -157.53 153.66 27.33 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.664 1.986 . . . . 0.0 111.822 -172.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 66.7 m -66.42 150.42 48.93 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.179 1.392 . . . . 0.0 112.48 170.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -84.49 11.13 9.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.786 1.235 . . . . 0.0 113.854 174.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -67.18 -18.36 65.23 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -176.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 66.7 p -140.66 151.4 63.22 Favored Pre-proline 0 N--CA 1.474 0.744 0 C-N-CA 125.901 1.681 . . . . 0.0 110.141 176.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -61.94 -28.31 80.77 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.199 2.599 . . . . 0.0 112.601 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.0 -42.14 94.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.856 0.862 . . . . 0.0 112.554 172.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.14 -38.17 87.8 Favored Glycine 0 N--CA 1.465 0.619 0 O-C-N 121.791 -0.568 . . . . 0.0 112.787 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -57.99 -47.42 83.03 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.244 0.618 . . . . 0.0 110.526 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.85 -39.91 93.5 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.184 0.594 . . . . 0.0 112.537 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -68.61 -16.51 63.87 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.486 1.114 . . . . 0.0 113.816 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -115.86 -1.36 12.61 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 125.514 1.526 . . . . 0.0 114.517 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -82.68 3.95 26.94 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 126.136 1.774 . . . . 0.0 113.023 166.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.88 158.81 0.64 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 130.118 3.367 . . . . 0.0 117.144 -169.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 2.3 m -122.46 148.61 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 126.326 1.85 . . . . 0.0 111.656 166.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -130.08 166.26 20.53 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.84 2.056 . . . . 0.0 110.891 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 13.1 tt -140.74 144.0 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.524 1.13 . . . . 0.0 111.919 172.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 23.3 t -144.68 136.48 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.343 1.457 . . . . 0.0 110.187 -174.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.09 136.23 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.11 0.964 . . . . 0.0 110.754 174.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.576 1.55 . . . . 0.0 113.731 -178.556 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 119.287 -0.387 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.22 159.9 51.45 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 C-N-CA 123.503 2.802 . . . . 0.0 112.534 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.2 152.29 72.22 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.228 2.619 . . . . 0.0 112.158 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 166.28 -175.25 41.78 Favored Glycine 0 CA--C 1.54 1.616 0 C-N-CA 124.442 1.02 . . . . 0.0 113.712 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.46 162.19 40.03 Favored 'Trans proline' 0 CA--C 1.548 1.178 0 C-N-CA 123.735 2.957 . . . . 0.0 112.324 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.3 158.67 55.86 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.387 2.725 . . . . 0.0 112.772 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -87.3 20.64 2.71 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.677 1.591 . . . . 0.0 114.245 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.6 p -61.1 132.16 52.88 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.916 1.286 . . . . 0.0 112.594 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 159.91 61.52 0.01 OUTLIER Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.348 0.975 . . . . 0.0 113.87 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -69.52 -19.98 36.56 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.995 3.13 . . . . 0.0 114.091 -171.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 9.9 t -122.57 -2.75 8.87 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 126.519 1.928 . . . . 0.0 111.762 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.54 -21.25 60.43 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 -171.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -137.48 38.56 2.46 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.516 2.326 . . . . 0.0 109.945 174.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 23.8 tp -61.13 -19.83 61.97 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.46 1.104 . . . . 0.0 113.796 -171.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -57.2 -46.31 82.99 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.74 -0.6 . . . . 0.0 111.843 169.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 22.8 t -68.66 -43.86 75.3 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 122.977 0.511 . . . . 0.0 111.284 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -71.57 -25.45 62.21 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 67.3 mt -83.07 -35.55 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 119.61 1.095 . . . . 0.0 110.627 171.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -63.44 -41.97 98.68 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.819 -1.175 . . . . 0.0 111.83 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.4 -36.34 83.67 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.212 1.005 . . . . 0.0 113.187 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.83 -27.72 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.9 m -80.38 -27.79 38.11 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.269 1.027 . . . . 0.0 112.437 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 69.95 25.69 75.27 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.02 1.295 . . . . 0.0 113.854 -172.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 88.88 -166.97 34.34 Favored Glycine 0 CA--C 1.54 1.656 0 C-N-CA 124.87 1.224 . . . . 0.0 113.57 -173.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.33 163.06 40.38 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.721 2.947 . . . . 0.0 112.312 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 19.3 mm -120.74 144.58 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.171 1.389 . . . . 0.0 111.069 -171.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -111.69 167.47 10.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.954 2.102 . . . . 0.0 113.115 -172.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -140.51 101.83 4.19 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.908 0.883 . . . . 0.0 111.803 -170.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -87.52 -178.26 48.23 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.541 1.067 . . . . 0.0 113.981 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 51.6 t30 36.17 -81.34 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 130.375 3.47 . . . . 0.0 115.796 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -71.13 -22.85 62.02 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.295 1.438 . . . . 0.0 114.084 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 89.2 10.23 66.36 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.918 1.247 . . . . 0.0 115.019 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -154.71 25.31 0.45 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 126.968 2.107 . . . . 0.0 112.105 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 58.2 m -81.67 81.84 7.6 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.878 1.271 . . . . 0.0 112.888 -171.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.76 101.33 0.47 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.689 0.756 . . . . 0.0 110.817 169.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.592 HG13 ' H ' ' A' ' 236' ' ' ASP . 9.8 pt -61.79 154.86 64.94 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.768 1.627 . . . . 0.0 112.491 173.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -62.56 -31.3 80.01 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.344 2.029 . . . . 0.0 112.184 174.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.5 90.65 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.791 0.836 . . . . 0.0 112.858 170.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.592 ' H ' HG13 ' A' ' 233' ' ' ILE . 21.9 t70 -62.61 -49.56 74.74 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.436 -0.79 . . . . 0.0 111.321 172.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -59.88 -30.24 68.86 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.166 -0.959 . . . . 0.0 112.912 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -70.72 -44.54 66.68 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 120.785 -1.197 . . . . 0.0 112.805 172.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 21.4 mm -57.89 -45.57 87.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.231 -0.918 . . . . 0.0 110.938 172.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.4 -32.07 73.5 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.954 0.902 . . . . 0.0 112.539 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -61.86 -42.55 99.19 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.088 0.955 . . . . 0.0 111.882 173.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -67.79 -35.65 79.03 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 87.9 t -64.45 -44.39 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.497 0.59 . . . . 0.0 110.916 173.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.81 89.86 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.422 0.689 . . . . 0.0 111.989 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.78 -39.13 93.51 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.122 0.569 . . . . 0.0 112.065 175.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -71.56 -30.68 66.15 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 79.3 mt -71.32 -40.76 70.56 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.976 0.911 . . . . 0.0 112.266 170.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -60.06 -27.05 66.64 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.121 1.368 . . . . 0.0 112.669 173.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -80.95 -6.96 59.37 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.11 1.764 . . . . 0.0 115.036 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 22.2 t -153.47 67.27 6.08 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.235 1.414 . . . . 0.0 108.862 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -63.84 -7.1 12.26 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.216 2.611 . . . . 0.0 112.39 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -71.28 -19.27 62.36 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.591 1.556 . . . . 0.0 113.24 171.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -117.88 89.04 3.04 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.543 1.537 . . . . 0.0 110.578 -173.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 68.1 mtt85 -53.26 155.45 2.72 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.544 1.138 . . . . 0.0 111.676 171.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 20.9 m -128.29 165.49 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.36 1.064 . . . . 0.0 111.844 171.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 30.2 m -127.98 137.14 52.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.403 1.481 . . . . 0.0 108.798 173.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.7 mt -113.69 117.32 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.421 ' HB3' HD12 ' A' ' 300' ' ' LEU . 21.5 m-20 -102.49 156.82 17.35 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.323 0.649 . . . . 0.0 110.426 175.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -148.52 154.95 26.16 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 122.178 -0.326 . . . . 0.0 112.836 167.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -128.16 163.41 24.73 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 127.539 2.336 . . . . 0.0 109.918 -169.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 73.1 p -148.63 173.67 12.94 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.917 2.487 . . . . 0.0 110.392 170.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -72.15 158.36 36.06 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.458 -1.401 . . . . 0.0 113.001 -173.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -84.97 -9.64 57.86 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.695 1.198 . . . . 0.0 113.168 -172.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -22.66 67.02 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.382 2.273 . . . . 0.0 115.527 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -74.98 -143.24 0.93 Allowed Glycine 0 CA--C 1.54 1.615 0 C-N-CA 126.448 1.975 . . . . 0.0 115.358 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 26.3 t -149.59 137.15 20.1 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.868 1.667 . . . . 0.0 109.723 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -53.17 -34.02 55.1 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -65.59 -22.74 70.01 Favored Glycine 0 CA--C 1.537 1.428 0 O-C-N 121.435 -0.791 . . . . 0.0 114.21 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 16.9 mm -100.59 -32.33 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 126.496 1.918 . . . . 0.0 112.188 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -82.71 -27.36 31.23 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.8 mm -57.65 -55.35 45.7 Favored Pre-proline 0 N--CA 1.469 0.515 0 C-N-CA 124.722 1.209 . . . . 0.0 112.206 169.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.38 -30.26 15.71 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 CA-C-N 120.468 1.203 . . . . 0.0 112.713 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.6 mp -64.42 -51.12 64.77 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 120.228 1.377 . . . . 0.0 111.833 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.3 m -69.34 -32.31 71.32 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.071 -0.651 . . . . 0.0 112.544 -176.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.64 -38.66 80.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 174.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -67.69 -38.23 83.41 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.424 0.689 . . . . 0.0 111.594 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 66.5 mmt-85 -61.1 -44.14 97.81 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.959 0.8 . . . . 0.0 111.275 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.77 -37.57 79.43 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -66.58 -37.87 85.83 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 125.376 1.47 . . . . 0.0 111.733 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 19.3 mm -65.98 -39.06 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.62 0.645 . . . . 0.0 111.268 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 38.3 t -64.92 -46.09 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.322 0.51 . . . . 0.0 110.592 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -61.11 -41.52 96.84 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.304 0.642 . . . . 0.0 111.616 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.05 -36.97 84.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.554 1.142 . . . . 0.0 111.47 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -63.63 -45.01 92.18 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.6 mp -69.07 -37.06 78.28 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.977 0.418 . . . . 0.0 111.672 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.84 -37.01 76.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.942 0.897 . . . . 0.0 111.013 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.97 -35.0 79.0 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 20.9 ttt85 -69.05 -35.52 76.66 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 170.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 151.34 4.54 0.18 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 116.935 1.534 . . . . 0.0 116.935 167.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.8 t -69.49 136.01 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 120.046 1.923 . . . . 0.0 108.964 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.32 138.88 58.68 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.979 -1.076 . . . . 0.0 110.528 172.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.75 -29.85 58.89 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.013 0.816 . . . . 0.0 113.317 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.28 -28.68 69.89 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.857 1.263 . . . . 0.0 113.648 173.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -93.36 -2.2 55.04 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.471 1.508 . . . . 0.0 114.217 -174.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 9.0 mt -129.04 108.09 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.518 1.127 . . . . 0.0 110.155 175.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -88.69 161.92 16.57 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.028 0.931 . . . . 0.0 110.323 167.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 35.5 p -135.41 144.37 46.49 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.192 0.997 . . . . 0.0 111.452 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 30.2 t -138.0 129.81 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.56 0.744 . . . . 0.0 111.32 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -84.85 96.1 2.01 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.518 1.056 . . . . 0.0 111.112 170.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.421 HD12 ' HB3' ' A' ' 258' ' ' ASN . 47.6 mt -88.54 30.14 0.93 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.552 1.941 . . . . 0.0 109.97 171.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 6.86 -74.97 0.0 OUTLIER Glycine 0 C--N 1.354 1.554 0 C-N-CA 128.191 2.805 . . . . 0.0 119.769 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 95.1 p -149.6 23.79 0.89 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.583 1.192 . . . . 0.0 113.252 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 7.3 m -71.26 158.63 6.12 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 C-N-CA 124.509 1.124 . . . . 0.0 111.498 173.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 39.42 54.24 5.28 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 125.514 1.526 . . . . 0.0 114.288 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.09 139.08 59.42 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.689 2.259 . . . . 0.0 111.626 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 17.8 pt -134.59 6.81 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.925 1.29 . . . . 0.0 114.314 -171.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.451 ' HB3' ' HB2' ' A' ' 318' ' ' ASN . . . -146.54 140.08 25.89 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.485 1.114 . . . . 0.0 110.62 167.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 51.0 m -71.05 143.61 50.65 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.425 1.49 . . . . 0.0 113.126 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -74.23 1.69 10.81 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 171.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.07 -17.26 63.23 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.053 1.341 . . . . 0.0 114.617 -175.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 67.9 p -140.47 150.94 62.51 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 125.49 1.516 . . . . 0.0 110.581 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -62.12 -30.06 81.85 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.25 2.633 . . . . 0.0 112.576 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -64.53 -44.42 90.92 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.575 0.75 . . . . 0.0 112.344 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.73 -35.46 85.58 Favored Glycine 0 CA--C 1.524 0.613 0 O-C-N 121.84 -0.538 . . . . 0.0 112.839 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -59.52 -49.35 78.11 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.073 0.949 . . . . 0.0 111.173 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.03 85.76 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.0 0.52 . . . . 0.0 111.969 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -71.12 -23.37 62.08 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.329 1.452 . . . . 0.0 114.302 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 307' ' ' ALA . 7.2 t30 -99.82 -18.14 17.31 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 119.656 1.116 . . . . 0.0 112.866 172.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -71.96 13.63 0.28 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.317 1.447 . . . . 0.0 114.337 170.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -61.86 163.8 7.14 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.206 1.802 . . . . 0.0 115.662 -170.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 28.9 m -125.29 151.52 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.941 1.696 . . . . 0.0 110.158 167.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -145.48 147.5 32.24 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.36 1.064 . . . . 0.0 111.919 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.3 132.52 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.171 1.388 . . . . 0.0 109.404 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 21.8 t -140.88 133.97 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.211 1.405 . . . . 0.0 109.895 -172.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.18 141.27 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 121.409 -0.807 . . . . 0.0 110.342 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.285 1.434 . . . . 0.0 111.864 -171.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 119.235 -0.412 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.61 160.88 47.53 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.481 2.788 . . . . 0.0 112.221 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.76 142.6 64.12 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.053 2.502 . . . . 0.0 112.008 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 172.59 57.5 0.05 OUTLIER Glycine 0 CA--C 1.538 1.521 0 CA-C-O 118.588 -1.118 . . . . 0.0 113.817 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.54 159.92 48.39 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.293 2.662 . . . . 0.0 112.611 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.65 155.13 71.83 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.228 2.619 . . . . 0.0 112.19 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.56 27.68 1.35 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.347 1.459 . . . . 0.0 112.702 -172.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 23.2 m -49.83 132.51 22.35 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.859 1.664 . . . . 0.0 113.463 -175.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 55.67 57.96 16.3 Favored Glycine 0 CA--C 1.542 1.749 0 C-N-CA 125.121 1.344 . . . . 0.0 114.833 -174.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.51 -19.07 28.86 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.84 3.027 . . . . 0.0 113.854 -172.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 43.3 t -121.38 -7.43 9.25 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.948 2.099 . . . . 0.0 111.998 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -63.76 -16.04 60.15 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.354 1.462 . . . . 0.0 114.861 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -137.21 41.33 2.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.4 2.28 . . . . 0.0 111.167 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 9.0 mt -46.82 -38.52 10.35 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.67 0.788 . . . . 0.0 111.822 172.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -59.95 -38.53 82.72 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.995 0.518 . . . . 0.0 111.956 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.2 t -68.78 -48.08 64.56 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.465 0.706 . . . . 0.0 112.061 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.9 85.51 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 177.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 90.8 mt -75.05 -34.54 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.335 1.054 . . . . 0.0 110.091 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -65.87 -41.28 91.79 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.816 -1.177 . . . . 0.0 111.712 172.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.91 -36.03 83.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.725 0.81 . . . . 0.0 113.153 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.4 p -80.06 -27.34 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.2 m -88.39 -25.75 22.53 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.534 1.134 . . . . 0.0 113.03 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.77 24.68 75.48 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.348 1.452 . . . . 0.0 114.061 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 101.57 -162.34 17.73 Favored Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.346 1.451 . . . . 0.0 112.54 -171.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -73.15 168.2 25.35 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.716 2.944 . . . . 0.0 112.561 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 40.9 mm -112.79 114.46 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.46 1.504 . . . . 0.0 110.63 -173.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -81.66 173.23 12.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.806 2.042 . . . . 0.0 112.671 171.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -118.7 151.68 37.53 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.859 0.864 . . . . 0.0 110.735 -173.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -59.66 165.73 10.44 Favored Glycine 0 CA--C 1.543 1.843 0 O-C-N 120.875 -1.141 . . . . 0.0 110.892 165.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -48.91 -22.33 0.82 Allowed 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 117.036 2.235 . . . . 0.0 117.036 -171.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -59.28 -22.46 61.2 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.582 1.553 . . . . 0.0 114.666 170.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.71 9.39 74.94 Favored Glycine 0 CA--C 1.543 1.827 0 C-N-CA 124.977 1.275 . . . . 0.0 114.79 -176.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -159.72 -5.82 0.06 Allowed 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 118.918 2.932 . . . . 0.0 118.918 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.6 m -72.43 81.72 1.06 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 122.355 2.343 . . . . 0.0 114.368 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 16.5 tp -63.75 109.61 1.77 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.422 2.289 . . . . 0.0 111.07 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.614 HG13 ' H ' ' A' ' 236' ' ' ASP . 10.4 pt -71.93 159.33 85.75 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 124.655 1.182 . . . . 0.0 112.853 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.97 -29.17 87.48 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.493 2.129 . . . . 0.0 112.17 174.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.95 98.1 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 169.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.614 ' H ' HG13 ' A' ' 233' ' ' ILE . 94.4 m-20 -66.27 -41.35 90.02 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.515 -0.741 . . . . 0.0 112.108 173.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -60.94 -32.16 71.68 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.282 -0.886 . . . . 0.0 112.404 172.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -69.89 -42.87 72.86 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.353 -1.467 . . . . 0.0 112.222 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 65.9 mt -56.7 -47.2 82.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.63 -0.669 . . . . 0.0 110.398 171.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.99 -30.97 72.0 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.493 0.717 . . . . 0.0 112.869 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -64.39 -43.08 95.58 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.588 -0.695 . . . . 0.0 111.824 174.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -64.32 -39.26 93.56 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.004 0.922 . . . . 0.0 112.082 175.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 70.0 t -65.36 -41.56 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.961 0.904 . . . . 0.0 111.601 175.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.08 95.74 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.237 0.615 . . . . 0.0 111.791 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -65.27 -39.01 92.04 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.817 0.847 . . . . 0.0 111.995 175.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -65.95 -35.68 81.26 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.756 0.822 . . . . 0.0 112.568 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 16.8 tp -73.57 -39.63 64.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.189 0.996 . . . . 0.0 112.157 173.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -60.71 -28.53 68.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.392 1.477 . . . . 0.0 112.497 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -75.94 -7.5 54.72 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.046 1.738 . . . . 0.0 114.788 173.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 24.3 t -150.69 68.93 8.5 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.435 1.494 . . . . 0.0 108.59 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -62.13 -7.1 9.23 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.459 2.773 . . . . 0.0 112.493 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -73.16 -18.03 61.31 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.737 1.615 . . . . 0.0 113.277 174.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -124.93 79.65 1.8 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.042 1.337 . . . . 0.0 111.306 -171.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -48.72 159.66 0.22 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.332 1.853 . . . . 0.0 113.104 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.3 162.28 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-O 121.712 0.768 . . . . 0.0 112.336 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.3 m -127.68 137.16 52.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.409 1.484 . . . . 0.0 108.993 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 94.3 mt -113.09 119.98 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 125.418 1.487 . . . . 0.0 107.689 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.529 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 0.5 OUTLIER -102.6 150.5 23.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.265 1.426 . . . . 0.0 109.437 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -149.99 151.91 23.91 Favored Glycine 0 CA--C 1.532 1.131 0 O-C-N 121.785 -0.572 . . . . 0.0 112.501 167.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -128.24 176.47 7.65 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 128.719 2.808 . . . . 0.0 109.075 -170.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.6 t -161.95 153.64 18.77 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 128.047 2.539 . . . . 0.0 111.832 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -63.91 160.91 16.64 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.353 -0.842 . . . . 0.0 109.906 165.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -93.56 33.85 1.23 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.658 0.783 . . . . 0.0 112.466 -175.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 24.3 m -68.51 -20.93 64.61 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.605 -1.31 . . . . 0.0 112.996 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -95.53 -142.09 12.55 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 126.001 1.762 . . . . 0.0 113.06 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 64.1 m -134.26 161.88 33.7 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.489 1.916 . . . . 0.0 109.342 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -54.03 -37.56 64.25 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.98 -1.075 . . . . 0.0 113.832 -174.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.11 -9.2 59.84 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.586 1.088 . . . . 0.0 115.107 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 8.7 mt -111.89 -31.16 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 127.14 2.176 . . . . 0.0 111.098 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -80.05 -33.07 39.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.867 1.267 . . . . 0.0 113.341 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 16.7 mm -56.91 -54.9 49.4 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 125.894 1.678 . . . . 0.0 112.687 172.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -70.16 -27.87 24.02 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.381 1.387 . . . . 0.0 112.314 174.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.81 -50.64 71.51 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 120.507 1.503 . . . . 0.0 111.256 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.7 m -68.65 -33.03 73.3 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.64 -36.43 73.42 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.83 0.852 . . . . 0.0 112.014 176.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -62.08 -46.09 90.61 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.547 0.739 . . . . 0.0 111.195 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -64.45 -36.86 85.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.816 0.28 . . . . 0.0 110.835 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -70.19 -38.49 75.37 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -65.05 -39.69 93.67 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 125.013 1.325 . . . . 0.0 110.653 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 67.7 mt -60.13 -42.81 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.179 0.592 . . . . 0.0 111.18 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 38.4 t -65.61 -43.77 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.192 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -61.88 -41.3 97.71 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.178 0.513 . . . . 0.0 111.937 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.5 -39.54 88.76 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.337 1.055 . . . . 0.0 111.046 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -66.01 -42.26 89.93 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.35 -40.96 94.26 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.094 0.557 . . . . 0.0 111.161 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.6 t -67.95 -38.2 79.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 O-C-N 121.66 -0.65 . . . . 0.0 111.063 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.0 -33.59 73.91 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.871 0.868 . . . . 0.0 113.202 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -64.07 -45.73 87.47 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.719 0.808 . . . . 0.0 110.953 170.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 158.54 2.43 0.08 OUTLIER Glycine 0 CA--C 1.528 0.87 0 N-CA-C 117.298 1.679 . . . . 0.0 117.298 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 4.4 t -72.77 135.83 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 120.404 2.102 . . . . 0.0 109.365 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.18 141.16 58.17 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.857 -1.152 . . . . 0.0 110.581 170.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.25 -27.79 53.35 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.193 0.902 . . . . 0.0 113.586 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.31 -28.28 69.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.764 1.226 . . . . 0.0 113.896 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -97.2 -0.05 47.48 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.707 1.603 . . . . 0.0 114.034 -173.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 18.7 mm -119.54 140.55 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.827 1.651 . . . . 0.0 109.157 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -132.16 162.13 31.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.691 1.596 . . . . 0.0 109.622 167.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 39.0 p -135.15 146.75 49.07 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.86 0.864 . . . . 0.0 112.017 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 25.8 t -140.42 136.0 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.912 1.285 . . . . 0.0 109.721 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -107.74 105.03 2.17 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.164 1.84 . . . . 0.0 110.887 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.529 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 1.9 mp -98.69 17.13 19.99 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 127.5 2.32 . . . . 0.0 112.969 -171.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 18.2 -97.37 0.01 OUTLIER Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.981 1.277 . . . . 0.0 116.287 -171.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 4.1 m -119.96 13.05 12.15 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -171.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 4.8 m -65.63 161.44 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 121.152 -0.967 . . . . 0.0 111.581 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 16.3 m120 40.41 54.8 6.82 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 125.305 1.442 . . . . 0.0 114.157 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.68 138.95 56.0 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.215 2.61 . . . . 0.0 112.27 -173.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 11.8 pt -138.84 0.81 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 125.074 1.349 . . . . 0.0 114.594 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 318' ' ' ASN . . . -148.68 139.6 22.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.455 1.102 . . . . 0.0 110.677 167.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 39.8 m -71.76 148.72 46.05 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.62 1.568 . . . . 0.0 113.798 -173.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -73.98 -2.79 25.58 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 171.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.46 -17.9 64.29 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.11 1.364 . . . . 0.0 114.529 -172.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 79.7 p -140.57 149.99 58.98 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.414 1.486 . . . . 0.0 110.561 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -62.13 -27.34 78.76 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.19 2.593 . . . . 0.0 112.634 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -62.4 -46.66 87.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.669 0.787 . . . . 0.0 111.764 170.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.22 -35.16 82.35 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 123.545 0.593 . . . . 0.0 112.669 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -59.03 -50.26 74.76 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.967 0.907 . . . . 0.0 110.896 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.74 -19.03 58.11 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 121.431 -0.793 . . . . 0.0 112.502 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -82.43 -15.07 53.93 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.07 1.748 . . . . 0.0 114.758 168.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 307' ' ' ALA 0.251 17.1 t-20 -101.17 -22.23 14.73 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 120.292 1.405 . . . . 0.0 111.286 168.658 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -68.95 11.24 0.21 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.04 -1.662 . . . . 0.0 114.308 166.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -61.15 165.97 4.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.732 2.013 . . . . 0.0 113.575 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 18.6 m -130.38 151.03 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.728 1.611 . . . . 0.0 111.262 176.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -139.62 159.83 41.27 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.368 1.467 . . . . 0.0 111.397 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 14.7 tt -135.81 135.16 51.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.8 1.24 . . . . 0.0 112.171 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 59.8 t -137.4 122.59 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.029 1.332 . . . . 0.0 110.223 -171.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 38.9 t -70.25 133.57 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.46 1.104 . . . . 0.0 109.274 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 . . . . . 0 C--O 1.251 1.153 0 C-N-CA 124.394 1.078 . . . . 0.0 113.307 -171.623 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 119.28 -0.39 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.15 160.74 48.68 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 123.503 2.802 . . . . 0.0 112.399 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.74 149.82 78.86 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.125 2.55 . . . . 0.0 112.144 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 175.71 57.8 0.06 OUTLIER Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.537 -1.146 . . . . 0.0 114.302 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -66.04 159.02 51.34 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.304 2.669 . . . . 0.0 112.49 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.46 116.27 3.97 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.35 2.7 . . . . 0.0 111.354 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -146.85 22.36 1.25 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.083 1.353 . . . . 0.0 113.121 -173.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 7.7 p -59.43 115.07 3.01 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.331 1.453 . . . . 0.0 112.737 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 169.48 60.38 0.03 OUTLIER Glycine 0 CA--C 1.537 1.469 0 C-N-CA 124.196 0.903 . . . . 0.0 114.287 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -70.83 -18.11 32.24 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.91 3.074 . . . . 0.0 113.689 -173.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 30.6 t -124.33 3.48 8.46 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 127.0 2.12 . . . . 0.0 111.601 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.25 -19.85 66.15 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.409 -1.432 . . . . 0.0 114.572 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -139.6 47.83 1.85 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.955 2.502 . . . . 0.0 109.755 172.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.49 -34.14 34.52 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.912 1.685 . . . . 0.0 112.314 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -66.68 -46.92 74.1 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.106 0.963 . . . . 0.0 112.012 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 14.4 t -65.8 -39.25 90.73 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.169 0.987 . . . . 0.0 112.143 177.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.58 95.11 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 4.2 mt -74.28 -32.69 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.737 0.815 . . . . 0.0 112.116 174.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -64.22 -34.52 78.29 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.168 -0.957 . . . . 0.0 112.182 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -70.17 -36.38 74.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.216 1.006 . . . . 0.0 112.699 172.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 36.7 t -62.05 -43.18 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.143 0.977 . . . . 0.0 111.738 171.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 64.9 p -83.01 -19.28 37.29 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 64.4 18.06 62.72 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.721 1.629 . . . . 0.0 114.304 -171.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 121.9 -146.58 17.05 Favored Glycine 0 CA--C 1.544 1.898 0 C-N-CA 125.214 1.387 . . . . 0.0 112.881 -173.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.67 171.76 15.74 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.967 3.111 . . . . 0.0 112.129 172.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -131.25 144.78 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.441 1.096 . . . . 0.0 110.159 171.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -115.06 173.74 6.34 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.974 1.709 . . . . 0.0 114.393 -170.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -132.06 88.15 2.52 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.345 1.458 . . . . 0.0 109.423 -176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -66.55 164.1 42.35 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.531 1.539 . . . . 0.0 115.282 -171.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 29.9 -66.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.925 1 C-N-CA 131.842 4.057 . . . . 0.0 117.655 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -63.08 -26.02 68.64 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.158 1.383 . . . . 0.0 113.389 173.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.79 7.67 77.82 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.78 1.181 . . . . 0.0 115.002 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -156.69 13.67 0.28 Allowed 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 126.511 1.924 . . . . 0.0 114.557 -175.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 35.1 m -93.45 88.3 5.89 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.341 -1.474 . . . . 0.0 112.405 -170.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 16.9 tp -71.03 96.97 1.38 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.065 1.346 . . . . 0.0 110.328 171.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.405 ' HB ' ' HD2' ' A' ' 234' ' ' PRO . 4.2 pt -66.11 159.82 68.35 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 125.102 1.361 . . . . 0.0 111.988 -172.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 233' ' ' ILE . 36.5 Cg_endo -62.42 -33.61 78.94 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.269 1.979 . . . . 0.0 112.674 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -67.18 -29.84 69.64 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.925 1.084 . . . . 0.0 113.925 171.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.88 -47.26 86.47 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.521 1.055 . . . . 0.0 111.924 174.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -58.6 -24.25 60.54 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.303 1.041 . . . . 0.0 113.157 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -39.5 87.73 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.258 -0.901 . . . . 0.0 112.005 174.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 37.2 mm -58.69 -47.21 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 120.889 -1.132 . . . . 0.0 110.392 171.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 7.9 mp -62.01 -37.3 84.37 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.438 0.695 . . . . 0.0 111.887 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -61.25 -39.72 91.38 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.073 1.349 . . . . 0.0 112.573 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 13.7 mmt85 -69.03 -39.19 79.37 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 172.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.3 t -64.85 -40.21 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.124 0.57 . . . . 0.0 110.918 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.66 98.14 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.397 1.079 . . . . 0.0 111.95 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.85 -36.96 84.95 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -76.11 -29.03 57.72 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.528 HD21 HG11 ' A' ' 255' ' ' VAL . 1.0 OUTLIER -66.41 -45.98 78.1 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.202 1.001 . . . . 0.0 111.437 169.568 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -58.07 -34.04 69.71 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.501 1.521 . . . . 0.0 112.645 173.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.96 -9.08 58.45 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.319 1.448 . . . . 0.0 114.564 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 13.1 t -157.74 66.54 3.61 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.01 1.324 . . . . 0.0 109.52 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -62.73 -9.3 15.76 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.085 2.523 . . . . 0.0 112.196 173.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -70.46 -16.61 62.94 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.776 1.63 . . . . 0.0 113.415 171.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -119.27 80.64 1.59 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.518 1.527 . . . . 0.0 110.687 -176.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 65.5 mtt85 -51.71 148.1 5.9 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.927 1.291 . . . . 0.0 111.553 173.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.528 HG11 HD21 ' A' ' 247' ' ' LEU . 34.2 m -125.54 158.41 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.519 1.128 . . . . 0.0 112.548 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 18.0 m -130.83 134.4 46.79 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 172.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 51.8 mt -104.76 124.85 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 125.198 1.399 . . . . 0.0 107.557 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.406 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 21.7 m-20 -114.32 129.54 56.64 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.276 1.03 . . . . 0.0 109.799 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -119.3 157.43 15.39 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 122.089 -0.382 . . . . 0.0 112.154 173.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -125.47 167.82 14.48 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 128.156 2.582 . . . . 0.0 108.615 -170.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.5 m -144.57 169.3 18.23 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 127.076 2.15 . . . . 0.0 109.747 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.32 158.15 5.77 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.806 1.242 . . . . 0.0 111.701 170.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -96.88 -4.4 40.25 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 121.32 -0.863 . . . . 0.0 112.997 173.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 2.3 p -68.33 -31.02 70.14 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.848 1.659 . . . . 0.0 114.886 177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -76.19 -161.25 10.91 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 126.471 1.986 . . . . 0.0 114.082 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 8.0 t -130.59 154.25 48.05 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.608 1.563 . . . . 0.0 109.858 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -58.61 -32.58 69.14 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -171.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.46 -13.91 56.04 Favored Glycine 0 CA--C 1.541 1.671 0 O-C-N 121.058 -1.026 . . . . 0.0 114.859 171.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 2.9 mt -106.62 -34.33 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 127.101 2.161 . . . . 0.0 111.346 173.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -78.93 -31.78 45.32 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -174.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 20.6 mm -61.16 -53.92 58.69 Favored Pre-proline 0 N--CA 1.47 0.538 0 C-N-CA 125.969 1.708 . . . . 0.0 112.042 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.76 -34.86 17.53 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 CA-C-N 120.913 1.362 . . . . 0.0 112.561 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 6.9 mp -66.72 -43.26 84.72 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.68 1.127 . . . . 0.0 112.561 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 31.2 p -69.12 -36.12 77.17 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.38 -40.11 77.6 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.225 0.61 . . . . 0.0 111.335 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 54.4 mm-40 -62.65 -40.33 96.7 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.436 0.694 . . . . 0.0 111.347 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 29.3 mtt85 -68.7 -23.17 64.34 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -83.63 -39.69 19.95 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 167.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -65.29 -35.96 82.62 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.416 1.486 . . . . 0.0 112.254 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 74.9 mt -66.17 -39.98 85.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 118.892 0.769 . . . . 0.0 110.552 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 88.2 t -65.62 -45.68 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 122.179 -0.326 . . . . 0.0 110.669 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.2 96.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.72 0.408 . . . . 0.0 111.456 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.88 -39.01 92.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.718 0.807 . . . . 0.0 111.738 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -65.85 -42.47 90.4 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 175.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 2.1 mp -68.72 -37.59 79.59 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 122.003 -0.435 . . . . 0.0 111.916 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 45.9 t -66.22 -40.1 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 O-C-N 121.439 -0.788 . . . . 0.0 110.731 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.09 -33.51 75.63 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 19.9 ttt85 -66.34 -41.95 88.84 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.478 168.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 156.91 1.04 0.1 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 173.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.8 t -69.64 132.9 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 120.399 2.099 . . . . 0.0 109.3 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.71 135.92 53.49 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.196 -0.94 . . . . 0.0 110.069 172.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.07 -26.81 50.13 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.525 1.06 . . . . 0.0 113.819 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.66 -29.52 70.13 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.763 1.225 . . . . 0.0 113.61 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -96.43 -7.61 34.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.155 1.782 . . . . 0.0 113.977 -175.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 3.4 tt -139.27 99.37 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 122.352 1.072 . . . . 0.0 112.331 -171.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -102.4 169.97 8.36 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.327 1.451 . . . . 0.0 112.265 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 40.1 p -137.85 146.92 44.03 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.417 1.087 . . . . 0.0 113.171 -176.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.4 t -141.15 139.51 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.433 1.493 . . . . 0.0 110.98 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -95.51 113.62 4.67 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.538 1.066 . . . . 0.0 111.429 169.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.406 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 42.3 mt -105.21 33.39 3.69 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.072 2.549 . . . . 0.0 110.13 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 0.72 -69.79 0.0 OUTLIER Glycine 0 C--N 1.35 1.359 0 N-CA-C 120.154 2.822 . . . . 0.0 120.154 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 54.2 p -148.72 24.65 0.96 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.7 1.75 . . . . 0.0 114.447 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 8.5 m -64.75 155.95 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 O-C-N 121.252 -0.905 . . . . 0.0 110.676 167.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 39.24 55.11 5.51 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 125.2 1.4 . . . . 0.0 114.083 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -61.71 149.51 89.65 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.237 2.625 . . . . 0.0 112.004 -172.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.38 -2.97 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -170.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' A' ' 318' ' ' ASN . . . -153.04 154.01 34.04 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.177 -0.952 . . . . 0.0 112.642 177.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 68.1 m -67.41 138.15 56.47 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.42 1.488 . . . . 0.0 111.237 167.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -92.25 11.64 25.08 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.603 1.161 . . . . 0.0 112.026 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.34 -16.56 62.44 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.408 1.483 . . . . 0.0 114.433 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 70.7 p -137.67 148.42 61.09 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 125.618 1.567 . . . . 0.0 110.425 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -61.78 -31.22 85.54 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.226 2.618 . . . . 0.0 112.568 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.88 -36.35 77.98 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -71.27 -39.8 61.72 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 121.529 0.516 . . . . 0.0 112.874 172.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -56.92 -45.85 82.4 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 124.123 0.969 . . . . 0.0 110.839 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.66 -39.55 88.78 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.906 0.882 . . . . 0.0 112.74 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -72.33 -20.43 61.48 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.551 1.54 . . . . 0.0 114.031 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 307' ' ' ALA . 39.8 t30 -102.6 -15.04 16.51 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.092 1.357 . . . . 0.0 113.364 172.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -82.07 12.61 4.03 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 126.614 1.966 . . . . 0.0 113.141 166.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -56.89 168.34 0.65 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.454 1.902 . . . . 0.0 115.326 -171.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 14.0 p -129.64 142.33 44.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 125.179 1.392 . . . . 0.0 110.189 167.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -139.91 165.34 27.59 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.76 2.024 . . . . 0.0 110.737 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 14.8 tt -138.28 154.0 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.1 0.96 . . . . 0.0 112.636 -175.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.5 161.55 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.334 1.854 . . . . 0.0 110.461 -175.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 59.0 t -107.3 135.84 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.52 1.128 . . . . 0.0 109.359 173.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.177 0 C-N-CA 125.177 1.391 . . . . 0.0 111.774 -173.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 119.316 -0.373 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -71.71 161.71 44.33 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.553 2.835 . . . . 0.0 112.403 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.75 150.5 79.09 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.106 2.538 . . . . 0.0 111.871 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 175.39 59.53 0.06 OUTLIER Glycine 0 CA--C 1.538 1.491 0 CA-C-O 118.575 -1.125 . . . . 0.0 114.184 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.32 159.32 50.68 Favored 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 123.324 2.683 . . . . 0.0 112.767 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.71 165.77 28.4 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.701 2.934 . . . . 0.0 112.882 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -136.42 22.92 3.19 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.301 1.441 . . . . 0.0 113.271 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 24.9 m -56.04 139.85 45.44 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.785 1.634 . . . . 0.0 112.622 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 52.1 58.77 9.9 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 125.245 1.402 . . . . 0.0 114.789 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.36 -19.37 38.1 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 124.055 3.17 . . . . 0.0 114.401 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 43.9 t -122.63 -8.4 8.5 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.254 1.822 . . . . 0.0 112.295 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -63.6 -16.76 61.76 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -174.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -137.89 40.71 2.34 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.199 2.2 . . . . 0.0 111.093 174.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.2 mt -46.86 -38.43 10.34 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.189 0.995 . . . . 0.0 112.193 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -60.46 -38.52 84.46 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.438 0.695 . . . . 0.0 112.296 -175.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.3 t -70.81 -45.64 64.26 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.359 0.664 . . . . 0.0 111.959 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.64 -40.67 97.75 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 15.3 mt -73.16 -33.83 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.883 0.873 . . . . 0.0 110.728 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.3 -39.16 92.13 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.363 -0.835 . . . . 0.0 112.046 172.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.97 76.34 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.273 1.029 . . . . 0.0 113.046 176.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.7 t -64.55 -40.8 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.139 0.976 . . . . 0.0 111.245 172.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 16.9 m -84.12 -24.49 30.26 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.881 0.873 . . . . 0.0 112.96 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.38 15.37 72.66 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 126.23 1.871 . . . . 0.0 115.135 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 126.78 -156.41 20.09 Favored Glycine 0 CA--C 1.542 1.747 0 C-N-CA 125.311 1.434 . . . . 0.0 112.962 -174.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.64 170.43 20.02 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 124.16 3.24 . . . . 0.0 111.817 169.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.93 108.69 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.579 1.151 . . . . 0.0 110.752 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -80.54 171.7 14.71 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.469 2.308 . . . . 0.0 112.554 169.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.442 ' O ' ' HB1' ' A' ' 316' ' ' ALA . 81.2 m-85 -119.29 150.95 39.27 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.099 0.475 . . . . 0.0 111.147 -171.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -57.31 170.76 3.26 Favored Glycine 0 CA--C 1.541 1.716 0 O-C-N 121.147 -0.971 . . . . 0.0 111.863 166.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -48.68 -28.19 3.39 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -171.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -65.29 -17.92 64.89 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.92 8.41 76.07 Favored Glycine 0 CA--C 1.542 1.774 0 C-N-CA 124.698 1.142 . . . . 0.0 115.215 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -167.53 8.88 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.1 t -73.84 105.42 5.11 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 122.053 2.206 . . . . 0.0 112.12 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.7 mp -74.13 102.5 4.26 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.169 0.988 . . . . 0.0 111.479 172.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.532 HG13 ' H ' ' A' ' 236' ' ' ASP . 5.9 pt -56.97 152.65 27.13 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.065 1.746 . . . . 0.0 112.635 167.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -63.15 -29.57 74.26 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.619 2.212 . . . . 0.0 112.406 173.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.71 92.03 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.737 0.815 . . . . 0.0 112.952 172.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.532 ' H ' HG13 ' A' ' 233' ' ' ILE . 28.4 t70 -61.62 -47.8 83.78 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 119.025 0.83 . . . . 0.0 111.663 171.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -61.11 -35.0 75.84 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.559 -0.713 . . . . 0.0 112.488 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -69.27 -42.65 75.24 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.761 -1.212 . . . . 0.0 112.555 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 56.1 mt -56.49 -47.26 82.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 121.162 -0.962 . . . . 0.0 110.496 171.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 73.5 mt -64.49 -33.34 75.66 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.585 0.754 . . . . 0.0 112.69 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -62.61 -41.58 99.07 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.289 1.036 . . . . 0.0 112.676 175.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -69.57 -36.49 76.33 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 74.3 t -67.31 -41.42 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.504 0.722 . . . . 0.0 111.19 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.01 93.7 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.889 0.876 . . . . 0.0 112.246 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -65.75 -36.98 85.11 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.751 -0.593 . . . . 0.0 112.047 173.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -63.5 -36.15 82.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.153 0.981 . . . . 0.0 112.711 174.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.71 -41.76 87.45 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.487 0.585 . . . . 0.0 112.173 171.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -60.93 -30.75 70.39 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.421 1.088 . . . . 0.0 112.532 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -74.99 -9.51 58.61 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.909 1.684 . . . . 0.0 114.627 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 17.1 t -155.92 69.39 5.1 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.483 1.513 . . . . 0.0 108.644 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -62.96 -5.54 7.82 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.518 2.812 . . . . 0.0 112.716 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -74.16 -17.89 60.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.463 1.505 . . . . 0.0 113.256 171.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -118.78 83.52 2.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.453 1.501 . . . . 0.0 111.251 -171.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 55.7 mtt85 -55.23 157.39 3.58 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.123 1.369 . . . . 0.0 112.129 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.18 161.29 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.6 m -128.89 140.77 51.53 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.339 1.456 . . . . 0.0 109.258 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 61.7 mt -113.84 127.03 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.815 1.246 . . . . 0.0 108.759 -173.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.508 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 1.4 m120 -119.73 118.4 30.8 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.919 1.688 . . . . 0.0 107.764 -172.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -121.77 151.16 16.98 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 118.549 0.613 . . . . 0.0 112.791 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -127.35 168.69 14.47 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 128.423 2.689 . . . . 0.0 109.81 -170.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.2 m -152.42 156.69 40.0 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.362 1.865 . . . . 0.0 109.642 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.66 157.63 37.65 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.53 -1.356 . . . . 0.0 109.761 165.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -92.0 33.22 1.07 Allowed 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 121.431 0.634 . . . . 0.0 112.642 -177.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 13.0 m -66.29 -23.14 66.33 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.016 1.326 . . . . 0.0 112.773 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -99.93 -139.69 10.96 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 126.384 1.945 . . . . 0.0 112.752 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 62.2 m -139.25 163.57 32.12 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.603 1.961 . . . . 0.0 109.587 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -53.61 -38.93 64.49 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 121.035 -1.04 . . . . 0.0 113.196 -177.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -65.93 -10.12 49.7 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 124.589 1.09 . . . . 0.0 115.197 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 13.8 mt -110.1 -32.45 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.796 2.038 . . . . 0.0 111.156 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -82.35 -29.77 30.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.344 1.058 . . . . 0.0 112.927 -174.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 21.1 mm -59.37 -55.57 44.71 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 125.724 1.61 . . . . 0.0 111.759 169.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.87 -31.93 19.11 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 CA-C-N 120.836 1.334 . . . . 0.0 113.284 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 4.3 mp -64.65 -50.63 66.32 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 120.23 1.377 . . . . 0.0 111.865 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 46.5 p -65.38 -33.19 75.37 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -72.32 -38.06 68.76 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.884 0.874 . . . . 0.0 112.169 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -62.92 -41.78 99.58 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.764 1.226 . . . . 0.0 111.103 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.7 mmt-85 -63.19 -38.74 92.37 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.678 0.672 . . . . 0.0 111.598 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -71.33 -38.4 71.69 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -65.68 -37.74 87.33 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 125.264 1.426 . . . . 0.0 112.08 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 82.1 mt -64.59 -41.36 92.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 118.587 0.631 . . . . 0.0 110.572 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 86.2 t -65.42 -41.73 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 122.047 -0.408 . . . . 0.0 111.527 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -64.68 -41.14 96.26 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.939 0.496 . . . . 0.0 111.882 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.59 -37.71 87.4 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.827 0.851 . . . . 0.0 111.57 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -65.09 -42.15 94.32 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 174.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.2 mp -63.99 -40.75 97.07 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.843 -0.536 . . . . 0.0 111.716 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 53.3 t -68.16 -38.45 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.67 0.788 . . . . 0.0 110.798 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.25 -34.39 77.35 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.131 0.972 . . . . 0.0 112.879 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -43.64 93.83 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.903 0.881 . . . . 0.0 111.279 170.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 156.67 1.86 0.1 OUTLIER Glycine 0 CA--C 1.53 1.019 0 N-CA-C 117.746 1.858 . . . . 0.0 117.746 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.0 m -73.67 145.83 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-N 121.066 2.433 . . . . 0.0 110.799 -174.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.61 140.25 55.53 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.616 -0.678 . . . . 0.0 110.788 172.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -54.54 -27.94 43.35 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.309 1.433 . . . . 0.0 113.843 171.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.1 -32.14 72.67 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.395 1.078 . . . . 0.0 113.316 172.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -90.23 2.29 55.57 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.261 1.424 . . . . 0.0 114.218 -173.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 14.9 tt -138.88 139.95 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.482 0.713 . . . . 0.0 112.559 -171.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -139.4 164.31 30.19 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.217 1.407 . . . . 0.0 111.631 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 45.9 p -138.99 146.11 40.52 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.662 1.185 . . . . 0.0 111.977 -175.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 40.5 t -142.18 138.39 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.792 1.637 . . . . 0.0 109.934 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -107.75 97.97 1.2 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.117 1.818 . . . . 0.0 111.692 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.508 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 1.9 mp -97.01 29.96 2.9 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.443 2.697 . . . . 0.0 110.223 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 0.61 -66.14 0.0 OUTLIER Glycine 0 C--N 1.346 1.122 0 N-CA-C 120.919 3.127 . . . . 0.0 120.919 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 91.5 p -146.81 16.1 1.23 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.064 1.432 . . . . 0.0 114.732 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 17.7 m -71.76 154.37 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 O-C-N 121.106 -0.996 . . . . 0.0 111.098 171.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 22.4 m120 41.71 50.16 4.45 Favored Pre-proline 0 CA--C 1.559 1.327 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.6 125.35 12.64 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.838 2.359 . . . . 0.0 111.404 -174.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 2.0 pp -97.84 -1.11 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -173.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -146.32 166.95 24.78 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.855 1.662 . . . . 0.0 111.714 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 85.9 p -80.92 158.58 25.22 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 122.253 1.025 . . . . 0.0 113.411 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -86.7 -4.87 59.23 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.601 1.16 . . . . 0.0 110.987 165.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.57 -18.69 61.59 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.815 1.646 . . . . 0.0 114.447 -174.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 71.6 p -133.26 142.88 45.95 Favored Pre-proline 0 N--CA 1.474 0.759 0 CA-C-N 119.337 0.971 . . . . 0.0 110.575 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.7 -28.12 68.74 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.447 2.764 . . . . 0.0 112.707 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -66.08 -41.14 91.1 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.43 -0.794 . . . . 0.0 111.468 170.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -64.49 -38.23 95.49 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 124.184 0.897 . . . . 0.0 113.087 174.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -58.96 -49.0 79.52 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 124.21 1.004 . . . . 0.0 111.23 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 225' ' ' PHE . . . -75.85 -22.84 55.83 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.249 -0.907 . . . . 0.0 112.105 -175.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -70.18 -34.58 73.14 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.061 1.344 . . . . 0.0 112.769 167.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.69 -16.51 26.85 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.144 1.378 . . . . 0.0 112.65 177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 57.3 mtt180 -70.54 11.81 0.32 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.831 1.652 . . . . 0.0 113.779 167.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -60.51 162.44 6.35 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.521 1.928 . . . . 0.0 114.038 -173.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.21 151.66 32.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.24 172.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -139.63 159.11 42.93 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.894 1.678 . . . . 0.0 111.542 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.35 129.28 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.179 1.392 . . . . 0.0 108.708 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 64.8 t -134.05 129.57 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.209 1.404 . . . . 0.0 110.359 -171.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 23.8 t -72.84 134.92 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.546 0.738 . . . . 0.0 109.749 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.208 0 C-N-CA 125.036 1.335 . . . . 0.0 111.707 -171.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 119.282 -0.389 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -67.9 156.9 64.12 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 123.404 2.736 . . . . 0.0 112.396 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -80.35 42.7 1.37 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.797 3.665 . . . . 0.0 113.76 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 145.37 178.12 20.67 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 126.308 1.908 . . . . 0.0 113.699 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -69.88 165.43 31.13 Favored 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 123.789 2.993 . . . . 0.0 112.16 173.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.46 62.51 6.24 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.772 3.648 . . . . 0.0 113.125 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.61 35.36 0.06 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 128.304 2.642 . . . . 0.0 114.443 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 12.1 t -58.49 148.79 27.15 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.325 1.45 . . . . 0.0 112.539 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 54.43 58.69 12.07 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 125.613 1.578 . . . . 0.0 114.626 -175.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -70.21 -16.78 35.76 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.14 3.227 . . . . 0.0 114.277 -171.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 49.3 t -120.45 -2.99 9.93 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 126.759 2.024 . . . . 0.0 111.832 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -63.59 -17.8 63.23 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 -171.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -138.3 29.4 2.46 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.953 2.101 . . . . 0.0 111.475 173.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.79 -19.14 64.77 Favored 'General case' 0 C--O 1.221 -0.44 0 O-C-N 121.437 -0.789 . . . . 0.0 112.721 -172.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -55.94 -40.12 72.7 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.642 1.11 . . . . 0.0 111.529 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 17.5 t -68.33 -44.49 75.2 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.311 0.645 . . . . 0.0 111.878 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.94 -35.96 82.85 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 55.0 mt -70.18 -39.96 77.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.651 1.58 . . . . 0.0 109.493 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -63.9 -40.01 95.51 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.11 -0.994 . . . . 0.0 111.897 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.96 -38.34 90.65 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.121 0.968 . . . . 0.0 112.772 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.91 -28.78 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 118.677 0.671 . . . . 0.0 112.201 177.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.4 m -71.52 -26.41 62.65 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.693 1.197 . . . . 0.0 112.24 169.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.03 25.48 74.62 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.409 1.481 . . . . 0.0 113.637 -172.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 97.3 -170.54 25.93 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.28 1.419 . . . . 0.0 112.751 -171.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.09 140.96 38.78 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.32 2.68 . . . . 0.0 110.992 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.94 142.05 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.634 1.174 . . . . 0.0 112.03 -170.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -104.88 174.16 6.0 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.219 1.807 . . . . 0.0 115.115 -171.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -134.29 84.14 2.09 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.14 1.376 . . . . 0.0 108.858 -173.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -48.54 151.96 2.73 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 126.727 2.108 . . . . 0.0 115.047 -170.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -2.63 -42.12 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 1 C-N-CA 133.628 4.771 . . . . 0.0 120.62 -171.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -63.19 -20.43 65.41 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.204 1.002 . . . . 0.0 113.472 168.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.67 8.06 77.51 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.465 1.507 . . . . 0.0 115.047 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -154.19 19.58 0.5 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 127.361 2.265 . . . . 0.0 112.005 -176.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 7.5 t -82.74 81.99 8.26 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.741 -1.225 . . . . 0.0 113.17 -170.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 22.0 tp -82.13 77.65 8.91 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.834 1.254 . . . . 0.0 110.206 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 3.8 pt -58.21 157.89 15.62 Favored Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 125.624 1.57 . . . . 0.0 112.135 -173.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -61.65 -32.68 87.2 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.224 1.949 . . . . 0.0 112.648 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -68.55 -29.12 67.61 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 172.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -59.1 -41.83 89.05 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.818 1.19 . . . . 0.0 112.359 175.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -60.96 -27.57 68.35 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.561 0.745 . . . . 0.0 112.933 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -64.01 -40.65 96.83 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.67 1.123 . . . . 0.0 111.752 175.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 45.2 mm -58.9 -44.52 90.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 121.579 -0.7 . . . . 0.0 110.221 171.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.05 -36.86 84.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.486 0.714 . . . . 0.0 112.795 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -60.97 -41.73 96.94 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 119.074 0.852 . . . . 0.0 112.157 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -66.3 -40.21 89.84 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.954 0.901 . . . . 0.0 112.311 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 76.2 t -66.78 -41.57 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 123.78 0.832 . . . . 0.0 110.81 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.02 -39.27 93.15 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.355 0.662 . . . . 0.0 112.049 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.7 -38.22 88.62 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.252 0.621 . . . . 0.0 112.082 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.38 -30.93 67.96 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 178.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.405 HD21 ' CG1' ' A' ' 255' ' ' VAL . 0.4 OUTLIER -69.79 -43.23 72.53 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.025 0.93 . . . . 0.0 112.585 169.626 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -60.43 -27.5 67.54 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.325 1.45 . . . . 0.0 112.745 174.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -79.36 -8.13 58.85 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.006 1.723 . . . . 0.0 114.843 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 37.2 t -152.99 68.5 6.72 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 125.285 1.434 . . . . 0.0 108.903 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -62.59 -8.85 14.03 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.244 2.63 . . . . 0.0 112.271 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -72.23 -16.5 61.94 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.669 1.588 . . . . 0.0 113.507 173.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -121.54 81.28 1.78 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.274 1.429 . . . . 0.0 110.705 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -49.89 143.04 8.16 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.412 1.485 . . . . 0.0 111.502 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.405 ' CG1' HD21 ' A' ' 247' ' ' LEU . 16.8 m -135.42 163.03 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 176.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 5.2 t -143.07 146.39 33.75 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 3.4 mt -101.92 106.7 20.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.476 -169.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.426 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 21.8 m-20 -81.87 154.41 25.86 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 166.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -148.69 152.75 24.74 Favored Glycine 0 CA--C 1.523 0.564 0 O-C-N 121.84 -0.537 . . . . 0.0 112.36 168.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -116.62 169.96 8.95 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.74 2.416 . . . . 0.0 108.633 -170.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.4 p -149.95 145.86 26.72 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.292 2.637 . . . . 0.0 109.78 171.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -63.44 168.31 4.68 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 120.984 -1.073 . . . . 0.0 112.929 174.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -101.33 21.08 14.67 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -171.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 3.9 m -68.71 -19.14 64.35 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.867 -1.145 . . . . 0.0 112.772 172.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -98.22 -152.55 28.12 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.12 1.819 . . . . 0.0 113.985 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 73.7 m -129.72 145.8 51.52 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.735 1.614 . . . . 0.0 110.472 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -53.56 -37.12 62.58 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.71 1.204 . . . . 0.0 113.754 -171.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -60.0 -28.86 66.88 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 123.955 0.788 . . . . 0.0 113.959 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 18.7 mm -95.94 -24.17 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 126.156 1.782 . . . . 0.0 112.142 175.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -86.76 -23.97 25.25 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -175.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 21.8 mm -58.67 -54.28 57.84 Favored Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 125.121 1.368 . . . . 0.0 112.228 167.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -70.63 -33.44 13.29 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 121.075 1.42 . . . . 0.0 113.116 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.457 HD13 HH12 ' A' ' 277' ' ' ARG . 1.2 mm? -72.35 -36.52 68.82 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.58 1.082 . . . . 0.0 112.856 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 61.7 p -68.82 -36.66 78.5 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.72 1.145 . . . . 0.0 113.536 171.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.36 85.12 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.339 1.055 . . . . 0.0 111.577 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -61.2 -42.7 99.05 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 124.918 1.287 . . . . 0.0 110.745 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.457 HH12 HD13 ' A' ' 273' ' ' LEU . 22.7 mtt85 -64.56 -32.12 73.64 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -75.92 -39.57 55.97 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 171.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -60.22 -45.65 92.45 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 125.319 1.448 . . . . 0.0 110.351 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 41.0 mm -66.27 -35.52 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 118.675 0.67 . . . . 0.0 111.011 -177.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.81 -44.28 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 O-C-N 121.992 -0.443 . . . . 0.0 111.162 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -66.1 -36.59 83.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.341 0.657 . . . . 0.0 111.658 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -63.03 -41.23 99.48 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.668 1.187 . . . . 0.0 111.458 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -64.1 -43.01 96.67 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 172.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.4 mp -63.12 -40.93 99.04 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.779 0.832 . . . . 0.0 111.659 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 39.1 t -63.98 -42.31 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.872 0.869 . . . . 0.0 110.922 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.36 -31.8 70.46 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -42.03 75.76 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.142 0.977 . . . . 0.0 111.901 172.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 159.77 -0.26 0.08 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 117.494 1.757 . . . . 0.0 117.494 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 2.6 t -74.87 124.28 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 120.664 2.232 . . . . 0.0 109.2 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.31 142.36 57.8 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.048 -1.032 . . . . 0.0 110.837 173.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -53.17 -28.88 35.24 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.169 1.366 . . . . 0.0 113.613 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -68.31 -22.57 64.71 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.23 1.412 . . . . 0.0 114.671 175.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -108.46 2.4 22.29 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.305 1.842 . . . . 0.0 113.898 -172.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 2.8 tp -133.76 124.85 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.372 1.469 . . . . 0.0 110.005 -172.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -122.91 172.69 8.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.731 1.212 . . . . 0.0 110.789 171.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 40.0 p -141.73 151.91 43.36 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.458 1.103 . . . . 0.0 112.527 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 7.8 t -142.57 132.77 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.396 1.078 . . . . 0.0 111.143 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -93.75 120.76 6.39 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 123.881 0.753 . . . . 0.0 111.256 169.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.426 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 63.8 mt -111.65 18.9 18.59 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.352 1.861 . . . . 0.0 113.327 -175.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 16.47 -105.87 0.01 OUTLIER Glycine 0 CA--C 1.541 1.666 0 C-N-CA 124.863 1.22 . . . . 0.0 116.103 -171.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 16.9 m -111.47 13.51 21.44 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -172.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 6.3 m -61.33 159.17 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.68 1.127 . . . . 0.0 111.737 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 38.1 53.99 3.84 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 125.622 1.569 . . . . 0.0 113.78 175.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -64.06 150.79 87.62 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.922 2.414 . . . . 0.0 113.081 -171.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 22.8 pt -134.72 -4.94 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 127.211 2.205 . . . . 0.0 113.365 -171.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 318' ' ' ASN . . . -147.77 152.81 38.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.593 1.157 . . . . 0.0 112.399 170.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 69.5 m -76.73 157.44 31.69 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.746 1.618 . . . . 0.0 112.936 174.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -73.14 -3.64 27.78 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.121 1.368 . . . . 0.0 113.273 170.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.19 -21.04 66.3 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.86 1.664 . . . . 0.0 115.367 -170.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 78.3 p -140.41 147.45 49.65 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 124.198 0.999 . . . . 0.0 111.182 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.73 -27.8 75.94 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.381 2.721 . . . . 0.0 112.603 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -65.06 -41.19 95.35 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.939 0.896 . . . . 0.0 112.386 170.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.55 -39.9 95.8 Favored Glycine 0 C--N 1.336 0.554 0 O-C-N 121.728 -0.607 . . . . 0.0 112.518 173.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -59.08 -43.29 91.79 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.771 0.828 . . . . 0.0 111.578 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.97 -41.61 99.59 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.892 0.877 . . . . 0.0 112.3 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.99 -11.41 60.86 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.613 1.565 . . . . 0.0 114.302 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.549 ' HB2' ' HB3' ' A' ' 307' ' ' ALA 0.256 0.4 OUTLIER -119.69 15.75 12.74 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.522 1.529 . . . . 0.0 111.667 172.001 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -105.56 8.58 33.36 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.992 1.717 . . . . 0.0 112.345 166.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -63.5 161.19 14.93 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -170.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 2.5 m -126.25 144.68 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 127.217 2.207 . . . . 0.0 110.779 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -147.57 134.69 20.42 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.468 1.107 . . . . 0.0 113.182 -171.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 23.2 mm -85.73 142.55 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.595 1.558 . . . . 0.0 110.758 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 43.5 t -139.6 129.39 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.394 1.077 . . . . 0.0 109.483 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 9.0 p -77.35 133.41 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.409 -0.807 . . . . 0.0 111.228 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 14.1 m120 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 125.233 1.413 . . . . 0.0 111.988 -177.698 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.225 0 CA-C-O 119.291 -0.385 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -70.5 160.39 49.65 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.458 2.772 . . . . 0.0 112.512 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.11 156.08 63.28 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.257 2.638 . . . . 0.0 111.973 173.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 69.56 -166.79 48.4 Favored Glycine 0 CA--C 1.544 1.894 0 C-N-CA 123.713 0.673 . . . . 0.0 114.029 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.51 159.58 52.87 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 123.322 2.681 . . . . 0.0 112.332 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.21 161.13 45.87 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.481 2.787 . . . . 0.0 112.797 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -75.57 22.21 0.13 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.117 1.767 . . . . 0.0 114.851 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 33.5 m -57.53 140.08 51.72 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.061 1.745 . . . . 0.0 112.844 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 48.91 58.35 7.78 Favored Glycine 0 CA--C 1.541 1.711 0 C-N-CA 125.627 1.584 . . . . 0.0 115.113 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -71.05 -14.76 32.2 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 124.19 3.26 . . . . 0.0 114.681 -171.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 33.0 t -133.6 -1.86 3.07 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 126.802 2.041 . . . . 0.0 112.092 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -62.24 -20.4 64.19 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 117.515 2.413 . . . . 0.0 117.515 -171.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -140.64 30.76 1.88 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.947 2.099 . . . . 0.0 111.292 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.0 tp -62.97 -19.73 64.58 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.341 -0.85 . . . . 0.0 113.221 -171.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -56.99 -39.5 74.77 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.222 0.919 . . . . 0.0 111.557 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 15.6 t -68.88 -43.63 74.91 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.549 0.74 . . . . 0.0 111.873 173.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.46 -35.01 79.63 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 60.8 mt -70.6 -39.49 76.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.466 1.506 . . . . 0.0 109.479 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -66.66 -33.42 75.6 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.221 -0.924 . . . . 0.0 112.873 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -70.43 -37.86 74.47 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.21 1.004 . . . . 0.0 112.402 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.26 -27.82 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 118.57 0.623 . . . . 0.0 112.451 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 68.5 p -84.8 -25.89 27.87 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 170.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.2 11.76 71.34 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 125.59 1.567 . . . . 0.0 113.855 -171.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 124.56 -174.46 17.07 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 126.565 2.031 . . . . 0.0 112.915 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -76.02 150.46 33.94 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.536 2.824 . . . . 0.0 110.337 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 10.5 mm -108.2 139.94 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -169.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -95.07 174.48 7.06 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 128.009 2.523 . . . . 0.0 114.613 -171.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -138.38 116.27 11.58 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.573 1.149 . . . . 0.0 110.636 -175.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -58.84 -162.71 0.07 OUTLIER Glycine 0 N--CA 1.477 1.381 0 C-N-CA 127.799 2.619 . . . . 0.0 117.056 -174.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -45.7 -37.59 5.99 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.451 1.9 . . . . 0.0 115.556 -175.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -69.65 -24.79 63.68 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.013 1.325 . . . . 0.0 113.913 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 90.37 -4.43 82.52 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 127.228 2.347 . . . . 0.0 115.16 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -156.34 16.87 0.34 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.132 1.373 . . . . 0.0 113.936 -171.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.0 t -85.33 100.1 11.59 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.647 -1.283 . . . . 0.0 110.851 -172.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 14.6 tp -80.26 93.83 5.97 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.615 1.166 . . . . 0.0 109.829 176.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 6.4 pt -63.49 160.0 46.38 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 125.776 1.631 . . . . 0.0 111.826 -173.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -61.91 -32.17 84.86 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.227 1.951 . . . . 0.0 112.596 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -67.67 -32.28 72.85 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 171.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.67 -44.32 90.17 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.508 1.049 . . . . 0.0 112.049 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -61.83 -20.12 63.31 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.01 0.924 . . . . 0.0 113.144 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -76.01 -42.75 47.08 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.557 1.071 . . . . 0.0 112.188 173.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 47.4 mm -58.92 -44.84 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 O-C-N 121.359 -0.838 . . . . 0.0 110.281 171.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.12 -34.68 78.97 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.654 0.782 . . . . 0.0 112.989 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -61.05 -42.12 97.87 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.049 0.94 . . . . 0.0 112.2 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -65.95 -38.47 88.69 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.303 1.041 . . . . 0.0 112.494 175.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 94.8 t -65.06 -42.68 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.167 0.587 . . . . 0.0 111.168 174.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.77 94.95 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.071 0.548 . . . . 0.0 111.875 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -64.08 -40.46 96.29 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.509 0.724 . . . . 0.0 111.988 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -70.96 -30.09 66.28 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.818 0.847 . . . . 0.0 113.092 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.591 HD21 HG11 ' A' ' 255' ' ' VAL . 0.2 OUTLIER -69.2 -43.98 73.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.838 0.855 . . . . 0.0 112.079 169.705 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -63.68 -23.07 67.22 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.014 1.326 . . . . 0.0 113.537 174.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.06 -10.02 59.08 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.275 1.43 . . . . 0.0 114.574 170.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 40.2 t -156.3 66.48 4.29 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 125.702 1.601 . . . . 0.0 109.141 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -64.78 -7.81 15.94 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.922 2.414 . . . . 0.0 111.773 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.91 -21.57 65.99 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.175 1.39 . . . . 0.0 113.017 170.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -107.93 95.22 5.53 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.123 1.369 . . . . 0.0 111.225 -175.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 23.3 mtt180 -49.72 141.21 10.23 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.524 1.13 . . . . 0.0 110.876 167.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.591 HG11 HD21 ' A' ' 247' ' ' LEU . 16.8 m -137.46 166.05 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.892 1.277 . . . . 0.0 111.561 173.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 7.2 t -149.16 146.74 27.81 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 118.387 2.736 . . . . 0.0 118.387 170.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 26.3 mt -100.4 115.02 40.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 124.982 1.313 . . . . 0.0 108.937 -171.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.407 ' HB3' HD12 ' A' ' 300' ' ' LEU . 7.2 m-20 -93.93 155.64 17.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.99 -0.444 . . . . 0.0 110.043 169.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -147.19 152.56 24.69 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 121.7 0.611 . . . . 0.0 113.349 167.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.86 170.43 10.11 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.187 2.595 . . . . 0.0 109.982 -169.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 51.0 p -143.65 160.86 39.93 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.188 2.195 . . . . 0.0 110.485 167.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.94 152.0 28.84 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 122.578 1.18 . . . . 0.0 112.232 168.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -3.85 29.42 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -171.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.93 -16.4 63.83 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.261 1.825 . . . . 0.0 114.931 -173.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.57 -157.78 31.93 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.306 1.431 . . . . 0.0 114.219 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 68.1 m -131.58 143.7 50.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.682 1.593 . . . . 0.0 109.702 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -50.57 -40.17 51.51 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.715 1.206 . . . . 0.0 114.019 -171.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -63.96 -27.19 70.93 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 123.657 0.646 . . . . 0.0 114.113 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 11.3 mm -97.72 -24.51 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.842 1.657 . . . . 0.0 111.767 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -80.42 -32.89 37.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.124 0.97 . . . . 0.0 113.193 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 18.6 mm -55.17 -55.86 34.76 Favored Pre-proline 0 N--CA 1.471 0.588 0 C-N-CA 125.418 1.487 . . . . 0.0 112.298 171.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.84 -30.14 17.71 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 120.721 1.293 . . . . 0.0 112.811 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 16.7 mt -66.02 -44.77 83.72 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 119.778 1.172 . . . . 0.0 112.789 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.33 -37.3 80.4 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 176.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.72 -34.47 75.68 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.249 1.02 . . . . 0.0 111.61 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -63.17 -42.83 99.45 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.293 1.037 . . . . 0.0 110.855 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -60.13 -44.01 95.26 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.875 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.25 -37.28 77.87 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -64.32 -41.36 96.86 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 125.631 1.573 . . . . 0.0 111.576 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 37.0 mm -67.14 -38.72 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 118.785 0.72 . . . . 0.0 110.896 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 99.7 t -68.04 -42.33 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 O-C-N 121.938 -0.476 . . . . 0.0 111.385 177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -65.64 -40.02 92.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.265 0.626 . . . . 0.0 111.305 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.15 -39.25 93.62 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.306 0.642 . . . . 0.0 111.75 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -65.02 -42.95 93.95 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.9 mp -67.53 -39.94 85.06 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.896 0.478 . . . . 0.0 111.41 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 50.7 t -66.65 -39.36 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 123.822 0.849 . . . . 0.0 110.672 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.73 -34.19 76.37 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 176.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -69.04 -38.08 78.95 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.76 -0.638 . . . . 0.0 112.612 170.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 151.46 9.32 0.1 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-O 117.481 -1.733 . . . . 0.0 116.952 168.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.9 130.13 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 120.482 2.141 . . . . 0.0 108.985 176.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.98 135.92 57.75 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.256 -0.902 . . . . 0.0 110.722 172.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -57.34 -29.82 60.73 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.696 1.141 . . . . 0.0 113.859 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.73 -37.26 85.84 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 122.161 -0.611 . . . . 0.0 112.476 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -85.49 -1.34 56.97 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.437 1.495 . . . . 0.0 113.966 -171.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 15.1 tt -139.85 93.64 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 124.92 1.288 . . . . 0.0 111.58 -171.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -85.64 174.2 9.58 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.209 -0.932 . . . . 0.0 110.632 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 38.4 p -136.26 148.77 48.17 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.485 1.114 . . . . 0.0 111.869 172.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 11.1 t -137.33 132.12 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.889 0.876 . . . . 0.0 111.994 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -91.06 104.91 3.22 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.589 1.09 . . . . 0.0 111.761 173.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.407 HD12 ' HB3' ' A' ' 258' ' ' ASN . 39.9 mt -105.38 32.08 4.5 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.989 2.115 . . . . 0.0 110.866 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 2.59 -72.66 0.0 OUTLIER Glycine 0 C--N 1.35 1.325 0 C-N-CA 127.796 2.617 . . . . 0.0 119.543 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 88.2 p -147.35 21.42 1.2 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.245 1.523 . . . . 0.0 113.989 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 9.0 m -66.43 156.38 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 121.083 -1.01 . . . . 0.0 111.618 172.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 35.91 55.64 2.65 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 125.978 1.711 . . . . 0.0 113.769 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -61.57 123.97 13.73 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.212 2.608 . . . . 0.0 112.588 -171.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 47.1 pt -90.7 -3.0 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.512 1.125 . . . . 0.0 113.86 -173.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 318' ' ' ASN . . . -153.08 166.8 31.32 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.81 1.644 . . . . 0.0 111.683 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 79.0 p -70.33 171.2 10.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.801 1.24 . . . . 0.0 113.633 175.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -113.29 3.42 15.94 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.828 1.251 . . . . 0.0 111.453 166.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.33 -21.39 62.06 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.718 1.607 . . . . 0.0 113.647 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 66.0 p -132.38 149.0 71.91 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 124.606 1.162 . . . . 0.0 110.934 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -62.35 -29.62 79.83 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.484 2.789 . . . . 0.0 112.541 176.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.51 -42.38 98.49 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.597 0.759 . . . . 0.0 112.239 171.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -66.25 -39.0 94.26 Favored Glycine 0 C--N 1.336 0.543 0 O-C-N 121.829 -0.544 . . . . 0.0 112.609 175.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -58.92 -46.85 86.93 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.46 0.704 . . . . 0.0 111.096 175.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.12 -40.92 99.01 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.713 0.805 . . . . 0.0 111.864 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -70.63 -12.04 61.31 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.397 1.479 . . . . 0.0 114.131 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 307' ' ' ALA 0.256 49.7 t30 -120.3 3.75 10.82 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.806 1.243 . . . . 0.0 113.958 172.315 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 54.2 mtt180 -83.09 1.48 40.03 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.335 1.454 . . . . 0.0 112.087 164.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.46 156.73 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 131.569 3.947 . . . . 0.0 115.914 -170.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 1.3 m -119.39 141.64 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.116 1.766 . . . . 0.0 110.989 167.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -136.18 166.92 22.29 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.952 1.701 . . . . 0.0 111.438 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 13.7 tt -133.54 142.81 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.199 0.999 . . . . 0.0 112.062 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 47.5 t -138.79 130.34 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.51 0.724 . . . . 0.0 109.726 -171.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 42.7 t -82.26 127.54 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.347 0.659 . . . . 0.0 110.328 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 61.7 t30 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 130.143 3.377 . . . . 0.0 116.38 177.905 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.742 0 CA-C-O 119.171 -0.794 . . . . 0.0 114.424 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.45 -12.99 32.5 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.441 3.427 . . . . 0.0 114.882 -171.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 20.2 t -133.2 -3.01 3.11 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 126.908 2.083 . . . . 0.0 111.878 176.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.67 -20.01 66.13 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -171.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -139.25 31.27 2.15 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.922 2.089 . . . . 0.0 111.35 174.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.7 tp -63.14 -17.1 61.99 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -171.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -53.71 -46.87 70.91 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.601 0.76 . . . . 0.0 111.489 167.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 20.1 t -69.17 -40.76 77.94 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.382 0.673 . . . . 0.0 111.409 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.39 -38.18 89.2 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 59.4 mt -71.98 -36.91 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.741 0.816 . . . . 0.0 109.593 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -65.61 -34.01 77.24 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.131 0.972 . . . . 0.0 112.557 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -70.18 -33.76 72.13 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.913 0.885 . . . . 0.0 112.86 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.0 t -65.54 -44.92 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 118.488 0.586 . . . . 0.0 111.192 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 69.5 p -77.26 -25.53 51.56 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -176.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 66.12 14.71 61.89 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.628 1.585 . . . . 0.0 114.212 -171.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 118.43 -171.83 14.23 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 126.024 1.774 . . . . 0.0 112.831 -172.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -76.5 167.39 25.7 Favored 'Trans proline' 0 CA--C 1.549 1.272 0 C-N-CA 123.682 2.922 . . . . 0.0 111.85 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.94 140.01 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 126.16 1.784 . . . . 0.0 113.143 -168.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -106.73 169.44 8.53 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.109 2.164 . . . . 0.0 115.614 -170.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.457 ' CZ ' ' HG3' ' A' ' 277' ' ' ARG . 92.0 m-85 -143.3 100.89 3.71 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.389 1.075 . . . . 0.0 111.586 -171.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -115.47 -174.45 17.96 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.71 1.624 . . . . 0.0 113.026 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 24.7 t30 50.43 -75.68 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 128.468 2.707 . . . . 0.0 114.527 -171.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -79.39 -25.54 42.12 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.454 1.902 . . . . 0.0 112.894 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.68 0.27 86.21 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.15 1.357 . . . . 0.0 115.542 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -162.21 26.44 0.11 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.519 1.528 . . . . 0.0 113.451 -175.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.8 t -120.32 97.36 5.55 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.356 1.062 . . . . 0.0 110.839 -171.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 18.6 tp -70.11 141.03 52.78 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.472 1.109 . . . . 0.0 113.178 -173.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.435 HG13 ' H ' ' A' ' 236' ' ' ASP . 6.4 pt -83.36 150.63 60.89 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.097 1.759 . . . . 0.0 113.906 -172.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.29 -31.21 73.82 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.48 2.786 . . . . 0.0 112.882 173.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.92 94.87 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.588 0.755 . . . . 0.0 112.384 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.435 ' H ' HG13 ' A' ' 233' ' ' ILE . 36.4 t70 -69.01 -39.96 78.98 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 170.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -60.4 -28.64 68.4 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.469 -1.394 . . . . 0.0 112.683 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -71.96 -41.2 68.0 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.689 -1.257 . . . . 0.0 113.24 170.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 90.8 mt -55.99 -44.13 77.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.042 -1.036 . . . . 0.0 110.134 168.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 31.7 mt -64.37 -32.31 73.87 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.196 0.998 . . . . 0.0 113.177 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -59.68 -42.87 93.89 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.704 1.138 . . . . 0.0 111.996 171.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -72.94 -32.83 65.52 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.149 0.58 . . . . 0.0 112.555 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 69.9 t -67.04 -43.23 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.639 0.775 . . . . 0.0 111.097 172.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.41 -42.44 95.96 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.083 0.553 . . . . 0.0 111.994 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.71 -37.17 85.7 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.362 0.665 . . . . 0.0 112.047 176.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.64 -34.21 73.71 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.919 0.888 . . . . 0.0 112.963 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.18 -45.9 75.56 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.739 0.815 . . . . 0.0 110.213 171.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 53.4 tttp -62.59 -23.39 67.01 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.079 1.751 . . . . 0.0 113.714 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -75.2 -8.35 56.36 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.847 1.659 . . . . 0.0 114.597 170.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 38.2 t -151.95 66.86 6.89 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 126.068 1.747 . . . . 0.0 108.507 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -63.83 -6.61 11.22 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.378 2.719 . . . . 0.0 112.318 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -71.72 -18.52 62.14 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.833 1.653 . . . . 0.0 113.229 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -120.76 87.14 2.7 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.688 1.595 . . . . 0.0 110.525 -172.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 63.7 mtt85 -52.69 158.49 1.3 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.812 1.245 . . . . 0.0 111.955 172.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.5 m -127.73 159.91 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.063 1.345 . . . . 0.0 111.722 174.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.1 m -125.96 138.05 53.73 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.46 1.504 . . . . 0.0 108.619 171.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.4 mt -119.33 121.59 66.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.001 1.32 . . . . 0.0 107.495 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -109.29 151.02 27.12 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.457 0.703 . . . . 0.0 110.288 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -139.84 156.9 25.09 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 122.007 -0.433 . . . . 0.0 112.475 167.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -127.73 169.57 13.69 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.893 2.477 . . . . 0.0 109.111 -170.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.5 m -149.14 153.01 37.08 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 127.366 2.266 . . . . 0.0 108.521 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -61.45 165.7 4.58 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.568 -1.333 . . . . 0.0 111.523 167.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -100.72 20.56 14.98 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -175.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.3 m -71.09 -20.19 62.37 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.816 -1.178 . . . . 0.0 112.943 169.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.09 -151.85 21.33 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 125.885 1.707 . . . . 0.0 113.38 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 8.3 t -139.44 164.35 30.11 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.302 1.441 . . . . 0.0 110.374 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -52.67 -42.17 64.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.975 0.91 . . . . 0.0 112.469 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -68.63 -5.09 42.85 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.436 1.017 . . . . 0.0 115.328 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 6.1 mt -115.79 -33.46 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.417 1.887 . . . . 0.0 111.266 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -86.94 -26.87 23.65 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.464 1.106 . . . . 0.0 113.257 -175.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 19.9 mm -60.0 -53.4 65.57 Favored Pre-proline 0 N--CA 1.469 0.496 0 C-N-CA 124.803 1.241 . . . . 0.0 111.546 168.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.27 -34.8 15.38 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 CA-C-N 120.831 1.333 . . . . 0.0 113.099 176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 17.9 mt -66.18 -44.8 82.98 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 120.345 1.429 . . . . 0.0 112.747 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 34.8 p -65.77 -37.12 85.47 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.74 -39.84 76.54 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.255 0.622 . . . . 0.0 111.716 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -63.22 -40.85 98.64 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.768 1.227 . . . . 0.0 111.037 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.457 ' HG3' ' CZ ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -63.8 -38.63 91.8 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 118.762 0.71 . . . . 0.0 112.143 177.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -72.59 -38.85 67.73 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -67.41 -36.26 80.92 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 125.481 1.513 . . . . 0.0 111.795 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 59.2 mt -62.56 -42.49 96.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 118.805 0.729 . . . . 0.0 110.843 175.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.02 -41.82 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 117.954 0.343 . . . . 0.0 110.952 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.04 97.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -69.14 -36.43 77.45 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.598 0.759 . . . . 0.0 111.158 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -66.44 -42.76 87.16 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.6 mp -64.26 -41.81 96.77 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.02 0.528 . . . . 0.0 111.233 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.04 -37.42 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 123.142 0.577 . . . . 0.0 111.404 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.01 -35.4 76.62 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -69.35 -37.67 77.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.888 0.875 . . . . 0.0 112.855 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 161.91 -1.54 0.07 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 118.093 1.997 . . . . 0.0 118.093 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 4.9 t -76.88 142.73 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 120.015 1.908 . . . . 0.0 110.368 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.13 137.68 47.18 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.679 -1.263 . . . . 0.0 110.858 167.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -57.74 -27.14 58.65 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.384 0.992 . . . . 0.0 113.906 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.63 -30.7 70.87 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.628 1.171 . . . . 0.0 113.21 173.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -88.32 -2.81 58.82 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.007 1.323 . . . . 0.0 114.377 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 5.1 mt -125.81 123.66 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.361 0.982 . . . . 0.0 111.403 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -105.16 159.24 16.01 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.453 1.501 . . . . 0.0 110.64 167.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 40.6 p -134.87 146.01 48.82 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.165 0.986 . . . . 0.0 111.792 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 25.3 t -138.86 130.49 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.112 0.965 . . . . 0.0 111.396 -175.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -87.54 100.93 2.64 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.552 1.072 . . . . 0.0 111.691 172.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 43.2 mt -97.35 33.34 2.01 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.918 2.087 . . . . 0.0 110.065 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 3.64 -72.69 0.0 OUTLIER Glycine 0 C--N 1.351 1.373 0 N-CA-C 120.33 2.892 . . . . 0.0 120.33 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 23.4 p -144.79 17.96 1.63 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.615 1.707 . . . . 0.0 113.892 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.7 m -70.59 161.33 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.059 1.344 . . . . 0.0 112.597 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 38.44 53.56 3.94 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 125.866 1.666 . . . . 0.0 113.269 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -64.34 151.7 84.38 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.658 2.239 . . . . 0.0 113.667 -170.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 45.9 pt -126.44 -3.76 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.901 1.68 . . . . 0.0 113.685 -172.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 318' ' ' ASN . . . -151.74 149.57 29.21 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.134 1.373 . . . . 0.0 111.439 172.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 69.8 m -70.36 147.36 49.66 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.41 1.484 . . . . 0.0 112.078 171.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -82.74 5.98 19.59 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.365 1.066 . . . . 0.0 113.802 173.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.42 -13.98 62.68 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.051 1.34 . . . . 0.0 114.444 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 67.6 p -138.33 147.78 56.85 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 125.713 1.605 . . . . 0.0 110.472 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -63.92 -31.36 67.15 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 123.333 2.689 . . . . 0.0 112.423 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.94 -38.62 91.58 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.605 -0.684 . . . . 0.0 112.413 171.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.38 -36.95 85.36 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 123.767 0.699 . . . . 0.0 112.53 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -58.69 -49.54 77.2 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.528 0.731 . . . . 0.0 110.709 172.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.9 -37.28 86.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.377 0.671 . . . . 0.0 112.349 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -68.05 -17.65 64.46 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.391 1.476 . . . . 0.0 113.831 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 307' ' ' ALA . 7.8 t30 -113.21 -8.09 13.55 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 174.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -74.42 9.71 1.61 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.868 1.667 . . . . 0.0 113.865 167.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.42 153.28 2.23 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.812 2.445 . . . . 0.0 114.8 -170.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 8.3 p -123.32 145.9 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.464 1.506 . . . . 0.0 109.648 168.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -142.98 158.53 43.51 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.413 1.485 . . . . 0.0 112.898 -174.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 20.2 tt -133.08 141.32 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.756 1.623 . . . . 0.0 111.745 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 16.9 t -144.46 133.5 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.365 1.466 . . . . 0.0 109.568 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 38.4 t -70.34 137.63 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.708 0.803 . . . . 0.0 109.893 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.253 1.252 0 C-N-CA 125.275 1.43 . . . . 0.0 111.766 -171.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.73 0 CA-C-O 119.173 -0.793 . . . . 0.0 114.156 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -70.78 -14.54 32.94 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.337 3.358 . . . . 0.0 114.352 -171.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 22.2 t -128.17 -3.24 5.67 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 127.32 2.248 . . . . 0.0 111.666 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.83 -18.55 65.43 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 -171.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -138.46 29.88 2.4 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.022 2.129 . . . . 0.0 111.604 175.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 6.8 tp -63.11 -17.66 62.56 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -53.65 -45.68 70.3 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.057 0.844 . . . . 0.0 111.361 167.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 20.7 t -68.51 -42.03 79.13 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 122.935 0.494 . . . . 0.0 111.616 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.32 -41.42 98.91 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 176.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 66.1 mt -71.56 -35.64 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.994 0.918 . . . . 0.0 109.759 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -68.48 -36.99 79.74 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.987 0.915 . . . . 0.0 112.661 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.99 76.62 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.075 0.95 . . . . 0.0 112.24 175.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 22.5 t -63.06 -41.35 92.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.588 1.155 . . . . 0.0 111.761 173.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 82.3 p -82.92 -19.26 37.63 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 66.12 15.8 63.51 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.961 1.743 . . . . 0.0 114.804 -172.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 129.74 -159.12 22.47 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 125.593 1.568 . . . . 0.0 112.937 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -74.66 171.42 18.22 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.702 2.934 . . . . 0.0 111.785 171.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 28.9 mt -113.39 136.24 50.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.005 1.722 . . . . 0.0 109.193 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -124.03 161.98 24.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.363 1.465 . . . . 0.0 113.005 -172.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -138.23 99.33 3.83 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.021 0.928 . . . . 0.0 111.93 -169.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -74.96 164.7 54.61 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.707 1.146 . . . . 0.0 113.831 -171.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 32.88 -78.02 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 130.238 3.415 . . . . 0.0 116.07 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.75 -28.2 67.43 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.177 1.391 . . . . 0.0 113.164 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 96.97 11.32 53.45 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 116.816 1.486 . . . . 0.0 116.816 167.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -156.68 25.93 0.33 Allowed 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.288 1.435 . . . . 0.0 112.746 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 52.9 m -92.37 90.94 7.44 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.598 1.159 . . . . 0.0 112.56 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.4 mp -68.36 104.33 1.85 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.662 0.785 . . . . 0.0 110.218 171.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.438 HG13 ' H ' ' A' ' 236' ' ' ASP . 21.3 pt -67.24 163.62 44.27 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 125.215 1.406 . . . . 0.0 110.567 173.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.57 -30.47 79.42 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 CA-C-N 121.433 1.548 . . . . 0.0 112.251 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -66.09 -31.59 72.55 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 170.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.438 ' H ' HG13 ' A' ' 233' ' ' ILE . 22.5 t0 -62.4 -54.29 42.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.625 1.102 . . . . 0.0 110.976 170.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -60.51 -29.12 68.89 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.33 -0.856 . . . . 0.0 112.882 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -65.68 -51.17 61.57 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.168 -0.957 . . . . 0.0 112.005 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.5 pp -69.05 -30.29 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 118.348 0.522 . . . . 0.0 111.56 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 60.2 mt -66.49 -36.66 83.3 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.497 0.719 . . . . 0.0 112.348 171.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -40.18 93.3 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.6 -0.688 . . . . 0.0 111.683 173.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -67.63 -37.63 82.74 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 67.9 t -63.36 -44.0 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 119.031 0.832 . . . . 0.0 111.22 173.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.12 -40.62 94.48 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.924 0.489 . . . . 0.0 111.226 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -66.33 -36.49 83.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.674 0.79 . . . . 0.0 112.605 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -70.82 -35.79 72.65 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.708 1.203 . . . . 0.0 112.854 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 11.7 tp -72.62 -38.72 67.68 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.428 1.491 . . . . 0.0 111.737 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -60.14 -28.07 67.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.518 1.927 . . . . 0.0 112.788 172.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -78.38 -5.25 51.74 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.37 1.468 . . . . 0.0 114.468 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 34.0 t -151.62 65.7 6.56 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.1 1.36 . . . . 0.0 108.859 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -65.09 -8.25 17.82 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.216 2.61 . . . . 0.0 111.881 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -70.39 -21.56 62.84 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.744 1.617 . . . . 0.0 113.256 171.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -120.64 90.01 3.24 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.693 1.597 . . . . 0.0 109.621 -173.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 71.8 mtt85 -49.5 153.18 1.17 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.551 1.14 . . . . 0.0 112.167 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.31 160.14 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 123.057 1.408 . . . . 0.0 110.308 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.6 m -138.37 144.73 40.43 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.697 -2.047 . . . . 0.0 110.428 -173.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 57.8 mt -128.7 112.77 27.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.164 1.385 . . . . 0.0 108.429 -172.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.9 153.14 17.91 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.049 0.94 . . . . 0.0 110.645 176.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -152.44 152.7 24.36 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 121.616 -0.677 . . . . 0.0 113.45 169.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -123.9 161.68 24.86 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 127.724 2.41 . . . . 0.0 109.011 -170.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 65.1 m -138.74 143.54 39.08 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.827 2.051 . . . . 0.0 109.376 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . 0.256 2.2 p30 -63.07 150.89 41.48 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 123.57 1.652 . . . . 0.0 114.551 -171.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -71.12 -2.3 15.24 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 113.164 -1.835 . . . . 0.0 115.299 -171.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.7 -15.71 61.68 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.14 0.976 . . . . 0.0 112.919 171.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.48 -165.43 41.31 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 125.312 1.434 . . . . 0.0 114.574 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 69.6 m -139.59 150.81 45.45 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.404 1.882 . . . . 0.0 109.681 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -54.37 -37.93 65.53 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -171.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.93 -26.73 71.46 Favored Glycine 0 CA--C 1.536 1.358 0 O-C-N 121.376 -0.828 . . . . 0.0 114.112 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 21.2 mm -98.01 -26.29 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.778 1.631 . . . . 0.0 112.195 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -88.69 -24.69 22.66 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.35 1.06 . . . . 0.0 113.139 -173.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 15.4 mm -57.92 -54.94 50.21 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 125.003 1.321 . . . . 0.0 111.989 167.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.98 -34.72 13.31 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 CA-C-N 120.723 1.294 . . . . 0.0 112.483 175.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.19 -40.79 86.59 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 120.211 1.369 . . . . 0.0 112.752 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 5.2 m -72.21 -35.17 68.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.314 0.961 . . . . 0.0 113.393 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.75 -39.26 80.41 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.228 0.611 . . . . 0.0 111.761 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -64.74 -38.77 92.13 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 123.812 0.845 . . . . 0.0 111.305 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -63.86 -40.21 96.01 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.747 0.703 . . . . 0.0 111.985 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.83 -37.9 79.5 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -67.33 -35.59 79.71 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.865 1.666 . . . . 0.0 112.425 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 62.7 mt -63.95 -42.28 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 123.329 0.652 . . . . 0.0 110.794 174.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 65.0 t -65.93 -42.64 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 122.067 -0.396 . . . . 0.0 111.111 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.57 -42.45 96.68 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.08 0.552 . . . . 0.0 111.512 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -65.38 -38.86 91.29 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.502 0.721 . . . . 0.0 111.792 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.62 -41.52 88.24 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.9 -42.94 89.57 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.549 0.739 . . . . 0.0 110.888 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.81 -37.02 77.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.479 0.712 . . . . 0.0 110.918 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -68.61 -33.81 74.67 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 33.5 ttt85 -69.0 -40.02 78.98 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.361 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 159.59 0.34 0.08 OUTLIER Glycine 0 CA--C 1.525 0.674 0 N-CA-C 117.514 1.766 . . . . 0.0 117.514 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.1 t -69.57 134.4 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 120.341 2.071 . . . . 0.0 109.455 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.72 138.2 58.45 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.923 -1.111 . . . . 0.0 110.628 169.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.57 -29.73 58.08 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.022 0.82 . . . . 0.0 113.452 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -63.51 -26.51 68.75 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.928 1.291 . . . . 0.0 113.892 173.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 24.3 m170 -98.48 4.25 48.32 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.987 1.715 . . . . 0.0 113.941 -174.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 16.2 mm -119.44 144.64 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.917 1.687 . . . . 0.0 109.255 174.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -136.18 161.13 36.59 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.222 1.809 . . . . 0.0 110.127 168.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 47.4 p -134.32 146.79 50.3 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.139 0.976 . . . . 0.0 111.386 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.0 t -138.85 120.47 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.23 1.012 . . . . 0.0 110.475 -173.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -83.95 99.28 2.21 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.561 1.076 . . . . 0.0 111.174 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 43.4 mt -97.47 31.95 2.39 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.862 2.065 . . . . 0.0 109.758 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 3.31 -72.07 0.0 OUTLIER Glycine 0 C--N 1.352 1.454 0 C-N-CA 128.006 2.717 . . . . 0.0 119.565 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 1.3 t -149.6 25.16 0.86 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.061 1.431 . . . . 0.0 113.152 173.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 14.2 m -67.79 161.08 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 120.921 -1.112 . . . . 0.0 112.149 174.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 39.98 53.94 5.74 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 125.959 1.704 . . . . 0.0 114.416 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.09 138.88 48.96 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.676 2.251 . . . . 0.0 111.597 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 26.0 pt -134.81 4.11 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.581 1.552 . . . . 0.0 113.438 -173.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.88 165.47 32.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.834 1.654 . . . . 0.0 110.689 170.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 18.3 m -116.73 159.47 22.22 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.868 1.667 . . . . 0.0 112.194 -172.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 49.2 p30 -79.42 5.25 13.17 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -67.54 -14.05 62.6 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.305 1.442 . . . . 0.0 114.587 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 42.4 p -138.22 147.8 57.22 Favored Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 126.485 1.914 . . . . 0.0 109.873 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -63.66 -31.3 69.95 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.142 2.561 . . . . 0.0 112.53 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -71.91 -36.4 69.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.876 0.87 . . . . 0.0 112.806 171.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.26 -37.57 94.12 Favored Glycine 0 N--CA 1.469 0.853 0 C-N-CA 124.006 0.812 . . . . 0.0 113.526 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -55.59 -49.97 71.36 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.819 1.248 . . . . 0.0 110.332 169.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.15 84.89 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -66.97 -18.85 65.58 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 174.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . 0.409 0.3 OUTLIER -110.6 17.82 20.32 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 167.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -112.85 10.74 19.12 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 127.264 2.226 . . . . 0.0 113.13 166.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -60.92 160.72 9.27 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -170.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 41.0 t -129.78 145.07 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 127.164 2.186 . . . . 0.0 108.897 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -134.32 155.98 49.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.259 1.424 . . . . 0.0 111.364 -174.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 39.0 mt -136.3 135.77 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.694 1.197 . . . . 0.0 108.903 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 47.7 t -140.66 132.94 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.582 1.553 . . . . 0.0 110.574 -171.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 14.6 p -90.57 125.87 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.002 0.921 . . . . 0.0 111.16 167.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 . . . . . 0 C--O 1.253 1.261 0 C-N-CA 125.792 1.637 . . . . 0.0 113.246 -177.859 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.448 0 CA-C-O 118.997 -0.891 . . . . 0.0 113.405 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -69.82 -18.58 36.63 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 124.113 3.209 . . . . 0.0 113.853 -171.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 44.7 t -120.85 -4.55 9.66 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.282 1.833 . . . . 0.0 112.303 176.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -64.58 -16.37 62.56 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -140.61 46.39 1.79 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.377 2.271 . . . . 0.0 110.955 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.0 mt -55.33 -28.56 54.56 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 118.402 -0.809 . . . . 0.0 112.548 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -54.78 -43.23 72.62 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.526 1.057 . . . . 0.0 111.528 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 19.2 t -69.57 -41.73 75.44 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.431 0.692 . . . . 0.0 111.99 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.68 -38.52 91.28 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 2.7 mm -68.69 -43.24 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -63.0 -38.38 90.94 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.605 -0.684 . . . . 0.0 112.245 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -71.12 -33.35 70.03 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.051 0.94 . . . . 0.0 113.224 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.08 -42.02 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 123.3 0.64 . . . . 0.0 111.409 172.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.8 m -86.34 -22.38 26.72 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 61.23 29.5 71.44 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.84 1.209 . . . . 0.0 113.866 -172.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 97.27 -175.33 30.61 Favored Glycine 0 CA--C 1.541 1.708 0 C-N-CA 125.71 1.624 . . . . 0.0 112.999 -171.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.18 150.34 33.1 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 123.685 2.923 . . . . 0.0 112.909 -174.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 52.5 mt -97.59 141.89 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.07 1.748 . . . . 0.0 110.952 -171.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -109.19 170.12 8.25 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.316 1.846 . . . . 0.0 115.866 -171.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -144.19 110.33 5.43 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.832 1.253 . . . . 0.0 110.372 -171.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -59.02 -166.24 0.14 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.989 1.756 . . . . 0.0 115.545 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -41.98 -39.74 1.98 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.528 1.931 . . . . 0.0 114.785 -175.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -62.1 -28.89 69.94 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.316 1.446 . . . . 0.0 114.363 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 96.0 -10.93 68.0 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.958 1.742 . . . . 0.0 115.687 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -152.57 12.23 0.53 Allowed 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -171.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 69.0 m -78.15 75.34 4.68 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 120.434 -1.416 . . . . 0.0 114.238 -171.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 14.5 tp -69.27 128.77 37.76 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.731 1.612 . . . . 0.0 110.659 171.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -98.81 164.04 17.69 Favored Pre-proline 0 N--CA 1.484 1.258 0 C-N-CA 124.441 1.096 . . . . 0.0 110.91 -171.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -63.81 -29.86 68.33 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.239 1.959 . . . . 0.0 112.985 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.16 90.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.777 0.831 . . . . 0.0 113.134 169.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -66.68 -43.34 84.71 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.457 -0.777 . . . . 0.0 111.468 172.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -61.29 -32.39 72.22 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.436 -0.79 . . . . 0.0 112.484 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -67.34 -41.07 85.82 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.669 -1.27 . . . . 0.0 112.278 172.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 67.7 mt -57.42 -46.03 85.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 O-C-N 121.345 -0.847 . . . . 0.0 110.441 169.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 39.6 mt -64.08 -35.09 79.6 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.436 -0.79 . . . . 0.0 112.906 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -61.16 -37.64 83.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.141 0.976 . . . . 0.0 112.614 173.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 86.5 mtt-85 -70.58 -37.01 73.88 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.687 1.195 . . . . 0.0 112.628 173.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.9 -41.95 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 118.91 0.777 . . . . 0.0 110.771 173.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.72 -38.14 90.0 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.712 0.805 . . . . 0.0 112.274 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.33 -38.11 89.15 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.446 0.698 . . . . 0.0 112.376 172.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -65.71 -34.84 79.14 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.625 0.77 . . . . 0.0 112.696 176.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.524 HD21 HG11 ' A' ' 255' ' ' VAL . 1.8 mm? -66.06 -45.64 80.62 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.98 1.312 . . . . 0.0 111.859 169.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.51 -30.19 70.46 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.551 1.54 . . . . 0.0 112.808 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.17 -9.66 58.8 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.078 1.751 . . . . 0.0 114.563 174.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 16.1 t -155.47 68.36 5.18 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 125.358 1.463 . . . . 0.0 108.885 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -62.62 -6.05 8.22 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.429 2.752 . . . . 0.0 112.679 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -73.17 -19.96 61.0 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.446 1.498 . . . . 0.0 113.324 172.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -115.54 93.91 4.48 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.21 1.404 . . . . 0.0 111.794 -171.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -50.65 147.5 4.66 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.118 1.367 . . . . 0.0 111.684 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.524 HG11 HD21 ' A' ' 247' ' ' LEU . 22.9 m -127.15 160.15 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.882 0.873 . . . . 0.0 111.487 167.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 22.9 m -127.26 139.38 52.95 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.909 1.683 . . . . 0.0 108.362 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 71.4 mt -119.13 123.83 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 124.923 1.289 . . . . 0.0 107.858 -171.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -113.76 148.6 36.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.302 0.641 . . . . 0.0 110.399 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -137.46 156.69 23.66 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 122.106 -0.371 . . . . 0.0 112.696 167.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -127.6 167.34 16.5 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.502 2.321 . . . . 0.0 109.885 -169.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.1 m -151.98 159.73 43.68 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.162 1.785 . . . . 0.0 110.627 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -63.75 163.02 12.32 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.956 -1.09 . . . . 0.0 111.43 166.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -104.98 20.34 19.0 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.564 0.746 . . . . 0.0 112.817 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 16.3 m -69.92 -20.1 63.36 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.809 1.244 . . . . 0.0 112.628 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.6 -150.01 18.1 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 126.156 1.836 . . . . 0.0 113.249 173.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 71.4 m -135.3 162.72 31.79 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.073 1.749 . . . . 0.0 110.09 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -52.62 -41.16 63.45 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.984 0.914 . . . . 0.0 112.968 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -67.9 -4.39 33.93 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.672 1.13 . . . . 0.0 115.238 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 6.2 mt -116.55 -33.0 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.932 2.093 . . . . 0.0 111.172 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -81.53 -31.22 32.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.555 1.142 . . . . 0.0 112.919 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 23.4 mm -60.52 -54.17 57.47 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.322 1.449 . . . . 0.0 111.761 170.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.54 -32.6 24.43 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 CA-C-N 121.065 1.416 . . . . 0.0 113.333 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 26.3 mt -67.88 -43.8 78.5 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.347 1.43 . . . . 0.0 113.124 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 28.5 p -66.46 -37.54 85.36 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.14 -38.09 78.62 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.556 0.742 . . . . 0.0 111.967 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -65.19 -38.76 91.51 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 125.129 1.372 . . . . 0.0 111.036 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -45.62 90.42 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.52 0.6 . . . . 0.0 111.877 173.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.38 -36.17 76.53 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -68.34 -36.51 79.36 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 125.758 1.623 . . . . 0.0 111.97 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 58.9 mt -63.55 -43.07 98.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 118.788 0.722 . . . . 0.0 110.625 174.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 57.4 t -66.89 -42.62 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.753 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.07 -41.7 99.5 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.026 0.53 . . . . 0.0 111.743 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.85 -38.84 87.14 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.121 0.568 . . . . 0.0 111.501 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -68.27 -40.68 81.8 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.3 mp -64.88 -43.68 92.15 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.302 0.641 . . . . 0.0 111.005 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 55.1 t -67.73 -37.22 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 O-C-N 121.758 -0.589 . . . . 0.0 111.088 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.95 -34.0 72.85 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -42.99 86.19 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.817 0.847 . . . . 0.0 111.591 171.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 161.08 -0.95 0.07 OUTLIER Glycine 0 CA--C 1.528 0.871 0 N-CA-C 117.413 1.725 . . . . 0.0 117.413 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.4 t -72.48 136.15 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 120.514 2.157 . . . . 0.0 109.814 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.59 140.75 56.93 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 120.946 -1.096 . . . . 0.0 110.641 168.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.21 -27.31 52.15 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.399 1.0 . . . . 0.0 113.694 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -61.68 -30.14 70.54 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.822 1.249 . . . . 0.0 113.538 173.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -92.77 -0.71 57.22 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.606 1.562 . . . . 0.0 113.968 -174.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 25.0 mm -121.04 141.12 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.825 1.65 . . . . 0.0 109.501 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -135.09 161.37 35.52 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.733 1.613 . . . . 0.0 110.253 167.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 45.6 p -137.02 146.39 45.23 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.942 0.897 . . . . 0.0 112.372 -175.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 35.3 t -141.35 133.63 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.571 1.148 . . . . 0.0 111.118 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -89.5 100.3 2.65 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.508 1.051 . . . . 0.0 111.801 172.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 38.2 mt -95.58 32.13 1.87 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.707 2.003 . . . . 0.0 110.618 174.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 3.18 -70.34 0.0 OUTLIER Glycine 0 C--N 1.35 1.329 0 N-CA-C 120.366 2.906 . . . . 0.0 120.366 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 94.3 p -144.53 13.76 1.56 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.769 1.284 . . . . 0.0 114.281 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 17.1 m -70.27 157.97 6.36 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 O-C-N 121.025 -1.047 . . . . 0.0 111.768 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 39.46 52.09 4.03 Favored Pre-proline 0 CA--C 1.557 1.23 0 C-N-CA 125.259 1.424 . . . . 0.0 114.119 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.18 112.73 1.78 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.38 2.72 . . . . 0.0 111.767 -171.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.538 ' H ' HD12 ' A' ' 306' ' ' ILE . 1.4 mp -71.02 -20.67 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 124.46 1.104 . . . . 0.0 112.476 -171.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -150.5 160.26 43.9 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.865 1.666 . . . . 0.0 112.376 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 49.6 m -71.19 151.25 44.55 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.177 1.791 . . . . 0.0 113.767 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -82.85 1.69 38.02 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.86 -14.4 63.01 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 40.6 p -141.42 147.58 47.06 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 126.326 1.85 . . . . 0.0 110.296 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -63.25 -32.58 73.22 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.166 2.577 . . . . 0.0 112.53 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -68.05 -36.45 79.89 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 173.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -70.2 -38.04 72.12 Favored Glycine 0 N--CA 1.467 0.722 0 C-N-CA 123.415 0.531 . . . . 0.0 113.361 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -57.63 -49.1 77.54 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 123.752 0.821 . . . . 0.0 109.975 171.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.17 84.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.57 0.748 . . . . 0.0 112.698 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -72.66 -12.74 61.15 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.225 1.41 . . . . 0.0 113.696 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.32 -12.5 15.04 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 170.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -81.96 2.48 30.56 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 126.571 1.948 . . . . 0.0 114.502 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 35.0 mtm180 -57.89 160.87 4.29 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -169.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.88 144.12 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.278 1.831 . . . . 0.0 109.954 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -139.7 159.41 42.23 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.137 1.375 . . . . 0.0 113.194 -173.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 4.5 mp -131.95 132.86 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.768 1.627 . . . . 0.0 108.71 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 21.4 t -140.58 138.52 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.635 1.574 . . . . 0.0 109.552 -171.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 22.4 t -69.7 135.81 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.029 -1.044 . . . . 0.0 110.429 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.5 t30 . . . . . 0 C--O 1.252 1.201 0 C-N-CA 125.143 1.377 . . . . 0.0 113.319 -177.901 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.728 0 CA-C-O 119.191 -0.783 . . . . 0.0 114.221 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -69.7 -15.34 37.27 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.323 3.349 . . . . 0.0 114.655 -171.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 22.0 t -128.91 -2.57 5.23 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 126.817 2.047 . . . . 0.0 111.776 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.64 -18.8 65.56 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -171.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -137.77 30.44 2.55 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.934 2.093 . . . . 0.0 111.52 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 6.9 tp -63.49 -16.58 61.1 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 121.521 -0.737 . . . . 0.0 112.949 -173.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -53.58 -45.6 70.02 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.954 0.797 . . . . 0.0 111.465 167.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 21.5 t -69.27 -42.77 75.09 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.292 0.637 . . . . 0.0 111.306 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.93 85.97 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 53.6 mt -73.53 -36.04 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.522 0.729 . . . . 0.0 109.659 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -65.08 -42.49 94.08 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.061 -1.024 . . . . 0.0 112.006 172.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.06 -37.56 87.97 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.947 0.899 . . . . 0.0 112.821 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.69 -28.36 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 118.354 0.525 . . . . 0.0 112.227 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.7 m -75.16 -26.5 59.16 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.094 0.958 . . . . 0.0 112.136 170.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.37 25.83 75.08 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.111 1.339 . . . . 0.0 113.65 -171.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 96.24 -176.71 33.13 Favored Glycine 0 CA--C 1.542 1.732 0 C-N-CA 125.532 1.539 . . . . 0.0 113.394 -172.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.24 147.83 33.58 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.834 3.023 . . . . 0.0 111.416 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -102.42 140.99 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -169.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -107.44 169.03 8.83 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.693 2.397 . . . . 0.0 113.763 -172.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -142.55 116.1 9.12 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.475 1.11 . . . . 0.0 110.608 -171.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -58.42 -170.22 0.24 Allowed Glycine 0 CA--C 1.535 1.302 0 C-N-CA 126.117 1.817 . . . . 0.0 116.39 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -46.43 -40.91 13.01 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.46 1.504 . . . . 0.0 115.017 -174.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.11 -33.27 71.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.396 1.478 . . . . 0.0 113.808 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 105.49 -5.06 40.55 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 117.02 1.568 . . . . 0.0 117.02 167.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -166.44 28.12 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 119.471 1.635 . . . . 0.0 113.038 -171.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 16.5 t -98.11 93.58 6.35 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.634 -1.291 . . . . 0.0 111.511 -171.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.0 mp -71.31 113.92 8.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.886 0.874 . . . . 0.0 109.82 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 11.8 pt -70.77 164.09 58.7 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 124.366 1.066 . . . . 0.0 110.23 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.25 -31.28 74.21 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 CA-C-N 121.942 1.729 . . . . 0.0 112.371 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -66.17 -32.35 73.74 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 170.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -59.03 -53.05 62.8 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.748 1.158 . . . . 0.0 110.697 171.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -58.59 -33.77 70.35 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.716 0.807 . . . . 0.0 112.611 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -66.24 -44.75 82.84 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.419 1.009 . . . . 0.0 112.505 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 34.2 mm -58.44 -43.61 87.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 121.589 -0.694 . . . . 0.0 110.747 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.13 -32.26 72.83 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.709 -0.619 . . . . 0.0 112.62 174.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -63.85 -41.38 97.82 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.578 1.151 . . . . 0.0 112.411 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -67.52 -38.69 84.61 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.423 1.089 . . . . 0.0 112.335 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 79.7 t -62.96 -45.03 99.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 123.507 0.723 . . . . 0.0 110.538 174.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.82 -36.84 84.52 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.155 0.582 . . . . 0.0 112.146 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.17 -39.29 92.71 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 172.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -65.62 -35.13 79.9 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.753 0.821 . . . . 0.0 112.73 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.462 ' CD2' HG11 ' A' ' 255' ' ' VAL . 97.0 mt -69.67 -41.6 75.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.44 1.096 . . . . 0.0 112.039 172.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.03 -23.93 67.68 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.392 1.877 . . . . 0.0 113.089 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.91 -8.75 57.94 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.536 1.534 . . . . 0.0 114.588 171.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 36.2 t -153.61 67.29 6.01 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.222 1.409 . . . . 0.0 108.85 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -64.68 -7.22 14.05 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.119 2.546 . . . . 0.0 112.013 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -70.14 -19.42 63.22 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.51 1.524 . . . . 0.0 113.215 171.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -118.99 89.88 3.22 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.513 1.525 . . . . 0.0 110.52 -172.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -51.53 150.97 3.38 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.04 1.336 . . . . 0.0 111.453 172.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.462 HG11 ' CD2' ' A' ' 247' ' ' LEU . 17.3 m -134.38 161.34 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.449 0.7 . . . . 0.0 112.669 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 20.8 m -128.03 137.37 52.17 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.153 1.381 . . . . 0.0 109.415 -178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.0 118.19 57.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.663 1.585 . . . . 0.0 107.7 -173.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.556 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 0.2 OUTLIER -98.98 151.19 21.17 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.022 1.329 . . . . 0.0 109.406 -178.023 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -152.01 155.49 26.16 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 121.491 -0.756 . . . . 0.0 113.912 168.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -132.53 168.4 18.29 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 129.033 2.933 . . . . 0.0 109.352 -170.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 31.2 m -145.27 151.56 38.56 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 127.102 2.161 . . . . 0.0 109.187 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -63.32 160.67 15.44 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 123.172 1.463 . . . . 0.0 113.574 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -83.04 7.87 14.49 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 113.993 -1.458 . . . . 0.0 114.927 -170.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.6 m -75.11 -15.26 60.61 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 120.993 -1.067 . . . . 0.0 113.508 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -95.24 -157.83 32.5 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.286 1.422 . . . . 0.0 114.595 -176.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 7.6 t -135.18 162.37 32.7 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.69 1.596 . . . . 0.0 110.371 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -52.84 -41.44 64.24 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.124 0.97 . . . . 0.0 112.796 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -67.83 -6.49 44.46 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 124.428 1.014 . . . . 0.0 115.238 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 4.2 mt -115.75 -33.63 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 126.644 1.978 . . . . 0.0 111.294 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -87.41 -24.35 24.23 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 18.3 mm -58.51 -54.06 59.87 Favored Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 124.531 1.132 . . . . 0.0 111.804 167.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.49 -33.23 11.12 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 120.579 1.243 . . . . 0.0 112.906 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 19.1 mt -65.11 -46.78 79.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 120.282 1.401 . . . . 0.0 112.092 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 24.2 m -70.87 -29.86 66.07 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -74.66 -34.96 62.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.788 0.835 . . . . 0.0 112.075 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -65.57 -39.89 92.15 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.027 0.931 . . . . 0.0 111.677 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.22 -43.17 98.87 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.271 0.942 . . . . 0.0 110.755 176.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.5 -37.98 86.25 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.27 -38.91 88.93 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.525 1.53 . . . . 0.0 112.036 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 74.1 mt -66.13 -39.52 84.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 122.688 0.395 . . . . 0.0 110.879 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.59 -44.75 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 O-C-N 121.972 -0.455 . . . . 0.0 110.906 173.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.92 -42.23 97.7 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.4 0.68 . . . . 0.0 111.662 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -66.72 -38.29 86.41 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.013 0.525 . . . . 0.0 111.897 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -68.81 -40.8 79.34 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.15 -43.22 95.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.328 0.651 . . . . 0.0 110.975 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 55.7 t -67.34 -37.46 79.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 O-C-N 121.753 -0.592 . . . . 0.0 111.257 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.43 -34.42 74.42 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -42.26 87.19 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.811 0.844 . . . . 0.0 111.796 172.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 161.64 -1.61 0.07 OUTLIER Glycine 0 CA--C 1.527 0.831 0 N-CA-C 117.473 1.749 . . . . 0.0 117.473 176.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 2.7 t -73.96 137.76 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 120.523 2.162 . . . . 0.0 109.493 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.78 137.91 58.07 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.655 -1.278 . . . . 0.0 110.461 168.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.8 -29.67 58.82 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.055 0.836 . . . . 0.0 113.456 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.44 -26.51 68.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.131 1.372 . . . . 0.0 113.782 173.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -97.25 2.23 50.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.801 1.641 . . . . 0.0 113.955 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 20.2 mm -119.64 141.78 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.699 1.6 . . . . 0.0 109.447 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -136.84 165.27 26.34 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.041 1.737 . . . . 0.0 110.535 169.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 44.6 p -136.02 145.68 46.33 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.277 1.031 . . . . 0.0 112.258 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 70.3 t -138.98 133.95 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.052 1.341 . . . . 0.0 110.919 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -103.24 105.32 2.67 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 126.131 1.825 . . . . 0.0 112.21 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.556 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 1.1 mp -103.94 32.8 3.73 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 129.138 2.975 . . . . 0.0 109.752 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 7.45 -73.92 0.0 OUTLIER Glycine 0 C--N 1.349 1.257 0 N-CA-C 119.467 2.547 . . . . 0.0 119.467 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 57.9 p -148.14 22.53 1.08 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.483 1.641 . . . . 0.0 114.435 172.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.7 m -70.13 159.55 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.092 1.357 . . . . 0.0 111.917 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 23.2 m120 39.76 52.74 4.75 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 125.062 1.345 . . . . 0.0 112.932 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -59.64 132.18 44.23 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.012 2.475 . . . . 0.0 113.674 -170.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 4.8 mp -77.13 -25.89 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 125.042 1.337 . . . . 0.0 111.586 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -157.53 153.66 27.33 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.664 1.986 . . . . 0.0 111.822 -172.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 66.7 m -66.42 150.42 48.93 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.179 1.392 . . . . 0.0 112.48 170.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -84.49 11.13 9.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.786 1.235 . . . . 0.0 113.854 174.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -67.18 -18.36 65.23 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -176.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 66.7 p -140.66 151.4 63.22 Favored Pre-proline 0 N--CA 1.474 0.744 0 C-N-CA 125.901 1.681 . . . . 0.0 110.141 176.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -61.94 -28.31 80.77 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.199 2.599 . . . . 0.0 112.601 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.0 -42.14 94.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.856 0.862 . . . . 0.0 112.554 172.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.14 -38.17 87.8 Favored Glycine 0 N--CA 1.465 0.619 0 O-C-N 121.791 -0.568 . . . . 0.0 112.787 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -57.99 -47.42 83.03 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.244 0.618 . . . . 0.0 110.526 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.85 -39.91 93.5 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.184 0.594 . . . . 0.0 112.537 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -68.61 -16.51 63.87 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.486 1.114 . . . . 0.0 113.816 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -115.86 -1.36 12.61 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 125.514 1.526 . . . . 0.0 114.517 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -82.68 3.95 26.94 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 126.136 1.774 . . . . 0.0 113.023 166.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.88 158.81 0.64 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 130.118 3.367 . . . . 0.0 117.144 -169.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 2.3 m -122.46 148.61 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 126.326 1.85 . . . . 0.0 111.656 166.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -130.08 166.26 20.53 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.84 2.056 . . . . 0.0 110.891 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 13.1 tt -140.74 144.0 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.524 1.13 . . . . 0.0 111.919 172.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 23.3 t -144.68 136.48 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.343 1.457 . . . . 0.0 110.187 -174.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.09 136.23 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.11 0.964 . . . . 0.0 110.754 174.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.576 1.55 . . . . 0.0 113.731 -178.556 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.49 0 CA-C-O 118.91 -0.939 . . . . 0.0 113.87 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -69.52 -19.98 36.56 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.995 3.13 . . . . 0.0 114.091 -171.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 9.9 t -122.57 -2.75 8.87 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 126.519 1.928 . . . . 0.0 111.762 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.54 -21.25 60.43 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 -171.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -137.48 38.56 2.46 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.516 2.326 . . . . 0.0 109.945 174.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 23.8 tp -61.13 -19.83 61.97 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.46 1.104 . . . . 0.0 113.796 -171.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -57.2 -46.31 82.99 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.74 -0.6 . . . . 0.0 111.843 169.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 22.8 t -68.66 -43.86 75.3 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 122.977 0.511 . . . . 0.0 111.284 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -71.57 -25.45 62.21 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 67.3 mt -83.07 -35.55 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 119.61 1.095 . . . . 0.0 110.627 171.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -63.44 -41.97 98.68 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.819 -1.175 . . . . 0.0 111.83 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.4 -36.34 83.67 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.212 1.005 . . . . 0.0 113.187 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.83 -27.72 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.9 m -80.38 -27.79 38.11 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.269 1.027 . . . . 0.0 112.437 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 69.95 25.69 75.27 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.02 1.295 . . . . 0.0 113.854 -172.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 88.88 -166.97 34.34 Favored Glycine 0 CA--C 1.54 1.656 0 C-N-CA 124.87 1.224 . . . . 0.0 113.57 -173.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.33 163.06 40.38 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.721 2.947 . . . . 0.0 112.312 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 19.3 mm -120.74 144.58 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.171 1.389 . . . . 0.0 111.069 -171.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -111.69 167.47 10.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.954 2.102 . . . . 0.0 113.115 -172.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -140.51 101.83 4.19 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.908 0.883 . . . . 0.0 111.803 -170.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -87.52 -178.26 48.23 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.541 1.067 . . . . 0.0 113.981 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 51.6 t30 36.17 -81.34 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 130.375 3.47 . . . . 0.0 115.796 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -71.13 -22.85 62.02 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.295 1.438 . . . . 0.0 114.084 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 89.2 10.23 66.36 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.918 1.247 . . . . 0.0 115.019 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -154.71 25.31 0.45 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 126.968 2.107 . . . . 0.0 112.105 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 58.2 m -81.67 81.84 7.6 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.878 1.271 . . . . 0.0 112.888 -171.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.76 101.33 0.47 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.689 0.756 . . . . 0.0 110.817 169.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.592 HG13 ' H ' ' A' ' 236' ' ' ASP . 9.8 pt -61.79 154.86 64.94 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.768 1.627 . . . . 0.0 112.491 173.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -62.56 -31.3 80.01 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.344 2.029 . . . . 0.0 112.184 174.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.5 90.65 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.791 0.836 . . . . 0.0 112.858 170.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.592 ' H ' HG13 ' A' ' 233' ' ' ILE . 21.9 t70 -62.61 -49.56 74.74 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.436 -0.79 . . . . 0.0 111.321 172.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -59.88 -30.24 68.86 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.166 -0.959 . . . . 0.0 112.912 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -70.72 -44.54 66.68 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 120.785 -1.197 . . . . 0.0 112.805 172.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 21.4 mm -57.89 -45.57 87.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.231 -0.918 . . . . 0.0 110.938 172.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.4 -32.07 73.5 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.954 0.902 . . . . 0.0 112.539 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -61.86 -42.55 99.19 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.088 0.955 . . . . 0.0 111.882 173.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -67.79 -35.65 79.03 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 87.9 t -64.45 -44.39 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.497 0.59 . . . . 0.0 110.916 173.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.81 89.86 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.422 0.689 . . . . 0.0 111.989 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.78 -39.13 93.51 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.122 0.569 . . . . 0.0 112.065 175.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -71.56 -30.68 66.15 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 79.3 mt -71.32 -40.76 70.56 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.976 0.911 . . . . 0.0 112.266 170.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -60.06 -27.05 66.64 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.121 1.368 . . . . 0.0 112.669 173.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -80.95 -6.96 59.37 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.11 1.764 . . . . 0.0 115.036 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 22.2 t -153.47 67.27 6.08 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.235 1.414 . . . . 0.0 108.862 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -63.84 -7.1 12.26 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.216 2.611 . . . . 0.0 112.39 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -71.28 -19.27 62.36 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.591 1.556 . . . . 0.0 113.24 171.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -117.88 89.04 3.04 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.543 1.537 . . . . 0.0 110.578 -173.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 68.1 mtt85 -53.26 155.45 2.72 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.544 1.138 . . . . 0.0 111.676 171.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 20.9 m -128.29 165.49 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.36 1.064 . . . . 0.0 111.844 171.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 30.2 m -127.98 137.14 52.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.403 1.481 . . . . 0.0 108.798 173.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.7 mt -113.69 117.32 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.421 ' HB3' HD12 ' A' ' 300' ' ' LEU . 21.5 m-20 -102.49 156.82 17.35 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.323 0.649 . . . . 0.0 110.426 175.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -148.52 154.95 26.16 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 122.178 -0.326 . . . . 0.0 112.836 167.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -128.16 163.41 24.73 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 127.539 2.336 . . . . 0.0 109.918 -169.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 73.1 p -148.63 173.67 12.94 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.917 2.487 . . . . 0.0 110.392 170.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -72.15 158.36 36.06 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.458 -1.401 . . . . 0.0 113.001 -173.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -84.97 -9.64 57.86 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.695 1.198 . . . . 0.0 113.168 -172.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -22.66 67.02 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.382 2.273 . . . . 0.0 115.527 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -74.98 -143.24 0.93 Allowed Glycine 0 CA--C 1.54 1.615 0 C-N-CA 126.448 1.975 . . . . 0.0 115.358 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 26.3 t -149.59 137.15 20.1 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.868 1.667 . . . . 0.0 109.723 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -53.17 -34.02 55.1 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -65.59 -22.74 70.01 Favored Glycine 0 CA--C 1.537 1.428 0 O-C-N 121.435 -0.791 . . . . 0.0 114.21 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 16.9 mm -100.59 -32.33 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 126.496 1.918 . . . . 0.0 112.188 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -82.71 -27.36 31.23 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.8 mm -57.65 -55.35 45.7 Favored Pre-proline 0 N--CA 1.469 0.515 0 C-N-CA 124.722 1.209 . . . . 0.0 112.206 169.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.38 -30.26 15.71 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 CA-C-N 120.468 1.203 . . . . 0.0 112.713 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.6 mp -64.42 -51.12 64.77 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 120.228 1.377 . . . . 0.0 111.833 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.3 m -69.34 -32.31 71.32 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.071 -0.651 . . . . 0.0 112.544 -176.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.64 -38.66 80.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 174.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -67.69 -38.23 83.41 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.424 0.689 . . . . 0.0 111.594 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 66.5 mmt-85 -61.1 -44.14 97.81 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.959 0.8 . . . . 0.0 111.275 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.77 -37.57 79.43 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -66.58 -37.87 85.83 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 125.376 1.47 . . . . 0.0 111.733 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 19.3 mm -65.98 -39.06 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.62 0.645 . . . . 0.0 111.268 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 38.3 t -64.92 -46.09 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.322 0.51 . . . . 0.0 110.592 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -61.11 -41.52 96.84 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.304 0.642 . . . . 0.0 111.616 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.05 -36.97 84.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.554 1.142 . . . . 0.0 111.47 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -63.63 -45.01 92.18 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.6 mp -69.07 -37.06 78.28 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.977 0.418 . . . . 0.0 111.672 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.84 -37.01 76.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.942 0.897 . . . . 0.0 111.013 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.97 -35.0 79.0 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 20.9 ttt85 -69.05 -35.52 76.66 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 170.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 151.34 4.54 0.18 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 116.935 1.534 . . . . 0.0 116.935 167.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.8 t -69.49 136.01 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 120.046 1.923 . . . . 0.0 108.964 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.32 138.88 58.68 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.979 -1.076 . . . . 0.0 110.528 172.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.75 -29.85 58.89 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.013 0.816 . . . . 0.0 113.317 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.28 -28.68 69.89 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.857 1.263 . . . . 0.0 113.648 173.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -93.36 -2.2 55.04 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.471 1.508 . . . . 0.0 114.217 -174.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 9.0 mt -129.04 108.09 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.518 1.127 . . . . 0.0 110.155 175.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -88.69 161.92 16.57 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.028 0.931 . . . . 0.0 110.323 167.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 35.5 p -135.41 144.37 46.49 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.192 0.997 . . . . 0.0 111.452 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 30.2 t -138.0 129.81 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.56 0.744 . . . . 0.0 111.32 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -84.85 96.1 2.01 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.518 1.056 . . . . 0.0 111.112 170.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.421 HD12 ' HB3' ' A' ' 258' ' ' ASN . 47.6 mt -88.54 30.14 0.93 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.552 1.941 . . . . 0.0 109.97 171.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 6.86 -74.97 0.0 OUTLIER Glycine 0 C--N 1.354 1.554 0 C-N-CA 128.191 2.805 . . . . 0.0 119.769 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 95.1 p -149.6 23.79 0.89 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.583 1.192 . . . . 0.0 113.252 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 7.3 m -71.26 158.63 6.12 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 C-N-CA 124.509 1.124 . . . . 0.0 111.498 173.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 39.42 54.24 5.28 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 125.514 1.526 . . . . 0.0 114.288 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.09 139.08 59.42 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.689 2.259 . . . . 0.0 111.626 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 17.8 pt -134.59 6.81 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.925 1.29 . . . . 0.0 114.314 -171.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.451 ' HB3' ' HB2' ' A' ' 318' ' ' ASN . . . -146.54 140.08 25.89 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.485 1.114 . . . . 0.0 110.62 167.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 51.0 m -71.05 143.61 50.65 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.425 1.49 . . . . 0.0 113.126 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -74.23 1.69 10.81 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 171.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.07 -17.26 63.23 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.053 1.341 . . . . 0.0 114.617 -175.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 67.9 p -140.47 150.94 62.51 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 125.49 1.516 . . . . 0.0 110.581 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -62.12 -30.06 81.85 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.25 2.633 . . . . 0.0 112.576 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -64.53 -44.42 90.92 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.575 0.75 . . . . 0.0 112.344 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.73 -35.46 85.58 Favored Glycine 0 CA--C 1.524 0.613 0 O-C-N 121.84 -0.538 . . . . 0.0 112.839 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -59.52 -49.35 78.11 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.073 0.949 . . . . 0.0 111.173 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.03 85.76 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.0 0.52 . . . . 0.0 111.969 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -71.12 -23.37 62.08 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.329 1.452 . . . . 0.0 114.302 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 307' ' ' ALA . 7.2 t30 -99.82 -18.14 17.31 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 119.656 1.116 . . . . 0.0 112.866 172.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -71.96 13.63 0.28 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.317 1.447 . . . . 0.0 114.337 170.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -61.86 163.8 7.14 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.206 1.802 . . . . 0.0 115.662 -170.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 28.9 m -125.29 151.52 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.941 1.696 . . . . 0.0 110.158 167.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -145.48 147.5 32.24 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.36 1.064 . . . . 0.0 111.919 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.3 132.52 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.171 1.388 . . . . 0.0 109.404 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 21.8 t -140.88 133.97 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.211 1.405 . . . . 0.0 109.895 -172.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.18 141.27 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 121.409 -0.807 . . . . 0.0 110.342 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.285 1.434 . . . . 0.0 111.864 -171.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.749 0 CA-C-O 119.04 -0.866 . . . . 0.0 114.833 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.51 -19.07 28.86 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.84 3.027 . . . . 0.0 113.854 -172.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 43.3 t -121.38 -7.43 9.25 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.948 2.099 . . . . 0.0 111.998 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -63.76 -16.04 60.15 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.354 1.462 . . . . 0.0 114.861 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -137.21 41.33 2.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.4 2.28 . . . . 0.0 111.167 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 9.0 mt -46.82 -38.52 10.35 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.67 0.788 . . . . 0.0 111.822 172.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -59.95 -38.53 82.72 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.995 0.518 . . . . 0.0 111.956 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.2 t -68.78 -48.08 64.56 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.465 0.706 . . . . 0.0 112.061 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.9 85.51 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 177.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 90.8 mt -75.05 -34.54 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.335 1.054 . . . . 0.0 110.091 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -65.87 -41.28 91.79 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.816 -1.177 . . . . 0.0 111.712 172.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.91 -36.03 83.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.725 0.81 . . . . 0.0 113.153 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.4 p -80.06 -27.34 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.2 m -88.39 -25.75 22.53 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.534 1.134 . . . . 0.0 113.03 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.77 24.68 75.48 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.348 1.452 . . . . 0.0 114.061 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 101.57 -162.34 17.73 Favored Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.346 1.451 . . . . 0.0 112.54 -171.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -73.15 168.2 25.35 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.716 2.944 . . . . 0.0 112.561 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 40.9 mm -112.79 114.46 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.46 1.504 . . . . 0.0 110.63 -173.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -81.66 173.23 12.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.806 2.042 . . . . 0.0 112.671 171.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -118.7 151.68 37.53 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.859 0.864 . . . . 0.0 110.735 -173.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -59.66 165.73 10.44 Favored Glycine 0 CA--C 1.543 1.843 0 O-C-N 120.875 -1.141 . . . . 0.0 110.892 165.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -48.91 -22.33 0.82 Allowed 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 117.036 2.235 . . . . 0.0 117.036 -171.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -59.28 -22.46 61.2 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.582 1.553 . . . . 0.0 114.666 170.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.71 9.39 74.94 Favored Glycine 0 CA--C 1.543 1.827 0 C-N-CA 124.977 1.275 . . . . 0.0 114.79 -176.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -159.72 -5.82 0.06 Allowed 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 118.918 2.932 . . . . 0.0 118.918 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.6 m -72.43 81.72 1.06 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 122.355 2.343 . . . . 0.0 114.368 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 16.5 tp -63.75 109.61 1.77 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.422 2.289 . . . . 0.0 111.07 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.614 HG13 ' H ' ' A' ' 236' ' ' ASP . 10.4 pt -71.93 159.33 85.75 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 124.655 1.182 . . . . 0.0 112.853 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.97 -29.17 87.48 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.493 2.129 . . . . 0.0 112.17 174.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.95 98.1 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 169.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.614 ' H ' HG13 ' A' ' 233' ' ' ILE . 94.4 m-20 -66.27 -41.35 90.02 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.515 -0.741 . . . . 0.0 112.108 173.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -60.94 -32.16 71.68 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.282 -0.886 . . . . 0.0 112.404 172.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -69.89 -42.87 72.86 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.353 -1.467 . . . . 0.0 112.222 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 65.9 mt -56.7 -47.2 82.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.63 -0.669 . . . . 0.0 110.398 171.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.99 -30.97 72.0 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.493 0.717 . . . . 0.0 112.869 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -64.39 -43.08 95.58 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.588 -0.695 . . . . 0.0 111.824 174.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -64.32 -39.26 93.56 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.004 0.922 . . . . 0.0 112.082 175.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 70.0 t -65.36 -41.56 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.961 0.904 . . . . 0.0 111.601 175.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.08 95.74 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.237 0.615 . . . . 0.0 111.791 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -65.27 -39.01 92.04 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.817 0.847 . . . . 0.0 111.995 175.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -65.95 -35.68 81.26 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.756 0.822 . . . . 0.0 112.568 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 16.8 tp -73.57 -39.63 64.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.189 0.996 . . . . 0.0 112.157 173.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -60.71 -28.53 68.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.392 1.477 . . . . 0.0 112.497 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -75.94 -7.5 54.72 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.046 1.738 . . . . 0.0 114.788 173.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 24.3 t -150.69 68.93 8.5 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.435 1.494 . . . . 0.0 108.59 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -62.13 -7.1 9.23 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.459 2.773 . . . . 0.0 112.493 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -73.16 -18.03 61.31 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.737 1.615 . . . . 0.0 113.277 174.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -124.93 79.65 1.8 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.042 1.337 . . . . 0.0 111.306 -171.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -48.72 159.66 0.22 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.332 1.853 . . . . 0.0 113.104 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.3 162.28 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-O 121.712 0.768 . . . . 0.0 112.336 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.3 m -127.68 137.16 52.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.409 1.484 . . . . 0.0 108.993 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 94.3 mt -113.09 119.98 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 125.418 1.487 . . . . 0.0 107.689 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.529 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 0.5 OUTLIER -102.6 150.5 23.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.265 1.426 . . . . 0.0 109.437 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -149.99 151.91 23.91 Favored Glycine 0 CA--C 1.532 1.131 0 O-C-N 121.785 -0.572 . . . . 0.0 112.501 167.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -128.24 176.47 7.65 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 128.719 2.808 . . . . 0.0 109.075 -170.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.6 t -161.95 153.64 18.77 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 128.047 2.539 . . . . 0.0 111.832 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -63.91 160.91 16.64 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.353 -0.842 . . . . 0.0 109.906 165.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -93.56 33.85 1.23 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.658 0.783 . . . . 0.0 112.466 -175.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 24.3 m -68.51 -20.93 64.61 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.605 -1.31 . . . . 0.0 112.996 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -95.53 -142.09 12.55 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 126.001 1.762 . . . . 0.0 113.06 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 64.1 m -134.26 161.88 33.7 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.489 1.916 . . . . 0.0 109.342 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -54.03 -37.56 64.25 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.98 -1.075 . . . . 0.0 113.832 -174.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.11 -9.2 59.84 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.586 1.088 . . . . 0.0 115.107 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 8.7 mt -111.89 -31.16 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 127.14 2.176 . . . . 0.0 111.098 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -80.05 -33.07 39.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.867 1.267 . . . . 0.0 113.341 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 16.7 mm -56.91 -54.9 49.4 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 125.894 1.678 . . . . 0.0 112.687 172.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -70.16 -27.87 24.02 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.381 1.387 . . . . 0.0 112.314 174.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.81 -50.64 71.51 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 120.507 1.503 . . . . 0.0 111.256 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.7 m -68.65 -33.03 73.3 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.64 -36.43 73.42 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.83 0.852 . . . . 0.0 112.014 176.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -62.08 -46.09 90.61 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.547 0.739 . . . . 0.0 111.195 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -64.45 -36.86 85.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.816 0.28 . . . . 0.0 110.835 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -70.19 -38.49 75.37 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -65.05 -39.69 93.67 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 125.013 1.325 . . . . 0.0 110.653 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 67.7 mt -60.13 -42.81 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.179 0.592 . . . . 0.0 111.18 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 38.4 t -65.61 -43.77 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.192 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -61.88 -41.3 97.71 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.178 0.513 . . . . 0.0 111.937 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.5 -39.54 88.76 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.337 1.055 . . . . 0.0 111.046 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -66.01 -42.26 89.93 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.35 -40.96 94.26 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.094 0.557 . . . . 0.0 111.161 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.6 t -67.95 -38.2 79.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 O-C-N 121.66 -0.65 . . . . 0.0 111.063 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.0 -33.59 73.91 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.871 0.868 . . . . 0.0 113.202 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -64.07 -45.73 87.47 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.719 0.808 . . . . 0.0 110.953 170.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 158.54 2.43 0.08 OUTLIER Glycine 0 CA--C 1.528 0.87 0 N-CA-C 117.298 1.679 . . . . 0.0 117.298 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 4.4 t -72.77 135.83 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 120.404 2.102 . . . . 0.0 109.365 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.18 141.16 58.17 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.857 -1.152 . . . . 0.0 110.581 170.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.25 -27.79 53.35 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.193 0.902 . . . . 0.0 113.586 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.31 -28.28 69.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.764 1.226 . . . . 0.0 113.896 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -97.2 -0.05 47.48 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.707 1.603 . . . . 0.0 114.034 -173.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 18.7 mm -119.54 140.55 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.827 1.651 . . . . 0.0 109.157 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -132.16 162.13 31.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.691 1.596 . . . . 0.0 109.622 167.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 39.0 p -135.15 146.75 49.07 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.86 0.864 . . . . 0.0 112.017 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 25.8 t -140.42 136.0 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.912 1.285 . . . . 0.0 109.721 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -107.74 105.03 2.17 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.164 1.84 . . . . 0.0 110.887 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.529 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 1.9 mp -98.69 17.13 19.99 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 127.5 2.32 . . . . 0.0 112.969 -171.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 18.2 -97.37 0.01 OUTLIER Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.981 1.277 . . . . 0.0 116.287 -171.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 4.1 m -119.96 13.05 12.15 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -171.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 4.8 m -65.63 161.44 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 121.152 -0.967 . . . . 0.0 111.581 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 16.3 m120 40.41 54.8 6.82 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 125.305 1.442 . . . . 0.0 114.157 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.68 138.95 56.0 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.215 2.61 . . . . 0.0 112.27 -173.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 11.8 pt -138.84 0.81 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 125.074 1.349 . . . . 0.0 114.594 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 318' ' ' ASN . . . -148.68 139.6 22.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.455 1.102 . . . . 0.0 110.677 167.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 39.8 m -71.76 148.72 46.05 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.62 1.568 . . . . 0.0 113.798 -173.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -73.98 -2.79 25.58 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 171.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.46 -17.9 64.29 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.11 1.364 . . . . 0.0 114.529 -172.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 79.7 p -140.57 149.99 58.98 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.414 1.486 . . . . 0.0 110.561 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -62.13 -27.34 78.76 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.19 2.593 . . . . 0.0 112.634 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -62.4 -46.66 87.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.669 0.787 . . . . 0.0 111.764 170.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.22 -35.16 82.35 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 123.545 0.593 . . . . 0.0 112.669 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -59.03 -50.26 74.76 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.967 0.907 . . . . 0.0 110.896 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.74 -19.03 58.11 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 121.431 -0.793 . . . . 0.0 112.502 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -82.43 -15.07 53.93 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.07 1.748 . . . . 0.0 114.758 168.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 307' ' ' ALA 0.251 17.1 t-20 -101.17 -22.23 14.73 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 120.292 1.405 . . . . 0.0 111.286 168.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -68.95 11.24 0.21 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.04 -1.662 . . . . 0.0 114.308 166.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -61.15 165.97 4.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.732 2.013 . . . . 0.0 113.575 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 18.6 m -130.38 151.03 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.728 1.611 . . . . 0.0 111.262 176.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -139.62 159.83 41.27 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.368 1.467 . . . . 0.0 111.397 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 14.7 tt -135.81 135.16 51.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.8 1.24 . . . . 0.0 112.171 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 59.8 t -137.4 122.59 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.029 1.332 . . . . 0.0 110.223 -171.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 38.9 t -70.25 133.57 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.46 1.104 . . . . 0.0 109.274 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 . . . . . 0 C--O 1.251 1.153 0 C-N-CA 124.394 1.078 . . . . 0.0 113.307 -171.623 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.469 0 CA-C-O 118.986 -0.897 . . . . 0.0 114.287 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -70.83 -18.11 32.24 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.91 3.074 . . . . 0.0 113.689 -173.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 30.6 t -124.33 3.48 8.46 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 127.0 2.12 . . . . 0.0 111.601 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.25 -19.85 66.15 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.409 -1.432 . . . . 0.0 114.572 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -139.6 47.83 1.85 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.955 2.502 . . . . 0.0 109.755 172.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.49 -34.14 34.52 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.912 1.685 . . . . 0.0 112.314 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -66.68 -46.92 74.1 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.106 0.963 . . . . 0.0 112.012 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 14.4 t -65.8 -39.25 90.73 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.169 0.987 . . . . 0.0 112.143 177.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.58 95.11 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 4.2 mt -74.28 -32.69 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.737 0.815 . . . . 0.0 112.116 174.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -64.22 -34.52 78.29 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.168 -0.957 . . . . 0.0 112.182 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -70.17 -36.38 74.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.216 1.006 . . . . 0.0 112.699 172.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 36.7 t -62.05 -43.18 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.143 0.977 . . . . 0.0 111.738 171.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 64.9 p -83.01 -19.28 37.29 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 64.4 18.06 62.72 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.721 1.629 . . . . 0.0 114.304 -171.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 121.9 -146.58 17.05 Favored Glycine 0 CA--C 1.544 1.898 0 C-N-CA 125.214 1.387 . . . . 0.0 112.881 -173.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.67 171.76 15.74 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.967 3.111 . . . . 0.0 112.129 172.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -131.25 144.78 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.441 1.096 . . . . 0.0 110.159 171.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -115.06 173.74 6.34 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.974 1.709 . . . . 0.0 114.393 -170.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -132.06 88.15 2.52 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.345 1.458 . . . . 0.0 109.423 -176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -66.55 164.1 42.35 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.531 1.539 . . . . 0.0 115.282 -171.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 29.9 -66.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.925 1 C-N-CA 131.842 4.057 . . . . 0.0 117.655 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -63.08 -26.02 68.64 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.158 1.383 . . . . 0.0 113.389 173.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.79 7.67 77.82 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.78 1.181 . . . . 0.0 115.002 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -156.69 13.67 0.28 Allowed 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 126.511 1.924 . . . . 0.0 114.557 -175.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 35.1 m -93.45 88.3 5.89 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.341 -1.474 . . . . 0.0 112.405 -170.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 16.9 tp -71.03 96.97 1.38 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.065 1.346 . . . . 0.0 110.328 171.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.405 ' HB ' ' HD2' ' A' ' 234' ' ' PRO . 4.2 pt -66.11 159.82 68.35 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 125.102 1.361 . . . . 0.0 111.988 -172.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 233' ' ' ILE . 36.5 Cg_endo -62.42 -33.61 78.94 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.269 1.979 . . . . 0.0 112.674 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -67.18 -29.84 69.64 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.925 1.084 . . . . 0.0 113.925 171.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.88 -47.26 86.47 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.521 1.055 . . . . 0.0 111.924 174.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -58.6 -24.25 60.54 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.303 1.041 . . . . 0.0 113.157 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -39.5 87.73 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.258 -0.901 . . . . 0.0 112.005 174.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 37.2 mm -58.69 -47.21 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 120.889 -1.132 . . . . 0.0 110.392 171.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 7.9 mp -62.01 -37.3 84.37 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.438 0.695 . . . . 0.0 111.887 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -61.25 -39.72 91.38 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.073 1.349 . . . . 0.0 112.573 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 13.7 mmt85 -69.03 -39.19 79.37 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 172.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.3 t -64.85 -40.21 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.124 0.57 . . . . 0.0 110.918 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.66 98.14 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.397 1.079 . . . . 0.0 111.95 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.85 -36.96 84.95 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -76.11 -29.03 57.72 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.528 HD21 HG11 ' A' ' 255' ' ' VAL . 1.0 OUTLIER -66.41 -45.98 78.1 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.202 1.001 . . . . 0.0 111.437 169.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -58.07 -34.04 69.71 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.501 1.521 . . . . 0.0 112.645 173.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.96 -9.08 58.45 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.319 1.448 . . . . 0.0 114.564 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 13.1 t -157.74 66.54 3.61 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.01 1.324 . . . . 0.0 109.52 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -62.73 -9.3 15.76 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.085 2.523 . . . . 0.0 112.196 173.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -70.46 -16.61 62.94 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.776 1.63 . . . . 0.0 113.415 171.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -119.27 80.64 1.59 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.518 1.527 . . . . 0.0 110.687 -176.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 65.5 mtt85 -51.71 148.1 5.9 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.927 1.291 . . . . 0.0 111.553 173.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.528 HG11 HD21 ' A' ' 247' ' ' LEU . 34.2 m -125.54 158.41 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.519 1.128 . . . . 0.0 112.548 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 18.0 m -130.83 134.4 46.79 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 172.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 51.8 mt -104.76 124.85 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 125.198 1.399 . . . . 0.0 107.557 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.406 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 21.7 m-20 -114.32 129.54 56.64 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.276 1.03 . . . . 0.0 109.799 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -119.3 157.43 15.39 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 122.089 -0.382 . . . . 0.0 112.154 173.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -125.47 167.82 14.48 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 128.156 2.582 . . . . 0.0 108.615 -170.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.5 m -144.57 169.3 18.23 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 127.076 2.15 . . . . 0.0 109.747 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.32 158.15 5.77 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.806 1.242 . . . . 0.0 111.701 170.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -96.88 -4.4 40.25 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 121.32 -0.863 . . . . 0.0 112.997 173.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 2.3 p -68.33 -31.02 70.14 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.848 1.659 . . . . 0.0 114.886 177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -76.19 -161.25 10.91 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 126.471 1.986 . . . . 0.0 114.082 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 8.0 t -130.59 154.25 48.05 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.608 1.563 . . . . 0.0 109.858 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -58.61 -32.58 69.14 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -171.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.46 -13.91 56.04 Favored Glycine 0 CA--C 1.541 1.671 0 O-C-N 121.058 -1.026 . . . . 0.0 114.859 171.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 2.9 mt -106.62 -34.33 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 127.101 2.161 . . . . 0.0 111.346 173.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -78.93 -31.78 45.32 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -174.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 20.6 mm -61.16 -53.92 58.69 Favored Pre-proline 0 N--CA 1.47 0.538 0 C-N-CA 125.969 1.708 . . . . 0.0 112.042 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.76 -34.86 17.53 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 CA-C-N 120.913 1.362 . . . . 0.0 112.561 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 6.9 mp -66.72 -43.26 84.72 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.68 1.127 . . . . 0.0 112.561 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 31.2 p -69.12 -36.12 77.17 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.38 -40.11 77.6 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.225 0.61 . . . . 0.0 111.335 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 54.4 mm-40 -62.65 -40.33 96.7 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.436 0.694 . . . . 0.0 111.347 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 29.3 mtt85 -68.7 -23.17 64.34 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -83.63 -39.69 19.95 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 167.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -65.29 -35.96 82.62 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.416 1.486 . . . . 0.0 112.254 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 74.9 mt -66.17 -39.98 85.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 118.892 0.769 . . . . 0.0 110.552 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 88.2 t -65.62 -45.68 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 122.179 -0.326 . . . . 0.0 110.669 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.2 96.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.72 0.408 . . . . 0.0 111.456 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.88 -39.01 92.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.718 0.807 . . . . 0.0 111.738 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -65.85 -42.47 90.4 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 175.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 2.1 mp -68.72 -37.59 79.59 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 122.003 -0.435 . . . . 0.0 111.916 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 45.9 t -66.22 -40.1 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 O-C-N 121.439 -0.788 . . . . 0.0 110.731 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.09 -33.51 75.63 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 19.9 ttt85 -66.34 -41.95 88.84 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.478 168.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 156.91 1.04 0.1 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 173.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.8 t -69.64 132.9 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 120.399 2.099 . . . . 0.0 109.3 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.71 135.92 53.49 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.196 -0.94 . . . . 0.0 110.069 172.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.07 -26.81 50.13 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.525 1.06 . . . . 0.0 113.819 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.66 -29.52 70.13 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.763 1.225 . . . . 0.0 113.61 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -96.43 -7.61 34.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.155 1.782 . . . . 0.0 113.977 -175.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 3.4 tt -139.27 99.37 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 122.352 1.072 . . . . 0.0 112.331 -171.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -102.4 169.97 8.36 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.327 1.451 . . . . 0.0 112.265 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 40.1 p -137.85 146.92 44.03 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.417 1.087 . . . . 0.0 113.171 -176.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.4 t -141.15 139.51 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.433 1.493 . . . . 0.0 110.98 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -95.51 113.62 4.67 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.538 1.066 . . . . 0.0 111.429 169.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.406 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 42.3 mt -105.21 33.39 3.69 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.072 2.549 . . . . 0.0 110.13 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 0.72 -69.79 0.0 OUTLIER Glycine 0 C--N 1.35 1.359 0 N-CA-C 120.154 2.822 . . . . 0.0 120.154 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 54.2 p -148.72 24.65 0.96 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.7 1.75 . . . . 0.0 114.447 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 8.5 m -64.75 155.95 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 O-C-N 121.252 -0.905 . . . . 0.0 110.676 167.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 39.24 55.11 5.51 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 125.2 1.4 . . . . 0.0 114.083 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -61.71 149.51 89.65 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.237 2.625 . . . . 0.0 112.004 -172.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.38 -2.97 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -170.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' A' ' 318' ' ' ASN . . . -153.04 154.01 34.04 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.177 -0.952 . . . . 0.0 112.642 177.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 68.1 m -67.41 138.15 56.47 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.42 1.488 . . . . 0.0 111.237 167.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -92.25 11.64 25.08 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.603 1.161 . . . . 0.0 112.026 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.34 -16.56 62.44 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.408 1.483 . . . . 0.0 114.433 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 70.7 p -137.67 148.42 61.09 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 125.618 1.567 . . . . 0.0 110.425 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -61.78 -31.22 85.54 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.226 2.618 . . . . 0.0 112.568 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.88 -36.35 77.98 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -71.27 -39.8 61.72 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 121.529 0.516 . . . . 0.0 112.874 172.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -56.92 -45.85 82.4 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 124.123 0.969 . . . . 0.0 110.839 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.66 -39.55 88.78 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.906 0.882 . . . . 0.0 112.74 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -72.33 -20.43 61.48 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.551 1.54 . . . . 0.0 114.031 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 307' ' ' ALA . 39.8 t30 -102.6 -15.04 16.51 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.092 1.357 . . . . 0.0 113.364 172.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -82.07 12.61 4.03 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 126.614 1.966 . . . . 0.0 113.141 166.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -56.89 168.34 0.65 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.454 1.902 . . . . 0.0 115.326 -171.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 14.0 p -129.64 142.33 44.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 125.179 1.392 . . . . 0.0 110.189 167.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -139.91 165.34 27.59 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.76 2.024 . . . . 0.0 110.737 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 14.8 tt -138.28 154.0 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.1 0.96 . . . . 0.0 112.636 -175.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.5 161.55 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.334 1.854 . . . . 0.0 110.461 -175.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 59.0 t -107.3 135.84 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.52 1.128 . . . . 0.0 109.359 173.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.177 0 C-N-CA 125.177 1.391 . . . . 0.0 111.774 -173.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.745 0 CA-C-O 119.105 -0.831 . . . . 0.0 114.789 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.36 -19.37 38.1 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 124.055 3.17 . . . . 0.0 114.401 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 43.9 t -122.63 -8.4 8.5 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.254 1.822 . . . . 0.0 112.295 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -63.6 -16.76 61.76 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -174.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -137.89 40.71 2.34 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.199 2.2 . . . . 0.0 111.093 174.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.2 mt -46.86 -38.43 10.34 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.189 0.995 . . . . 0.0 112.193 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -60.46 -38.52 84.46 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.438 0.695 . . . . 0.0 112.296 -175.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.3 t -70.81 -45.64 64.26 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.359 0.664 . . . . 0.0 111.959 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.64 -40.67 97.75 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 15.3 mt -73.16 -33.83 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.883 0.873 . . . . 0.0 110.728 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.3 -39.16 92.13 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.363 -0.835 . . . . 0.0 112.046 172.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.97 76.34 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.273 1.029 . . . . 0.0 113.046 176.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.7 t -64.55 -40.8 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.139 0.976 . . . . 0.0 111.245 172.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 16.9 m -84.12 -24.49 30.26 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.881 0.873 . . . . 0.0 112.96 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.38 15.37 72.66 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 126.23 1.871 . . . . 0.0 115.135 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 126.78 -156.41 20.09 Favored Glycine 0 CA--C 1.542 1.747 0 C-N-CA 125.311 1.434 . . . . 0.0 112.962 -174.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.64 170.43 20.02 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 124.16 3.24 . . . . 0.0 111.817 169.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.93 108.69 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.579 1.151 . . . . 0.0 110.752 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -80.54 171.7 14.71 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.469 2.308 . . . . 0.0 112.554 169.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.442 ' O ' ' HB1' ' A' ' 316' ' ' ALA . 81.2 m-85 -119.29 150.95 39.27 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.099 0.475 . . . . 0.0 111.147 -171.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -57.31 170.76 3.26 Favored Glycine 0 CA--C 1.541 1.716 0 O-C-N 121.147 -0.971 . . . . 0.0 111.863 166.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -48.68 -28.19 3.39 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -171.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -65.29 -17.92 64.89 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.92 8.41 76.07 Favored Glycine 0 CA--C 1.542 1.774 0 C-N-CA 124.698 1.142 . . . . 0.0 115.215 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -167.53 8.88 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.1 t -73.84 105.42 5.11 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 122.053 2.206 . . . . 0.0 112.12 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.7 mp -74.13 102.5 4.26 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.169 0.988 . . . . 0.0 111.479 172.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.532 HG13 ' H ' ' A' ' 236' ' ' ASP . 5.9 pt -56.97 152.65 27.13 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.065 1.746 . . . . 0.0 112.635 167.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -63.15 -29.57 74.26 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.619 2.212 . . . . 0.0 112.406 173.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.71 92.03 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.737 0.815 . . . . 0.0 112.952 172.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.532 ' H ' HG13 ' A' ' 233' ' ' ILE . 28.4 t70 -61.62 -47.8 83.78 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 119.025 0.83 . . . . 0.0 111.663 171.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -61.11 -35.0 75.84 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.559 -0.713 . . . . 0.0 112.488 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -69.27 -42.65 75.24 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.761 -1.212 . . . . 0.0 112.555 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 56.1 mt -56.49 -47.26 82.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 121.162 -0.962 . . . . 0.0 110.496 171.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 73.5 mt -64.49 -33.34 75.66 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.585 0.754 . . . . 0.0 112.69 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -62.61 -41.58 99.07 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.289 1.036 . . . . 0.0 112.676 175.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -69.57 -36.49 76.33 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 74.3 t -67.31 -41.42 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.504 0.722 . . . . 0.0 111.19 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.01 93.7 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.889 0.876 . . . . 0.0 112.246 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -65.75 -36.98 85.11 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.751 -0.593 . . . . 0.0 112.047 173.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -63.5 -36.15 82.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.153 0.981 . . . . 0.0 112.711 174.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.71 -41.76 87.45 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.487 0.585 . . . . 0.0 112.173 171.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -60.93 -30.75 70.39 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.421 1.088 . . . . 0.0 112.532 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -74.99 -9.51 58.61 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.909 1.684 . . . . 0.0 114.627 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 17.1 t -155.92 69.39 5.1 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.483 1.513 . . . . 0.0 108.644 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -62.96 -5.54 7.82 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.518 2.812 . . . . 0.0 112.716 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -74.16 -17.89 60.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.463 1.505 . . . . 0.0 113.256 171.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -118.78 83.52 2.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.453 1.501 . . . . 0.0 111.251 -171.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 55.7 mtt85 -55.23 157.39 3.58 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.123 1.369 . . . . 0.0 112.129 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.18 161.29 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.6 m -128.89 140.77 51.53 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.339 1.456 . . . . 0.0 109.258 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 61.7 mt -113.84 127.03 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.815 1.246 . . . . 0.0 108.759 -173.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.508 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 1.4 m120 -119.73 118.4 30.8 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.919 1.688 . . . . 0.0 107.764 -172.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -121.77 151.16 16.98 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 118.549 0.613 . . . . 0.0 112.791 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -127.35 168.69 14.47 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 128.423 2.689 . . . . 0.0 109.81 -170.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.2 m -152.42 156.69 40.0 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.362 1.865 . . . . 0.0 109.642 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.66 157.63 37.65 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.53 -1.356 . . . . 0.0 109.761 165.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -92.0 33.22 1.07 Allowed 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 121.431 0.634 . . . . 0.0 112.642 -177.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 13.0 m -66.29 -23.14 66.33 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.016 1.326 . . . . 0.0 112.773 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -99.93 -139.69 10.96 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 126.384 1.945 . . . . 0.0 112.752 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 62.2 m -139.25 163.57 32.12 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.603 1.961 . . . . 0.0 109.587 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -53.61 -38.93 64.49 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 121.035 -1.04 . . . . 0.0 113.196 -177.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -65.93 -10.12 49.7 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 124.589 1.09 . . . . 0.0 115.197 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 13.8 mt -110.1 -32.45 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.796 2.038 . . . . 0.0 111.156 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -82.35 -29.77 30.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.344 1.058 . . . . 0.0 112.927 -174.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 21.1 mm -59.37 -55.57 44.71 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 125.724 1.61 . . . . 0.0 111.759 169.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.87 -31.93 19.11 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 CA-C-N 120.836 1.334 . . . . 0.0 113.284 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 4.3 mp -64.65 -50.63 66.32 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 120.23 1.377 . . . . 0.0 111.865 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 46.5 p -65.38 -33.19 75.37 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -72.32 -38.06 68.76 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.884 0.874 . . . . 0.0 112.169 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -62.92 -41.78 99.58 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.764 1.226 . . . . 0.0 111.103 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.7 mmt-85 -63.19 -38.74 92.37 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.678 0.672 . . . . 0.0 111.598 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -71.33 -38.4 71.69 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -65.68 -37.74 87.33 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 125.264 1.426 . . . . 0.0 112.08 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 82.1 mt -64.59 -41.36 92.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 118.587 0.631 . . . . 0.0 110.572 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 86.2 t -65.42 -41.73 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 122.047 -0.408 . . . . 0.0 111.527 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -64.68 -41.14 96.26 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.939 0.496 . . . . 0.0 111.882 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.59 -37.71 87.4 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.827 0.851 . . . . 0.0 111.57 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -65.09 -42.15 94.32 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 174.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.2 mp -63.99 -40.75 97.07 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.843 -0.536 . . . . 0.0 111.716 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 53.3 t -68.16 -38.45 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.67 0.788 . . . . 0.0 110.798 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.25 -34.39 77.35 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.131 0.972 . . . . 0.0 112.879 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -43.64 93.83 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.903 0.881 . . . . 0.0 111.279 170.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 156.67 1.86 0.1 OUTLIER Glycine 0 CA--C 1.53 1.019 0 N-CA-C 117.746 1.858 . . . . 0.0 117.746 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.0 m -73.67 145.83 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-N 121.066 2.433 . . . . 0.0 110.799 -174.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.61 140.25 55.53 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.616 -0.678 . . . . 0.0 110.788 172.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -54.54 -27.94 43.35 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.309 1.433 . . . . 0.0 113.843 171.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.1 -32.14 72.67 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.395 1.078 . . . . 0.0 113.316 172.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -90.23 2.29 55.57 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.261 1.424 . . . . 0.0 114.218 -173.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 14.9 tt -138.88 139.95 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.482 0.713 . . . . 0.0 112.559 -171.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -139.4 164.31 30.19 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.217 1.407 . . . . 0.0 111.631 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 45.9 p -138.99 146.11 40.52 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.662 1.185 . . . . 0.0 111.977 -175.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 40.5 t -142.18 138.39 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.792 1.637 . . . . 0.0 109.934 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -107.75 97.97 1.2 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.117 1.818 . . . . 0.0 111.692 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.508 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 1.9 mp -97.01 29.96 2.9 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.443 2.697 . . . . 0.0 110.223 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 0.61 -66.14 0.0 OUTLIER Glycine 0 C--N 1.346 1.122 0 N-CA-C 120.919 3.127 . . . . 0.0 120.919 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 91.5 p -146.81 16.1 1.23 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.064 1.432 . . . . 0.0 114.732 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 17.7 m -71.76 154.37 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 O-C-N 121.106 -0.996 . . . . 0.0 111.098 171.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 22.4 m120 41.71 50.16 4.45 Favored Pre-proline 0 CA--C 1.559 1.327 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.6 125.35 12.64 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.838 2.359 . . . . 0.0 111.404 -174.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 2.0 pp -97.84 -1.11 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -173.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -146.32 166.95 24.78 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.855 1.662 . . . . 0.0 111.714 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 85.9 p -80.92 158.58 25.22 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 122.253 1.025 . . . . 0.0 113.411 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -86.7 -4.87 59.23 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.601 1.16 . . . . 0.0 110.987 165.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.57 -18.69 61.59 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.815 1.646 . . . . 0.0 114.447 -174.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 71.6 p -133.26 142.88 45.95 Favored Pre-proline 0 N--CA 1.474 0.759 0 CA-C-N 119.337 0.971 . . . . 0.0 110.575 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.7 -28.12 68.74 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.447 2.764 . . . . 0.0 112.707 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -66.08 -41.14 91.1 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.43 -0.794 . . . . 0.0 111.468 170.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -64.49 -38.23 95.49 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 124.184 0.897 . . . . 0.0 113.087 174.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -58.96 -49.0 79.52 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 124.21 1.004 . . . . 0.0 111.23 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 225' ' ' PHE . . . -75.85 -22.84 55.83 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.249 -0.907 . . . . 0.0 112.105 -175.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -70.18 -34.58 73.14 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.061 1.344 . . . . 0.0 112.769 167.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.69 -16.51 26.85 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.144 1.378 . . . . 0.0 112.65 177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 57.3 mtt180 -70.54 11.81 0.32 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.831 1.652 . . . . 0.0 113.779 167.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -60.51 162.44 6.35 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.521 1.928 . . . . 0.0 114.038 -173.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.21 151.66 32.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.24 172.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -139.63 159.11 42.93 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.894 1.678 . . . . 0.0 111.542 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.35 129.28 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.179 1.392 . . . . 0.0 108.708 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 64.8 t -134.05 129.57 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.209 1.404 . . . . 0.0 110.359 -171.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 23.8 t -72.84 134.92 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.546 0.738 . . . . 0.0 109.749 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.208 0 C-N-CA 125.036 1.335 . . . . 0.0 111.707 -171.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.668 0 CA-C-O 119.198 -0.779 . . . . 0.0 114.626 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -70.21 -16.78 35.76 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.14 3.227 . . . . 0.0 114.277 -171.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 49.3 t -120.45 -2.99 9.93 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 126.759 2.024 . . . . 0.0 111.832 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -63.59 -17.8 63.23 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 -171.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -138.3 29.4 2.46 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.953 2.101 . . . . 0.0 111.475 173.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.79 -19.14 64.77 Favored 'General case' 0 C--O 1.221 -0.44 0 O-C-N 121.437 -0.789 . . . . 0.0 112.721 -172.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -55.94 -40.12 72.7 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.642 1.11 . . . . 0.0 111.529 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 17.5 t -68.33 -44.49 75.2 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.311 0.645 . . . . 0.0 111.878 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.94 -35.96 82.85 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 55.0 mt -70.18 -39.96 77.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.651 1.58 . . . . 0.0 109.493 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -63.9 -40.01 95.51 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.11 -0.994 . . . . 0.0 111.897 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.96 -38.34 90.65 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.121 0.968 . . . . 0.0 112.772 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.91 -28.78 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 118.677 0.671 . . . . 0.0 112.201 177.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.4 m -71.52 -26.41 62.65 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.693 1.197 . . . . 0.0 112.24 169.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.03 25.48 74.62 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.409 1.481 . . . . 0.0 113.637 -172.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 97.3 -170.54 25.93 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.28 1.419 . . . . 0.0 112.751 -171.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.09 140.96 38.78 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.32 2.68 . . . . 0.0 110.992 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.94 142.05 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.634 1.174 . . . . 0.0 112.03 -170.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -104.88 174.16 6.0 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.219 1.807 . . . . 0.0 115.115 -171.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -134.29 84.14 2.09 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.14 1.376 . . . . 0.0 108.858 -173.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -48.54 151.96 2.73 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 126.727 2.108 . . . . 0.0 115.047 -170.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -2.63 -42.12 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 1 C-N-CA 133.628 4.771 . . . . 0.0 120.62 -171.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -63.19 -20.43 65.41 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.204 1.002 . . . . 0.0 113.472 168.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.67 8.06 77.51 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.465 1.507 . . . . 0.0 115.047 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -154.19 19.58 0.5 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 127.361 2.265 . . . . 0.0 112.005 -176.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 7.5 t -82.74 81.99 8.26 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.741 -1.225 . . . . 0.0 113.17 -170.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 22.0 tp -82.13 77.65 8.91 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.834 1.254 . . . . 0.0 110.206 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 3.8 pt -58.21 157.89 15.62 Favored Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 125.624 1.57 . . . . 0.0 112.135 -173.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -61.65 -32.68 87.2 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.224 1.949 . . . . 0.0 112.648 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -68.55 -29.12 67.61 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 172.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -59.1 -41.83 89.05 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.818 1.19 . . . . 0.0 112.359 175.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -60.96 -27.57 68.35 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.561 0.745 . . . . 0.0 112.933 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -64.01 -40.65 96.83 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.67 1.123 . . . . 0.0 111.752 175.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 45.2 mm -58.9 -44.52 90.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 121.579 -0.7 . . . . 0.0 110.221 171.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.05 -36.86 84.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.486 0.714 . . . . 0.0 112.795 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -60.97 -41.73 96.94 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 119.074 0.852 . . . . 0.0 112.157 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -66.3 -40.21 89.84 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.954 0.901 . . . . 0.0 112.311 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 76.2 t -66.78 -41.57 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 123.78 0.832 . . . . 0.0 110.81 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.02 -39.27 93.15 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.355 0.662 . . . . 0.0 112.049 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.7 -38.22 88.62 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.252 0.621 . . . . 0.0 112.082 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.38 -30.93 67.96 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 178.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.405 HD21 ' CG1' ' A' ' 255' ' ' VAL . 0.4 OUTLIER -69.79 -43.23 72.53 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.025 0.93 . . . . 0.0 112.585 169.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -60.43 -27.5 67.54 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.325 1.45 . . . . 0.0 112.745 174.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -79.36 -8.13 58.85 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.006 1.723 . . . . 0.0 114.843 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 37.2 t -152.99 68.5 6.72 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 125.285 1.434 . . . . 0.0 108.903 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -62.59 -8.85 14.03 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.244 2.63 . . . . 0.0 112.271 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -72.23 -16.5 61.94 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.669 1.588 . . . . 0.0 113.507 173.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -121.54 81.28 1.78 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.274 1.429 . . . . 0.0 110.705 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -49.89 143.04 8.16 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.412 1.485 . . . . 0.0 111.502 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.405 ' CG1' HD21 ' A' ' 247' ' ' LEU . 16.8 m -135.42 163.03 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 176.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 5.2 t -143.07 146.39 33.75 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 3.4 mt -101.92 106.7 20.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.476 -169.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.426 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 21.8 m-20 -81.87 154.41 25.86 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 166.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -148.69 152.75 24.74 Favored Glycine 0 CA--C 1.523 0.564 0 O-C-N 121.84 -0.537 . . . . 0.0 112.36 168.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -116.62 169.96 8.95 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.74 2.416 . . . . 0.0 108.633 -170.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.4 p -149.95 145.86 26.72 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.292 2.637 . . . . 0.0 109.78 171.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -63.44 168.31 4.68 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 120.984 -1.073 . . . . 0.0 112.929 174.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -101.33 21.08 14.67 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -171.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 3.9 m -68.71 -19.14 64.35 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.867 -1.145 . . . . 0.0 112.772 172.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -98.22 -152.55 28.12 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.12 1.819 . . . . 0.0 113.985 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 73.7 m -129.72 145.8 51.52 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.735 1.614 . . . . 0.0 110.472 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -53.56 -37.12 62.58 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.71 1.204 . . . . 0.0 113.754 -171.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -60.0 -28.86 66.88 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 123.955 0.788 . . . . 0.0 113.959 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 18.7 mm -95.94 -24.17 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 126.156 1.782 . . . . 0.0 112.142 175.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -86.76 -23.97 25.25 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -175.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 21.8 mm -58.67 -54.28 57.84 Favored Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 125.121 1.368 . . . . 0.0 112.228 167.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -70.63 -33.44 13.29 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 121.075 1.42 . . . . 0.0 113.116 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.457 HD13 HH12 ' A' ' 277' ' ' ARG . 1.2 mm? -72.35 -36.52 68.82 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.58 1.082 . . . . 0.0 112.856 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 61.7 p -68.82 -36.66 78.5 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.72 1.145 . . . . 0.0 113.536 171.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.36 85.12 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.339 1.055 . . . . 0.0 111.577 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -61.2 -42.7 99.05 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 124.918 1.287 . . . . 0.0 110.745 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.457 HH12 HD13 ' A' ' 273' ' ' LEU . 22.7 mtt85 -64.56 -32.12 73.64 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -75.92 -39.57 55.97 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 171.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -60.22 -45.65 92.45 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 125.319 1.448 . . . . 0.0 110.351 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 41.0 mm -66.27 -35.52 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 118.675 0.67 . . . . 0.0 111.011 -177.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.81 -44.28 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 O-C-N 121.992 -0.443 . . . . 0.0 111.162 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -66.1 -36.59 83.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.341 0.657 . . . . 0.0 111.658 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -63.03 -41.23 99.48 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.668 1.187 . . . . 0.0 111.458 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -64.1 -43.01 96.67 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 172.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.4 mp -63.12 -40.93 99.04 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.779 0.832 . . . . 0.0 111.659 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 39.1 t -63.98 -42.31 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.872 0.869 . . . . 0.0 110.922 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.36 -31.8 70.46 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -42.03 75.76 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.142 0.977 . . . . 0.0 111.901 172.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 159.77 -0.26 0.08 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 117.494 1.757 . . . . 0.0 117.494 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 2.6 t -74.87 124.28 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 120.664 2.232 . . . . 0.0 109.2 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.31 142.36 57.8 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.048 -1.032 . . . . 0.0 110.837 173.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -53.17 -28.88 35.24 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.169 1.366 . . . . 0.0 113.613 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -68.31 -22.57 64.71 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.23 1.412 . . . . 0.0 114.671 175.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -108.46 2.4 22.29 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.305 1.842 . . . . 0.0 113.898 -172.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 2.8 tp -133.76 124.85 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.372 1.469 . . . . 0.0 110.005 -172.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -122.91 172.69 8.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.731 1.212 . . . . 0.0 110.789 171.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 40.0 p -141.73 151.91 43.36 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.458 1.103 . . . . 0.0 112.527 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 7.8 t -142.57 132.77 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.396 1.078 . . . . 0.0 111.143 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -93.75 120.76 6.39 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 123.881 0.753 . . . . 0.0 111.256 169.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.426 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 63.8 mt -111.65 18.9 18.59 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.352 1.861 . . . . 0.0 113.327 -175.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 16.47 -105.87 0.01 OUTLIER Glycine 0 CA--C 1.541 1.666 0 C-N-CA 124.863 1.22 . . . . 0.0 116.103 -171.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 16.9 m -111.47 13.51 21.44 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -172.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 6.3 m -61.33 159.17 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.68 1.127 . . . . 0.0 111.737 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 38.1 53.99 3.84 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 125.622 1.569 . . . . 0.0 113.78 175.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -64.06 150.79 87.62 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.922 2.414 . . . . 0.0 113.081 -171.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 22.8 pt -134.72 -4.94 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 127.211 2.205 . . . . 0.0 113.365 -171.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 318' ' ' ASN . . . -147.77 152.81 38.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.593 1.157 . . . . 0.0 112.399 170.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 69.5 m -76.73 157.44 31.69 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.746 1.618 . . . . 0.0 112.936 174.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -73.14 -3.64 27.78 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.121 1.368 . . . . 0.0 113.273 170.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.19 -21.04 66.3 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.86 1.664 . . . . 0.0 115.367 -170.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 78.3 p -140.41 147.45 49.65 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 124.198 0.999 . . . . 0.0 111.182 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.73 -27.8 75.94 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.381 2.721 . . . . 0.0 112.603 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -65.06 -41.19 95.35 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.939 0.896 . . . . 0.0 112.386 170.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.55 -39.9 95.8 Favored Glycine 0 C--N 1.336 0.554 0 O-C-N 121.728 -0.607 . . . . 0.0 112.518 173.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -59.08 -43.29 91.79 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.771 0.828 . . . . 0.0 111.578 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.97 -41.61 99.59 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.892 0.877 . . . . 0.0 112.3 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.99 -11.41 60.86 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.613 1.565 . . . . 0.0 114.302 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.549 ' HB2' ' HB3' ' A' ' 307' ' ' ALA 0.256 0.4 OUTLIER -119.69 15.75 12.74 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.522 1.529 . . . . 0.0 111.667 172.001 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -105.56 8.58 33.36 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.992 1.717 . . . . 0.0 112.345 166.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -63.5 161.19 14.93 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -170.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 2.5 m -126.25 144.68 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 127.217 2.207 . . . . 0.0 110.779 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -147.57 134.69 20.42 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.468 1.107 . . . . 0.0 113.182 -171.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 23.2 mm -85.73 142.55 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.595 1.558 . . . . 0.0 110.758 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 43.5 t -139.6 129.39 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.394 1.077 . . . . 0.0 109.483 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 9.0 p -77.35 133.41 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.409 -0.807 . . . . 0.0 111.228 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 14.1 m120 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 125.233 1.413 . . . . 0.0 111.988 -177.698 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.711 0 CA-C-O 119.129 -0.817 . . . . 0.0 115.113 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -71.05 -14.76 32.2 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 124.19 3.26 . . . . 0.0 114.681 -171.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 33.0 t -133.6 -1.86 3.07 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 126.802 2.041 . . . . 0.0 112.092 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -62.24 -20.4 64.19 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 117.515 2.413 . . . . 0.0 117.515 -171.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -140.64 30.76 1.88 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.947 2.099 . . . . 0.0 111.292 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.0 tp -62.97 -19.73 64.58 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.341 -0.85 . . . . 0.0 113.221 -171.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -56.99 -39.5 74.77 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.222 0.919 . . . . 0.0 111.557 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 15.6 t -68.88 -43.63 74.91 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.549 0.74 . . . . 0.0 111.873 173.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.46 -35.01 79.63 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 60.8 mt -70.6 -39.49 76.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.466 1.506 . . . . 0.0 109.479 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -66.66 -33.42 75.6 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.221 -0.924 . . . . 0.0 112.873 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -70.43 -37.86 74.47 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.21 1.004 . . . . 0.0 112.402 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.26 -27.82 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 118.57 0.623 . . . . 0.0 112.451 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 68.5 p -84.8 -25.89 27.87 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 170.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.2 11.76 71.34 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 125.59 1.567 . . . . 0.0 113.855 -171.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 124.56 -174.46 17.07 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 126.565 2.031 . . . . 0.0 112.915 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -76.02 150.46 33.94 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.536 2.824 . . . . 0.0 110.337 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 10.5 mm -108.2 139.94 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -169.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -95.07 174.48 7.06 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 128.009 2.523 . . . . 0.0 114.613 -171.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -138.38 116.27 11.58 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.573 1.149 . . . . 0.0 110.636 -175.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -58.84 -162.71 0.07 OUTLIER Glycine 0 N--CA 1.477 1.381 0 C-N-CA 127.799 2.619 . . . . 0.0 117.056 -174.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -45.7 -37.59 5.99 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.451 1.9 . . . . 0.0 115.556 -175.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -69.65 -24.79 63.68 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.013 1.325 . . . . 0.0 113.913 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 90.37 -4.43 82.52 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 127.228 2.347 . . . . 0.0 115.16 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -156.34 16.87 0.34 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.132 1.373 . . . . 0.0 113.936 -171.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.0 t -85.33 100.1 11.59 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.647 -1.283 . . . . 0.0 110.851 -172.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 14.6 tp -80.26 93.83 5.97 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.615 1.166 . . . . 0.0 109.829 176.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 6.4 pt -63.49 160.0 46.38 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 125.776 1.631 . . . . 0.0 111.826 -173.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -61.91 -32.17 84.86 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.227 1.951 . . . . 0.0 112.596 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -67.67 -32.28 72.85 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 171.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.67 -44.32 90.17 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.508 1.049 . . . . 0.0 112.049 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -61.83 -20.12 63.31 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.01 0.924 . . . . 0.0 113.144 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -76.01 -42.75 47.08 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.557 1.071 . . . . 0.0 112.188 173.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 47.4 mm -58.92 -44.84 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 O-C-N 121.359 -0.838 . . . . 0.0 110.281 171.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.12 -34.68 78.97 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.654 0.782 . . . . 0.0 112.989 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -61.05 -42.12 97.87 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.049 0.94 . . . . 0.0 112.2 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -65.95 -38.47 88.69 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.303 1.041 . . . . 0.0 112.494 175.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 94.8 t -65.06 -42.68 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.167 0.587 . . . . 0.0 111.168 174.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.77 94.95 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.071 0.548 . . . . 0.0 111.875 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -64.08 -40.46 96.29 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.509 0.724 . . . . 0.0 111.988 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -70.96 -30.09 66.28 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.818 0.847 . . . . 0.0 113.092 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.591 HD21 HG11 ' A' ' 255' ' ' VAL . 0.2 OUTLIER -69.2 -43.98 73.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.838 0.855 . . . . 0.0 112.079 169.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -63.68 -23.07 67.22 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.014 1.326 . . . . 0.0 113.537 174.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.06 -10.02 59.08 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.275 1.43 . . . . 0.0 114.574 170.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 40.2 t -156.3 66.48 4.29 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 125.702 1.601 . . . . 0.0 109.141 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -64.78 -7.81 15.94 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.922 2.414 . . . . 0.0 111.773 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.91 -21.57 65.99 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.175 1.39 . . . . 0.0 113.017 170.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -107.93 95.22 5.53 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.123 1.369 . . . . 0.0 111.225 -175.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 23.3 mtt180 -49.72 141.21 10.23 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.524 1.13 . . . . 0.0 110.876 167.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.591 HG11 HD21 ' A' ' 247' ' ' LEU . 16.8 m -137.46 166.05 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.892 1.277 . . . . 0.0 111.561 173.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 7.2 t -149.16 146.74 27.81 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 118.387 2.736 . . . . 0.0 118.387 170.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 26.3 mt -100.4 115.02 40.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 124.982 1.313 . . . . 0.0 108.937 -171.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.407 ' HB3' HD12 ' A' ' 300' ' ' LEU . 7.2 m-20 -93.93 155.64 17.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.99 -0.444 . . . . 0.0 110.043 169.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -147.19 152.56 24.69 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 121.7 0.611 . . . . 0.0 113.349 167.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.86 170.43 10.11 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.187 2.595 . . . . 0.0 109.982 -169.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 51.0 p -143.65 160.86 39.93 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.188 2.195 . . . . 0.0 110.485 167.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.94 152.0 28.84 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 122.578 1.18 . . . . 0.0 112.232 168.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -3.85 29.42 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -171.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.93 -16.4 63.83 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.261 1.825 . . . . 0.0 114.931 -173.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.57 -157.78 31.93 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.306 1.431 . . . . 0.0 114.219 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 68.1 m -131.58 143.7 50.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.682 1.593 . . . . 0.0 109.702 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -50.57 -40.17 51.51 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.715 1.206 . . . . 0.0 114.019 -171.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -63.96 -27.19 70.93 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 123.657 0.646 . . . . 0.0 114.113 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 11.3 mm -97.72 -24.51 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.842 1.657 . . . . 0.0 111.767 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -80.42 -32.89 37.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.124 0.97 . . . . 0.0 113.193 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 18.6 mm -55.17 -55.86 34.76 Favored Pre-proline 0 N--CA 1.471 0.588 0 C-N-CA 125.418 1.487 . . . . 0.0 112.298 171.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.84 -30.14 17.71 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 120.721 1.293 . . . . 0.0 112.811 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 16.7 mt -66.02 -44.77 83.72 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 119.778 1.172 . . . . 0.0 112.789 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.33 -37.3 80.4 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 176.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.72 -34.47 75.68 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.249 1.02 . . . . 0.0 111.61 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -63.17 -42.83 99.45 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.293 1.037 . . . . 0.0 110.855 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -60.13 -44.01 95.26 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.875 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.25 -37.28 77.87 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -64.32 -41.36 96.86 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 125.631 1.573 . . . . 0.0 111.576 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 37.0 mm -67.14 -38.72 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 118.785 0.72 . . . . 0.0 110.896 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 99.7 t -68.04 -42.33 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 O-C-N 121.938 -0.476 . . . . 0.0 111.385 177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -65.64 -40.02 92.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.265 0.626 . . . . 0.0 111.305 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.15 -39.25 93.62 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.306 0.642 . . . . 0.0 111.75 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -65.02 -42.95 93.95 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.9 mp -67.53 -39.94 85.06 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.896 0.478 . . . . 0.0 111.41 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 50.7 t -66.65 -39.36 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 123.822 0.849 . . . . 0.0 110.672 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.73 -34.19 76.37 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 176.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -69.04 -38.08 78.95 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.76 -0.638 . . . . 0.0 112.612 170.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 151.46 9.32 0.1 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-O 117.481 -1.733 . . . . 0.0 116.952 168.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.9 130.13 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 120.482 2.141 . . . . 0.0 108.985 176.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.98 135.92 57.75 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.256 -0.902 . . . . 0.0 110.722 172.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -57.34 -29.82 60.73 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.696 1.141 . . . . 0.0 113.859 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.73 -37.26 85.84 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 122.161 -0.611 . . . . 0.0 112.476 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -85.49 -1.34 56.97 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.437 1.495 . . . . 0.0 113.966 -171.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 15.1 tt -139.85 93.64 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 124.92 1.288 . . . . 0.0 111.58 -171.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -85.64 174.2 9.58 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.209 -0.932 . . . . 0.0 110.632 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 38.4 p -136.26 148.77 48.17 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.485 1.114 . . . . 0.0 111.869 172.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 11.1 t -137.33 132.12 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.889 0.876 . . . . 0.0 111.994 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -91.06 104.91 3.22 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.589 1.09 . . . . 0.0 111.761 173.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.407 HD12 ' HB3' ' A' ' 258' ' ' ASN . 39.9 mt -105.38 32.08 4.5 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.989 2.115 . . . . 0.0 110.866 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 2.59 -72.66 0.0 OUTLIER Glycine 0 C--N 1.35 1.325 0 C-N-CA 127.796 2.617 . . . . 0.0 119.543 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 88.2 p -147.35 21.42 1.2 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.245 1.523 . . . . 0.0 113.989 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 9.0 m -66.43 156.38 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 121.083 -1.01 . . . . 0.0 111.618 172.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 35.91 55.64 2.65 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 125.978 1.711 . . . . 0.0 113.769 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -61.57 123.97 13.73 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.212 2.608 . . . . 0.0 112.588 -171.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 47.1 pt -90.7 -3.0 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.512 1.125 . . . . 0.0 113.86 -173.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 318' ' ' ASN . . . -153.08 166.8 31.32 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.81 1.644 . . . . 0.0 111.683 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 79.0 p -70.33 171.2 10.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.801 1.24 . . . . 0.0 113.633 175.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -113.29 3.42 15.94 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.828 1.251 . . . . 0.0 111.453 166.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.33 -21.39 62.06 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.718 1.607 . . . . 0.0 113.647 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 66.0 p -132.38 149.0 71.91 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 124.606 1.162 . . . . 0.0 110.934 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -62.35 -29.62 79.83 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.484 2.789 . . . . 0.0 112.541 176.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.51 -42.38 98.49 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.597 0.759 . . . . 0.0 112.239 171.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -66.25 -39.0 94.26 Favored Glycine 0 C--N 1.336 0.543 0 O-C-N 121.829 -0.544 . . . . 0.0 112.609 175.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -58.92 -46.85 86.93 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.46 0.704 . . . . 0.0 111.096 175.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.12 -40.92 99.01 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.713 0.805 . . . . 0.0 111.864 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -70.63 -12.04 61.31 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.397 1.479 . . . . 0.0 114.131 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 307' ' ' ALA 0.256 49.7 t30 -120.3 3.75 10.82 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.806 1.243 . . . . 0.0 113.958 172.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 54.2 mtt180 -83.09 1.48 40.03 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.335 1.454 . . . . 0.0 112.087 164.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.46 156.73 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 131.569 3.947 . . . . 0.0 115.914 -170.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 1.3 m -119.39 141.64 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.116 1.766 . . . . 0.0 110.989 167.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -136.18 166.92 22.29 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.952 1.701 . . . . 0.0 111.438 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 13.7 tt -133.54 142.81 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.199 0.999 . . . . 0.0 112.062 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 47.5 t -138.79 130.34 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.51 0.724 . . . . 0.0 109.726 -171.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 42.7 t -82.26 127.54 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.347 0.659 . . . . 0.0 110.328 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 61.7 t30 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 130.143 3.377 . . . . 0.0 116.38 177.905 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 119.377 -0.344 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.61 159.34 53.1 Favored 'Trans proline' 0 CA--C 1.547 1.134 0 C-N-CA 123.46 2.773 . . . . 0.0 112.636 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.65 163.46 38.89 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.571 2.847 . . . . 0.0 112.406 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 78.15 -170.82 55.03 Favored Glycine 0 CA--C 1.543 1.837 0 C-N-CA 123.949 0.785 . . . . 0.0 114.515 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.89 162.76 40.14 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 123.755 2.97 . . . . 0.0 112.807 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -67.19 165.75 25.57 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.588 2.859 . . . . 0.0 113.117 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -135.44 25.41 3.47 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.452 1.501 . . . . 0.0 113.086 -171.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 36.8 p -58.35 151.83 18.89 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.786 1.234 . . . . 0.0 112.708 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 50.31 57.44 10.29 Favored Glycine 0 CA--C 1.542 1.742 0 C-N-CA 125.119 1.342 . . . . 0.0 114.424 -171.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.45 -12.99 32.5 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.441 3.427 . . . . 0.0 114.882 -171.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 20.2 t -133.2 -3.01 3.11 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 126.908 2.083 . . . . 0.0 111.878 176.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.67 -20.01 66.13 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -171.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -139.25 31.27 2.15 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.922 2.089 . . . . 0.0 111.35 174.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.7 tp -63.14 -17.1 61.99 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -171.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -53.71 -46.87 70.91 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.601 0.76 . . . . 0.0 111.489 167.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 20.1 t -69.17 -40.76 77.94 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.382 0.673 . . . . 0.0 111.409 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.39 -38.18 89.2 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 59.4 mt -71.98 -36.91 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.741 0.816 . . . . 0.0 109.593 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -65.61 -34.01 77.24 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.131 0.972 . . . . 0.0 112.557 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -70.18 -33.76 72.13 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.913 0.885 . . . . 0.0 112.86 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.0 t -65.54 -44.92 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 118.488 0.586 . . . . 0.0 111.192 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 69.5 p -77.26 -25.53 51.56 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -176.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 66.12 14.71 61.89 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.628 1.585 . . . . 0.0 114.212 -171.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 118.43 -171.83 14.23 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 126.024 1.774 . . . . 0.0 112.831 -172.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -76.5 167.39 25.7 Favored 'Trans proline' 0 CA--C 1.549 1.272 0 C-N-CA 123.682 2.922 . . . . 0.0 111.85 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.94 140.01 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 126.16 1.784 . . . . 0.0 113.143 -168.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -106.73 169.44 8.53 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.109 2.164 . . . . 0.0 115.614 -170.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.457 ' CZ ' ' HG3' ' A' ' 277' ' ' ARG . 92.0 m-85 -143.3 100.89 3.71 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.389 1.075 . . . . 0.0 111.586 -171.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -115.47 -174.45 17.96 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.71 1.624 . . . . 0.0 113.026 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 24.7 t30 50.43 -75.68 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 128.468 2.707 . . . . 0.0 114.527 -171.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -79.39 -25.54 42.12 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.454 1.902 . . . . 0.0 112.894 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.68 0.27 86.21 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.15 1.357 . . . . 0.0 115.542 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -162.21 26.44 0.11 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.519 1.528 . . . . 0.0 113.451 -175.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.8 t -120.32 97.36 5.55 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.356 1.062 . . . . 0.0 110.839 -171.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 18.6 tp -70.11 141.03 52.78 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.472 1.109 . . . . 0.0 113.178 -173.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.435 HG13 ' H ' ' A' ' 236' ' ' ASP . 6.4 pt -83.36 150.63 60.89 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.097 1.759 . . . . 0.0 113.906 -172.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.29 -31.21 73.82 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.48 2.786 . . . . 0.0 112.882 173.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.92 94.87 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.588 0.755 . . . . 0.0 112.384 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.435 ' H ' HG13 ' A' ' 233' ' ' ILE . 36.4 t70 -69.01 -39.96 78.98 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 170.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -60.4 -28.64 68.4 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.469 -1.394 . . . . 0.0 112.683 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -71.96 -41.2 68.0 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.689 -1.257 . . . . 0.0 113.24 170.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 90.8 mt -55.99 -44.13 77.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.042 -1.036 . . . . 0.0 110.134 168.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 31.7 mt -64.37 -32.31 73.87 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.196 0.998 . . . . 0.0 113.177 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -59.68 -42.87 93.89 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.704 1.138 . . . . 0.0 111.996 171.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -72.94 -32.83 65.52 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.149 0.58 . . . . 0.0 112.555 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 69.9 t -67.04 -43.23 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.639 0.775 . . . . 0.0 111.097 172.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.41 -42.44 95.96 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.083 0.553 . . . . 0.0 111.994 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.71 -37.17 85.7 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.362 0.665 . . . . 0.0 112.047 176.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.64 -34.21 73.71 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.919 0.888 . . . . 0.0 112.963 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.18 -45.9 75.56 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.739 0.815 . . . . 0.0 110.213 171.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 53.4 tttp -62.59 -23.39 67.01 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.079 1.751 . . . . 0.0 113.714 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -75.2 -8.35 56.36 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.847 1.659 . . . . 0.0 114.597 170.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 38.2 t -151.95 66.86 6.89 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 126.068 1.747 . . . . 0.0 108.507 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -63.83 -6.61 11.22 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.378 2.719 . . . . 0.0 112.318 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -71.72 -18.52 62.14 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.833 1.653 . . . . 0.0 113.229 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -120.76 87.14 2.7 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.688 1.595 . . . . 0.0 110.525 -172.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 63.7 mtt85 -52.69 158.49 1.3 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.812 1.245 . . . . 0.0 111.955 172.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.5 m -127.73 159.91 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.063 1.345 . . . . 0.0 111.722 174.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.1 m -125.96 138.05 53.73 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.46 1.504 . . . . 0.0 108.619 171.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.4 mt -119.33 121.59 66.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.001 1.32 . . . . 0.0 107.495 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -109.29 151.02 27.12 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.457 0.703 . . . . 0.0 110.288 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -139.84 156.9 25.09 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 122.007 -0.433 . . . . 0.0 112.475 167.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -127.73 169.57 13.69 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.893 2.477 . . . . 0.0 109.111 -170.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.5 m -149.14 153.01 37.08 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 127.366 2.266 . . . . 0.0 108.521 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -61.45 165.7 4.58 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.568 -1.333 . . . . 0.0 111.523 167.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -100.72 20.56 14.98 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -175.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.3 m -71.09 -20.19 62.37 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.816 -1.178 . . . . 0.0 112.943 169.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.09 -151.85 21.33 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 125.885 1.707 . . . . 0.0 113.38 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 8.3 t -139.44 164.35 30.11 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.302 1.441 . . . . 0.0 110.374 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -52.67 -42.17 64.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.975 0.91 . . . . 0.0 112.469 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -68.63 -5.09 42.85 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.436 1.017 . . . . 0.0 115.328 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 6.1 mt -115.79 -33.46 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.417 1.887 . . . . 0.0 111.266 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -86.94 -26.87 23.65 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.464 1.106 . . . . 0.0 113.257 -175.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 19.9 mm -60.0 -53.4 65.57 Favored Pre-proline 0 N--CA 1.469 0.496 0 C-N-CA 124.803 1.241 . . . . 0.0 111.546 168.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.27 -34.8 15.38 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 CA-C-N 120.831 1.333 . . . . 0.0 113.099 176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 17.9 mt -66.18 -44.8 82.98 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 120.345 1.429 . . . . 0.0 112.747 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 34.8 p -65.77 -37.12 85.47 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.74 -39.84 76.54 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.255 0.622 . . . . 0.0 111.716 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -63.22 -40.85 98.64 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.768 1.227 . . . . 0.0 111.037 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.457 ' HG3' ' CZ ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -63.8 -38.63 91.8 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 118.762 0.71 . . . . 0.0 112.143 177.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -72.59 -38.85 67.73 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -67.41 -36.26 80.92 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 125.481 1.513 . . . . 0.0 111.795 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 59.2 mt -62.56 -42.49 96.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 118.805 0.729 . . . . 0.0 110.843 175.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.02 -41.82 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 117.954 0.343 . . . . 0.0 110.952 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.04 97.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -69.14 -36.43 77.45 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.598 0.759 . . . . 0.0 111.158 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -66.44 -42.76 87.16 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.6 mp -64.26 -41.81 96.77 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.02 0.528 . . . . 0.0 111.233 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.04 -37.42 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 123.142 0.577 . . . . 0.0 111.404 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.01 -35.4 76.62 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -69.35 -37.67 77.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.888 0.875 . . . . 0.0 112.855 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 161.91 -1.54 0.07 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 118.093 1.997 . . . . 0.0 118.093 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 4.9 t -76.88 142.73 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 120.015 1.908 . . . . 0.0 110.368 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.13 137.68 47.18 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.679 -1.263 . . . . 0.0 110.858 167.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -57.74 -27.14 58.65 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.384 0.992 . . . . 0.0 113.906 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.63 -30.7 70.87 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.628 1.171 . . . . 0.0 113.21 173.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -88.32 -2.81 58.82 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.007 1.323 . . . . 0.0 114.377 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 5.1 mt -125.81 123.66 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.361 0.982 . . . . 0.0 111.403 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -105.16 159.24 16.01 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.453 1.501 . . . . 0.0 110.64 167.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 40.6 p -134.87 146.01 48.82 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.165 0.986 . . . . 0.0 111.792 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 25.3 t -138.86 130.49 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.112 0.965 . . . . 0.0 111.396 -175.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -87.54 100.93 2.64 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.552 1.072 . . . . 0.0 111.691 172.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 43.2 mt -97.35 33.34 2.01 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.918 2.087 . . . . 0.0 110.065 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 3.64 -72.69 0.0 OUTLIER Glycine 0 C--N 1.351 1.373 0 N-CA-C 120.33 2.892 . . . . 0.0 120.33 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 23.4 p -144.79 17.96 1.63 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.615 1.707 . . . . 0.0 113.892 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.7 m -70.59 161.33 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.059 1.344 . . . . 0.0 112.597 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 38.44 53.56 3.94 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 125.866 1.666 . . . . 0.0 113.269 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -64.34 151.7 84.38 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.658 2.239 . . . . 0.0 113.667 -170.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 45.9 pt -126.44 -3.76 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.901 1.68 . . . . 0.0 113.685 -172.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 318' ' ' ASN . . . -151.74 149.57 29.21 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.134 1.373 . . . . 0.0 111.439 172.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 69.8 m -70.36 147.36 49.66 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.41 1.484 . . . . 0.0 112.078 171.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -82.74 5.98 19.59 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.365 1.066 . . . . 0.0 113.802 173.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.42 -13.98 62.68 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.051 1.34 . . . . 0.0 114.444 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 67.6 p -138.33 147.78 56.85 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 125.713 1.605 . . . . 0.0 110.472 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -63.92 -31.36 67.15 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 123.333 2.689 . . . . 0.0 112.423 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.94 -38.62 91.58 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.605 -0.684 . . . . 0.0 112.413 171.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.38 -36.95 85.36 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 123.767 0.699 . . . . 0.0 112.53 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -58.69 -49.54 77.2 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.528 0.731 . . . . 0.0 110.709 172.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.9 -37.28 86.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.377 0.671 . . . . 0.0 112.349 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -68.05 -17.65 64.46 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.391 1.476 . . . . 0.0 113.831 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 307' ' ' ALA . 7.8 t30 -113.21 -8.09 13.55 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 174.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -74.42 9.71 1.61 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.868 1.667 . . . . 0.0 113.865 167.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.42 153.28 2.23 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.812 2.445 . . . . 0.0 114.8 -170.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 8.3 p -123.32 145.9 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.464 1.506 . . . . 0.0 109.648 168.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -142.98 158.53 43.51 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.413 1.485 . . . . 0.0 112.898 -174.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 20.2 tt -133.08 141.32 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.756 1.623 . . . . 0.0 111.745 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 16.9 t -144.46 133.5 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.365 1.466 . . . . 0.0 109.568 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 38.4 t -70.34 137.63 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.708 0.803 . . . . 0.0 109.893 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.253 1.252 0 C-N-CA 125.275 1.43 . . . . 0.0 111.766 -171.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 119.284 -0.388 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.57 160.89 47.44 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 123.481 2.787 . . . . 0.0 112.263 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.27 134.05 34.94 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.077 2.518 . . . . 0.0 111.662 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 171.81 56.82 0.04 OUTLIER Glycine 0 CA--C 1.539 1.561 0 CA-C-O 118.594 -1.115 . . . . 0.0 114.092 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.48 159.94 48.16 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 123.277 2.651 . . . . 0.0 112.557 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -64.5 133.27 36.43 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.311 2.674 . . . . 0.0 111.392 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.51 24.44 1.56 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.179 1.392 . . . . 0.0 113.176 -172.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 27.8 m -53.16 134.49 38.83 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.466 1.507 . . . . 0.0 112.685 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 57.95 58.83 12.53 Favored Glycine 0 CA--C 1.542 1.73 0 C-N-CA 124.625 1.107 . . . . 0.0 114.156 -173.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -70.78 -14.54 32.94 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.337 3.358 . . . . 0.0 114.352 -171.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 22.2 t -128.17 -3.24 5.67 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 127.32 2.248 . . . . 0.0 111.666 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.83 -18.55 65.43 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 -171.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -138.46 29.88 2.4 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.022 2.129 . . . . 0.0 111.604 175.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 6.8 tp -63.11 -17.66 62.56 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -53.65 -45.68 70.3 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.057 0.844 . . . . 0.0 111.361 167.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 20.7 t -68.51 -42.03 79.13 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 122.935 0.494 . . . . 0.0 111.616 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.32 -41.42 98.91 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 176.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 66.1 mt -71.56 -35.64 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.994 0.918 . . . . 0.0 109.759 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -68.48 -36.99 79.74 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.987 0.915 . . . . 0.0 112.661 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.99 76.62 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.075 0.95 . . . . 0.0 112.24 175.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 22.5 t -63.06 -41.35 92.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.588 1.155 . . . . 0.0 111.761 173.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 82.3 p -82.92 -19.26 37.63 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 66.12 15.8 63.51 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.961 1.743 . . . . 0.0 114.804 -172.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 129.74 -159.12 22.47 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 125.593 1.568 . . . . 0.0 112.937 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -74.66 171.42 18.22 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.702 2.934 . . . . 0.0 111.785 171.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 28.9 mt -113.39 136.24 50.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.005 1.722 . . . . 0.0 109.193 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -124.03 161.98 24.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.363 1.465 . . . . 0.0 113.005 -172.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -138.23 99.33 3.83 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.021 0.928 . . . . 0.0 111.93 -169.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -74.96 164.7 54.61 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.707 1.146 . . . . 0.0 113.831 -171.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 32.88 -78.02 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 130.238 3.415 . . . . 0.0 116.07 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.75 -28.2 67.43 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.177 1.391 . . . . 0.0 113.164 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 96.97 11.32 53.45 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 116.816 1.486 . . . . 0.0 116.816 167.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -156.68 25.93 0.33 Allowed 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.288 1.435 . . . . 0.0 112.746 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 52.9 m -92.37 90.94 7.44 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.598 1.159 . . . . 0.0 112.56 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.4 mp -68.36 104.33 1.85 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.662 0.785 . . . . 0.0 110.218 171.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.438 HG13 ' H ' ' A' ' 236' ' ' ASP . 21.3 pt -67.24 163.62 44.27 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 125.215 1.406 . . . . 0.0 110.567 173.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.57 -30.47 79.42 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 CA-C-N 121.433 1.548 . . . . 0.0 112.251 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -66.09 -31.59 72.55 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 170.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.438 ' H ' HG13 ' A' ' 233' ' ' ILE . 22.5 t0 -62.4 -54.29 42.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.625 1.102 . . . . 0.0 110.976 170.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -60.51 -29.12 68.89 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.33 -0.856 . . . . 0.0 112.882 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -65.68 -51.17 61.57 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.168 -0.957 . . . . 0.0 112.005 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.5 pp -69.05 -30.29 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 118.348 0.522 . . . . 0.0 111.56 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 60.2 mt -66.49 -36.66 83.3 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.497 0.719 . . . . 0.0 112.348 171.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -40.18 93.3 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.6 -0.688 . . . . 0.0 111.683 173.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -67.63 -37.63 82.74 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 67.9 t -63.36 -44.0 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 119.031 0.832 . . . . 0.0 111.22 173.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.12 -40.62 94.48 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.924 0.489 . . . . 0.0 111.226 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -66.33 -36.49 83.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.674 0.79 . . . . 0.0 112.605 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -70.82 -35.79 72.65 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.708 1.203 . . . . 0.0 112.854 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 11.7 tp -72.62 -38.72 67.68 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.428 1.491 . . . . 0.0 111.737 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -60.14 -28.07 67.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.518 1.927 . . . . 0.0 112.788 172.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -78.38 -5.25 51.74 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.37 1.468 . . . . 0.0 114.468 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 34.0 t -151.62 65.7 6.56 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.1 1.36 . . . . 0.0 108.859 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -65.09 -8.25 17.82 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.216 2.61 . . . . 0.0 111.881 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -70.39 -21.56 62.84 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.744 1.617 . . . . 0.0 113.256 171.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -120.64 90.01 3.24 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.693 1.597 . . . . 0.0 109.621 -173.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 71.8 mtt85 -49.5 153.18 1.17 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.551 1.14 . . . . 0.0 112.167 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.31 160.14 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 123.057 1.408 . . . . 0.0 110.308 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.6 m -138.37 144.73 40.43 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.697 -2.047 . . . . 0.0 110.428 -173.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 57.8 mt -128.7 112.77 27.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.164 1.385 . . . . 0.0 108.429 -172.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.9 153.14 17.91 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.049 0.94 . . . . 0.0 110.645 176.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -152.44 152.7 24.36 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 121.616 -0.677 . . . . 0.0 113.45 169.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -123.9 161.68 24.86 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 127.724 2.41 . . . . 0.0 109.011 -170.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 65.1 m -138.74 143.54 39.08 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.827 2.051 . . . . 0.0 109.376 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . 0.256 2.2 p30 -63.07 150.89 41.48 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 123.57 1.652 . . . . 0.0 114.551 -171.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -71.12 -2.3 15.24 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 113.164 -1.835 . . . . 0.0 115.299 -171.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.7 -15.71 61.68 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.14 0.976 . . . . 0.0 112.919 171.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.48 -165.43 41.31 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 125.312 1.434 . . . . 0.0 114.574 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 69.6 m -139.59 150.81 45.45 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.404 1.882 . . . . 0.0 109.681 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -54.37 -37.93 65.53 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -171.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.93 -26.73 71.46 Favored Glycine 0 CA--C 1.536 1.358 0 O-C-N 121.376 -0.828 . . . . 0.0 114.112 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 21.2 mm -98.01 -26.29 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.778 1.631 . . . . 0.0 112.195 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -88.69 -24.69 22.66 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.35 1.06 . . . . 0.0 113.139 -173.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 15.4 mm -57.92 -54.94 50.21 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 125.003 1.321 . . . . 0.0 111.989 167.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.98 -34.72 13.31 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 CA-C-N 120.723 1.294 . . . . 0.0 112.483 175.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.19 -40.79 86.59 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 120.211 1.369 . . . . 0.0 112.752 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 5.2 m -72.21 -35.17 68.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.314 0.961 . . . . 0.0 113.393 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.75 -39.26 80.41 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.228 0.611 . . . . 0.0 111.761 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -64.74 -38.77 92.13 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 123.812 0.845 . . . . 0.0 111.305 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -63.86 -40.21 96.01 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.747 0.703 . . . . 0.0 111.985 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.83 -37.9 79.5 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -67.33 -35.59 79.71 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.865 1.666 . . . . 0.0 112.425 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 62.7 mt -63.95 -42.28 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 123.329 0.652 . . . . 0.0 110.794 174.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 65.0 t -65.93 -42.64 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 122.067 -0.396 . . . . 0.0 111.111 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.57 -42.45 96.68 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.08 0.552 . . . . 0.0 111.512 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -65.38 -38.86 91.29 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.502 0.721 . . . . 0.0 111.792 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.62 -41.52 88.24 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.9 -42.94 89.57 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.549 0.739 . . . . 0.0 110.888 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.81 -37.02 77.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.479 0.712 . . . . 0.0 110.918 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -68.61 -33.81 74.67 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 33.5 ttt85 -69.0 -40.02 78.98 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.361 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 159.59 0.34 0.08 OUTLIER Glycine 0 CA--C 1.525 0.674 0 N-CA-C 117.514 1.766 . . . . 0.0 117.514 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.1 t -69.57 134.4 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 120.341 2.071 . . . . 0.0 109.455 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.72 138.2 58.45 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.923 -1.111 . . . . 0.0 110.628 169.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.57 -29.73 58.08 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.022 0.82 . . . . 0.0 113.452 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -63.51 -26.51 68.75 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.928 1.291 . . . . 0.0 113.892 173.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 24.3 m170 -98.48 4.25 48.32 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.987 1.715 . . . . 0.0 113.941 -174.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 16.2 mm -119.44 144.64 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.917 1.687 . . . . 0.0 109.255 174.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -136.18 161.13 36.59 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.222 1.809 . . . . 0.0 110.127 168.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 47.4 p -134.32 146.79 50.3 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.139 0.976 . . . . 0.0 111.386 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.0 t -138.85 120.47 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.23 1.012 . . . . 0.0 110.475 -173.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -83.95 99.28 2.21 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.561 1.076 . . . . 0.0 111.174 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 43.4 mt -97.47 31.95 2.39 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.862 2.065 . . . . 0.0 109.758 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 3.31 -72.07 0.0 OUTLIER Glycine 0 C--N 1.352 1.454 0 C-N-CA 128.006 2.717 . . . . 0.0 119.565 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 1.3 t -149.6 25.16 0.86 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.061 1.431 . . . . 0.0 113.152 173.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 14.2 m -67.79 161.08 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 120.921 -1.112 . . . . 0.0 112.149 174.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 39.98 53.94 5.74 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 125.959 1.704 . . . . 0.0 114.416 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.09 138.88 48.96 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.676 2.251 . . . . 0.0 111.597 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 26.0 pt -134.81 4.11 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.581 1.552 . . . . 0.0 113.438 -173.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -149.88 165.47 32.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.834 1.654 . . . . 0.0 110.689 170.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 18.3 m -116.73 159.47 22.22 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.868 1.667 . . . . 0.0 112.194 -172.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 49.2 p30 -79.42 5.25 13.17 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -67.54 -14.05 62.6 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.305 1.442 . . . . 0.0 114.587 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 42.4 p -138.22 147.8 57.22 Favored Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 126.485 1.914 . . . . 0.0 109.873 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -63.66 -31.3 69.95 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.142 2.561 . . . . 0.0 112.53 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -71.91 -36.4 69.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.876 0.87 . . . . 0.0 112.806 171.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.26 -37.57 94.12 Favored Glycine 0 N--CA 1.469 0.853 0 C-N-CA 124.006 0.812 . . . . 0.0 113.526 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -55.59 -49.97 71.36 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.819 1.248 . . . . 0.0 110.332 169.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.15 84.89 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -66.97 -18.85 65.58 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 174.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . 0.409 0.3 OUTLIER -110.6 17.82 20.32 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 167.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -112.85 10.74 19.12 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 127.264 2.226 . . . . 0.0 113.13 166.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -60.92 160.72 9.27 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -170.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 41.0 t -129.78 145.07 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 127.164 2.186 . . . . 0.0 108.897 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -134.32 155.98 49.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.259 1.424 . . . . 0.0 111.364 -174.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 39.0 mt -136.3 135.77 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.694 1.197 . . . . 0.0 108.903 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 47.7 t -140.66 132.94 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.582 1.553 . . . . 0.0 110.574 -171.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 14.6 p -90.57 125.87 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.002 0.921 . . . . 0.0 111.16 167.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 . . . . . 0 C--O 1.253 1.261 0 C-N-CA 125.792 1.637 . . . . 0.0 113.246 -177.859 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 119.277 -0.392 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.68 160.23 50.49 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.53 2.82 . . . . 0.0 112.346 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.41 137.0 41.76 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.092 2.528 . . . . 0.0 111.524 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 164.19 61.67 0.02 OUTLIER Glycine 0 CA--C 1.538 1.528 0 CA-C-O 118.451 -1.194 . . . . 0.0 113.789 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -64.42 153.6 76.11 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 123.086 2.524 . . . . 0.0 112.528 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.63 157.1 56.58 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.485 2.79 . . . . 0.0 113.049 -175.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -80.82 36.7 0.4 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.135 1.774 . . . . 0.0 112.937 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 51.8 p -59.97 148.17 36.23 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.309 1.444 . . . . 0.0 113.516 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 170.94 62.29 0.04 OUTLIER Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.757 1.17 . . . . 0.0 113.405 -177.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -69.82 -18.58 36.63 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 124.113 3.209 . . . . 0.0 113.853 -171.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 44.7 t -120.85 -4.55 9.66 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.282 1.833 . . . . 0.0 112.303 176.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -64.58 -16.37 62.56 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -140.61 46.39 1.79 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.377 2.271 . . . . 0.0 110.955 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.0 mt -55.33 -28.56 54.56 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 118.402 -0.809 . . . . 0.0 112.548 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -54.78 -43.23 72.62 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.526 1.057 . . . . 0.0 111.528 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 19.2 t -69.57 -41.73 75.44 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.431 0.692 . . . . 0.0 111.99 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.68 -38.52 91.28 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 2.7 mm -68.69 -43.24 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -63.0 -38.38 90.94 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.605 -0.684 . . . . 0.0 112.245 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -71.12 -33.35 70.03 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.051 0.94 . . . . 0.0 113.224 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.08 -42.02 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 123.3 0.64 . . . . 0.0 111.409 172.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.8 m -86.34 -22.38 26.72 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 61.23 29.5 71.44 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.84 1.209 . . . . 0.0 113.866 -172.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 97.27 -175.33 30.61 Favored Glycine 0 CA--C 1.541 1.708 0 C-N-CA 125.71 1.624 . . . . 0.0 112.999 -171.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.18 150.34 33.1 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 123.685 2.923 . . . . 0.0 112.909 -174.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 52.5 mt -97.59 141.89 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.07 1.748 . . . . 0.0 110.952 -171.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -109.19 170.12 8.25 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.316 1.846 . . . . 0.0 115.866 -171.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -144.19 110.33 5.43 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.832 1.253 . . . . 0.0 110.372 -171.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -59.02 -166.24 0.14 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.989 1.756 . . . . 0.0 115.545 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -41.98 -39.74 1.98 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.528 1.931 . . . . 0.0 114.785 -175.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -62.1 -28.89 69.94 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.316 1.446 . . . . 0.0 114.363 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 96.0 -10.93 68.0 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.958 1.742 . . . . 0.0 115.687 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -152.57 12.23 0.53 Allowed 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -171.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 69.0 m -78.15 75.34 4.68 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 120.434 -1.416 . . . . 0.0 114.238 -171.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 14.5 tp -69.27 128.77 37.76 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.731 1.612 . . . . 0.0 110.659 171.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -98.81 164.04 17.69 Favored Pre-proline 0 N--CA 1.484 1.258 0 C-N-CA 124.441 1.096 . . . . 0.0 110.91 -171.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -63.81 -29.86 68.33 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.239 1.959 . . . . 0.0 112.985 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.16 90.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.777 0.831 . . . . 0.0 113.134 169.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -66.68 -43.34 84.71 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.457 -0.777 . . . . 0.0 111.468 172.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -61.29 -32.39 72.22 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.436 -0.79 . . . . 0.0 112.484 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -67.34 -41.07 85.82 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.669 -1.27 . . . . 0.0 112.278 172.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 67.7 mt -57.42 -46.03 85.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 O-C-N 121.345 -0.847 . . . . 0.0 110.441 169.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 39.6 mt -64.08 -35.09 79.6 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.436 -0.79 . . . . 0.0 112.906 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -61.16 -37.64 83.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.141 0.976 . . . . 0.0 112.614 173.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 86.5 mtt-85 -70.58 -37.01 73.88 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.687 1.195 . . . . 0.0 112.628 173.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.9 -41.95 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 118.91 0.777 . . . . 0.0 110.771 173.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.72 -38.14 90.0 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.712 0.805 . . . . 0.0 112.274 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.33 -38.11 89.15 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.446 0.698 . . . . 0.0 112.376 172.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -65.71 -34.84 79.14 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.625 0.77 . . . . 0.0 112.696 176.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.524 HD21 HG11 ' A' ' 255' ' ' VAL . 1.8 mm? -66.06 -45.64 80.62 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.98 1.312 . . . . 0.0 111.859 169.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.51 -30.19 70.46 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.551 1.54 . . . . 0.0 112.808 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.17 -9.66 58.8 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.078 1.751 . . . . 0.0 114.563 174.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 16.1 t -155.47 68.36 5.18 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 125.358 1.463 . . . . 0.0 108.885 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -62.62 -6.05 8.22 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.429 2.752 . . . . 0.0 112.679 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -73.17 -19.96 61.0 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.446 1.498 . . . . 0.0 113.324 172.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -115.54 93.91 4.48 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.21 1.404 . . . . 0.0 111.794 -171.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -50.65 147.5 4.66 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.118 1.367 . . . . 0.0 111.684 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.524 HG11 HD21 ' A' ' 247' ' ' LEU . 22.9 m -127.15 160.15 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.882 0.873 . . . . 0.0 111.487 167.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 22.9 m -127.26 139.38 52.95 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.909 1.683 . . . . 0.0 108.362 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 71.4 mt -119.13 123.83 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 124.923 1.289 . . . . 0.0 107.858 -171.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -113.76 148.6 36.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.302 0.641 . . . . 0.0 110.399 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -137.46 156.69 23.66 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 122.106 -0.371 . . . . 0.0 112.696 167.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -127.6 167.34 16.5 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.502 2.321 . . . . 0.0 109.885 -169.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.1 m -151.98 159.73 43.68 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.162 1.785 . . . . 0.0 110.627 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -63.75 163.02 12.32 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.956 -1.09 . . . . 0.0 111.43 166.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -104.98 20.34 19.0 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.564 0.746 . . . . 0.0 112.817 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 16.3 m -69.92 -20.1 63.36 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.809 1.244 . . . . 0.0 112.628 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.6 -150.01 18.1 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 126.156 1.836 . . . . 0.0 113.249 173.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 71.4 m -135.3 162.72 31.79 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.073 1.749 . . . . 0.0 110.09 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -52.62 -41.16 63.45 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.984 0.914 . . . . 0.0 112.968 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -67.9 -4.39 33.93 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.672 1.13 . . . . 0.0 115.238 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 6.2 mt -116.55 -33.0 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.932 2.093 . . . . 0.0 111.172 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -81.53 -31.22 32.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.555 1.142 . . . . 0.0 112.919 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 23.4 mm -60.52 -54.17 57.47 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.322 1.449 . . . . 0.0 111.761 170.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.54 -32.6 24.43 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 CA-C-N 121.065 1.416 . . . . 0.0 113.333 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 26.3 mt -67.88 -43.8 78.5 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.347 1.43 . . . . 0.0 113.124 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 28.5 p -66.46 -37.54 85.36 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.14 -38.09 78.62 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.556 0.742 . . . . 0.0 111.967 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -65.19 -38.76 91.51 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 125.129 1.372 . . . . 0.0 111.036 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -45.62 90.42 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.52 0.6 . . . . 0.0 111.877 173.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.38 -36.17 76.53 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -68.34 -36.51 79.36 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 125.758 1.623 . . . . 0.0 111.97 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 58.9 mt -63.55 -43.07 98.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 118.788 0.722 . . . . 0.0 110.625 174.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 57.4 t -66.89 -42.62 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.753 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.07 -41.7 99.5 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.026 0.53 . . . . 0.0 111.743 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.85 -38.84 87.14 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.121 0.568 . . . . 0.0 111.501 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -68.27 -40.68 81.8 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.3 mp -64.88 -43.68 92.15 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.302 0.641 . . . . 0.0 111.005 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 55.1 t -67.73 -37.22 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 O-C-N 121.758 -0.589 . . . . 0.0 111.088 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.95 -34.0 72.85 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -42.99 86.19 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.817 0.847 . . . . 0.0 111.591 171.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 161.08 -0.95 0.07 OUTLIER Glycine 0 CA--C 1.528 0.871 0 N-CA-C 117.413 1.725 . . . . 0.0 117.413 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.4 t -72.48 136.15 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 120.514 2.157 . . . . 0.0 109.814 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.59 140.75 56.93 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 120.946 -1.096 . . . . 0.0 110.641 168.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.21 -27.31 52.15 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.399 1.0 . . . . 0.0 113.694 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -61.68 -30.14 70.54 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.822 1.249 . . . . 0.0 113.538 173.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -92.77 -0.71 57.22 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.606 1.562 . . . . 0.0 113.968 -174.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 25.0 mm -121.04 141.12 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.825 1.65 . . . . 0.0 109.501 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -135.09 161.37 35.52 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.733 1.613 . . . . 0.0 110.253 167.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 45.6 p -137.02 146.39 45.23 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.942 0.897 . . . . 0.0 112.372 -175.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 35.3 t -141.35 133.63 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.571 1.148 . . . . 0.0 111.118 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -89.5 100.3 2.65 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.508 1.051 . . . . 0.0 111.801 172.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 38.2 mt -95.58 32.13 1.87 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.707 2.003 . . . . 0.0 110.618 174.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 3.18 -70.34 0.0 OUTLIER Glycine 0 C--N 1.35 1.329 0 N-CA-C 120.366 2.906 . . . . 0.0 120.366 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 94.3 p -144.53 13.76 1.56 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.769 1.284 . . . . 0.0 114.281 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 17.1 m -70.27 157.97 6.36 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 O-C-N 121.025 -1.047 . . . . 0.0 111.768 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 39.46 52.09 4.03 Favored Pre-proline 0 CA--C 1.557 1.23 0 C-N-CA 125.259 1.424 . . . . 0.0 114.119 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.18 112.73 1.78 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.38 2.72 . . . . 0.0 111.767 -171.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.538 ' H ' HD12 ' A' ' 306' ' ' ILE . 1.4 mp -71.02 -20.67 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 124.46 1.104 . . . . 0.0 112.476 -171.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -150.5 160.26 43.9 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.865 1.666 . . . . 0.0 112.376 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 49.6 m -71.19 151.25 44.55 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.177 1.791 . . . . 0.0 113.767 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -82.85 1.69 38.02 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.86 -14.4 63.01 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 40.6 p -141.42 147.58 47.06 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 126.326 1.85 . . . . 0.0 110.296 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -63.25 -32.58 73.22 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.166 2.577 . . . . 0.0 112.53 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -68.05 -36.45 79.89 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 173.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -70.2 -38.04 72.12 Favored Glycine 0 N--CA 1.467 0.722 0 C-N-CA 123.415 0.531 . . . . 0.0 113.361 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -57.63 -49.1 77.54 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 123.752 0.821 . . . . 0.0 109.975 171.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.17 84.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.57 0.748 . . . . 0.0 112.698 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -72.66 -12.74 61.15 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.225 1.41 . . . . 0.0 113.696 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.32 -12.5 15.04 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 170.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -81.96 2.48 30.56 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 126.571 1.948 . . . . 0.0 114.502 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 35.0 mtm180 -57.89 160.87 4.29 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -169.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.88 144.12 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.278 1.831 . . . . 0.0 109.954 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -139.7 159.41 42.23 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.137 1.375 . . . . 0.0 113.194 -173.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 4.5 mp -131.95 132.86 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.768 1.627 . . . . 0.0 108.71 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 21.4 t -140.58 138.52 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.635 1.574 . . . . 0.0 109.552 -171.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 22.4 t -69.7 135.81 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.029 -1.044 . . . . 0.0 110.429 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.5 t30 . . . . . 0 C--O 1.252 1.201 0 C-N-CA 125.143 1.377 . . . . 0.0 113.319 -177.901 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 119.366 -0.35 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -70.4 160.79 48.32 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.545 2.83 . . . . 0.0 112.514 178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.42 153.33 74.23 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.237 2.625 . . . . 0.0 111.97 174.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 168.99 -173.88 43.5 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 124.178 0.894 . . . . 0.0 113.821 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.59 163.78 33.64 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 123.883 3.055 . . . . 0.0 112.527 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.76 167.38 19.52 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.568 2.846 . . . . 0.0 113.103 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -126.81 25.57 6.33 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.584 1.554 . . . . 0.0 113.212 -171.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 18.4 t -55.61 141.33 37.98 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.759 1.224 . . . . 0.0 112.026 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 54.33 59.02 10.69 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 125.223 1.392 . . . . 0.0 114.221 -172.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -69.7 -15.34 37.27 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.323 3.349 . . . . 0.0 114.655 -171.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 22.0 t -128.91 -2.57 5.23 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 126.817 2.047 . . . . 0.0 111.776 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.64 -18.8 65.56 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -171.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -137.77 30.44 2.55 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.934 2.093 . . . . 0.0 111.52 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 6.9 tp -63.49 -16.58 61.1 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 121.521 -0.737 . . . . 0.0 112.949 -173.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -53.58 -45.6 70.02 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.954 0.797 . . . . 0.0 111.465 167.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 21.5 t -69.27 -42.77 75.09 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.292 0.637 . . . . 0.0 111.306 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.93 85.97 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 53.6 mt -73.53 -36.04 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.522 0.729 . . . . 0.0 109.659 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -65.08 -42.49 94.08 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.061 -1.024 . . . . 0.0 112.006 172.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.06 -37.56 87.97 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.947 0.899 . . . . 0.0 112.821 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.69 -28.36 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 118.354 0.525 . . . . 0.0 112.227 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.7 m -75.16 -26.5 59.16 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.094 0.958 . . . . 0.0 112.136 170.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.37 25.83 75.08 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.111 1.339 . . . . 0.0 113.65 -171.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 96.24 -176.71 33.13 Favored Glycine 0 CA--C 1.542 1.732 0 C-N-CA 125.532 1.539 . . . . 0.0 113.394 -172.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.24 147.83 33.58 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.834 3.023 . . . . 0.0 111.416 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -102.42 140.99 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -169.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -107.44 169.03 8.83 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.693 2.397 . . . . 0.0 113.763 -172.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -142.55 116.1 9.12 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.475 1.11 . . . . 0.0 110.608 -171.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -58.42 -170.22 0.24 Allowed Glycine 0 CA--C 1.535 1.302 0 C-N-CA 126.117 1.817 . . . . 0.0 116.39 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -46.43 -40.91 13.01 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.46 1.504 . . . . 0.0 115.017 -174.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.11 -33.27 71.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.396 1.478 . . . . 0.0 113.808 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 105.49 -5.06 40.55 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 117.02 1.568 . . . . 0.0 117.02 167.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -166.44 28.12 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 119.471 1.635 . . . . 0.0 113.038 -171.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 16.5 t -98.11 93.58 6.35 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.634 -1.291 . . . . 0.0 111.511 -171.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.0 mp -71.31 113.92 8.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.886 0.874 . . . . 0.0 109.82 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 11.8 pt -70.77 164.09 58.7 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 124.366 1.066 . . . . 0.0 110.23 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.25 -31.28 74.21 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 CA-C-N 121.942 1.729 . . . . 0.0 112.371 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -66.17 -32.35 73.74 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 170.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -59.03 -53.05 62.8 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.748 1.158 . . . . 0.0 110.697 171.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -58.59 -33.77 70.35 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.716 0.807 . . . . 0.0 112.611 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -66.24 -44.75 82.84 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.419 1.009 . . . . 0.0 112.505 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 34.2 mm -58.44 -43.61 87.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 121.589 -0.694 . . . . 0.0 110.747 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.13 -32.26 72.83 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.709 -0.619 . . . . 0.0 112.62 174.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -63.85 -41.38 97.82 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.578 1.151 . . . . 0.0 112.411 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -67.52 -38.69 84.61 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.423 1.089 . . . . 0.0 112.335 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 79.7 t -62.96 -45.03 99.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 123.507 0.723 . . . . 0.0 110.538 174.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.82 -36.84 84.52 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.155 0.582 . . . . 0.0 112.146 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.17 -39.29 92.71 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 172.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -65.62 -35.13 79.9 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.753 0.821 . . . . 0.0 112.73 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.462 ' CD2' HG11 ' A' ' 255' ' ' VAL . 97.0 mt -69.67 -41.6 75.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.44 1.096 . . . . 0.0 112.039 172.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.03 -23.93 67.68 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.392 1.877 . . . . 0.0 113.089 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.91 -8.75 57.94 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.536 1.534 . . . . 0.0 114.588 171.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 36.2 t -153.61 67.29 6.01 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.222 1.409 . . . . 0.0 108.85 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -64.68 -7.22 14.05 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.119 2.546 . . . . 0.0 112.013 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -70.14 -19.42 63.22 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.51 1.524 . . . . 0.0 113.215 171.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -118.99 89.88 3.22 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.513 1.525 . . . . 0.0 110.52 -172.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -51.53 150.97 3.38 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.04 1.336 . . . . 0.0 111.453 172.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.462 HG11 ' CD2' ' A' ' 247' ' ' LEU . 17.3 m -134.38 161.34 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.449 0.7 . . . . 0.0 112.669 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 20.8 m -128.03 137.37 52.17 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.153 1.381 . . . . 0.0 109.415 -178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.0 118.19 57.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.663 1.585 . . . . 0.0 107.7 -173.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.556 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 0.2 OUTLIER -98.98 151.19 21.17 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.022 1.329 . . . . 0.0 109.406 -178.023 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -152.01 155.49 26.16 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 121.491 -0.756 . . . . 0.0 113.912 168.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -132.53 168.4 18.29 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 129.033 2.933 . . . . 0.0 109.352 -170.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 31.2 m -145.27 151.56 38.56 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 127.102 2.161 . . . . 0.0 109.187 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -63.32 160.67 15.44 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 123.172 1.463 . . . . 0.0 113.574 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -83.04 7.87 14.49 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 113.993 -1.458 . . . . 0.0 114.927 -170.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.6 m -75.11 -15.26 60.61 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 120.993 -1.067 . . . . 0.0 113.508 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -95.24 -157.83 32.5 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.286 1.422 . . . . 0.0 114.595 -176.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 7.6 t -135.18 162.37 32.7 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.69 1.596 . . . . 0.0 110.371 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -52.84 -41.44 64.24 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.124 0.97 . . . . 0.0 112.796 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -67.83 -6.49 44.46 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 124.428 1.014 . . . . 0.0 115.238 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 4.2 mt -115.75 -33.63 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 126.644 1.978 . . . . 0.0 111.294 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -87.41 -24.35 24.23 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 18.3 mm -58.51 -54.06 59.87 Favored Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 124.531 1.132 . . . . 0.0 111.804 167.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.49 -33.23 11.12 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 120.579 1.243 . . . . 0.0 112.906 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 19.1 mt -65.11 -46.78 79.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 120.282 1.401 . . . . 0.0 112.092 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 24.2 m -70.87 -29.86 66.07 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -74.66 -34.96 62.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.788 0.835 . . . . 0.0 112.075 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -65.57 -39.89 92.15 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.027 0.931 . . . . 0.0 111.677 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.22 -43.17 98.87 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.271 0.942 . . . . 0.0 110.755 176.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.5 -37.98 86.25 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.27 -38.91 88.93 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.525 1.53 . . . . 0.0 112.036 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 74.1 mt -66.13 -39.52 84.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 122.688 0.395 . . . . 0.0 110.879 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.59 -44.75 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 O-C-N 121.972 -0.455 . . . . 0.0 110.906 173.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.92 -42.23 97.7 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.4 0.68 . . . . 0.0 111.662 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -66.72 -38.29 86.41 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.013 0.525 . . . . 0.0 111.897 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -68.81 -40.8 79.34 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.15 -43.22 95.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.328 0.651 . . . . 0.0 110.975 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 55.7 t -67.34 -37.46 79.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 O-C-N 121.753 -0.592 . . . . 0.0 111.257 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.43 -34.42 74.42 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -42.26 87.19 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.811 0.844 . . . . 0.0 111.796 172.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 161.64 -1.61 0.07 OUTLIER Glycine 0 CA--C 1.527 0.831 0 N-CA-C 117.473 1.749 . . . . 0.0 117.473 176.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 2.7 t -73.96 137.76 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 120.523 2.162 . . . . 0.0 109.493 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.78 137.91 58.07 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.655 -1.278 . . . . 0.0 110.461 168.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.8 -29.67 58.82 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.055 0.836 . . . . 0.0 113.456 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.44 -26.51 68.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.131 1.372 . . . . 0.0 113.782 173.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -97.25 2.23 50.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.801 1.641 . . . . 0.0 113.955 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 20.2 mm -119.64 141.78 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.699 1.6 . . . . 0.0 109.447 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -136.84 165.27 26.34 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.041 1.737 . . . . 0.0 110.535 169.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 44.6 p -136.02 145.68 46.33 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.277 1.031 . . . . 0.0 112.258 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 70.3 t -138.98 133.95 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.052 1.341 . . . . 0.0 110.919 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -103.24 105.32 2.67 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 126.131 1.825 . . . . 0.0 112.21 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.556 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 1.1 mp -103.94 32.8 3.73 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 129.138 2.975 . . . . 0.0 109.752 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 7.45 -73.92 0.0 OUTLIER Glycine 0 C--N 1.349 1.257 0 N-CA-C 119.467 2.547 . . . . 0.0 119.467 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 57.9 p -148.14 22.53 1.08 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.483 1.641 . . . . 0.0 114.435 172.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.7 m -70.13 159.55 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.092 1.357 . . . . 0.0 111.917 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 23.2 m120 39.76 52.74 4.75 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 125.062 1.345 . . . . 0.0 112.932 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -59.64 132.18 44.23 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.012 2.475 . . . . 0.0 113.674 -170.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 4.8 mp -77.13 -25.89 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 125.042 1.337 . . . . 0.0 111.586 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -157.53 153.66 27.33 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.664 1.986 . . . . 0.0 111.822 -172.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 66.7 m -66.42 150.42 48.93 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.179 1.392 . . . . 0.0 112.48 170.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -84.49 11.13 9.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.786 1.235 . . . . 0.0 113.854 174.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -67.18 -18.36 65.23 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -176.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 66.7 p -140.66 151.4 63.22 Favored Pre-proline 0 N--CA 1.474 0.744 0 C-N-CA 125.901 1.681 . . . . 0.0 110.141 176.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -61.94 -28.31 80.77 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.199 2.599 . . . . 0.0 112.601 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.0 -42.14 94.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.856 0.862 . . . . 0.0 112.554 172.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.14 -38.17 87.8 Favored Glycine 0 N--CA 1.465 0.619 0 O-C-N 121.791 -0.568 . . . . 0.0 112.787 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -57.99 -47.42 83.03 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.244 0.618 . . . . 0.0 110.526 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.85 -39.91 93.5 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.184 0.594 . . . . 0.0 112.537 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -68.61 -16.51 63.87 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.486 1.114 . . . . 0.0 113.816 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -115.86 -1.36 12.61 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 125.514 1.526 . . . . 0.0 114.517 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -82.68 3.95 26.94 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 126.136 1.774 . . . . 0.0 113.023 166.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.88 158.81 0.64 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 130.118 3.367 . . . . 0.0 117.144 -169.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 2.3 m -122.46 148.61 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 126.326 1.85 . . . . 0.0 111.656 166.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -130.08 166.26 20.53 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.84 2.056 . . . . 0.0 110.891 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 13.1 tt -140.74 144.0 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.524 1.13 . . . . 0.0 111.919 172.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 23.3 t -144.68 136.48 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.343 1.457 . . . . 0.0 110.187 -174.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.09 136.23 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.11 0.964 . . . . 0.0 110.754 174.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.576 1.55 . . . . 0.0 113.731 -178.556 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 119.287 -0.387 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.22 159.9 51.45 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 C-N-CA 123.503 2.802 . . . . 0.0 112.534 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.2 152.29 72.22 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.228 2.619 . . . . 0.0 112.158 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 166.28 -175.25 41.78 Favored Glycine 0 CA--C 1.54 1.616 0 C-N-CA 124.442 1.02 . . . . 0.0 113.712 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.46 162.19 40.03 Favored 'Trans proline' 0 CA--C 1.548 1.178 0 C-N-CA 123.735 2.957 . . . . 0.0 112.324 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.3 158.67 55.86 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.387 2.725 . . . . 0.0 112.772 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -87.3 20.64 2.71 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.677 1.591 . . . . 0.0 114.245 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.6 p -61.1 132.16 52.88 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.916 1.286 . . . . 0.0 112.594 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 159.91 61.52 0.01 OUTLIER Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.348 0.975 . . . . 0.0 113.87 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -69.52 -19.98 36.56 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.995 3.13 . . . . 0.0 114.091 -171.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 9.9 t -122.57 -2.75 8.87 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 126.519 1.928 . . . . 0.0 111.762 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.54 -21.25 60.43 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 -171.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -137.48 38.56 2.46 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.516 2.326 . . . . 0.0 109.945 174.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 23.8 tp -61.13 -19.83 61.97 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.46 1.104 . . . . 0.0 113.796 -171.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -57.2 -46.31 82.99 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.74 -0.6 . . . . 0.0 111.843 169.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 22.8 t -68.66 -43.86 75.3 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 122.977 0.511 . . . . 0.0 111.284 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -71.57 -25.45 62.21 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 67.3 mt -83.07 -35.55 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 119.61 1.095 . . . . 0.0 110.627 171.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -63.44 -41.97 98.68 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.819 -1.175 . . . . 0.0 111.83 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.4 -36.34 83.67 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.212 1.005 . . . . 0.0 113.187 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.83 -27.72 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.9 m -80.38 -27.79 38.11 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.269 1.027 . . . . 0.0 112.437 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 69.95 25.69 75.27 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.02 1.295 . . . . 0.0 113.854 -172.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 88.88 -166.97 34.34 Favored Glycine 0 CA--C 1.54 1.656 0 C-N-CA 124.87 1.224 . . . . 0.0 113.57 -173.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.33 163.06 40.38 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.721 2.947 . . . . 0.0 112.312 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 19.3 mm -120.74 144.58 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.171 1.389 . . . . 0.0 111.069 -171.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -111.69 167.47 10.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.954 2.102 . . . . 0.0 113.115 -172.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -140.51 101.83 4.19 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.908 0.883 . . . . 0.0 111.803 -170.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -87.52 -178.26 48.23 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.541 1.067 . . . . 0.0 113.981 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 51.6 t30 36.17 -81.34 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 130.375 3.47 . . . . 0.0 115.796 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -71.13 -22.85 62.02 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.295 1.438 . . . . 0.0 114.084 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 89.2 10.23 66.36 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.918 1.247 . . . . 0.0 115.019 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -154.71 25.31 0.45 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 126.968 2.107 . . . . 0.0 112.105 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 58.2 m -81.67 81.84 7.6 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.878 1.271 . . . . 0.0 112.888 -171.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.76 101.33 0.47 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.689 0.756 . . . . 0.0 110.817 169.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.592 HG13 ' H ' ' A' ' 236' ' ' ASP . 9.8 pt -61.79 154.86 64.94 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.768 1.627 . . . . 0.0 112.491 173.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -62.56 -31.3 80.01 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.344 2.029 . . . . 0.0 112.184 174.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.5 90.65 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.791 0.836 . . . . 0.0 112.858 170.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.592 ' H ' HG13 ' A' ' 233' ' ' ILE . 21.9 t70 -62.61 -49.56 74.74 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.436 -0.79 . . . . 0.0 111.321 172.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -59.88 -30.24 68.86 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.166 -0.959 . . . . 0.0 112.912 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -70.72 -44.54 66.68 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 120.785 -1.197 . . . . 0.0 112.805 172.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 21.4 mm -57.89 -45.57 87.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.231 -0.918 . . . . 0.0 110.938 172.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.4 -32.07 73.5 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.954 0.902 . . . . 0.0 112.539 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -61.86 -42.55 99.19 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.088 0.955 . . . . 0.0 111.882 173.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -67.79 -35.65 79.03 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 87.9 t -64.45 -44.39 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.497 0.59 . . . . 0.0 110.916 173.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.81 89.86 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.422 0.689 . . . . 0.0 111.989 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.78 -39.13 93.51 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.122 0.569 . . . . 0.0 112.065 175.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -71.56 -30.68 66.15 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 79.3 mt -71.32 -40.76 70.56 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.976 0.911 . . . . 0.0 112.266 170.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -60.06 -27.05 66.64 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.121 1.368 . . . . 0.0 112.669 173.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -80.95 -6.96 59.37 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.11 1.764 . . . . 0.0 115.036 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 22.2 t -153.47 67.27 6.08 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.235 1.414 . . . . 0.0 108.862 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -63.84 -7.1 12.26 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.216 2.611 . . . . 0.0 112.39 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -71.28 -19.27 62.36 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.591 1.556 . . . . 0.0 113.24 171.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -117.88 89.04 3.04 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.543 1.537 . . . . 0.0 110.578 -173.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 68.1 mtt85 -53.26 155.45 2.72 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.544 1.138 . . . . 0.0 111.676 171.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 20.9 m -128.29 165.49 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.36 1.064 . . . . 0.0 111.844 171.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 30.2 m -127.98 137.14 52.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.403 1.481 . . . . 0.0 108.798 173.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 72.7 mt -113.69 117.32 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.421 ' HB3' HD12 ' A' ' 300' ' ' LEU . 21.5 m-20 -102.49 156.82 17.35 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.323 0.649 . . . . 0.0 110.426 175.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -148.52 154.95 26.16 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 122.178 -0.326 . . . . 0.0 112.836 167.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -128.16 163.41 24.73 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 127.539 2.336 . . . . 0.0 109.918 -169.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 73.1 p -148.63 173.67 12.94 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.917 2.487 . . . . 0.0 110.392 170.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -72.15 158.36 36.06 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.458 -1.401 . . . . 0.0 113.001 -173.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -84.97 -9.64 57.86 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.695 1.198 . . . . 0.0 113.168 -172.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -22.66 67.02 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.382 2.273 . . . . 0.0 115.527 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -74.98 -143.24 0.93 Allowed Glycine 0 CA--C 1.54 1.615 0 C-N-CA 126.448 1.975 . . . . 0.0 115.358 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 26.3 t -149.59 137.15 20.1 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.868 1.667 . . . . 0.0 109.723 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -53.17 -34.02 55.1 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -65.59 -22.74 70.01 Favored Glycine 0 CA--C 1.537 1.428 0 O-C-N 121.435 -0.791 . . . . 0.0 114.21 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 16.9 mm -100.59 -32.33 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 126.496 1.918 . . . . 0.0 112.188 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -82.71 -27.36 31.23 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.8 mm -57.65 -55.35 45.7 Favored Pre-proline 0 N--CA 1.469 0.515 0 C-N-CA 124.722 1.209 . . . . 0.0 112.206 169.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.38 -30.26 15.71 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 CA-C-N 120.468 1.203 . . . . 0.0 112.713 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.6 mp -64.42 -51.12 64.77 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 120.228 1.377 . . . . 0.0 111.833 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.3 m -69.34 -32.31 71.32 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.071 -0.651 . . . . 0.0 112.544 -176.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.64 -38.66 80.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 174.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -67.69 -38.23 83.41 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.424 0.689 . . . . 0.0 111.594 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 66.5 mmt-85 -61.1 -44.14 97.81 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.959 0.8 . . . . 0.0 111.275 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.77 -37.57 79.43 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -66.58 -37.87 85.83 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 125.376 1.47 . . . . 0.0 111.733 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 19.3 mm -65.98 -39.06 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.62 0.645 . . . . 0.0 111.268 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 38.3 t -64.92 -46.09 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.322 0.51 . . . . 0.0 110.592 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -61.11 -41.52 96.84 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.304 0.642 . . . . 0.0 111.616 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.05 -36.97 84.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.554 1.142 . . . . 0.0 111.47 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -63.63 -45.01 92.18 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.6 mp -69.07 -37.06 78.28 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.977 0.418 . . . . 0.0 111.672 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.84 -37.01 76.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.942 0.897 . . . . 0.0 111.013 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.97 -35.0 79.0 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 20.9 ttt85 -69.05 -35.52 76.66 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 170.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 151.34 4.54 0.18 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 116.935 1.534 . . . . 0.0 116.935 167.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.8 t -69.49 136.01 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 120.046 1.923 . . . . 0.0 108.964 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.32 138.88 58.68 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.979 -1.076 . . . . 0.0 110.528 172.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.75 -29.85 58.89 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.013 0.816 . . . . 0.0 113.317 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.28 -28.68 69.89 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.857 1.263 . . . . 0.0 113.648 173.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -93.36 -2.2 55.04 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.471 1.508 . . . . 0.0 114.217 -174.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 9.0 mt -129.04 108.09 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.518 1.127 . . . . 0.0 110.155 175.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -88.69 161.92 16.57 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.028 0.931 . . . . 0.0 110.323 167.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 35.5 p -135.41 144.37 46.49 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.192 0.997 . . . . 0.0 111.452 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 30.2 t -138.0 129.81 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.56 0.744 . . . . 0.0 111.32 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -84.85 96.1 2.01 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.518 1.056 . . . . 0.0 111.112 170.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.421 HD12 ' HB3' ' A' ' 258' ' ' ASN . 47.6 mt -88.54 30.14 0.93 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.552 1.941 . . . . 0.0 109.97 171.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 6.86 -74.97 0.0 OUTLIER Glycine 0 C--N 1.354 1.554 0 C-N-CA 128.191 2.805 . . . . 0.0 119.769 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 95.1 p -149.6 23.79 0.89 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.583 1.192 . . . . 0.0 113.252 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 7.3 m -71.26 158.63 6.12 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 C-N-CA 124.509 1.124 . . . . 0.0 111.498 173.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 39.42 54.24 5.28 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 125.514 1.526 . . . . 0.0 114.288 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.09 139.08 59.42 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.689 2.259 . . . . 0.0 111.626 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 17.8 pt -134.59 6.81 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.925 1.29 . . . . 0.0 114.314 -171.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.451 ' HB3' ' HB2' ' A' ' 318' ' ' ASN . . . -146.54 140.08 25.89 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.485 1.114 . . . . 0.0 110.62 167.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 51.0 m -71.05 143.61 50.65 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.425 1.49 . . . . 0.0 113.126 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -74.23 1.69 10.81 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 171.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.07 -17.26 63.23 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.053 1.341 . . . . 0.0 114.617 -175.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 67.9 p -140.47 150.94 62.51 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 125.49 1.516 . . . . 0.0 110.581 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -62.12 -30.06 81.85 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.25 2.633 . . . . 0.0 112.576 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -64.53 -44.42 90.92 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.575 0.75 . . . . 0.0 112.344 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.73 -35.46 85.58 Favored Glycine 0 CA--C 1.524 0.613 0 O-C-N 121.84 -0.538 . . . . 0.0 112.839 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -59.52 -49.35 78.11 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.073 0.949 . . . . 0.0 111.173 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.03 85.76 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.0 0.52 . . . . 0.0 111.969 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -71.12 -23.37 62.08 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.329 1.452 . . . . 0.0 114.302 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 307' ' ' ALA . 7.2 t30 -99.82 -18.14 17.31 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 119.656 1.116 . . . . 0.0 112.866 172.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -71.96 13.63 0.28 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.317 1.447 . . . . 0.0 114.337 170.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -61.86 163.8 7.14 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.206 1.802 . . . . 0.0 115.662 -170.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 28.9 m -125.29 151.52 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.941 1.696 . . . . 0.0 110.158 167.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -145.48 147.5 32.24 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.36 1.064 . . . . 0.0 111.919 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.3 132.52 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.171 1.388 . . . . 0.0 109.404 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 21.8 t -140.88 133.97 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.211 1.405 . . . . 0.0 109.895 -172.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.18 141.27 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 121.409 -0.807 . . . . 0.0 110.342 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.285 1.434 . . . . 0.0 111.864 -171.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 119.235 -0.412 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.61 160.88 47.53 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.481 2.788 . . . . 0.0 112.221 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.76 142.6 64.12 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.053 2.502 . . . . 0.0 112.008 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 172.59 57.5 0.05 OUTLIER Glycine 0 CA--C 1.538 1.521 0 CA-C-O 118.588 -1.118 . . . . 0.0 113.817 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.54 159.92 48.39 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.293 2.662 . . . . 0.0 112.611 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.65 155.13 71.83 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.228 2.619 . . . . 0.0 112.19 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -144.56 27.68 1.35 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.347 1.459 . . . . 0.0 112.702 -172.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 23.2 m -49.83 132.51 22.35 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.859 1.664 . . . . 0.0 113.463 -175.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 55.67 57.96 16.3 Favored Glycine 0 CA--C 1.542 1.749 0 C-N-CA 125.121 1.344 . . . . 0.0 114.833 -174.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.51 -19.07 28.86 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.84 3.027 . . . . 0.0 113.854 -172.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 43.3 t -121.38 -7.43 9.25 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.948 2.099 . . . . 0.0 111.998 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -63.76 -16.04 60.15 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.354 1.462 . . . . 0.0 114.861 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -137.21 41.33 2.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.4 2.28 . . . . 0.0 111.167 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 9.0 mt -46.82 -38.52 10.35 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.67 0.788 . . . . 0.0 111.822 172.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -59.95 -38.53 82.72 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.995 0.518 . . . . 0.0 111.956 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.2 t -68.78 -48.08 64.56 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.465 0.706 . . . . 0.0 112.061 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.9 85.51 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 177.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 90.8 mt -75.05 -34.54 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.335 1.054 . . . . 0.0 110.091 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -65.87 -41.28 91.79 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.816 -1.177 . . . . 0.0 111.712 172.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.91 -36.03 83.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.725 0.81 . . . . 0.0 113.153 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.4 p -80.06 -27.34 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.2 m -88.39 -25.75 22.53 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.534 1.134 . . . . 0.0 113.03 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.77 24.68 75.48 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.348 1.452 . . . . 0.0 114.061 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 101.57 -162.34 17.73 Favored Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.346 1.451 . . . . 0.0 112.54 -171.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -73.15 168.2 25.35 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.716 2.944 . . . . 0.0 112.561 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 40.9 mm -112.79 114.46 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.46 1.504 . . . . 0.0 110.63 -173.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -81.66 173.23 12.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.806 2.042 . . . . 0.0 112.671 171.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -118.7 151.68 37.53 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.859 0.864 . . . . 0.0 110.735 -173.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -59.66 165.73 10.44 Favored Glycine 0 CA--C 1.543 1.843 0 O-C-N 120.875 -1.141 . . . . 0.0 110.892 165.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -48.91 -22.33 0.82 Allowed 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 117.036 2.235 . . . . 0.0 117.036 -171.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -59.28 -22.46 61.2 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.582 1.553 . . . . 0.0 114.666 170.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.71 9.39 74.94 Favored Glycine 0 CA--C 1.543 1.827 0 C-N-CA 124.977 1.275 . . . . 0.0 114.79 -176.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -159.72 -5.82 0.06 Allowed 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 118.918 2.932 . . . . 0.0 118.918 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.6 m -72.43 81.72 1.06 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 122.355 2.343 . . . . 0.0 114.368 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 16.5 tp -63.75 109.61 1.77 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.422 2.289 . . . . 0.0 111.07 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.614 HG13 ' H ' ' A' ' 236' ' ' ASP . 10.4 pt -71.93 159.33 85.75 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 124.655 1.182 . . . . 0.0 112.853 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.97 -29.17 87.48 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.493 2.129 . . . . 0.0 112.17 174.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.95 98.1 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 169.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.614 ' H ' HG13 ' A' ' 233' ' ' ILE . 94.4 m-20 -66.27 -41.35 90.02 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.515 -0.741 . . . . 0.0 112.108 173.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -60.94 -32.16 71.68 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.282 -0.886 . . . . 0.0 112.404 172.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -69.89 -42.87 72.86 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.353 -1.467 . . . . 0.0 112.222 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 65.9 mt -56.7 -47.2 82.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.63 -0.669 . . . . 0.0 110.398 171.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.99 -30.97 72.0 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.493 0.717 . . . . 0.0 112.869 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -64.39 -43.08 95.58 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.588 -0.695 . . . . 0.0 111.824 174.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -64.32 -39.26 93.56 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.004 0.922 . . . . 0.0 112.082 175.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 70.0 t -65.36 -41.56 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.961 0.904 . . . . 0.0 111.601 175.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.08 95.74 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.237 0.615 . . . . 0.0 111.791 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -65.27 -39.01 92.04 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.817 0.847 . . . . 0.0 111.995 175.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -65.95 -35.68 81.26 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.756 0.822 . . . . 0.0 112.568 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 16.8 tp -73.57 -39.63 64.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.189 0.996 . . . . 0.0 112.157 173.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -60.71 -28.53 68.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.392 1.477 . . . . 0.0 112.497 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -75.94 -7.5 54.72 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.046 1.738 . . . . 0.0 114.788 173.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 24.3 t -150.69 68.93 8.5 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.435 1.494 . . . . 0.0 108.59 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -62.13 -7.1 9.23 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.459 2.773 . . . . 0.0 112.493 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -73.16 -18.03 61.31 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.737 1.615 . . . . 0.0 113.277 174.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -124.93 79.65 1.8 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.042 1.337 . . . . 0.0 111.306 -171.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -48.72 159.66 0.22 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.332 1.853 . . . . 0.0 113.104 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.3 162.28 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-O 121.712 0.768 . . . . 0.0 112.336 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.3 m -127.68 137.16 52.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.409 1.484 . . . . 0.0 108.993 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 94.3 mt -113.09 119.98 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 125.418 1.487 . . . . 0.0 107.689 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.529 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 0.5 OUTLIER -102.6 150.5 23.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.265 1.426 . . . . 0.0 109.437 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -149.99 151.91 23.91 Favored Glycine 0 CA--C 1.532 1.131 0 O-C-N 121.785 -0.572 . . . . 0.0 112.501 167.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -128.24 176.47 7.65 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 128.719 2.808 . . . . 0.0 109.075 -170.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.6 t -161.95 153.64 18.77 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 128.047 2.539 . . . . 0.0 111.832 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -63.91 160.91 16.64 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.353 -0.842 . . . . 0.0 109.906 165.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -93.56 33.85 1.23 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.658 0.783 . . . . 0.0 112.466 -175.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 24.3 m -68.51 -20.93 64.61 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.605 -1.31 . . . . 0.0 112.996 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -95.53 -142.09 12.55 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 126.001 1.762 . . . . 0.0 113.06 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 64.1 m -134.26 161.88 33.7 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.489 1.916 . . . . 0.0 109.342 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -54.03 -37.56 64.25 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.98 -1.075 . . . . 0.0 113.832 -174.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.11 -9.2 59.84 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.586 1.088 . . . . 0.0 115.107 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 8.7 mt -111.89 -31.16 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 127.14 2.176 . . . . 0.0 111.098 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -80.05 -33.07 39.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.867 1.267 . . . . 0.0 113.341 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 16.7 mm -56.91 -54.9 49.4 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 125.894 1.678 . . . . 0.0 112.687 172.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -70.16 -27.87 24.02 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.381 1.387 . . . . 0.0 112.314 174.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.81 -50.64 71.51 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 120.507 1.503 . . . . 0.0 111.256 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.7 m -68.65 -33.03 73.3 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.64 -36.43 73.42 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.83 0.852 . . . . 0.0 112.014 176.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -62.08 -46.09 90.61 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.547 0.739 . . . . 0.0 111.195 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -64.45 -36.86 85.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.816 0.28 . . . . 0.0 110.835 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -70.19 -38.49 75.37 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -65.05 -39.69 93.67 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 125.013 1.325 . . . . 0.0 110.653 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 67.7 mt -60.13 -42.81 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.179 0.592 . . . . 0.0 111.18 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 38.4 t -65.61 -43.77 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.192 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -61.88 -41.3 97.71 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.178 0.513 . . . . 0.0 111.937 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.5 -39.54 88.76 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.337 1.055 . . . . 0.0 111.046 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -66.01 -42.26 89.93 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.35 -40.96 94.26 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.094 0.557 . . . . 0.0 111.161 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.6 t -67.95 -38.2 79.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 O-C-N 121.66 -0.65 . . . . 0.0 111.063 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.0 -33.59 73.91 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.871 0.868 . . . . 0.0 113.202 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -64.07 -45.73 87.47 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.719 0.808 . . . . 0.0 110.953 170.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 158.54 2.43 0.08 OUTLIER Glycine 0 CA--C 1.528 0.87 0 N-CA-C 117.298 1.679 . . . . 0.0 117.298 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 4.4 t -72.77 135.83 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 120.404 2.102 . . . . 0.0 109.365 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.18 141.16 58.17 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.857 -1.152 . . . . 0.0 110.581 170.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.25 -27.79 53.35 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.193 0.902 . . . . 0.0 113.586 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.31 -28.28 69.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.764 1.226 . . . . 0.0 113.896 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -97.2 -0.05 47.48 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.707 1.603 . . . . 0.0 114.034 -173.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 18.7 mm -119.54 140.55 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.827 1.651 . . . . 0.0 109.157 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -132.16 162.13 31.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.691 1.596 . . . . 0.0 109.622 167.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 39.0 p -135.15 146.75 49.07 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.86 0.864 . . . . 0.0 112.017 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 25.8 t -140.42 136.0 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.912 1.285 . . . . 0.0 109.721 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -107.74 105.03 2.17 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.164 1.84 . . . . 0.0 110.887 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.529 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 1.9 mp -98.69 17.13 19.99 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 127.5 2.32 . . . . 0.0 112.969 -171.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 18.2 -97.37 0.01 OUTLIER Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.981 1.277 . . . . 0.0 116.287 -171.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 4.1 m -119.96 13.05 12.15 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -171.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 4.8 m -65.63 161.44 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 121.152 -0.967 . . . . 0.0 111.581 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 16.3 m120 40.41 54.8 6.82 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 125.305 1.442 . . . . 0.0 114.157 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.68 138.95 56.0 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.215 2.61 . . . . 0.0 112.27 -173.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 11.8 pt -138.84 0.81 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 125.074 1.349 . . . . 0.0 114.594 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 318' ' ' ASN . . . -148.68 139.6 22.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.455 1.102 . . . . 0.0 110.677 167.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 39.8 m -71.76 148.72 46.05 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.62 1.568 . . . . 0.0 113.798 -173.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -73.98 -2.79 25.58 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 171.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.46 -17.9 64.29 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.11 1.364 . . . . 0.0 114.529 -172.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 79.7 p -140.57 149.99 58.98 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.414 1.486 . . . . 0.0 110.561 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -62.13 -27.34 78.76 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.19 2.593 . . . . 0.0 112.634 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -62.4 -46.66 87.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.669 0.787 . . . . 0.0 111.764 170.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.22 -35.16 82.35 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 123.545 0.593 . . . . 0.0 112.669 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -59.03 -50.26 74.76 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.967 0.907 . . . . 0.0 110.896 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.74 -19.03 58.11 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 121.431 -0.793 . . . . 0.0 112.502 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -82.43 -15.07 53.93 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.07 1.748 . . . . 0.0 114.758 168.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 307' ' ' ALA 0.251 17.1 t-20 -101.17 -22.23 14.73 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 120.292 1.405 . . . . 0.0 111.286 168.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -68.95 11.24 0.21 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.04 -1.662 . . . . 0.0 114.308 166.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -61.15 165.97 4.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.732 2.013 . . . . 0.0 113.575 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 18.6 m -130.38 151.03 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.728 1.611 . . . . 0.0 111.262 176.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -139.62 159.83 41.27 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.368 1.467 . . . . 0.0 111.397 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 14.7 tt -135.81 135.16 51.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.8 1.24 . . . . 0.0 112.171 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 59.8 t -137.4 122.59 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.029 1.332 . . . . 0.0 110.223 -171.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 38.9 t -70.25 133.57 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.46 1.104 . . . . 0.0 109.274 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 . . . . . 0 C--O 1.251 1.153 0 C-N-CA 124.394 1.078 . . . . 0.0 113.307 -171.623 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 119.28 -0.39 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.15 160.74 48.68 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 123.503 2.802 . . . . 0.0 112.399 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.74 149.82 78.86 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.125 2.55 . . . . 0.0 112.144 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 175.71 57.8 0.06 OUTLIER Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.537 -1.146 . . . . 0.0 114.302 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -66.04 159.02 51.34 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.304 2.669 . . . . 0.0 112.49 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.46 116.27 3.97 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.35 2.7 . . . . 0.0 111.354 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -146.85 22.36 1.25 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.083 1.353 . . . . 0.0 113.121 -173.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 7.7 p -59.43 115.07 3.01 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.331 1.453 . . . . 0.0 112.737 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 169.48 60.38 0.03 OUTLIER Glycine 0 CA--C 1.537 1.469 0 C-N-CA 124.196 0.903 . . . . 0.0 114.287 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -70.83 -18.11 32.24 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.91 3.074 . . . . 0.0 113.689 -173.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 30.6 t -124.33 3.48 8.46 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 127.0 2.12 . . . . 0.0 111.601 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.25 -19.85 66.15 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.409 -1.432 . . . . 0.0 114.572 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -139.6 47.83 1.85 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.955 2.502 . . . . 0.0 109.755 172.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.49 -34.14 34.52 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.912 1.685 . . . . 0.0 112.314 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -66.68 -46.92 74.1 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.106 0.963 . . . . 0.0 112.012 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 14.4 t -65.8 -39.25 90.73 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.169 0.987 . . . . 0.0 112.143 177.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.58 95.11 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 4.2 mt -74.28 -32.69 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.737 0.815 . . . . 0.0 112.116 174.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -64.22 -34.52 78.29 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.168 -0.957 . . . . 0.0 112.182 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -70.17 -36.38 74.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.216 1.006 . . . . 0.0 112.699 172.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 36.7 t -62.05 -43.18 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.143 0.977 . . . . 0.0 111.738 171.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 64.9 p -83.01 -19.28 37.29 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 64.4 18.06 62.72 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.721 1.629 . . . . 0.0 114.304 -171.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 121.9 -146.58 17.05 Favored Glycine 0 CA--C 1.544 1.898 0 C-N-CA 125.214 1.387 . . . . 0.0 112.881 -173.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.67 171.76 15.74 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.967 3.111 . . . . 0.0 112.129 172.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -131.25 144.78 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.441 1.096 . . . . 0.0 110.159 171.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -115.06 173.74 6.34 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.974 1.709 . . . . 0.0 114.393 -170.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -132.06 88.15 2.52 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.345 1.458 . . . . 0.0 109.423 -176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -66.55 164.1 42.35 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.531 1.539 . . . . 0.0 115.282 -171.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 29.9 -66.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.925 1 C-N-CA 131.842 4.057 . . . . 0.0 117.655 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -63.08 -26.02 68.64 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.158 1.383 . . . . 0.0 113.389 173.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.79 7.67 77.82 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.78 1.181 . . . . 0.0 115.002 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -156.69 13.67 0.28 Allowed 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 126.511 1.924 . . . . 0.0 114.557 -175.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 35.1 m -93.45 88.3 5.89 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.341 -1.474 . . . . 0.0 112.405 -170.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 16.9 tp -71.03 96.97 1.38 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.065 1.346 . . . . 0.0 110.328 171.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.405 ' HB ' ' HD2' ' A' ' 234' ' ' PRO . 4.2 pt -66.11 159.82 68.35 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 125.102 1.361 . . . . 0.0 111.988 -172.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 233' ' ' ILE . 36.5 Cg_endo -62.42 -33.61 78.94 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.269 1.979 . . . . 0.0 112.674 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -67.18 -29.84 69.64 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.925 1.084 . . . . 0.0 113.925 171.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.88 -47.26 86.47 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.521 1.055 . . . . 0.0 111.924 174.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -58.6 -24.25 60.54 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.303 1.041 . . . . 0.0 113.157 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -39.5 87.73 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.258 -0.901 . . . . 0.0 112.005 174.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 37.2 mm -58.69 -47.21 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 120.889 -1.132 . . . . 0.0 110.392 171.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 7.9 mp -62.01 -37.3 84.37 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.438 0.695 . . . . 0.0 111.887 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -61.25 -39.72 91.38 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.073 1.349 . . . . 0.0 112.573 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 13.7 mmt85 -69.03 -39.19 79.37 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 172.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.3 t -64.85 -40.21 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.124 0.57 . . . . 0.0 110.918 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.66 98.14 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.397 1.079 . . . . 0.0 111.95 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.85 -36.96 84.95 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -76.11 -29.03 57.72 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.528 HD21 HG11 ' A' ' 255' ' ' VAL . 1.0 OUTLIER -66.41 -45.98 78.1 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.202 1.001 . . . . 0.0 111.437 169.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -58.07 -34.04 69.71 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.501 1.521 . . . . 0.0 112.645 173.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.96 -9.08 58.45 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.319 1.448 . . . . 0.0 114.564 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 13.1 t -157.74 66.54 3.61 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.01 1.324 . . . . 0.0 109.52 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -62.73 -9.3 15.76 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.085 2.523 . . . . 0.0 112.196 173.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -70.46 -16.61 62.94 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.776 1.63 . . . . 0.0 113.415 171.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -119.27 80.64 1.59 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.518 1.527 . . . . 0.0 110.687 -176.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 65.5 mtt85 -51.71 148.1 5.9 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.927 1.291 . . . . 0.0 111.553 173.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.528 HG11 HD21 ' A' ' 247' ' ' LEU . 34.2 m -125.54 158.41 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.519 1.128 . . . . 0.0 112.548 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 18.0 m -130.83 134.4 46.79 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 172.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 51.8 mt -104.76 124.85 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 125.198 1.399 . . . . 0.0 107.557 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.406 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 21.7 m-20 -114.32 129.54 56.64 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.276 1.03 . . . . 0.0 109.799 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -119.3 157.43 15.39 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 122.089 -0.382 . . . . 0.0 112.154 173.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -125.47 167.82 14.48 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 128.156 2.582 . . . . 0.0 108.615 -170.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.5 m -144.57 169.3 18.23 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 127.076 2.15 . . . . 0.0 109.747 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.32 158.15 5.77 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.806 1.242 . . . . 0.0 111.701 170.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -96.88 -4.4 40.25 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 121.32 -0.863 . . . . 0.0 112.997 173.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 2.3 p -68.33 -31.02 70.14 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.848 1.659 . . . . 0.0 114.886 177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -76.19 -161.25 10.91 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 126.471 1.986 . . . . 0.0 114.082 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 8.0 t -130.59 154.25 48.05 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.608 1.563 . . . . 0.0 109.858 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -58.61 -32.58 69.14 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -171.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.46 -13.91 56.04 Favored Glycine 0 CA--C 1.541 1.671 0 O-C-N 121.058 -1.026 . . . . 0.0 114.859 171.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 2.9 mt -106.62 -34.33 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 127.101 2.161 . . . . 0.0 111.346 173.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -78.93 -31.78 45.32 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -174.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 20.6 mm -61.16 -53.92 58.69 Favored Pre-proline 0 N--CA 1.47 0.538 0 C-N-CA 125.969 1.708 . . . . 0.0 112.042 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.76 -34.86 17.53 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 CA-C-N 120.913 1.362 . . . . 0.0 112.561 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 6.9 mp -66.72 -43.26 84.72 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.68 1.127 . . . . 0.0 112.561 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 31.2 p -69.12 -36.12 77.17 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.38 -40.11 77.6 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.225 0.61 . . . . 0.0 111.335 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 54.4 mm-40 -62.65 -40.33 96.7 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.436 0.694 . . . . 0.0 111.347 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 29.3 mtt85 -68.7 -23.17 64.34 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -83.63 -39.69 19.95 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 167.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -65.29 -35.96 82.62 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.416 1.486 . . . . 0.0 112.254 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 74.9 mt -66.17 -39.98 85.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 118.892 0.769 . . . . 0.0 110.552 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 88.2 t -65.62 -45.68 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 122.179 -0.326 . . . . 0.0 110.669 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.2 96.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.72 0.408 . . . . 0.0 111.456 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.88 -39.01 92.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.718 0.807 . . . . 0.0 111.738 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -65.85 -42.47 90.4 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 175.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 2.1 mp -68.72 -37.59 79.59 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 122.003 -0.435 . . . . 0.0 111.916 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 45.9 t -66.22 -40.1 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 O-C-N 121.439 -0.788 . . . . 0.0 110.731 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.09 -33.51 75.63 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 19.9 ttt85 -66.34 -41.95 88.84 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.478 168.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 156.91 1.04 0.1 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 173.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.8 t -69.64 132.9 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 120.399 2.099 . . . . 0.0 109.3 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.71 135.92 53.49 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.196 -0.94 . . . . 0.0 110.069 172.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.07 -26.81 50.13 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.525 1.06 . . . . 0.0 113.819 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.66 -29.52 70.13 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.763 1.225 . . . . 0.0 113.61 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -96.43 -7.61 34.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.155 1.782 . . . . 0.0 113.977 -175.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 3.4 tt -139.27 99.37 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 122.352 1.072 . . . . 0.0 112.331 -171.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -102.4 169.97 8.36 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.327 1.451 . . . . 0.0 112.265 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 40.1 p -137.85 146.92 44.03 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.417 1.087 . . . . 0.0 113.171 -176.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.4 t -141.15 139.51 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.433 1.493 . . . . 0.0 110.98 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -95.51 113.62 4.67 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.538 1.066 . . . . 0.0 111.429 169.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.406 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 42.3 mt -105.21 33.39 3.69 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.072 2.549 . . . . 0.0 110.13 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 0.72 -69.79 0.0 OUTLIER Glycine 0 C--N 1.35 1.359 0 N-CA-C 120.154 2.822 . . . . 0.0 120.154 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 54.2 p -148.72 24.65 0.96 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.7 1.75 . . . . 0.0 114.447 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 8.5 m -64.75 155.95 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 O-C-N 121.252 -0.905 . . . . 0.0 110.676 167.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 39.24 55.11 5.51 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 125.2 1.4 . . . . 0.0 114.083 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -61.71 149.51 89.65 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.237 2.625 . . . . 0.0 112.004 -172.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.38 -2.97 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -170.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' A' ' 318' ' ' ASN . . . -153.04 154.01 34.04 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.177 -0.952 . . . . 0.0 112.642 177.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 68.1 m -67.41 138.15 56.47 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.42 1.488 . . . . 0.0 111.237 167.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -92.25 11.64 25.08 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.603 1.161 . . . . 0.0 112.026 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.34 -16.56 62.44 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.408 1.483 . . . . 0.0 114.433 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 70.7 p -137.67 148.42 61.09 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 125.618 1.567 . . . . 0.0 110.425 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -61.78 -31.22 85.54 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.226 2.618 . . . . 0.0 112.568 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.88 -36.35 77.98 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -71.27 -39.8 61.72 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 121.529 0.516 . . . . 0.0 112.874 172.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -56.92 -45.85 82.4 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 124.123 0.969 . . . . 0.0 110.839 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.66 -39.55 88.78 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.906 0.882 . . . . 0.0 112.74 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -72.33 -20.43 61.48 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.551 1.54 . . . . 0.0 114.031 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 307' ' ' ALA . 39.8 t30 -102.6 -15.04 16.51 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.092 1.357 . . . . 0.0 113.364 172.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -82.07 12.61 4.03 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 126.614 1.966 . . . . 0.0 113.141 166.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -56.89 168.34 0.65 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.454 1.902 . . . . 0.0 115.326 -171.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 14.0 p -129.64 142.33 44.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 125.179 1.392 . . . . 0.0 110.189 167.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -139.91 165.34 27.59 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.76 2.024 . . . . 0.0 110.737 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 14.8 tt -138.28 154.0 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.1 0.96 . . . . 0.0 112.636 -175.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.5 161.55 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.334 1.854 . . . . 0.0 110.461 -175.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 59.0 t -107.3 135.84 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.52 1.128 . . . . 0.0 109.359 173.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.177 0 C-N-CA 125.177 1.391 . . . . 0.0 111.774 -173.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 119.316 -0.373 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -71.71 161.71 44.33 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.553 2.835 . . . . 0.0 112.403 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.75 150.5 79.09 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.106 2.538 . . . . 0.0 111.871 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 175.39 59.53 0.06 OUTLIER Glycine 0 CA--C 1.538 1.491 0 CA-C-O 118.575 -1.125 . . . . 0.0 114.184 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.32 159.32 50.68 Favored 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 123.324 2.683 . . . . 0.0 112.767 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.71 165.77 28.4 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.701 2.934 . . . . 0.0 112.882 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -136.42 22.92 3.19 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.301 1.441 . . . . 0.0 113.271 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 24.9 m -56.04 139.85 45.44 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.785 1.634 . . . . 0.0 112.622 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 52.1 58.77 9.9 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 125.245 1.402 . . . . 0.0 114.789 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.36 -19.37 38.1 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 124.055 3.17 . . . . 0.0 114.401 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 43.9 t -122.63 -8.4 8.5 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.254 1.822 . . . . 0.0 112.295 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -63.6 -16.76 61.76 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -174.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -137.89 40.71 2.34 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.199 2.2 . . . . 0.0 111.093 174.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.2 mt -46.86 -38.43 10.34 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.189 0.995 . . . . 0.0 112.193 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -60.46 -38.52 84.46 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.438 0.695 . . . . 0.0 112.296 -175.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.3 t -70.81 -45.64 64.26 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.359 0.664 . . . . 0.0 111.959 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.64 -40.67 97.75 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 15.3 mt -73.16 -33.83 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.883 0.873 . . . . 0.0 110.728 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.3 -39.16 92.13 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.363 -0.835 . . . . 0.0 112.046 172.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.97 76.34 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.273 1.029 . . . . 0.0 113.046 176.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.7 t -64.55 -40.8 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.139 0.976 . . . . 0.0 111.245 172.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 16.9 m -84.12 -24.49 30.26 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.881 0.873 . . . . 0.0 112.96 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.38 15.37 72.66 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 126.23 1.871 . . . . 0.0 115.135 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 126.78 -156.41 20.09 Favored Glycine 0 CA--C 1.542 1.747 0 C-N-CA 125.311 1.434 . . . . 0.0 112.962 -174.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.64 170.43 20.02 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 124.16 3.24 . . . . 0.0 111.817 169.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.93 108.69 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.579 1.151 . . . . 0.0 110.752 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -80.54 171.7 14.71 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.469 2.308 . . . . 0.0 112.554 169.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.442 ' O ' ' HB1' ' A' ' 316' ' ' ALA . 81.2 m-85 -119.29 150.95 39.27 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.099 0.475 . . . . 0.0 111.147 -171.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -57.31 170.76 3.26 Favored Glycine 0 CA--C 1.541 1.716 0 O-C-N 121.147 -0.971 . . . . 0.0 111.863 166.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -48.68 -28.19 3.39 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -171.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -65.29 -17.92 64.89 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.92 8.41 76.07 Favored Glycine 0 CA--C 1.542 1.774 0 C-N-CA 124.698 1.142 . . . . 0.0 115.215 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -167.53 8.88 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.1 t -73.84 105.42 5.11 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 122.053 2.206 . . . . 0.0 112.12 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.7 mp -74.13 102.5 4.26 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.169 0.988 . . . . 0.0 111.479 172.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.532 HG13 ' H ' ' A' ' 236' ' ' ASP . 5.9 pt -56.97 152.65 27.13 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.065 1.746 . . . . 0.0 112.635 167.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -63.15 -29.57 74.26 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.619 2.212 . . . . 0.0 112.406 173.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.71 92.03 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.737 0.815 . . . . 0.0 112.952 172.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.532 ' H ' HG13 ' A' ' 233' ' ' ILE . 28.4 t70 -61.62 -47.8 83.78 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 119.025 0.83 . . . . 0.0 111.663 171.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -61.11 -35.0 75.84 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.559 -0.713 . . . . 0.0 112.488 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -69.27 -42.65 75.24 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.761 -1.212 . . . . 0.0 112.555 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 56.1 mt -56.49 -47.26 82.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 121.162 -0.962 . . . . 0.0 110.496 171.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 73.5 mt -64.49 -33.34 75.66 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.585 0.754 . . . . 0.0 112.69 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -62.61 -41.58 99.07 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.289 1.036 . . . . 0.0 112.676 175.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -69.57 -36.49 76.33 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 74.3 t -67.31 -41.42 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.504 0.722 . . . . 0.0 111.19 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.01 93.7 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.889 0.876 . . . . 0.0 112.246 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -65.75 -36.98 85.11 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.751 -0.593 . . . . 0.0 112.047 173.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -63.5 -36.15 82.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.153 0.981 . . . . 0.0 112.711 174.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.71 -41.76 87.45 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.487 0.585 . . . . 0.0 112.173 171.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -60.93 -30.75 70.39 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.421 1.088 . . . . 0.0 112.532 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -74.99 -9.51 58.61 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.909 1.684 . . . . 0.0 114.627 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 17.1 t -155.92 69.39 5.1 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.483 1.513 . . . . 0.0 108.644 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -62.96 -5.54 7.82 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.518 2.812 . . . . 0.0 112.716 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -74.16 -17.89 60.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.463 1.505 . . . . 0.0 113.256 171.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -118.78 83.52 2.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.453 1.501 . . . . 0.0 111.251 -171.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 55.7 mtt85 -55.23 157.39 3.58 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.123 1.369 . . . . 0.0 112.129 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.18 161.29 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.6 m -128.89 140.77 51.53 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.339 1.456 . . . . 0.0 109.258 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 61.7 mt -113.84 127.03 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.815 1.246 . . . . 0.0 108.759 -173.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.508 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 1.4 m120 -119.73 118.4 30.8 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.919 1.688 . . . . 0.0 107.764 -172.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -121.77 151.16 16.98 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 118.549 0.613 . . . . 0.0 112.791 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -127.35 168.69 14.47 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 128.423 2.689 . . . . 0.0 109.81 -170.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.2 m -152.42 156.69 40.0 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.362 1.865 . . . . 0.0 109.642 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.66 157.63 37.65 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.53 -1.356 . . . . 0.0 109.761 165.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -92.0 33.22 1.07 Allowed 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 121.431 0.634 . . . . 0.0 112.642 -177.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 13.0 m -66.29 -23.14 66.33 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.016 1.326 . . . . 0.0 112.773 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -99.93 -139.69 10.96 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 126.384 1.945 . . . . 0.0 112.752 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 62.2 m -139.25 163.57 32.12 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.603 1.961 . . . . 0.0 109.587 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -53.61 -38.93 64.49 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 121.035 -1.04 . . . . 0.0 113.196 -177.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -65.93 -10.12 49.7 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 124.589 1.09 . . . . 0.0 115.197 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 13.8 mt -110.1 -32.45 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.796 2.038 . . . . 0.0 111.156 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -82.35 -29.77 30.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.344 1.058 . . . . 0.0 112.927 -174.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 21.1 mm -59.37 -55.57 44.71 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 125.724 1.61 . . . . 0.0 111.759 169.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.87 -31.93 19.11 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 CA-C-N 120.836 1.334 . . . . 0.0 113.284 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 4.3 mp -64.65 -50.63 66.32 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 120.23 1.377 . . . . 0.0 111.865 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 46.5 p -65.38 -33.19 75.37 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -72.32 -38.06 68.76 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.884 0.874 . . . . 0.0 112.169 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -62.92 -41.78 99.58 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.764 1.226 . . . . 0.0 111.103 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.7 mmt-85 -63.19 -38.74 92.37 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.678 0.672 . . . . 0.0 111.598 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -71.33 -38.4 71.69 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -65.68 -37.74 87.33 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 125.264 1.426 . . . . 0.0 112.08 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 82.1 mt -64.59 -41.36 92.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 118.587 0.631 . . . . 0.0 110.572 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 86.2 t -65.42 -41.73 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 122.047 -0.408 . . . . 0.0 111.527 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -64.68 -41.14 96.26 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.939 0.496 . . . . 0.0 111.882 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.59 -37.71 87.4 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.827 0.851 . . . . 0.0 111.57 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -65.09 -42.15 94.32 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 174.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.2 mp -63.99 -40.75 97.07 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.843 -0.536 . . . . 0.0 111.716 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 53.3 t -68.16 -38.45 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.67 0.788 . . . . 0.0 110.798 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.25 -34.39 77.35 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.131 0.972 . . . . 0.0 112.879 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -43.64 93.83 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.903 0.881 . . . . 0.0 111.279 170.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 156.67 1.86 0.1 OUTLIER Glycine 0 CA--C 1.53 1.019 0 N-CA-C 117.746 1.858 . . . . 0.0 117.746 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 3.0 m -73.67 145.83 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-N 121.066 2.433 . . . . 0.0 110.799 -174.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.61 140.25 55.53 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.616 -0.678 . . . . 0.0 110.788 172.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -54.54 -27.94 43.35 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.309 1.433 . . . . 0.0 113.843 171.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.1 -32.14 72.67 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.395 1.078 . . . . 0.0 113.316 172.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -90.23 2.29 55.57 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.261 1.424 . . . . 0.0 114.218 -173.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 14.9 tt -138.88 139.95 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.482 0.713 . . . . 0.0 112.559 -171.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -139.4 164.31 30.19 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.217 1.407 . . . . 0.0 111.631 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 45.9 p -138.99 146.11 40.52 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.662 1.185 . . . . 0.0 111.977 -175.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 40.5 t -142.18 138.39 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.792 1.637 . . . . 0.0 109.934 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -107.75 97.97 1.2 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.117 1.818 . . . . 0.0 111.692 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.508 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 1.9 mp -97.01 29.96 2.9 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.443 2.697 . . . . 0.0 110.223 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 0.61 -66.14 0.0 OUTLIER Glycine 0 C--N 1.346 1.122 0 N-CA-C 120.919 3.127 . . . . 0.0 120.919 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 91.5 p -146.81 16.1 1.23 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.064 1.432 . . . . 0.0 114.732 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 17.7 m -71.76 154.37 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 O-C-N 121.106 -0.996 . . . . 0.0 111.098 171.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 22.4 m120 41.71 50.16 4.45 Favored Pre-proline 0 CA--C 1.559 1.327 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.6 125.35 12.64 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.838 2.359 . . . . 0.0 111.404 -174.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 2.0 pp -97.84 -1.11 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -173.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -146.32 166.95 24.78 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.855 1.662 . . . . 0.0 111.714 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 85.9 p -80.92 158.58 25.22 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 122.253 1.025 . . . . 0.0 113.411 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -86.7 -4.87 59.23 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.601 1.16 . . . . 0.0 110.987 165.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.57 -18.69 61.59 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.815 1.646 . . . . 0.0 114.447 -174.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 71.6 p -133.26 142.88 45.95 Favored Pre-proline 0 N--CA 1.474 0.759 0 CA-C-N 119.337 0.971 . . . . 0.0 110.575 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.7 -28.12 68.74 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.447 2.764 . . . . 0.0 112.707 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -66.08 -41.14 91.1 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.43 -0.794 . . . . 0.0 111.468 170.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -64.49 -38.23 95.49 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 124.184 0.897 . . . . 0.0 113.087 174.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -58.96 -49.0 79.52 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 124.21 1.004 . . . . 0.0 111.23 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 225' ' ' PHE . . . -75.85 -22.84 55.83 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.249 -0.907 . . . . 0.0 112.105 -175.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -70.18 -34.58 73.14 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.061 1.344 . . . . 0.0 112.769 167.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.69 -16.51 26.85 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.144 1.378 . . . . 0.0 112.65 177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 57.3 mtt180 -70.54 11.81 0.32 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.831 1.652 . . . . 0.0 113.779 167.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -60.51 162.44 6.35 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.521 1.928 . . . . 0.0 114.038 -173.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.21 151.66 32.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.24 172.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -139.63 159.11 42.93 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.894 1.678 . . . . 0.0 111.542 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.35 129.28 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.179 1.392 . . . . 0.0 108.708 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 64.8 t -134.05 129.57 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.209 1.404 . . . . 0.0 110.359 -171.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 23.8 t -72.84 134.92 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.546 0.738 . . . . 0.0 109.749 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.208 0 C-N-CA 125.036 1.335 . . . . 0.0 111.707 -171.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 119.282 -0.389 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -67.9 156.9 64.12 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 123.404 2.736 . . . . 0.0 112.396 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -80.35 42.7 1.37 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.797 3.665 . . . . 0.0 113.76 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 145.37 178.12 20.67 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 126.308 1.908 . . . . 0.0 113.699 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -69.88 165.43 31.13 Favored 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 123.789 2.993 . . . . 0.0 112.16 173.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.46 62.51 6.24 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.772 3.648 . . . . 0.0 113.125 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.61 35.36 0.06 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 128.304 2.642 . . . . 0.0 114.443 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 12.1 t -58.49 148.79 27.15 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.325 1.45 . . . . 0.0 112.539 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 54.43 58.69 12.07 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 125.613 1.578 . . . . 0.0 114.626 -175.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -70.21 -16.78 35.76 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.14 3.227 . . . . 0.0 114.277 -171.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 49.3 t -120.45 -2.99 9.93 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 126.759 2.024 . . . . 0.0 111.832 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -63.59 -17.8 63.23 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 -171.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -138.3 29.4 2.46 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.953 2.101 . . . . 0.0 111.475 173.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.79 -19.14 64.77 Favored 'General case' 0 C--O 1.221 -0.44 0 O-C-N 121.437 -0.789 . . . . 0.0 112.721 -172.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -55.94 -40.12 72.7 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.642 1.11 . . . . 0.0 111.529 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 17.5 t -68.33 -44.49 75.2 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.311 0.645 . . . . 0.0 111.878 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.94 -35.96 82.85 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 55.0 mt -70.18 -39.96 77.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.651 1.58 . . . . 0.0 109.493 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -63.9 -40.01 95.51 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.11 -0.994 . . . . 0.0 111.897 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.96 -38.34 90.65 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.121 0.968 . . . . 0.0 112.772 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.91 -28.78 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 118.677 0.671 . . . . 0.0 112.201 177.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.4 m -71.52 -26.41 62.65 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.693 1.197 . . . . 0.0 112.24 169.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.03 25.48 74.62 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.409 1.481 . . . . 0.0 113.637 -172.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 97.3 -170.54 25.93 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.28 1.419 . . . . 0.0 112.751 -171.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.09 140.96 38.78 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.32 2.68 . . . . 0.0 110.992 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.94 142.05 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.634 1.174 . . . . 0.0 112.03 -170.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -104.88 174.16 6.0 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.219 1.807 . . . . 0.0 115.115 -171.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -134.29 84.14 2.09 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.14 1.376 . . . . 0.0 108.858 -173.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -48.54 151.96 2.73 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 126.727 2.108 . . . . 0.0 115.047 -170.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -2.63 -42.12 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 1 C-N-CA 133.628 4.771 . . . . 0.0 120.62 -171.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -63.19 -20.43 65.41 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.204 1.002 . . . . 0.0 113.472 168.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 86.67 8.06 77.51 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.465 1.507 . . . . 0.0 115.047 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -154.19 19.58 0.5 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 127.361 2.265 . . . . 0.0 112.005 -176.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 7.5 t -82.74 81.99 8.26 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.741 -1.225 . . . . 0.0 113.17 -170.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 22.0 tp -82.13 77.65 8.91 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.834 1.254 . . . . 0.0 110.206 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 3.8 pt -58.21 157.89 15.62 Favored Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 125.624 1.57 . . . . 0.0 112.135 -173.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -61.65 -32.68 87.2 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.224 1.949 . . . . 0.0 112.648 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -68.55 -29.12 67.61 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 172.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -59.1 -41.83 89.05 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.818 1.19 . . . . 0.0 112.359 175.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -60.96 -27.57 68.35 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.561 0.745 . . . . 0.0 112.933 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -64.01 -40.65 96.83 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.67 1.123 . . . . 0.0 111.752 175.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 45.2 mm -58.9 -44.52 90.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 121.579 -0.7 . . . . 0.0 110.221 171.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.05 -36.86 84.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.486 0.714 . . . . 0.0 112.795 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -60.97 -41.73 96.94 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 119.074 0.852 . . . . 0.0 112.157 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -66.3 -40.21 89.84 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.954 0.901 . . . . 0.0 112.311 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 76.2 t -66.78 -41.57 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 123.78 0.832 . . . . 0.0 110.81 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.02 -39.27 93.15 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.355 0.662 . . . . 0.0 112.049 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.7 -38.22 88.62 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.252 0.621 . . . . 0.0 112.082 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.38 -30.93 67.96 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 178.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.405 HD21 ' CG1' ' A' ' 255' ' ' VAL . 0.4 OUTLIER -69.79 -43.23 72.53 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.025 0.93 . . . . 0.0 112.585 169.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -60.43 -27.5 67.54 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.325 1.45 . . . . 0.0 112.745 174.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -79.36 -8.13 58.85 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.006 1.723 . . . . 0.0 114.843 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 37.2 t -152.99 68.5 6.72 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 125.285 1.434 . . . . 0.0 108.903 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -62.59 -8.85 14.03 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.244 2.63 . . . . 0.0 112.271 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -72.23 -16.5 61.94 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.669 1.588 . . . . 0.0 113.507 173.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -121.54 81.28 1.78 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.274 1.429 . . . . 0.0 110.705 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -49.89 143.04 8.16 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.412 1.485 . . . . 0.0 111.502 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.405 ' CG1' HD21 ' A' ' 247' ' ' LEU . 16.8 m -135.42 163.03 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 176.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 5.2 t -143.07 146.39 33.75 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 3.4 mt -101.92 106.7 20.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.476 -169.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.426 ' HB3' ' CD1' ' A' ' 300' ' ' LEU . 21.8 m-20 -81.87 154.41 25.86 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 166.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -148.69 152.75 24.74 Favored Glycine 0 CA--C 1.523 0.564 0 O-C-N 121.84 -0.537 . . . . 0.0 112.36 168.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -116.62 169.96 8.95 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.74 2.416 . . . . 0.0 108.633 -170.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.4 p -149.95 145.86 26.72 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.292 2.637 . . . . 0.0 109.78 171.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -63.44 168.31 4.68 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 120.984 -1.073 . . . . 0.0 112.929 174.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -101.33 21.08 14.67 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -171.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 3.9 m -68.71 -19.14 64.35 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.867 -1.145 . . . . 0.0 112.772 172.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -98.22 -152.55 28.12 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.12 1.819 . . . . 0.0 113.985 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 73.7 m -129.72 145.8 51.52 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.735 1.614 . . . . 0.0 110.472 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -53.56 -37.12 62.58 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.71 1.204 . . . . 0.0 113.754 -171.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -60.0 -28.86 66.88 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 123.955 0.788 . . . . 0.0 113.959 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 18.7 mm -95.94 -24.17 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 126.156 1.782 . . . . 0.0 112.142 175.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -86.76 -23.97 25.25 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -175.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 21.8 mm -58.67 -54.28 57.84 Favored Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 125.121 1.368 . . . . 0.0 112.228 167.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -70.63 -33.44 13.29 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 121.075 1.42 . . . . 0.0 113.116 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.457 HD13 HH12 ' A' ' 277' ' ' ARG . 1.2 mm? -72.35 -36.52 68.82 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.58 1.082 . . . . 0.0 112.856 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 61.7 p -68.82 -36.66 78.5 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.72 1.145 . . . . 0.0 113.536 171.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.36 85.12 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.339 1.055 . . . . 0.0 111.577 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -61.2 -42.7 99.05 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 124.918 1.287 . . . . 0.0 110.745 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.457 HH12 HD13 ' A' ' 273' ' ' LEU . 22.7 mtt85 -64.56 -32.12 73.64 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -75.92 -39.57 55.97 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 171.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -60.22 -45.65 92.45 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 125.319 1.448 . . . . 0.0 110.351 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 41.0 mm -66.27 -35.52 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 118.675 0.67 . . . . 0.0 111.011 -177.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.81 -44.28 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 O-C-N 121.992 -0.443 . . . . 0.0 111.162 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -66.1 -36.59 83.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.341 0.657 . . . . 0.0 111.658 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -63.03 -41.23 99.48 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.668 1.187 . . . . 0.0 111.458 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -64.1 -43.01 96.67 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 172.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.4 mp -63.12 -40.93 99.04 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.779 0.832 . . . . 0.0 111.659 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 39.1 t -63.98 -42.31 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.872 0.869 . . . . 0.0 110.922 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.36 -31.8 70.46 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -42.03 75.76 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.142 0.977 . . . . 0.0 111.901 172.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 159.77 -0.26 0.08 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 117.494 1.757 . . . . 0.0 117.494 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 2.6 t -74.87 124.28 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 120.664 2.232 . . . . 0.0 109.2 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.31 142.36 57.8 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.048 -1.032 . . . . 0.0 110.837 173.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -53.17 -28.88 35.24 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.169 1.366 . . . . 0.0 113.613 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -68.31 -22.57 64.71 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.23 1.412 . . . . 0.0 114.671 175.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -108.46 2.4 22.29 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.305 1.842 . . . . 0.0 113.898 -172.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 2.8 tp -133.76 124.85 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.372 1.469 . . . . 0.0 110.005 -172.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -122.91 172.69 8.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.731 1.212 . . . . 0.0 110.789 171.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 40.0 p -141.73 151.91 43.36 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.458 1.103 . . . . 0.0 112.527 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 7.8 t -142.57 132.77 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.396 1.078 . . . . 0.0 111.143 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -93.75 120.76 6.39 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 123.881 0.753 . . . . 0.0 111.256 169.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.426 ' CD1' ' HB3' ' A' ' 258' ' ' ASN . 63.8 mt -111.65 18.9 18.59 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.352 1.861 . . . . 0.0 113.327 -175.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 16.47 -105.87 0.01 OUTLIER Glycine 0 CA--C 1.541 1.666 0 C-N-CA 124.863 1.22 . . . . 0.0 116.103 -171.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 16.9 m -111.47 13.51 21.44 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -172.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 6.3 m -61.33 159.17 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.68 1.127 . . . . 0.0 111.737 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 38.1 53.99 3.84 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 125.622 1.569 . . . . 0.0 113.78 175.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -64.06 150.79 87.62 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.922 2.414 . . . . 0.0 113.081 -171.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 22.8 pt -134.72 -4.94 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 127.211 2.205 . . . . 0.0 113.365 -171.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 318' ' ' ASN . . . -147.77 152.81 38.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.593 1.157 . . . . 0.0 112.399 170.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 69.5 m -76.73 157.44 31.69 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.746 1.618 . . . . 0.0 112.936 174.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -73.14 -3.64 27.78 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.121 1.368 . . . . 0.0 113.273 170.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.19 -21.04 66.3 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.86 1.664 . . . . 0.0 115.367 -170.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 78.3 p -140.41 147.45 49.65 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 124.198 0.999 . . . . 0.0 111.182 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.73 -27.8 75.94 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.381 2.721 . . . . 0.0 112.603 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -65.06 -41.19 95.35 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.939 0.896 . . . . 0.0 112.386 170.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.55 -39.9 95.8 Favored Glycine 0 C--N 1.336 0.554 0 O-C-N 121.728 -0.607 . . . . 0.0 112.518 173.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -59.08 -43.29 91.79 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.771 0.828 . . . . 0.0 111.578 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.97 -41.61 99.59 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.892 0.877 . . . . 0.0 112.3 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.99 -11.41 60.86 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.613 1.565 . . . . 0.0 114.302 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.549 ' HB2' ' HB3' ' A' ' 307' ' ' ALA 0.256 0.4 OUTLIER -119.69 15.75 12.74 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.522 1.529 . . . . 0.0 111.667 172.001 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -105.56 8.58 33.36 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.992 1.717 . . . . 0.0 112.345 166.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -63.5 161.19 14.93 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -170.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 2.5 m -126.25 144.68 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 127.217 2.207 . . . . 0.0 110.779 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -147.57 134.69 20.42 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.468 1.107 . . . . 0.0 113.182 -171.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 23.2 mm -85.73 142.55 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.595 1.558 . . . . 0.0 110.758 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 43.5 t -139.6 129.39 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.394 1.077 . . . . 0.0 109.483 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 9.0 p -77.35 133.41 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.409 -0.807 . . . . 0.0 111.228 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 14.1 m120 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 125.233 1.413 . . . . 0.0 111.988 -177.698 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.225 0 CA-C-O 119.291 -0.385 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -70.5 160.39 49.65 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.458 2.772 . . . . 0.0 112.512 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.11 156.08 63.28 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.257 2.638 . . . . 0.0 111.973 173.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 69.56 -166.79 48.4 Favored Glycine 0 CA--C 1.544 1.894 0 C-N-CA 123.713 0.673 . . . . 0.0 114.029 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.51 159.58 52.87 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 123.322 2.681 . . . . 0.0 112.332 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.21 161.13 45.87 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.481 2.787 . . . . 0.0 112.797 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -75.57 22.21 0.13 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.117 1.767 . . . . 0.0 114.851 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 33.5 m -57.53 140.08 51.72 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.061 1.745 . . . . 0.0 112.844 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 48.91 58.35 7.78 Favored Glycine 0 CA--C 1.541 1.711 0 C-N-CA 125.627 1.584 . . . . 0.0 115.113 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -71.05 -14.76 32.2 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 124.19 3.26 . . . . 0.0 114.681 -171.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 33.0 t -133.6 -1.86 3.07 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 126.802 2.041 . . . . 0.0 112.092 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -62.24 -20.4 64.19 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 117.515 2.413 . . . . 0.0 117.515 -171.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -140.64 30.76 1.88 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.947 2.099 . . . . 0.0 111.292 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.0 tp -62.97 -19.73 64.58 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.341 -0.85 . . . . 0.0 113.221 -171.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -56.99 -39.5 74.77 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.222 0.919 . . . . 0.0 111.557 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 15.6 t -68.88 -43.63 74.91 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.549 0.74 . . . . 0.0 111.873 173.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.46 -35.01 79.63 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 60.8 mt -70.6 -39.49 76.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.466 1.506 . . . . 0.0 109.479 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -66.66 -33.42 75.6 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.221 -0.924 . . . . 0.0 112.873 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -70.43 -37.86 74.47 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.21 1.004 . . . . 0.0 112.402 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.26 -27.82 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 118.57 0.623 . . . . 0.0 112.451 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 68.5 p -84.8 -25.89 27.87 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 170.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.2 11.76 71.34 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 125.59 1.567 . . . . 0.0 113.855 -171.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 124.56 -174.46 17.07 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 126.565 2.031 . . . . 0.0 112.915 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -76.02 150.46 33.94 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.536 2.824 . . . . 0.0 110.337 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 10.5 mm -108.2 139.94 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -169.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -95.07 174.48 7.06 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 128.009 2.523 . . . . 0.0 114.613 -171.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -138.38 116.27 11.58 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.573 1.149 . . . . 0.0 110.636 -175.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -58.84 -162.71 0.07 OUTLIER Glycine 0 N--CA 1.477 1.381 0 C-N-CA 127.799 2.619 . . . . 0.0 117.056 -174.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -45.7 -37.59 5.99 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.451 1.9 . . . . 0.0 115.556 -175.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -69.65 -24.79 63.68 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.013 1.325 . . . . 0.0 113.913 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 90.37 -4.43 82.52 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 127.228 2.347 . . . . 0.0 115.16 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -156.34 16.87 0.34 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.132 1.373 . . . . 0.0 113.936 -171.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.0 t -85.33 100.1 11.59 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.647 -1.283 . . . . 0.0 110.851 -172.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 14.6 tp -80.26 93.83 5.97 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.615 1.166 . . . . 0.0 109.829 176.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 6.4 pt -63.49 160.0 46.38 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 125.776 1.631 . . . . 0.0 111.826 -173.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -61.91 -32.17 84.86 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.227 1.951 . . . . 0.0 112.596 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -67.67 -32.28 72.85 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 171.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.67 -44.32 90.17 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.508 1.049 . . . . 0.0 112.049 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -61.83 -20.12 63.31 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.01 0.924 . . . . 0.0 113.144 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -76.01 -42.75 47.08 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.557 1.071 . . . . 0.0 112.188 173.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 47.4 mm -58.92 -44.84 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 O-C-N 121.359 -0.838 . . . . 0.0 110.281 171.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.12 -34.68 78.97 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.654 0.782 . . . . 0.0 112.989 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -61.05 -42.12 97.87 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.049 0.94 . . . . 0.0 112.2 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -65.95 -38.47 88.69 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.303 1.041 . . . . 0.0 112.494 175.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 94.8 t -65.06 -42.68 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.167 0.587 . . . . 0.0 111.168 174.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.77 94.95 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.071 0.548 . . . . 0.0 111.875 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -64.08 -40.46 96.29 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.509 0.724 . . . . 0.0 111.988 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -70.96 -30.09 66.28 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.818 0.847 . . . . 0.0 113.092 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.591 HD21 HG11 ' A' ' 255' ' ' VAL . 0.2 OUTLIER -69.2 -43.98 73.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.838 0.855 . . . . 0.0 112.079 169.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -63.68 -23.07 67.22 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.014 1.326 . . . . 0.0 113.537 174.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.06 -10.02 59.08 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.275 1.43 . . . . 0.0 114.574 170.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 40.2 t -156.3 66.48 4.29 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 125.702 1.601 . . . . 0.0 109.141 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -64.78 -7.81 15.94 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.922 2.414 . . . . 0.0 111.773 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.91 -21.57 65.99 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.175 1.39 . . . . 0.0 113.017 170.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -107.93 95.22 5.53 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.123 1.369 . . . . 0.0 111.225 -175.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 23.3 mtt180 -49.72 141.21 10.23 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.524 1.13 . . . . 0.0 110.876 167.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.591 HG11 HD21 ' A' ' 247' ' ' LEU . 16.8 m -137.46 166.05 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.892 1.277 . . . . 0.0 111.561 173.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 7.2 t -149.16 146.74 27.81 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 118.387 2.736 . . . . 0.0 118.387 170.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 26.3 mt -100.4 115.02 40.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 124.982 1.313 . . . . 0.0 108.937 -171.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.407 ' HB3' HD12 ' A' ' 300' ' ' LEU . 7.2 m-20 -93.93 155.64 17.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.99 -0.444 . . . . 0.0 110.043 169.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -147.19 152.56 24.69 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 121.7 0.611 . . . . 0.0 113.349 167.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.86 170.43 10.11 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.187 2.595 . . . . 0.0 109.982 -169.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 51.0 p -143.65 160.86 39.93 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.188 2.195 . . . . 0.0 110.485 167.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.94 152.0 28.84 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 122.578 1.18 . . . . 0.0 112.232 168.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -3.85 29.42 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -171.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.93 -16.4 63.83 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.261 1.825 . . . . 0.0 114.931 -173.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.57 -157.78 31.93 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.306 1.431 . . . . 0.0 114.219 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 68.1 m -131.58 143.7 50.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.682 1.593 . . . . 0.0 109.702 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -50.57 -40.17 51.51 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.715 1.206 . . . . 0.0 114.019 -171.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -63.96 -27.19 70.93 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 123.657 0.646 . . . . 0.0 114.113 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 11.3 mm -97.72 -24.51 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.842 1.657 . . . . 0.0 111.767 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -80.42 -32.89 37.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.124 0.97 . . . . 0.0 113.193 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 18.6 mm -55.17 -55.86 34.76 Favored Pre-proline 0 N--CA 1.471 0.588 0 C-N-CA 125.418 1.487 . . . . 0.0 112.298 171.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.84 -30.14 17.71 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 120.721 1.293 . . . . 0.0 112.811 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 16.7 mt -66.02 -44.77 83.72 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 119.778 1.172 . . . . 0.0 112.789 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.33 -37.3 80.4 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 176.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.72 -34.47 75.68 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.249 1.02 . . . . 0.0 111.61 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -63.17 -42.83 99.45 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.293 1.037 . . . . 0.0 110.855 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -60.13 -44.01 95.26 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.875 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.25 -37.28 77.87 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -64.32 -41.36 96.86 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 125.631 1.573 . . . . 0.0 111.576 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 37.0 mm -67.14 -38.72 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 118.785 0.72 . . . . 0.0 110.896 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 99.7 t -68.04 -42.33 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 O-C-N 121.938 -0.476 . . . . 0.0 111.385 177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -65.64 -40.02 92.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.265 0.626 . . . . 0.0 111.305 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.15 -39.25 93.62 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.306 0.642 . . . . 0.0 111.75 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -65.02 -42.95 93.95 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.9 mp -67.53 -39.94 85.06 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.896 0.478 . . . . 0.0 111.41 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 50.7 t -66.65 -39.36 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 123.822 0.849 . . . . 0.0 110.672 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.73 -34.19 76.37 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 176.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -69.04 -38.08 78.95 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.76 -0.638 . . . . 0.0 112.612 170.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 151.46 9.32 0.1 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-O 117.481 -1.733 . . . . 0.0 116.952 168.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.9 130.13 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 120.482 2.141 . . . . 0.0 108.985 176.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.98 135.92 57.75 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.256 -0.902 . . . . 0.0 110.722 172.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -57.34 -29.82 60.73 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.696 1.141 . . . . 0.0 113.859 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.73 -37.26 85.84 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 122.161 -0.611 . . . . 0.0 112.476 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -85.49 -1.34 56.97 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.437 1.495 . . . . 0.0 113.966 -171.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 15.1 tt -139.85 93.64 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 124.92 1.288 . . . . 0.0 111.58 -171.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -85.64 174.2 9.58 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.209 -0.932 . . . . 0.0 110.632 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 38.4 p -136.26 148.77 48.17 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.485 1.114 . . . . 0.0 111.869 172.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 11.1 t -137.33 132.12 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.889 0.876 . . . . 0.0 111.994 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -91.06 104.91 3.22 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.589 1.09 . . . . 0.0 111.761 173.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.407 HD12 ' HB3' ' A' ' 258' ' ' ASN . 39.9 mt -105.38 32.08 4.5 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.989 2.115 . . . . 0.0 110.866 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 2.59 -72.66 0.0 OUTLIER Glycine 0 C--N 1.35 1.325 0 C-N-CA 127.796 2.617 . . . . 0.0 119.543 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 88.2 p -147.35 21.42 1.2 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.245 1.523 . . . . 0.0 113.989 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 9.0 m -66.43 156.38 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 121.083 -1.01 . . . . 0.0 111.618 172.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 35.91 55.64 2.65 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 125.978 1.711 . . . . 0.0 113.769 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -61.57 123.97 13.73 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.212 2.608 . . . . 0.0 112.588 -171.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 47.1 pt -90.7 -3.0 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.512 1.125 . . . . 0.0 113.86 -173.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 318' ' ' ASN . . . -153.08 166.8 31.32 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.81 1.644 . . . . 0.0 111.683 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 79.0 p -70.33 171.2 10.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.801 1.24 . . . . 0.0 113.633 175.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -113.29 3.42 15.94 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.828 1.251 . . . . 0.0 111.453 166.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.33 -21.39 62.06 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.718 1.607 . . . . 0.0 113.647 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 66.0 p -132.38 149.0 71.91 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 124.606 1.162 . . . . 0.0 110.934 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -62.35 -29.62 79.83 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.484 2.789 . . . . 0.0 112.541 176.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.51 -42.38 98.49 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.597 0.759 . . . . 0.0 112.239 171.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -66.25 -39.0 94.26 Favored Glycine 0 C--N 1.336 0.543 0 O-C-N 121.829 -0.544 . . . . 0.0 112.609 175.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -58.92 -46.85 86.93 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.46 0.704 . . . . 0.0 111.096 175.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.12 -40.92 99.01 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.713 0.805 . . . . 0.0 111.864 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -70.63 -12.04 61.31 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.397 1.479 . . . . 0.0 114.131 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 307' ' ' ALA 0.256 49.7 t30 -120.3 3.75 10.82 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.806 1.243 . . . . 0.0 113.958 172.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 54.2 mtt180 -83.09 1.48 40.03 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.335 1.454 . . . . 0.0 112.087 164.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.46 156.73 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 131.569 3.947 . . . . 0.0 115.914 -170.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 1.3 m -119.39 141.64 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.116 1.766 . . . . 0.0 110.989 167.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -136.18 166.92 22.29 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.952 1.701 . . . . 0.0 111.438 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 13.7 tt -133.54 142.81 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.199 0.999 . . . . 0.0 112.062 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 47.5 t -138.79 130.34 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.51 0.724 . . . . 0.0 109.726 -171.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 42.7 t -82.26 127.54 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.347 0.659 . . . . 0.0 110.328 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 61.7 t30 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 130.143 3.377 . . . . 0.0 116.38 177.905 . . . . . . . . 0 0 . 1 stop_ save_